: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.

Pulmonary Hypertension, January 2024
Free Subscription

Abstracts
Retrieve all available abstracts of the following 2032 articles:
HTML format

Single Articles

BADAGLIACCA R, Ghio S, Manzi G, Vizza CD, et al
Right Ventricular/Pulmonary Artery Coupling in Patients With Heart Failure With Preserved Ejection Fraction: A Clue for Pulmonary Hypertension?
J Am Heart Assoc. 2023 Dec 29:e032639. doi: 10.1161/JAHA.123.032639.
Abstract

CHEN ZW, Chung YW, Cheng JF, Huang CY, et al
Right Ventricular-Vascular Uncoupling Predicts Pulmonary Hypertension in Clinically Diagnosed Heart Failure With Preserved Ejection Fraction.
J Am Heart Assoc. 2023 Dec 29:e030025. doi: 10.1161/JAHA.123.030025.
Abstract

HE Z, Zhang D, Wang X
Fibrosing mediastinitis manifesting as refractory pleural effusion and severe pulmonary hypertension successfully treated by percutaneous pulmonary vein stenting.
Eur Heart J. 2023 Dec 28:ehad862. doi: 10.1093.
Abstract

KLEINNIBBELINK G, Buckley BJR, Harrison SL, Williams N, et al
Exercised-based cardiac rehabilitation associates with lower all-cause mortality in patients with primary pulmonary hypertension.
Front Sports Act Living. 2023;5:1247615.
Abstract

WILLIAMS EE, Bednarczuk N, Nanjundappa M, Greenough A, et al
Monitoring persistent pulmonary hypertension of the newborn using the arterial to end tidal carbon dioxide gradient.
J Clin Monit Comput. 2023 Dec 27. doi: 10.1007/s10877-023-01105.
Abstract

STUBBS H, Lua S, Ingram J, Jani BD, et al
Remote exercise testing in pulmonary hypertension (PHRET).
Pulm Circ. 2023;13:e12325.
Abstract

KAVGACI A, Tunaoglu FS, Kula S, Oguz AD, et al
Early Echocardiographic Findings of Pulmonary Hypertension-specific Therapy in Children.
Medeni Med J. 2023;38:268-275.
Abstract

LAN C, Fang G, Qiu C, Li X, et al
Inhibition of DYRK1A attenuates vascular remodeling in pulmonary arterial hypertension via suppressing STAT3/Pim-1/NFAT pathway.
Clin Exp Hypertens. 2024;46:2297642.
Abstract

LONE AM, Kanthimathinathan HK
Milrinone in pediatric heart failure and pulmonary hypertension: Is meta-analyses the answer?
Eur J Pediatr. 2023 Dec 26. doi: 10.1007/s00431-023-05402.
Abstract

HAFNER F, Johansson C, Schwarzkopf L, Forster K, et al
Current diagnosis and treatment practice for pulmonary hypertension in bronchopulmonary dysplasia-A survey study in Germany (PUsH BPD).
Pulm Circ. 2023;13:e12320.
Abstract

MORLAND K, Gerges C, Elwing J, Visovatti SH, et al
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Grou
Pulm Circ. 2023;13:e12317.
Abstract

SYNN AJ, Harder EM, Nardelli P, Ross JC, et al
Automated CT-Based Quantification of Pulmonary Veins Shows Greater Central Venous Dilation in Group 2 Pulmonary Hypertension Compared With Group 1 Pulmonary Arterial Hypertension and Control Subjects.
CHEST Pulm. 2023;1:100020.
Abstract

SUZUKI Y, Nagaoka T, Terayama Y, Nagata Y, et al
Prognostic analysis of pulmonary hypertension with lung parenchymal lesion: Comparison of mortality with and without connective tissue disease.
Respir Investig. 2023;62:167-175.
Abstract

YEGAMBARAM M, Sun X, Flores AG, Lu Q, et al
Novel Relationship between Mitofusin 2-Mediated Mitochondrial Hyperfusion, Metabolic Remodeling, and Glycolysis in Pulmonary Arterial Endothelial Cells.
Int J Mol Sci. 2023;24:17533.
Abstract

PAPAVASSILIOU KA, Gogou VA, Papavassiliou AG
Angiotensin-Converting Enzyme 2 (ACE2) Signaling in Pulmonary Arterial Hypertension: Underpinning Mechanisms and Potential Targeting Strategies.
Int J Mol Sci. 2023;24:17441.
Abstract

TOPYLA-PUTOWSKA W, Tomaszewski M, Wojtkowska A, Wysokinski A, et al
Novel Echocardiographic Measurements of Right Ventricular-Pulmonary Artery Coupling in Predicting the Prognosis of Precapillary Pulmonary Hypertension.
J Pers Med. 2023;13:1627.
Abstract

PILKA M, Darocha S, Florczyk M, Manczak R, et al
The Utility of a Resting Electrocardiogram (ECG-PH Index) in Evaluating the Efficacy of Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension.
J Clin Med. 2023;12:7621.
Abstract

KUROPATKINA T, Atiakshin D, Sychev F, Artemieva M, et al
Hydrogen Inhalation Reduces Lung Inflammation and Blood Pressure in the Experimental Model of Pulmonary Hypertension in Rats.
Biomedicines. 2023;11:3141.
Abstract

YAN S, Sheak JR, Walker BR, Jernigan NL, et al
Contribution of Mitochondrial Reactive Oxygen Species to Chronic Hypoxia-Induced Pulmonary Hypertension.
Antioxidants (Basel). 2023;12:2060.
Abstract

LUN X, Yang J, Liu Y, Zhao F, et al
Risk factors of systemic lupus erythematosus patients with pulmonary arterial hypertension: A systematic review and meta-analysis.
Medicine (Baltimore). 2023;102:e36654.
Abstract

ELKHAPERY A, Hammami MB, Sulica R, Boppana H, et al
Pulmonary Vasodilator Therapy in Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (Severe PH-COPD): A Systematic Review and Meta-Analysis.
J Cardiovasc Dev Dis. 2023;10:498.
Abstract

HOPKINS CD, Wessel C, Chen O, El-Kersh K, et al
A hypothesis: Potential contributions of metals to the pathogenesis of pulmonary artery hypertension.
Life Sci. 2024;336:122289.
Abstract

XIONG J, Peng Y, Li J, Cai S, et al
Total iron binding capacity: an independent predictor of prognosis for pulmonary arterial hypertension in systemic lupus erythematosus.
Scand J Rheumatol. 2024;53:44-48.
Abstract

NANDI D, Kumar S, Singh R
Does Bronchial Artery Hypertrophies After Descending Thoracic Aorta Stenting in Takayasu Arteritis? - A Clinical Dilemma.
Vasc Endovascular Surg. 2024;58:218-222.
Abstract

Pulmonary hypertension.
Nat Rev Dis Primers. 2024;10:2.
Abstract

MOCUMBI A, Humbert M, Saxena A, Jing ZC, et al
Pulmonary hypertension.
Nat Rev Dis Primers. 2024;10:1.
Abstract

DONG R, Liang Y, Ni M, Wang D, et al
Electrocardiogram Parameters Associated With the Diagnosis of Pulmonary Hypertension in High-Altitude Tibetan Populations: A Retrospective Single-Centre Study.
Heart Lung Circ. 2024 Jan 3:S1443-9506(23)04418.
Abstract

TANG C, Shi F, Ji Y, Zhu J, et al
Aldehyde Dehydrogenase 2 (ALDH2) rs671 Polymorphism is a Predictor of Pulmonary Hypertension Due to Left Heart Disease.
Heart Lung Circ. 2024 Jan 4:S1443-9506(23)04446.
Abstract

KIELY DG, Hamilton N, Wood S, Durrington C, et al
Risk assessment and real-world outcomes in chronic thromboembolic pulmonary hypertension: insights from a UK pulmonary hypertension referral service.
BMJ Open. 2024;14:e080068.
Abstract

LIU M, Wang X, Yan Z, Wang Z, et al
Network Analysis on Family Resilience, Fear of Progression, and Quality of Life in Chinese Patients with Pulmonary Hypertension.
Heart Lung. 2024;64:128-136.
Abstract

HUANG YZ, Wu JC, Lu GF, Li HB, et al
Pulmonary Hypertension Induces Serotonin Hyperreactivity and Metabolic Reprogramming in Coronary Arteries via NOX1/4-TRPM2 Signaling Pathway.
Hypertension. 2024 Jan 4. doi: 10.1161/HYPERTENSIONAHA.123.21345.
Abstract

NATHAN SD, Tehrani B, Zhao Q, Arias R, et al
Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis.
Pulm Circ. 2024;14:e12311.
Abstract

SATAWIRIYA M, Khongphatthanayothin A, Limsuwan A
Reversible severe pulmonary hypertension related to scurvy in children.
BMC Cardiovasc Disord. 2024;24:24.
Abstract

WAN JJ, Yi J, Wang FY, Zhang C, et al
Expression and regulation of HIF-1a in hypoxic pulmonary hypertension: Focus on pathological mechanism and Pharmacological Treatment.
Int J Med Sci. 2024;21:45-60.
Abstract

WANG J, Liu J, Tao X, Xie W, et al
Safety and efficacy of balloon pulmonary angioplasty for technically operable chronic thromboembolic pulmonary hypertension.
Pulm Circ. 2023;14:e12327.
Abstract

YE T, Song Z, Zhou Y, Liu Z, et al
TRPV2 inhibitor tranilast prevents atrial fibrillation in rat models of pulmonary hypertension.
Cell Calcium. 2023;117:102840.
Abstract

UMETANI K, Atsumi M
Haemodialysis patient with chronic kidney disease and pulmonary hypertension treated effectively with pulmonary vasodilators.
BMJ Case Rep. 2023;16:e255810.
Abstract

TALWAR S, Gangoor N, Maldar SB, Pinto CJ, et al
Isolated unilateral pulmonary artery atresia in an adult presenting with cor pulmonale.
BMJ Case Rep. 2023;16:e256663.
Abstract

SHARIYA AM, Martynyuk TV, Shariya MA, Ustyuzhanin DV, et al
[Applying of magnetic resonance tomography for assessment of cardiac remodeling and risk stratification in patients with pulmonary arterial hypertension].
Ter Arkh. 2023;95:291-295.
Abstract

CHAZOVA IE
[Chronic thromboembolic pulmonary hypertension: current diagnostic and treatment options: A review].
Ter Arkh. 2023;95:1017-1021.
Abstract

GAO AL, Gong JN, Li JF, Yang YH, et al
[A case of heritable pulmonary arterial hypertension treated with long-term oral low-dose imatinib].
Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:36-38.
Abstract

TRAMMELL AW, Hart CM
LKB1 Regulates Pulmonary Hypertension Endothelial Cell Mitochondria: Another Layer of the Pulmonary Vascular Onion?
Am J Respir Cell Mol Biol. 2024;70:5-7.
Abstract

CALLISTO A, Hansen D, Walker J, Ngian GS, et al
Impact of the COVID-19 Pandemic on Health Care Access and Diagnosis of Pulmonary Arterial Hypertension Among Patients With Systemic Sclerosis.
Arthritis Care Res (Hoboken). 2024;76:81-87.
Abstract

LENTINE KL, Levine DJ, Runo JR, Caliskan Y, et al
Complexities and outcomes of pulmonary hypertension in kidney transplant patients: a comprehensive review.
Turkish J Nephrol. 2024;33:8-26.
Abstract

IVANOV B, Krasivskyi I, Forster F, Gaisendrees C, et al
Impact of pulmonary hypertension on short-term outcomes in patients undergoing surgical aortic valve replacement for severe aortic valve stenosis.
Perfusion. 2024 Jan 11:2676591241227883. doi: 10.1177/02676591241227883.
Abstract

OUELLET S, Drolet C, Morissette G, Pellerin A, et al
Vasopressin in newborns with refractory acute pulmonary hypertension.
Pediatr Res. 2024 Jan 11. doi: 10.1038/s41390-023-02995.
Abstract

YANG Y, Li X, Wang P, Shu S, et al
The significance of dynamic monitoring plasma TMAO level in pulmonary arterial hypertension - a cohort study.
Ther Adv Respir Dis. 2024;18:17534666231224692.
Abstract

SINGHI AK, Mohapatra SK, Biswas N, Bandyopadhyay KH, et al
PULMOEAST: A Comprehensive Analysis of Pulmonary Hypertension in Eastern India.
Cureus. 2023;15:e50996.
Abstract

SHLOBIN OA, Shen E, Wort SJ, Piccari L, et al
Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension.
Pulm Circ. 2024;14:e12310.
Abstract

DESAI R, Gandhi Z, Shiza ST, Jain A, et al
Prevalence and impact of tobacco use disorder on in-hospital mortality in patients hospitalized with non-group 1 pulmonary hypertension: a nationwide propensity score-matched analysis, 2019.
EXCLI J. 2023;22:1200-1210.
Abstract

D'AGOSTINO A, Lanzafame LG, Buono L, Crisci G, et al
Modulating NO-GC Pathway in Pulmonary Arterial Hypertension.
Int J Mol Sci. 2023;25:36.
Abstract

CONTRERAS J, Nussbaum J, Cangialosi P, Thapi S, et al
Pulmonary Hypertension in Underrepresented Minorities: A Narrative Review.
J Clin Med. 2024;13:285.
Abstract

MATOS JI, Garcia-Rodriguez SN, Costa-Rodriguez N, Caro-Vadillo A, et al
Right Ventricle Strain Assessed by 2-Dimensional Speckle Tracking Echocardiography (2D-STE) to Evaluate Pulmonary Hypertension in Dogs with Dirofilaria immitis.
Animals (Basel). 2023;14:26.
Abstract

ZHANG A, Ding L, Zhang H, Mi L, et al
Radiofrequency catheter ablation for pulmonary hypertension patients with atrial flutter.
ESC Heart Fail. 2024 Jan 10. doi: 10.1002/ehf2.14659.
Abstract

YU X, Qin W, Cai H, Ren C, et al
Analyzing the molecular mechanism of xuefuzhuyu decoction in the treatment of pulmonary hypertension with network pharmacology and bioinformatics and verifying molecular docking.
Comput Biol Med. 2023;169:107863.
Abstract

TAI YY, Yu Q, Tang Y, Sun W, et al
Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension.
Sci Transl Med. 2024;16:eadd2029.
Abstract

ZHANG J, Xu C, Tang X, Sun S, et al
Endothelium-specific SIRT7 targeting ameliorates pulmonary hypertension through KLF4 deacetylation.
Cardiovasc Res. 2024 Jan 10:cvae011. doi: 10.1093.
Abstract

RAJKUMAR S, Jha AK, Parida S, Thangaswamy CR, et al
Effect of Acute Vasodilator Testing Using Oxygen in Pulmonary Hypertension Due to Left Heart Disease.
Semin Cardiothorac Vasc Anesth. 2024 Jan 10:10892532241227082.
Abstract

HUANG J, Zhang W, Fu W, Le J, et al
Noninvasive evaluation of pulmonary hypertension using the second heart sound parameters collected by a mobile cardiac acoustic monitoring system.
Front Cardiovasc Med. 2023;10:1292647.
Abstract

ALVAREZ TRONCOSO J, Soto Abanades C, Robles-Marhuenda A, Alcolea Batres S, et al
Prevalence, risk factors and echocardiographic predictors of pulmonary hypertension in systemic lupus erythematosus: towards a screening protocol.
RMD Open. 2024;10:e003674.
Abstract

BRITO J, Pinto FJ, Placido R
Chronic fibrothrombotic deposits: a cause or consequence of pulmonary hypertension?
Rev Esp Cardiol (Engl Ed). 2024 Jan 6:S1885-5857(24)00015.
Abstract

SCHULZE KM, Horn AG, Weber RE, Behnke BJ, et al
Pulmonary hypertension alters blood flow distribution and impairs the hyperemic response in the rat diaphragm.
Front Physiol. 2023;14:1281715.
Abstract

ABDEEN AMZ, Alagha Z, Clark C, Al-Astal A, et al
Paradoxical Worsening of Pulmonary Hypertension Following Closure of Arteriovenous Fistula: A Case Report and Literature Review.
Cureus. 2023;15:e50064.
Abstract

SONAGLIONI A, Nicolosi GL, Rispoli GA, Lombardo M, et al
Incidental Finding of Lipomatous Hypertrophy of the Right Atrial Free Wall in an Elderly Female With Severe Pulmonary Hypertension: Early Detection by Multimodality Imaging.
Cureus. 2023;15:e50665.
Abstract

ZHENG SW, Wang Z, Zhai ZG, Sun YH, et al
[Progresses in pulmonary hypertension associated with left-sided heart failure].
Zhonghua Nei Ke Za Zhi. 2024;63:113-120.
Abstract

ULRICH A, Wu Y, Draisma H, Wharton J, et al
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension.
Nat Commun. 2024;15:330.
Abstract

SALAZAR AM, Panama G, Kim AG, Rayamajhi S, et al
Clinical outcomes between direct oral anticoagulants versus vitamin K antagonists in chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis.
Curr Probl Cardiol. 2024;49:102377.
Abstract

TOMITA S, Nakanishi N, Ogata T, Higuchi Y, et al
The Cavin-1/Caveolin-1 interaction attenuates BMP/Smad signaling in pulmonary hypertension by interfering with BMPR2/Caveolin-1 binding.
Commun Biol. 2024;7:40.
Abstract

GUPTA S, Mohta A, Thameem D
Vasoreactive pulmonary artery hypertension in non-fibrotic hypersensitive pneumonitis.
BMJ Case Rep. 2024;17:e255921.
Abstract

DONG S, Guo X, Wang H, Sun C, et al
Liver injury due to endothelin receptor antagonists: a real-world study based on post-marketing drug monitoring data.
Ther Adv Respir Dis. 2024;18:17534666231223606.
Abstract

DE BIE FR, Regin Y, Dubois A, Scuglia M, et al
Prenatal treprostinil improves pulmonary arteriolar hypermuscularization in the rabbit model of congenital diaphragmatic hernia.
Biomed Pharmacother. 2024;170:115996.
Abstract

AKSOY A, Kocakaya D, Demircioglu O, Cimsit NC, et al
Angiographic findings of pulmonary arterial involvement in Behcet's Disease: Do they correlate with symptoms and acute phase response?
Respir Med. 2024;221:107481.
Abstract

CHE Y, Xia T, Liu H, Li C, et al
Preparation of betaine injection and its therapeutic effect in pulmonary arterial hypertension.
Basic Clin Pharmacol Toxicol. 2024;134:219-230.
Abstract

HUANG Z, Duan A, Zhao Z, Zhao Q, et al
Sleep-disordered breathing patterns and prognosis in pulmonary arterial hypertension: A cluster analysis of nocturnal cardiorespiratory signals.
Sleep Med. 2024;113:61-69.
Abstract

SZABARI MV, Ni C, Davila D, Viragh K, et al
Pulmonary Arterial Tumor Embolism From Recurrent Metastatic Renal Cell Carcinoma on FDG PET/CT.
Clin Nucl Med. 2023 Nov 17. doi: 10.1097/RLU.0000000000004956.
Abstract

SALAHUDDIN M, Shahid S, Tariq U, Aqeel M, et al
Outcomes of patients with elevated pulmonary artery systolic pressure on echocardiography due to chronic lung diseases.
Respir Investig. 2024;62:69-74.
Abstract

KULARATNE M, Boucly A, Savale L, Solinas S, et al
Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension.
Expert Opin Pharmacother. 2023;24:2101-2115.
Abstract

MANSOOR M, Shahid S, Tariq S, Aziz A, et al
Letter to Editor: Prevalence and Determinants of Delay in Time-to-Diagnosis for Pulmonary Arterial Hypertension (PAH) Patients in Gansu China: An Observational Cohort Study.
Curr Probl Cardiol. 2024;49:102133.
Abstract

BZDEGA K, Biela M, Deutsch GH, Kitzmiller JA, et al
A novel non-recurrent CNV deletion involving TBX4 and leaving TBX2 intact causes congenital alveolar dysplasia.
Clin Genet. 2024;105:190-195.
Abstract

HUO X, Zeng Z, Lin Y, Lin J, et al
Clinical characteristics of systemic sclerosis patients with occupational silicosis.
Clin Rheumatol. 2024;43:277-287.
Abstract

TOWER DR, Day RW, Marrone T, Palmquist R, et al
Rapid genome diagnosis of alveolar capillary dysplasia leading to treatment in a child with respiratory and cardiac failure.
Cold Spring Harb Mol Case Stud. 2024;9:a006292.
Abstract

TOSHIMA T, Rhu J, Yoon YI, Ito T, et al
Aborted living-donor liver transplantation in the real-world setting, lessons from 13 937 cases of Vanguard Multi-center Study of International Living Donor Liver Transplantation Group.
Am J Transplant. 2024;24:57-69.
Abstract

LAI Y, Chen M, Chen M, Li C, et al
Gender differences in the incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: A meta-analysis.
Medicine (Baltimore). 2024;103:e35150.
Abstract

SANTAMANS AM, Cicuendez B, Mora A, Villalba-Orero M, et al
MCJ: A mitochondrial target for cardiac intervention in pulmonary hypertension.
Sci Adv. 2024;10:eadk6524.
Abstract

ZANOTTO TM, Goncalves AESS, Saad MJA
Pulmonary hypertension and insulin resistance: a mechanistic overview.
Front Endocrinol (Lausanne). 2024;14:1283233.
Abstract

JIN J, Rothamel P, Buchel J, Kammer B, et al
Case Report: Stuve-Wiedemann syndrome-a rare cause of persistent pulmonary hypertension of the newborn.
Front Pediatr. 2024;11:1329404.
Abstract

WARNER ED, Corsi DR, Jimenez D, Bierowski M, et al
Determinants of Pulmonary Hypertension in Patients with End-stage Kidney Disease and Arteriovenous Access.
Curr Probl Cardiol. 2024 Jan 16:102406. doi: 10.1016/j.cpcardiol.2024.102406.
Abstract

YAGHOOBI N, Maghsudi M, Malek H, Bakhshandeh H, et al
Role of CT attenuation correction gated SPECT MPI in prediction of pulmonary hypertension.
J Nucl Cardiol. 2023;31:101777.
Abstract

LI S, Lyu Q, Shi Q, Bai Y, et al
Intermittent short-duration reoxygenation relieves high-altitude pulmonary hypertension via NOX4/H2O2/PPAR-gamma axis.
Clin Sci (Lond). 2024 Jan 18:CS20231508. doi: 10.1042/CS20231508.
Abstract

KONG L, Lv M, Qiao CL, Sun XX, et al
The effect of pituitrin on postoperative outcomes in patients with pulmonary hypertension undergoing cardiac surgery: a study protocol for a randomized controlled trial.
Front Cardiovasc Med. 2024;10:1269624.
Abstract

HUANG J, Zhu H, Liu S, Li M, et al
Protein profiling in systemic sclerosis patients with different pulmonary complications using proteomic antibody microarray.
Arthritis Res Ther. 2024;26:29.
Abstract

MOCUMBI A, Humbert M, Saxena A, Jing ZC, et al
Publisher Correction: Pulmonary hypertension.
Nat Rev Dis Primers. 2024;10:5.
Abstract

VAN HEERDEN JK, Louw EH, Thienemann F, Engel ME, et al
The prevalence of pulmonary hypertension in post-tuberculosis and active tuberculosis populations: a systematic review and meta-analysis.
Eur Respir Rev. 2024;33:230154.
Abstract

LECHARTIER B, Boucly A, Solinas S, Gopalan D, et al
Pulmonary veno-occlusive disease: illustrative cases and literature review.
Eur Respir Rev. 2024;33:230156.
Abstract

ZAROGOULIDIS P, Petridis D, Huang H, Bai C, et al
Nebulisation of Paclitaxel, Sotatercept and Iloprost for pulmonary hypertension for lung cancer. From In vitro to In vivo.
J Cancer. 2024;15:871-879.
Abstract

YANG Y, Xu J, Shu S, Wang P, et al
Circulating acetylcholine serves as a potential biomarker role in pulmonary hypertension.
BMC Pulm Med. 2024;24:35.
Abstract

HSIAO CY, Lu WH
Effective control of refractory pulmonary hypertension with iloprost inhalation in an infant with congenital absence of the right pulmonary artery: a case report.
Cardiol Young. 2024 Jan 15:1-4. doi: 10.1017/S104795112300450.
Abstract

ZHANG Y, Zhang Y, Liao C, Wang X, et al
Prognostic implication of glomerular filtration rates in patients with chronic thromboembolic pulmonary hypertension who have undergone balloon pulmonary angioplasty.
Exp Ther Med. 2023;27:18.
Abstract

FERNICOLA F, Carli A, Arienti F, Viola Vasarri M, et al
Fatal severe persistent pulmonary hypertension with lung microvasculature parietal hyperplasia in a neonate with congenital cytomegalovirus infection treated in-utero with valacyclovir: A case report.
Eur J Obstet Gynecol Reprod Biol. 2024 Jan 11:S0301-2115(24)00011.
Abstract

CHOI R, Narayanan R, Jandu S, Savage W, et al
Optimization of resting tension for wire myography in male rat pulmonary arteries.
Physiol Rep. 2024;12:e15911.
Abstract

HUYNH T
Commentary on studies investigating low-dose diazoxide in hyperinsulinism.
Clin Endocrinol (Oxf). 2024;100:138-139.
Abstract

WALIGORA M, Smorag M, Bukala N, Zygmunt M, et al
ECG patterns to predict pulmonary arterial hypertension in patients with severe tricuspid regurgitation.
J Electrocardiol. 2024;82:52-58.
Abstract

LI M, Ying M, Gu S, Zhou Z, et al
Matrine alleviates hypoxia-induced inflammation and pulmonary vascular remodelling via RPS5/NF-kappaB signalling pathway.
J Biochem Mol Toxicol. 2024;38:e23583.
Abstract

YAVUZ YE, Soylu A, Gurbuz AS
The relationship of systemic and pulmonary arterial parameters with HFpEF scores (H(2) FPEF, HFA-PEFF) and diastolic dysfunction parameters in heart failure patients with preserved ejection fraction.
J Clin Ultrasound. 2024;52:39-50.
Abstract

MCLAUGHLIN V, Alsumali A, Liu R, Klok R, et al
Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH).
Adv Ther. 2024;41:130-151.
Abstract

PAMUKCU O, Narin N, Sunkak S, Tuncay A, et al
Evaluation of preterm infants having bronchopulmonary dysplasia with echocardiography and serum biomarkers.
Cardiol Young. 2024;34:137-144.
Abstract

LI R, Song M, Wang R, Su N, et al
Can CT-Based Arterial and Venous Morphological Markers of Chronic Obstructive Pulmonary Disease Explain Pulmonary Vascular Remodeling?
Acad Radiol. 2024;31:22-34.
Abstract

YUAN M, Hu X, Xing W, Wu X, et al
B2M is a Biomarker Associated With Immune Infiltration In High Altitude Pulmonary Edema.
Comb Chem High Throughput Screen. 2024;27:168-185.
Abstract

PLOEGSTRA MJ, Ivy DD, Beghetti M, Bonnet D, et al
Long-term outcome of children with newly diagnosed pulmonary arterial hypertension: results from the global TOPP registry.
Eur Heart J Qual Care Clin Outcomes. 2024;10:66-76.
Abstract

RILEY JM, Fradin JJ, Russ DH, Warner ED, et al
Post-Capillary Pulmonary Hypertension: Clinical Review.
J Clin Med. 2024;13:625.
Abstract

BAILEY M, DuBrock HM
Pulmonary hypertension patient perspectives toward pulmonary rehabilitation.
Pulm Circ. 2024;14:e12338.
Abstract

ANAND V, Covington MK, Saraswati U, Scott CG, et al
Prevalence, sex differences, and implications of pulmonary hypertension in patients with apical hypertrophic cardiomyopathy.
Front Cardiovasc Med. 2024;10:1288747.
Abstract

LEBAR K, Liu W, Pang J, Chicco A, et al
Role of the Microtubule Network in the Passive Anisotropic Viscoelasticity of Right Ventricle with Pulmonary Hypertension Progression.
Acta Biomater. 2024 Jan 23:S1742-7061(24)00035.
Abstract

YOU YT, Zuo H, Li JM, Zhu XB, et al
Mediastinal Cryobiopsy for Pathological Diagnosis of Fibrosing Mediastinitis-Associated Pulmonary Hypertension.
Respiration. 2024 Jan 25:1-5. doi: 10.1159/000535395.
Abstract

CARAVITA S, Gori M, Garascia A, Baratto C, et al
[Pulmonary hypertension associated with left heart diseases: pathophysiology, diagnosis, treatment].
G Ital Cardiol (Rome). 2024;25:88-97.
Abstract

SUN L, Liu L, Liang D, Liu L, et al
SOCS5, targeted by miR-155-5p, plays a negative regulatory role in pulmonary hypertension through inhibiting JAK2/STAT3 signaling pathway.
BMC Pulm Med. 2024;24:52.
Abstract

CAO JK, Fan HQ, Xiao YB, Wang D, et al
[Establishment and efficiency test of a clinical prediction model of bronchopulmonary dysplasia associated pulmonary hypertension in very premature infants].
Zhonghua Er Ke Za Zhi. 2024;62:129-137.
Abstract

MCCORMACK C, Kehoe B, Cullivan S, McCaffrey N, et al
Safety, feasibility and effectiveness of the remotely delivered Pulmonary Hypertension and Home-Based (PHAHB) physical activity intervention.
ERJ Open Res. 2024;10:00608-2023.
Abstract

ALBULUSHI A, Al-Saidii K, Al-Farhan H
Impact of Tricuspid Regurgitation Severity on Mortality in Pulmonary Hypertension Patients: A Comprehensive Analysis.
Curr Probl Cardiol. 2024 Jan 21:102405. doi: 10.1016/j.cpcardiol.2024.102405.
Abstract

PRADERE P, Le Pavec J, Bos S, Pozza A, et al
Outcomes of listing for lung and heart-lung transplantation in pulmonary hypertension: comparative experience in France and the UK.
ERJ Open Res. 2024;10:00521-2023.
Abstract

ZENG Y, Zhakeer G, Li B, Yu Q, et al
A novel clinical prediction scoring system of high-altitude pulmonary hypertension.
Front Cardiovasc Med. 2024;10:1290895.
Abstract

JASINSKA-STROSCHEIN M
An updated review of experimental rodent models of pulmonary hypertension and left heart disease.
Front Pharmacol. 2024;14:1308095.
Abstract

PADERVINSKIENE L, Azukaite J, Hoppenot D, Krivickiene A, et al
The Prognostic Value of One-Year Changes in Biventricular Mechanics for Three-Year Survival in Patients with Precapillary Pulmonary Hypertension: A Cardiovascular Magnetic Resonance Feature Tracking Study.
Medicina (Kaunas). 2024;60:141.
Abstract

ASENOV K, Dimov R, Kraeva M, Basheva-Kraeva Y, et al
EUS-Guided Combined Injection Therapy as a Secondary Prophylaxis of Gastric Variceal Bleeding in a Patient Contraindicated for TIPS: Case Report.
Medicina (Kaunas). 2024;60:116.
Abstract

AVERJANOVAITE V, Gumbiene L, Zeleckiene I, Sileikiene V, et al
Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients.
Medicina (Kaunas). 2023;60:58.
Abstract

FUKUMOTO Y
Pathophysiology and Treatment of Pulmonary Arterial Hypertension.
Int J Mol Sci. 2024;25:1166.
Abstract

OKAYA T, Kawasaki T, Sato S, Koyanagi Y, et al
Functional Roles of CD26/DPP4 in Bleomycin-Induced Pulmonary Hypertension Associated with Interstitial Lung Disease.
Int J Mol Sci. 2024;25:748.
Abstract

LIU A, Price LC, Sharma R, Wells AU, et al
Sarcoidosis Associated Pulmonary Hypertension.
Biomedicines. 2024;12:177.
Abstract

MASON T, Mukherjee B, Marino P
Pulmonary Hypertension and the Gut Microbiome.
Biomedicines. 2024;12:169.
Abstract

SANTOS EW, Khatoon S, Di Mise A, Zheng YM, et al
Mitochondrial Dynamics in Pulmonary Hypertension.
Biomedicines. 2023;12:53.
Abstract

GHANI H, Pepke-Zaba J
Chronic Thromboembolic Pulmonary Hypertension: A Review of the Multifaceted Pathobiology.
Biomedicines. 2023;12:46.
Abstract

YANG KM, Wang MT, Tao CW, Wu YJ, et al
The long-term outcome of chronic thromboembolic pulmonary hypertension: Pulmonary endarterectomy and balloon pulmonary angioplasty.
J Chin Med Assoc. 2024 Jan 22. doi: 10.1097/JCMA.0000000000001059.
Abstract

HEISS J, Grun K, Singerer I, Tempel L, et al
Expression of Inflammatory Genes in Murine Lungs in a Model of Experimental Pulmonary Hypertension: Effects of an Antibody-Based Targeted Delivery of Interleukin-9.
Adv Respir Med. 2024;92:27-35.
Abstract

LEKANE M, Burnotte P, Gommeren K, Mc Entee K, et al
Left ventricular eccentricity index to assess precapillary pulmonary hypertension in dogs.
J Vet Cardiol. 2023;51:220-231.
Abstract

NUNES H, Brillet PY, Bernaudin JF, Gille T, et al
Fibrotic Pulmonary Sarcoidosis.
Clin Chest Med. 2024;45:199-212.
Abstract

SAVALE L, Dorfmuller P, Boucly A, Jais X, et al
Sarcoidosis-Associated Pulmonary Hypertension.
Clin Chest Med. 2024;45:185-197.
Abstract

KIRKIL G
Predictors of Mortality in Sarcoidosis.
Clin Chest Med. 2024;45:175-183.
Abstract

CHARIF F, Dakroub F, Bou Akl I, Kularatne M, et al
Pulmonary arterial hypertension and COVID-19: Piecing the puzzle.
Respir Med Res. 2023;84:101053.
Abstract

DING R, Sang S, Yi J, Xie H, et al
G6PD is a prognostic biomarker correlated with immune infiltrates in lung adenocarcinoma and pulmonary arterial hypertension.
Aging (Albany NY). 2024;16:466-492.
Abstract

AL-HOSNI R, Kaye R, Choi CS, Tammaro P, et al
The TMEM16A channel as a potential therapeutic target in vascular disease.
Curr Opin Nephrol Hypertens. 2024;33:161-169.
Abstract

CHE H, Yi J, Zhao X, Yu H, et al
Characterization of PKCalpha-rutin interactions and their application as a treatment strategy for pulmonary arterial hypertension by inhibiting ferroptosis.
Food Funct. 2024;15:779-793.
Abstract

KOSTYUNINA DS, Pakhomov NV, Jouida A, Dillon E, et al
Transcriptomics and proteomics revealed sex differences in human pulmonary microvascular endothelial cells.
Physiol Genomics. 2024;56:194-220.
Abstract

A X, Huayu M, Li Z, Su S, et al
In vivo pharmacokinetic study of vanillic acid in monocrotaline-induced pulmonary arterial hypertension rats and its tissue distribution.
Biomed Chromatogr. 2024;38:e5793.
Abstract

ERHARDSSON M, Faxen UL, Venkateshvaran A, Hage C, et al
Acyl ghrelin increases cardiac output while preserving right ventricular-pulmonary arterial coupling in heart failure.
ESC Heart Fail. 2024;11:601-605.
Abstract

KAMP JC, Neubert L, Schupp JC, Braubach P, et al
Multilamellated Basement Membranes in the Capillary Network of Alveolar Capillary Dysplasia.
Am J Pathol. 2024;194:180-194.
Abstract

MUHLBACHER A, Beaudet A, Brand M, Janssen EM, et al
Patient Preferences in Pulmonary Arterial Hypertension, a Latent Class Analysis to Identify Preference Heterogeneity.
Value Health. 2024;27:206-215.
Abstract

NABEH OA, Saud AI, Amin B, Khedr AS, et al
A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension.
Am J Cardiovasc Drugs. 2024;24:39-54.
Abstract

DOUGHTY ES, Norvik C, Levin A, Bodmer J, et al
Long-Term Effect of TBX4 Germline Mutation on Pulmonary Clinico-Histopathologic Phenotype.
Pediatr Dev Pathol. 2024;27:83-89.
Abstract

BOXHAMMER E, Dienhart C, Kletzer J, Ramsauer S, et al
Elevated systolic pulmonary artery pressure is a substantial predictor of increased mortality after transcatheter aortic valve replacement in males, not in females.
Clin Res Cardiol. 2024;113:138-155.
Abstract

JHA AK
Phenotypic characterization of heart failure with preserved ejection fraction.
Eur J Heart Fail. 2023 Aug 10. doi: 10.1002/ejhf.2996.
Abstract

SATHIAVAGEESAN S, Shanmugam VB, Sundaram V
The impact of vascular access location on pulmonary arterial pressure in chronic kidney disease patients undergoing hemodialysis.
Semin Dial. 2023 Apr 2. doi: 10.1111/sdi.13154.
Abstract

CRISPINO SP, Segreti A, La Porta Y, Liporace P, et al
A sudden right-to-left shunt: the importance of evaluating patent foramen ovale during exercise.
Monaldi Arch Chest Dis. 2023;94.
Abstract

CHOUDHARY R, Kumari S, Ali M, Thinlas T, et al
Respiratory tract infection: an unfamiliar risk factor in high-altitude pulmonary edema.
Brief Funct Genomics. 2024;23:38-45.
Abstract

ZHU F, de Oliveira CB, Mohsen N, Kharrat A, et al
Challenges in clinical identification of right ventricular dysfunction in preterm infants with persistent pulmonary hypertension of the newborn.
Early Hum Dev. 2024;190:105942.
Abstract

EKICI M, Ileri S, Unaldi E, Bayram GSK, et al
Are Behcet's disease patients with Budd-Chiari at increased risk for the development of pulmonary hypertension?
Rheumatology (Oxford). 2024 Feb 1:keae067. doi: 10.1093.
Abstract

DU P, Gao X, Sun Q, Gong M, et al
Association between uric acid and cardiac outcomes mediated by neutrophil-to-lymphocyte ratio in patients with left ventricular diastolic dysfunction and pulmonary hypertension.
Sci Rep. 2024;14:2751.
Abstract

HANG C, Zu L, Luo X, Wang Y, et al
Ddx5 Targeted Epigenetic Modification of Pericytes in Pulmonary Hypertension Following Intrauterine Growth Restriction.
Am J Respir Cell Mol Biol. 2024 Feb 1. doi: 10.1165/rcmb.2023-0244.
Abstract

VETEL K, Eyries M, Savale L, Kanengiesser C, et al
Pulmonary Veno-Occlusive Disease and Pulmonary Fibrosis in a Family with EIF2AK4 Pathogenic Variants.
Am J Respir Cell Mol Biol. 2024;70:143-145.
Abstract

EL KABBOUT R, Azhar N, Breuils-Bonnet S, Martineau S, et al
Time Is Running Out in Pulmonary Arterial Hypertension: The Epigenetic Clock Is Clicking.
Am J Respir Cell Mol Biol. 2024;70:140-143.
Abstract

ARSLAN A, Smith J, Qureshi MR, Uysal A, et al
Evolution of pulmonary hypertension in interstitial lung disease: a journey through past, present, and future.
Front Med (Lausanne). 2024;10:1306032.
Abstract

STOKES G, Li Z, Talaba N, Genthe W, et al
Rescuing lung development through embryonic inhibition of histone acetylation.
Sci Transl Med. 2024;16:eadc8930.
Abstract

KHAN S, Randhawa S, Patail H, Spira Y, et al
Pharmacological Update and Emerging Treatments of Pulmonary Hypertension.
Cardiol Rev. 2024 Jan 31. doi: 10.1097/CRD.0000000000000647.
Abstract

Correction to: Discrimination Between Pre- and Postcapillary Pulmonary Hypertension Using Platelet RNA.
J Am Heart Assoc. 2024 Jan 31:e027751. doi: 10.1161/JAHA.122.027751.
Abstract

SILVA J, Carvoeiro A, Cerqueira P, Calheiros A, et al
Reversible Pulmonary Hypertension Related to Hyperthyroidism: A Case Report.
Cureus. 2023;15:e51377.
Abstract

ZHANG J, Li Q, Liao P, Xiao R, et al
Calcium sensing receptor: A promising therapeutic target in pulmonary hypertension.
Life Sci. 2024;340:122472.
Abstract

PORT SC
Is there a role for nuclear cardiology in pulmonary hypertension?
J Nucl Cardiol. 2024;31:101776.
Abstract

PARIKH R, Thomas A, Sharofi A, Moallem N, et al
Severe pulmonary hypertension-interstitial lung disease presenting as right ventricular failure: stabilisation with intravenous prostacyclin and maintenance with inhaled prostacyclin.
ERJ Open Res. 2024;10:00659-2023.
Abstract

BUTERA G, Piccinelli E, Kolesnik A, Averin K, et al
Implantation of atrial flow regulator devices in patients with congenital heart disease and children with severe pulmonary hypertension or cardiomyopathy-an international multicenter case series.
Front Cardiovasc Med. 2024;10:1332395.
Abstract

SUN T, Yuan W, Wei Y, Liao D, et al
The Regulatory Role and Mechanism of Energy Metabolism in Vascular Diseases.
Front Biosci (Landmark Ed). 2024;29:26.
Abstract

YANG Y, Huang X, Lin J
Anti-MDA5 antibody-associated clinically amyopathic dermatomyositis diagnosed after the onset of pulmonary hypertension.
Int J Rheum Dis. 2024;27:e15027.
Abstract

EMAMI MEYBODI M, Bamarinejad A, Bamarinejad F, Abhari AP, et al
Prognostic Implication of Preprocedural Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis.
Cardiol Rev. 2024 Jan 29. doi: 10.1097/CRD.0000000000000583.
Abstract

SHI H, Gao P, Liu H, Su J, et al
Diagnostic value of combined FVC%/DLCO% and echocardiography in connective tissue disorder?associated pulmonary hypertension.
Med Int (Lond). 2024;4:8.
Abstract

KIM YJ, Shin SH, Kim EK, Kim HS, et al
Short term effect of intravenous treprostinil in term and preterm infants with pulmonary hypertension.
BMC Pediatr. 2024;24:83.
Abstract

MARTIN MV, Menchero AG, Ferreiro RG, Morist AA, et al
Expert center and balloon pulmonary angioplasty network program in chronic thromboembolic pulmonary hypertension: safety and effectiveness of a pioneering experience.
Rev Esp Cardiol (Engl Ed). 2024 Jan 25:S1885-5857(24)00034.
Abstract

GROSS CR, Varghese R, Zafirova Z
Perioperative Management of Novel Pharmacotherapies for Heart Failure and Pulmonary Hypertension.
Anesthesiol Clin. 2024;42:117-130.
Abstract

NEVES DA SILVA HV, Weinman JP, Englund EK, Deterding RR, et al
Computed tomographic findings in TBX4 mutation: a common cause of severe pulmonary artery hypertension in children.
Pediatr Radiol. 2024 Jan 9. doi: 10.1007/s00247-023-05848.
Abstract

MASOOD M, Singh P, Hariss D, Khan F, et al
Nitric oxide as a double-edged sword in pulmonary viral infections: Mechanistic insights and potential therapeutic implications.
Gene. 2024;899:148148.
Abstract

AHMED HF, Guzman-Gomez A, Desai M, Dani A, et al
Lung Transplantation for Pulmonary Vascular Disease in Children: A United Network for Organ Sharing Analysis.
Pediatr Cardiol. 2024;45:385-393.
Abstract

ROBINSON G, Zielstorff M, Sevilla R, Vanko A, et al
Multimodal Imaging Reveals that Sustained Inhibition of HIF-Prolyl Hydroxylases Induces Opposing Effects on Right and Left Ventricular Function in Healthy Rats.
Mol Imaging Biol. 2024;26:179-187.
Abstract

LI H, Liu S, Dai W, Yao B, et al
Pressure-sensitive multivesicular liposomes as a smart drug-delivery system for high-altitude pulmonary edema.
J Control Release. 2024;365:301-316.
Abstract

KUWAJIMA K, Ogawa M, Ruiz I, Yamane T, et al
Comparison of prognostic value among echocardiographic surrogates of right ventricular-pulmonary arterial coupling: A three-dimensional echocardiographic study.
Echocardiography. 2024;41:e15717.
Abstract

BOUCETTA H, Zhang L, Sosnik A, He W, et al
Pulmonary arterial hypertension nanotherapeutics: New pharmacological targets and drug delivery strategies.
J Control Release. 2024;365:236-258.
Abstract

GILLAM-KRAKAUER M, Reese J
We Still Don't Know When to Close a Patent Ductus Arteriosus in Very Premature Infants.
J Pediatr. 2023 Nov 3:113817. doi: 10.1016/j.jpeds.2023.113817.
Abstract

HUERTAS NIETO S, Velazquez Martin M, Sarnago Cebada F, Jimenez Lopez-Guarch C, et al
Value of exercise right heart catheterization in the differential diagnosis of chronic thromboembolic pulmonary disease.
Rev Esp Cardiol (Engl Ed). 2024;77:158-166.
Abstract

BIEDERMANN P, Sitte-Koch V, Schweiger M, Meinold A, et al
Pulmonary hemodynamics before and after pediatric heart transplantation.
Clin Transplant. 2023 Oct 12:e15162. doi: 10.1111/ctr.15162.
Abstract

ADLY G, Mithoefer O, Elliott Epps J, Hajj JM, et al
Right Ventricular Contractility and Pulmonary Arterial Coupling After Less Invasive Left Ventricular Assist Device Implantation.
ASAIO J. 2024;70:99-106.
Abstract

SAINATHAN S, Ryan J, Mullinari L, Sanchez P, et al
Lung transplantation in primary pulmonary arterial hypertension and pulmonary venous hypertension.
Clin Transplant. 2024;38:e15158.
Abstract

FAVERIO P, Paciocco G, Tassistro E, Rebora P, et al
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study.
Intern Emerg Med. 2024;19:183-190.
Abstract

HUANG J, An Q, Shi H, Li C, et al
Retrospective cohort study of pulmonary arterial hypertension associated with connective tissue disease effect on patients' prognosis.
Clin Rheumatol. 2023;42:3131-3142.
Abstract

RANASINGHE ADCU, Tennakoon TMPB, Schwarz MA
Emerging Epigenetic Targets and Their Molecular Impact on Vascular Remodeling in Pulmonary Hypertension.
Cells. 2024;13:244.
Abstract

ZHANG Y, Zhang M, Yang H, Li H, et al
Serum proteome profiling reveals heparanase as a candidate biomarker for chronic thromboembolic pulmonary hypertension.
iScience. 2024;27:108930.
Abstract

MIN S, Wesselowski SR, Nabity MB, Yankin I, et al
Pulmonary hypertension is associated with hypocoagulability in dogs: a retrospective analysis of 66 cases (2013-2021).
Am J Vet Res. 2024 Feb 12:1-8. doi: 10.2460/ajvr.23.11.0252.
Abstract

FUJII S, Nagayoshi S, Matsumoto T, Miyamoto T, et al
Spontaneous hemodynamic improvement after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension is observed within a short term after balloon pulmonary angioplasty.
Cardiovasc Interv Ther. 2024 Feb 8. doi: 10.1007/s12928-024-00987.
Abstract

KANG Y, Jiang X
Pregnancy outcomes and risk factors of serious cardiovascular adverse events in pregnant women with pulmonary hypertension.
Int J Surg. 2024 Feb 8. doi: 10.1097/JS9.0000000000001016.
Abstract

GAO N, Lv Y, Cui Y, Wang P, et al
Bosentan in the treatment of persistent pulmonary hypertension in newborns: a systematic review and meta-analysis.
Cardiol Young. 2024 Feb 8:1-8. doi: 10.1017/S1047951123004456.
Abstract

WILLEMS L, Kurakula K, Verhaegen J, Klok FA, et al
Angiogenesis in Chronic Thromboembolic Pulmonary Hypertension: A Janus-Faced Player?
Arterioscler Thromb Vasc Biol. 2024 Feb 8. doi: 10.1161/ATVBAHA.123.319852.
Abstract

CHALERMPROMMA P, Surachetpong SD
Indicators for pulmonary hypertension in dogs with degenerative mitral valve disease.
Vet World. 2023;16:2515-2520.
Abstract

QU SS, Li YL, Huang RR, Guo H, et al
[Impact of hyperoxia on the phenotype of pulmonary artery smooth muscle cells].
Zhonghua Xin Xue Guan Bing Za Zhi. 2024;52:185-190.
Abstract

HUANG J, Li QY, Ji W, Guo XF, et al
[Clinical and genetic analysis of a patient with HUPRA syndrome due to missense variants of SARS2 gene and literature review].
Zhonghua Xin Xue Guan Bing Za Zhi. 2024;52:172-179.
Abstract

JAIN L
Pulmonary Hypertension of the Newborn.
Clin Perinatol. 2024;51:xv-xvii.
Abstract

LAKSHMINRUSIMHA S, Abman SH
Neonatal Pulmonary Hypertension: Phenotypes, Physiology, and Management.
Clin Perinatol. 2024;51:xix-xxii.
Abstract

COOKSON MW, Kinsella JP
Inhaled Nitric Oxide in Neonatal Pulmonary Hypertension.
Clin Perinatol. 2024;51:95-111.
Abstract

LAKSHMINRUSIMHA S, Abman SH
Oxygen Targets in Neonatal Pulmonary Hypertension: Individualized, "Precision-Medicine" Approach.
Clin Perinatol. 2024;51:77-94.
Abstract

BOYD SM, Kluckow M, McNamara PJ
Targeted Neonatal Echocardiography in the Management of Neonatal Pulmonary Hypertension.
Clin Perinatol. 2024;51:45-76.
Abstract

STIEREN ES, Sankaran D, Lakshminrusimha S, Rottkamp CA, et al
Comorbidities and Late Outcomes in Neonatal Pulmonary Hypertension.
Clin Perinatol. 2024;51:271-289.
Abstract

COLETTI K, Wild KT, Foglia EE, Otter SC, et al
Randomized Controlled Trials of Pulmonary Vasodilator Therapy Adjunctive to Inhaled Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn: A Systematic Review.
Clin Perinatol. 2024;51:253-269.
Abstract

BANDIYA P, Madappa R, Joshi AR
Etiology, Diagnosis and Management of Persistent Pulmonary Hypertension of the Newborn in Resource-limited Settings.
Clin Perinatol. 2024;51:237-252.
Abstract

DANHAIVE O, Galambos C, Lakshminrusimha S, Abman SH, et al
Pulmonary Hypertension in Developmental Lung Diseases.
Clin Perinatol. 2024;51:217-235.
Abstract

YOUNG KC, Schmidt AF, Tan AW, Sbragia L, et al
Pathogenesis and Physiologic Mechanisms of Neonatal Pulmonary Hypertension: Preclinical Studies.
Clin Perinatol. 2024;51:21-43.
Abstract

ABMAN SH, Lakshminrusimha S
Pulmonary Hypertension in Established Bronchopulmonary Dysplasia: Physiologic Approaches to Clinical Care.
Clin Perinatol. 2024;51:195-216.
Abstract

MANI S, Mirza H, Ziegler J, Chandrasekharan P, et al
Early Pulmonary Hypertension in Preterm Infants.
Clin Perinatol. 2024;51:171-193.
Abstract

MOORE SS, Keller RL, Altit G
Congenital Diaphragmatic Hernia: Pulmonary Hypertension and Pulmonary Vascular Disease.
Clin Perinatol. 2024;51:151-170.
Abstract

GEISINGER R, Rios DR, McNamara PJ, Levy PT, et al
Asphyxia, Therapeutic Hypothermia, and Pulmonary Hypertension.
Clin Perinatol. 2024;51:127-149.
Abstract

CARROLL J, Rao R, Steinhorn RH
Targeted Therapies for Neonatal Pulmonary Hypertension: Beyond Nitric Oxide.
Clin Perinatol. 2024;51:113-126.
Abstract

NABESHIMA Y, Kitano T, Node K, Takeuchi M, et al
Prognostic value of right ventricular free-wall longitudinal strain in patients with pulmonary hypertension: systematic review and meta-analyses.
Open Heart. 2024;11:e002561.
Abstract

CAGUANA-VELEZ OA, Khilzi K, Piccari L, Rodriguez-Sevilla JJ, et al
Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism in SARS-CoV-2.
Respiration. 2024 Feb 7:1-9. doi: 10.1159/000536064.
Abstract

WANG J, Kuang J, Zhang S, Liu Z, et al
Comprehensive characterization of small noncoding RNA profiles in hypoxia-induced pulmonary hypertension (HPH) rat tissues.
iScience. 2024;27:108815.
Abstract

ALKHATEEBALTAMIMI D, Khalidi K, Khasawneh R, Alzaben A, et al
Recurrent Syncope Unveiling Pulmonary Hypertension Secondary to Pulmonary Artery Thrombi in a Pediatric Patient.
Cureus. 2024;16:e51812.
Abstract

GAYEN SK, Zulty M, Criner GJ
Elevated pulmonary vascular resistance is associated with increased lung transplant waitlist mortality among patients with chronic obstructive pulmonary disease and pulmonary hypertension: a retrospective cohort analysis.
Respir Res. 2024;25:79.
Abstract

ANDERSON J, Grell R, Haines D
Anaesthetic management of a patient with severe pulmonary hypertension, moderate tricuspid regurgitation and moderate right ventricular dysfunction presenting for a dilation and curettage.
BMJ Case Rep. 2024;17:e257225.
Abstract

DWIVEDI K, Sharkey M, Delaney L, Alabed S, et al
Improving Prognostication in Pulmonary Hypertension Using AI-quantified Fibrosis and Radiologic Severity Scoring at Baseline CT.
Radiology. 2024;310:e231718.
Abstract

ZHENG H, Wu D, Chen X, He W, et al
Endothelial downregulation of nuclear m6A reader YTHDC1 promotes pulmonary vascular remodeling in sugen hypoxia model of pulmonary hypertension.
Heliyon. 2024;10:e24963.
Abstract

AHMED S, Ahmed A, Radegran G
Structured evaluation of unclear dyspnea-An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Pulm Circ. 2024;14:e12340.
Abstract

OSTASEVICIUS V, Jurenas V, Venslauskas M, Kizauskiene L, et al
Low-frequency ultrasound for pulmonary hypertension therapy.
Respir Res. 2024;25:70.
Abstract

COMARITA IK, Tanko G, Anghelache IL, Georgescu A, et al
The siRNA-mediated knockdown of AP-1 restores the function of the pulmonary artery and the right ventricle by reducing perivascular and interstitial fibrosis and key molecular players in cardiopulmonary disease.
J Transl Med. 2024;22:137.
Abstract

ZHANG J, Zhang Y, Yin Y, Feng Y, et al
'Fear, uncertain, tired......' psychological distress among pulmonary hypertension patients: a qualitative interview study.
BMC Psychiatry. 2024;24:100.
Abstract

HINZE CA, Park DH, Bollmann BA
Pulmonary Artery Aneurysm in Longstanding Idiopathic Pulmonary Arterial Hypertension.
Dtsch Arztebl Int. 2023;120.
Abstract

BENSLIMANE Z, Yavuz S, Francis N
A rare presentation of childhood interstitial lung disease attributed to KDM3B gene mutation: a case report.
Pan Afr Med J. 2023;46:84.
Abstract

BRANESCU I, Vladareanu S, Shetty S, Alexandru DO, et al
Sildenafil in Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia: Friend or Foe?
Curr Health Sci J. 2023;49:319-324.
Abstract

BATTA A, Hatwal J
Development of pulmonary hypertension remains a major hurdle to corrective surgery in Down syndrome.
World J Cardiol. 2024;16:1-4.
Abstract

KASSA B, Fonseca-Balladares DC, Kumar R, Lee MH, et al
Experimental Schistosoma haematobium pulmonary hypertension.
Pulm Circ. 2024;14:e12336.
Abstract

WANG W, Gong JN, Wang JF, Ding Y, et al
[Hemodynamic changes with serial balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension].
Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:120-125.
Abstract

ANAND V, Weston AD, Scott CG, Kane GC, et al
Machine Learning for Diagnosis of Pulmonary Hypertension by Echocardiography.
Mayo Clin Proc. 2024;99:260-270.
Abstract

JIANG G, Shi LF, Li LJ, Duan XJ, et al
Activation of the p62-Keap1-Nrf2 pathway improves pulmonary arterial hypertension in MCT-induced rats by inhibiting autophagy.
FASEB J. 2024;38:e23452.
Abstract

LAN WF, Deng Y, Dai P, Wu DD, et al
Right ventricular-pulmonary arterial coupling ratio derived from 3-dimensional echocardiography predicts outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension patients.
Lupus. 2024;33:155-165.
Abstract

LI MH, Liu X, Xie YL, Tang XG, et al
Sodium butyrate alleviates right ventricular hypertrophy in pulmonary arterial hypertension by inhibiting H19 and affecting the activation of let-7g-5p/IGF1 receptor/ERK.
Eur J Pharmacol. 2024 Jan 2:176315. doi: 10.1016/j.ejphar.2024.176315.
Abstract

LU J, Alenezi F, Bier E, Leewiwatwong S, et al
Optimized quantitative mapping of cardiopulmonary oscillations using hyperpolarized (129) Xe gas exchange MRI: Digital phantoms and clinical evaluation in CTEPH.
Magn Reson Med. 2024;91:1541-1555.
Abstract

LIU Q, Yang Y, Wu M, Wang M, et al
Hub gene ELK3-mediated reprogramming lipid metabolism regulates phenotypic switching of pulmonary artery smooth muscle cells to develop pulmonary arterial hypertension induced by PM(2.5).
J Hazard Mater. 2024;465:133190.
Abstract

GRUNIG E, Rahaghi F, Elwing J, Vizza CD, et al
Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension.
Adv Ther. 2024;41:618-637.
Abstract

KIM D, Choi KH, Kim H, Lee JH, et al
Right lower lung midline herniation as a rare complication in an infant with heart-lung transplantation: A case report.
Pediatr Transplant. 2024;28:e14656.
Abstract

XANTHOULI P, Echampati I, Lorenz HM, Heussel CP, et al
Respiratory involvement in connective tissue diseases.
Eur J Intern Med. 2024;120:11-16.
Abstract

REYES-HERNANDEZ ME, Bischoff AR, Giesinger RE, Rios DR, et al
Echocardiography Assessment of Left Ventricular Function in Extremely Preterm Infants, Born at Less Than 28 Weeks' Gestation, With Bronchopulmonary Dysplasia and Systemic Hypertension.
J Am Soc Echocardiogr. 2024;37:237-247.
Abstract

KOPEC G, Araszkiewicz A, Magon W, Stepniewski J, et al
Results of atrial flow regulator implantation in pulmonary arterial hypertension patients with severe heart failure despite maximal medical therapy.
Kardiol Pol. 2024;82:75-78.
Abstract

SHI S, Zhu X, Cheang I, Liao S, et al
Development and validation of a diagnostic nomogram in pulmonary hypertension due to left heart disease.
Heart Lung. 2024;65:11-18.
Abstract

MURAKAMI T, Ohno Y, Horinouchi H, Noda S, et al
Vericiguat and transcatheter edge-to-edge mitral valve repair for combined post- and pre-capillary pulmonary hypertension due to left ventricular low ejection fraction and functional mitral regurgitation.
J Cardiol Cases. 2023;29:78-81.
Abstract

SHARMA S, Antoniak S
New Insights in the Pathology of Chronic Thromboembolic Pulmonary Hypertension.
JACC Basic Transl Sci. 2024;9:117-119.
Abstract

SMALL M, Perchenet L, Bennett A, Linder J, et al
The diagnostic journey of pulmonary arterial hypertension patients: results from a multinational real-world survey.
Ther Adv Respir Dis. 2024;18:17534666231218886.
Abstract

DUENAS-MEZA E, Severiche-Bueno DF, Santos Quintero C, Talani Ochoa J, et al
Prevalence of pulmonary hypertension in children with obstructive sleep apnea living at high altitude.
Sleep Med X. 2024;7:100106.
Abstract

ROSEN C, Jacqmart C, Charlier C, Beghetti M, et al
[Risks of magistral preparations in pediatrics].
Rev Med Liege. 2024;79:104-109.
Abstract

GARRETT ME, Foster MW, Telen MJ, Ashley-Koch AE, et al
Nontargeted Plasma Proteomic Analysis of Renal Disease and Pulmonary Hypertension in Patients with Sickle Cell Disease.
J Proteome Res. 2024 Feb 14. doi: 10.1021/acs.jproteome.3c00748.
Abstract

PEER SB, Loor G, Han JW, Shafii AE, et al
Surgical right pulmonary artery to left atrial shunt for severe pulmonary hypertension and bridge to lung transplantation.
JTCVS Tech. 2023;23:178-181.
Abstract

DEBOEVER N, Eapen GA, Casal RF, Durand JB, et al
Endobronchial ultrasound: A novel screening test for pulmonary hypertension prior to major pulmonary surgery.
JTCVS Tech. 2023;23:146-153.
Abstract

YOSHIDA S, Eichelberger O, Ulis M, Kreger AM, et al
Intra-Amniotic Sildenafil and Rosiglitazone Late in Gestation Ameliorate the Pulmonary Hypertension Phenotype in Congenital Diaphragmatic Hernia.
J Pediatr Surg. 2024 Jan 23:S0022-3468(24)00017.
Abstract

YIM IHW, Parker KH, Drury NE, Lim HS, et al
Pulmonary artery wave intensity analysis in pulmonary hypertension associated with heart failure and reduced left ventricular ejection fraction.
Pulm Circ. 2024;14:e12345.
Abstract

ZHOU J, Guo D, Xu ZZ, Liao JS, et al
Nupr1-mediated vascular smooth muscle cell phenotype transformation involved in methamphetamine induces pulmonary hypertension.
Cell Biol Toxicol. 2024;40:13.
Abstract

DEL VALLE KT, Krowka MJ, Schinstock CA, Nath KA, et al
Hemodynamic response to inhaled nitric oxide in patients with pulmonary hypertension and chronic kidney disease: A retrospective cohort study.
Pulm Circ. 2024;14:e12341.
Abstract

BAILEY ME, Durst L, Cajigas HR, Kane GC, et al
Using PAH-SYMPACT to assess quality of life in patients with pulmonary hypertension associated with chronic lung disease.
Pulm Circ. 2024;14:e12343.
Abstract

FAKHRY B, Peterson L, Comhair SAA, Sharp J, et al
Blood Cholesterol and Triglycerides Associate with Right Ventricular Function in Pulmonary Hypertension.
medRxiv. 2024 Jan 22:2024.01.20.24301498. doi: 10.1101/2024.01.20.24301498.
Abstract

OWUSU IK, Amponsah GM, Wiafe YA
Severe Pulmonary Hypertension From Combined Ventricular Septal Defect and Rheumatic MIitral Valve Disease: A Case Report and Literature Review.
Clin Med Insights Case Rep. 2024;17:11795476241231140.
Abstract

CUETO-ROBLEDO G, Cantero-Ceballos MD, Gonzalez-Hermosillo LM, Navarro-Vergara DI, et al
Severe Pulmonary Hypertension in Pulmonary Alveolar Microlithiasis: A Comprehensive Literature Review.
Curr Probl Cardiol. 2024 Feb 9:102453. doi: 10.1016/j.cpcardiol.2024.102453.
Abstract

LEE J, Cho DH, Min HJ, Son YB, et al
Higher sclerostin is associated with pulmonary hypertension in pre-dialysis end-stage kidney disease patients: a cross-sectional prospective observational cohort study.
BMC Pulm Med. 2024;24:78.
Abstract

INOUE K, Andersen OS, Remme EW, Khan FH, et al
Echocardiographic Evaluation of Left Ventricular Filling Pressure in Patients With Pulmonary Hypertension.
JACC Cardiovasc Imaging. 2024 Jan 28:S1936-878X(24)00024.
Abstract

VAIDY A, Vahdatpour CA, Mazurek J
Exercise Testing in Patients with Pulmonary Hypertension.
J Clin Med. 2024;13:795.
Abstract

BIGDELU L, Alimi H, Fazlinezhad A, Ghaderi F, et al
Novel echocardiographic parameters in pulmonary hypertension assessment and the relationship between echocardiography and 6-minute walking test.
Medicine (Baltimore). 2024;103:e35294.
Abstract

MOURA DE AZEVEDO S, Furtado I, Carvalho L, Reis A, et al
10-year success story in CTEPH treatment: breaking the myth of rareness.
BMJ Case Rep. 2024;17:e257942.
Abstract

RAHIMI M, Rahimi S, Karimi Torshizi MA, Sharafi M, et al
The effect of peroxisome proliferator-activated receptor gamma (PPARgamma) as a mediator of dietary fatty acids and thiazolidinedione in pulmonary arterial hypertension induced by cold stress of broilers.
Res Vet Sci. 2024;168:105157.
Abstract

KIM H, Liu Y, Kim J, Kim Y, et al
Pericytes contribute to pulmonary vascular remodeling via HIF2alpha signaling.
EMBO Rep. 2024;25:616-645.
Abstract

HAN PL, Jiang L, Cheng JL, Shi K, et al
Artificial intelligence-assisted diagnosis of congenital heart disease and associated pulmonary arterial hypertension from chest radiographs: A multi-reader multi-case study.
Eur J Radiol. 2023;171:111277.
Abstract

BOBROVSKI VG, Pinheiro AL, de-Castro JAL, Rech EB, et al
Schistosomiasis: A neglected cause of pulmonary arterial hypertension in Brazil.
Curr Probl Cardiol. 2024;49:102340.
Abstract

BENINCASA G, Strozziero MG, Trama U, Napoli C, et al
Unsolved Issues on Beneficial Effects of Combination Therapy With Sotatercept in Pulmonary Arterial Hypertension.
Heart Lung Circ. 2024;33:12-13.
Abstract

KIPFMUELLER F, Leyens J, Pugnaloni F, Bo B, et al
Spontaneous breathing in selected neonates with very mild congenital diaphragmatic hernia.
Pediatr Pulmonol. 2023 Nov 29. doi: 10.1002/ppul.26791.
Abstract

EDEL GG, Hol JA, Slot E, von der Thusen JH, et al
Clinical Relevance of Rapid FOXF1-Targeted Sequencing in Patients Suspected of Alveolar Capillary Dysplasia With Misalignment of Pulmonary Veins.
Lab Invest. 2023;103:100233.
Abstract

OKNINSKA M, Zajda K, Zambrowska Z, Grzanka M, et al
Role of Oxygen Starvation in Right Ventricular Decompensation and Failure in Pulmonary Arterial Hypertension.
JACC Heart Fail. 2024;12:235-247.
Abstract

OKUNUSHI K, Kobayashi H, Yoh Y, Kunimatsu M, et al
A case report of a child with pulmonary hypertension associated with SARS-CoV-2 infection.
Front Pediatr. 2024;12:1336589.
Abstract

BOLLOVA D, Reptova A, Valkovicova T, Gazdikova K, et al
Risk of chronic thromboembolic pulmonary hypertension after splenectomy.
Bratisl Lek Listy. 2024;125:176-182.
Abstract

SATO S, Ito T, Tabata T, Ogawa A, et al
Corrigendum: Effect of balloon pulmonary angioplasty on cardio-ankle vascular index and biventricular remodeling in patients with chronic thromboembolic pulmonary hypertension.
Front Cardiovasc Med. 2024;11:1377556.
Abstract

KOPEC G, Forfia P, Abe K, Beaudet A, et al
Recognition, diagnosis, and operability assessment of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross-sectional scientific survey (CLARITY).
Pulm Circ. 2024;14:e12330.
Abstract

LIN P, Jiang F, Li X, Zhao Y, et al
International trends in pulmonary hypertension mortality between 2001 and 2019: Retrospective analysis of the WHO mortality database.
Heliyon. 2024;10:e26139.
Abstract

MULLER J, Appenzeller P, Lichtblau M, Saxer S, et al
Effects of 5-Week Oral Acetazolamide on Incremental Cycling Exercise in Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension: A Randomized Placebo-Controlled, Double-Blinded, Crossover Trial.
Respiration. 2024 Feb 21:1-10. doi: 10.1159/000536399.
Abstract

ONGEN HG, Akdeniz B, Duzenli MA, Chernyavsky A, et al
Diagnosis and Treatment Patterns of Chronic Thromboembolic Pulmonary Hypertension in Russia, Kazakhstan, Turkey, Lebanon, and Saudi Arabia: A Registry Study.
Drugs Real World Outcomes. 2024 Feb 21. doi: 10.1007/s40801-023-00407.
Abstract

SHEN T, Shi J, Zhao X, Fu L, et al
Presenilin 1 Is a Therapeutic Target in Pulmonary Hypertension and Promotes Vascular Remodeling.
Am J Respir Cell Mol Biol. 2024 Feb 21. doi: 10.1165/rcmb.2022-0426.
Abstract

ZHANG W, Li M, Ye X, Jiang M, et al
Disturbance of mitochondrial dynamics in myocardium of broilers with pulmonary hypertension syndrome.
Br Poult Sci. 2024 Feb 21:1-11. doi: 10.1080/00071668.2024.2308277.
Abstract

MIAO H, Hui H, Fan W, Lin Y, et al
Overexpressed pigment epithelium-derived factor alleviates pulmonary hypertension in two rat models induced by monocrotaline and SU5416/hypoxia.
Biomed Pharmacother. 2024;172:116303.
Abstract

LI K, Shen C, Wen N, Han Y, et al
EPO regulates the differentiation and homing of bone marrow mesenchymal stem cells through Notch1/Jagged pathway to treat pulmonary hypertension.
Heliyon. 2024;10:e25234.
Abstract

MINAMITANI Y, Kato S, Hosokawa M, Nakashima T, et al
Inhaled nitric oxide therapy for preterm infants after 7 days of age: a scoping review protocol.
BMJ Open. 2024;14:e080298.
Abstract

HOSKING M, Bates A
Therapy in pediatric pulmonary hypertension: memoire of an unfinished journey.
Can J Cardiol. 2024 Feb 17:S0828-282X(24)00173.
Abstract

FUJII S, Nagayoshi S, Miyamoto T, Ogawa K, et al
The beneficial effects of balloon pulmonary angioplasty for patients with chronic thromboembolic pulmonary hypertension are accompanied by increased body mass index and improved nutritional status.
Pulm Circ. 2024;14:e12347.
Abstract

LIU B, Yi D, Li S, Ramirez K, et al
Endothelial fatty acid-binding proteins contribute to the pathogenesis of pulmonary hypertension.
bioRxiv [Preprint]. 2024 Feb 11:2024.02.11.579846.
Abstract

DUARTE AC, Alegria S, Vinagre F, Ferreira F, et al
Can subcutaneous treprostinil be an alternative for treating pulmonary hypertension in patients with systemic sclerosis-related interstitial lung disease?
ARP Rheumatol. 2024.
Abstract

KASHIWADA T, Tanaka Y, Tanaka T, Okano T, et al
Clinical course of COPD patients with exercise-induced elevation of pulmonary artery pressure or less severe pulmonary hypertension presenting with respiratory symptoms and the impact of bosentan intervention-prospective, single-center, randomized, pa
BMC Pulm Med. 2024;24:90.
Abstract

DAI L, Chen Y, Wu J, He Z, et al
A novel complement C3 inhibitor CP40-KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway.
J Transl Med. 2024;22:164.
Abstract

TORBIC H, Tonelli AR
Sotatercept for Pulmonary Arterial Hypertension in the Inpatient Setting.
J Cardiovasc Pharmacol Ther. 2024;29:10742484231225310.
Abstract

MULLER A, Escribano-Subias P, Fernandes CC, Fontana M, et al
Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE.
Adv Ther. 2024;41:1103-1119.
Abstract

BARBERA J, Jansa P, Klings E, Ristic A, et al
Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension.
Adv Ther. 2024;41:1062-1074.
Abstract

LEWIS MI, Shapiro S, Oudiz RJ, Nakamura M, et al
The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells.
EBioMedicine. 2024;100:104900.
Abstract

LIAO K, Mackenzie H, Ait-Oudhia S, Manimaran S, et al
The Impact of Immunogenicity on the Pharmacokinetics, Efficacy, and Safety of Sotatercept in a Phase III Study of Pulmonary Arterial Hypertension.
Clin Pharmacol Ther. 2024;115:478-487.
Abstract

SCHONFELD T, Seitz P, Krieghoff C, Ponorac S, et al
High-pitch CT pulmonary angiography (CTPA) with ultra-low contrast medium volume for the detection of pulmonary embolism: a comparison with standard CTPA.
Eur Radiol. 2023 Sep 1. doi: 10.1007/s00330-023-10101.
Abstract

DING W, Gu Y, Wang H, Wu H, et al
Prenatal MRI assessment of mediastinal shift angle as a feasible and effective risk stratification tool in isolated right-sided congenital diaphragmatic hernia.
Eur Radiol. 2024;34:1524-1533.
Abstract

SESHADRI N, Kim LY, McGrath-Morrow SA, Collaco JM, et al
Human Milk Cessation in the NICU in Infants with Bronchopulmonary Dysplasia.
Am J Perinatol. 2021 Nov 9. doi: 10.1055/a-1692-0796.
Abstract

BARTAKKE AA, Saez de Ibarra Sanchez JI
Successful perioperative management of a primary pulmonary arterial angiosarcoma: case report.
Braz J Anesthesiol. 2024;74:744186.
Abstract

JOYE S, Bhattacharya S, Kharrat A, Jasani B, et al
Shape of Pulmonary Artery Doppler Flow Profile and Right Ventricular Hemodynamics in Neonates.
J Pediatr. 2023 Dec 3:113864. doi: 10.1016/j.jpeds.2023.113864.
Abstract

BATRA J, Mourad M, Collado FK, Takeda K, et al
Case report of pregnancy complicated by severe pulmonary hypertension from mitral stenosis and placenta accreta spectrum disorder: management of two life-threatening conditions.
Eur Heart J Case Rep. 2024;8:ytae055.
Abstract

MUELLER-GRAF F, Frenkel P, Merz J, Reuter S, et al
Respiratory gating improves correlation between pulse wave transit time and pulmonary artery pressure in experimental pulmonary hypertension.
Physiol Meas. 2024 Feb 29. doi: 10.1088/1361-6579.
Abstract

ISHIZU T, Hayashi Y, Tokushige N, Omura J, et al
Real-world diagnostic landscape and incidence of pulmonary hypertension in adult congenital heart disease patients using administrative claims data in Japan.
Curr Med Res Opin. 2024 Feb 29:1-13. doi: 10.1080/03007995.2024.2323632.
Abstract

IVARSSON B, Johansson A, Kjellstrom B
Change in health-related quality of life at early follow-up in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Pulm Circ. 2024;14:e12349.
Abstract

SOLTANI HEKMAT A, Amini F, Javanmardi K
Effects of alamandine on monocrotaline-induced pulmonary hypertension in rats.
Iran J Basic Med Sci. 2024;27:500-508.
Abstract

ARANGO-GRANADOS MC, Osorio-Gonzalez LJ, Munoz-Patino V
Bedside Ultrasound to Guide the Diagnosis and Treatment of Fulminant Right Heart Failure: A Case Report.
Am J Case Rep. 2024;25:e942694.
Abstract

VAN DE VEERDONK MC, Roosma L, Trip P, Gopalan D, et al
Clinical-imaging-pathological correlation in pulmonary hypertension associated with left heart disease.
Eur Respir Rev. 2024;33:230144.
Abstract

GAO X, Jiang X, Wu Z, Chen N, et al
Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension.
J Interv Cardiol. 2024;2024:4512655.
Abstract

WANG Y, Zhu Z, Niu L, Liu B, et al
Geometric remodeling of tricuspid valve in pulmonary hypertension and its correlation with pulmonary hypertension severity: a prospectively case-control study using four-dimensional automatic tricuspid valve quantification technology.
Quant Imaging Med Surg. 2024;14:1699-1715.
Abstract

IMAI S, Sakao S, Nagata J, Naito A, et al
Artificial intelligence-based model for predicting pulmonary arterial hypertension on chest x-ray images.
BMC Pulm Med. 2024;24:101.
Abstract

PAEZ-CARPIO A, Vollmer I, Zarco FX, Matute-Gonzalez M, et al
Imaging of chronic thromboembolic pulmonary hypertension before, during and after balloon pulmonary angioplasty.
Diagn Interv Imaging. 2024 Feb 26:S2211-5684(24)00040.
Abstract

LI M, Shang X, Lou H, Wang Z, et al
Active Anchoring Stimuli-responsive Nano-craft to relieve Pulmonary Vasoconstriction by Targeting Smooth Muscle Cell for Hypoxic Pulmonary Hypertension Treatment.
Adv Healthc Mater. 2024 Feb 27:e2400113. doi: 10.1002/adhm.202400113.
Abstract

VATRANO M, Manzi G, Picariello C, D'Alto M, et al
[ANMCO/SIC Consensus statement on pulmonary arterial hypertension].
G Ital Cardiol (Rome). 2024;25:192-201.
Abstract

DENG W, Guo W, Yang A, Lin D, et al
A better method to evaluate the reliability of echocardiography for assessment of pulmonary hypertension: comparison of tricuspid regurgitant spectrum quality grading and tricuspid valve regurgitation degree.
J Thorac Dis. 2024;16:51-64.
Abstract

KIMYON AS, Cetinkaya A, Hallioglu Kilinc O, Aras N, et al
The evaluation of the SMAD1 rs1016792 polymorphism and gene expression on pulmonary hypertension due to congenital heart disease in children: a preliminary study.
Nucleosides Nucleotides Nucleic Acids. 2024.
Abstract

NAKANO T, Wada S, Nishisako R, Sakurai Y, et al
Massive hemoptysis from a bronchial-pulmonary arterial fistula.
Pediatr Int. 2024;66:e15741.
Abstract

ESTRADA RA, Auger WR, Sahay S
Chronic Thromboembolic Pulmonary Hypertension.
JAMA. 2024 Feb 26. doi: 10.1001/jama.2023.24265.
Abstract

HRYZHAK I, Pryshliak O, Kobryn T, Fedorov S, et al
Clinical and echocardiographic findings in patients with COVID-19 across different severity levels.
J Med Life. 2023;16:1692-1700.
Abstract

JI XY, Lei CJ, Kong S, Li HF, et al
Hydroxy-Safflower Yellow A Mitigates Vascular Remodeling in Rat Pulmonary Arterial Hypertension.
Drug Des Devel Ther. 2024;18:475-491.
Abstract

YANG X, Sun J, Yang H, Guo T, et al
[Diagnosis of pulmonary hypertension associated with congenital heart disease based on statistical features of the second heart sound].
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2024;41:41-50.
Abstract

SANIVARAPU RR, Arjun S, Otero J, Munshi R, et al
In-hospital outcomes of pulmonary hypertension in HIV patients: A population based cohort study.
Int J Cardiol. 2024 Feb 23:131900. doi: 10.1016/j.ijcard.2024.131900.
Abstract

KENNEWEG F, Hobohm L, Bang C, Gupta SK, et al
Circulating miR-let7a levels predict future diagnosis of chronic thromboembolic pulmonary hypertension.
Sci Rep. 2024;14:4514.
Abstract

KAYALI SM, Dietz BE 2nd, Siddiq BS, Ghaly M, et al
Chronic thromboembolic pulmonary hypertension and balloon pulmonary angioplasty - Where are we in 2024?
Curr Probl Cardiol. 2024;49:102481.
Abstract

FOROSHANI S, Airo M, Levine A, Frishman WH, et al
COVID-19 and Pulmonary Hypertension: An Interesting Dynamic.
Cardiol Rev. 2024 Feb 24. doi: 10.1097/CRD.0000000000000679.
Abstract

MERELES D, Rudolph J, Greiner S, Aurich M, et al
Acute changes in cardiac dimensions, function, and longitudinal mechanics in healthy individuals with and without high-altitude induced pulmonary hypertension at 4559 m.
Echocardiography. 2024;41:e15786.
Abstract

EREMINIENE E, Stuoka M, Ordiene R, Plisiene J, et al
Acquired Cardiovascular Diseases in Patients with Pulmonary Hypertension Due to Congenital Heart Disease: A Case Report.
Medicina (Kaunas). 2024;60:266.
Abstract

GONCHAROVA N, Lapshin K, Berezina A, Simakova M, et al
Elderly Patients with Idiopathic Pulmonary Hypertension: Clinical Characteristics, Survival, and Risk Stratification in a Single-Center Prospective Registry.
Life (Basel). 2024;14:259.
Abstract

WEI ZX, Cai XX, Fei YD, Wang Q, et al
Ntsr1 contributes to pulmonary hypertension by enhancing endoplasmic reticulum stress via JAK2-STAT3-Thbs1 signaling.
Transl Res. 2024 Feb 21:S1931-5244(24)00031-8. doi: 10.1016/j.trsl.2024.
Abstract

WANG Y, Rong C, Liu J, Liu X, et al
Pulmonary arterial sarcoma: A case report.
Medicine (Baltimore). 2024;103:e37194.
Abstract

ASAL AEA, Oshaiba ZF, Mansour ENA, Abd Elaziz OH, et al
Serum pentraxin 3 levels in term neonates with persistent pulmonary hypertension.
J Neonatal Perinatal Med. 2024 Feb 21. doi: 10.3233/NPM-230211.
Abstract

SEKI N, Tsujimoto H, Tanemura S, Ishigaki S, et al
Th17/IL-17A axis is critical for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc): SSc patients with high levels of serum IL-17A exhibit reduced lung functions and increased prevalence of PAH.
Cytokine. 2024;176:156534.
Abstract

TANG L, Zhou X, Guo A, Han L, et al
Blockade of ZFX Alleviates Hypoxia-Induced Pulmonary Vascular Remodeling by Regulating the YAP Signaling.
Cardiovasc Toxicol. 2024;24:158-170.
Abstract

PICCINELLI E, Frazzetto F, Pilati M, Butera G, et al
Stent Implantation Across the Atrial Flow Regulator Device.
Pediatr Cardiol. 2024;45:695-698.
Abstract

LIPCZYNSKA M, Derejska M, Swierczynski R, Kusmierczyk-Droszcz B, et al
Noncardiac surgery in Eisenmenger syndrome.
Pol Arch Intern Med. 2024;134:16652.
Abstract

CONNES P
Blood rheology and vascular function in sickle cell trait and sickle cell disease: From pathophysiological mechanisms to clinical usefulness.
Clin Hemorheol Microcirc. 2024;86.
Abstract

JIA Q, Ouyang Y, Yang Y, Yao S, et al
Osteopontin: A Novel Therapeutic Target for Respiratory Diseases.
Lung. 2024;202:25-39.
Abstract

LIN K, Sarnari R, Gordon DZ, Markl M, et al
Cine MRI-derived radiomics features indicate hemodynamic changes in the pulmonary artery.
Int J Cardiovasc Imaging. 2024;40:287-294.
Abstract

FULOP P, Valocik G, Barbierik Vachalcova M, Zenuch P, et al
Aortic stenosis and right ventricular dysfunction.
Int J Cardiovasc Imaging. 2024;40:299-305.
Abstract

CAIN MT, Schafer M, Park S, Barker AJ, et al
Characterization of pulmonary arterial stiffness using cardiac MRI.
Int J Cardiovasc Imaging. 2024;40:425-439.
Abstract

ANASTASIOU V, Papazoglou AS, Moysidis DV, Daios S, et al
The prognostic impact of right ventricular-pulmonary arterial coupling in heart failure: a systematic review and meta-analysis.
Heart Fail Rev. 2024;29:13-26.
Abstract

SONG J, Chen Y, Chen Y, Wang S, et al
Ferrostatin-1 Blunts Right Ventricular Hypertrophy and Dysfunction in Pulmonary Arterial Hypertension by Suppressing the HMOX1/GSH Signaling.
J Cardiovasc Transl Res. 2024;17:183-196.
Abstract

CHAO C, Wang M, Mei K, Ma C, et al
An inverse causal relationship between serum 25-hydroxyvitamin D levels and pulmonary hypertension: A two-sample Mendelian randomization study.
Pulm Circ. 2024;14:e12350.
Abstract

TERUI Y, Ohura S, Nozaki T, Yagi T, et al
Pulmonary hypertension in an adult patient with congenital central hypoventilation syndrome: a case report.
Eur Heart J Case Rep. 2024;8:ytae109.
Abstract

LI X, Zhang Y, Zhang S, Zhao Q, et al
Tumor biomarkers in evaluating the severity and prognosis of idiopathic pulmonary arterial hypertension: A comprehensive analysis.
Clin Transl Sci. 2024;17:e13751.
Abstract

KAVGACI A, Kula S, Berber Marasli E, Zinnuroglu M, et al
Evaluation of handgrip strength in children with pulmonary hypertension.
Cardiol Young. 2024 Mar 7:1-5. doi: 10.1017/S1047951124000398.
Abstract

WU XF, Sun TT, Lin JL, Guo WL, et al
[Pulmonary artery stenting in chronic thromboembolic pulmonary hypertension: a report of 2 cases].
Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:228-232.
Abstract

MESSIKA J, Eloy P, Boulate D, Charvet A, et al
Protocol for venoarterial ExtraCorporeal Membrane Oxygenation to reduce morbidity and mortality following bilateral lung TransPlantation: the ECMOToP randomised controlled trial.
BMJ Open. 2024;14:e077770.
Abstract

WANG Y, Guo D, Gong J, Wang J, et al
Efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension patients with pulmonary comorbidity.
Int J Cardiol Heart Vasc. 2024;51:101363.
Abstract

PILIERO N, Salvat M, Finas M, Curioz F, et al
Upfront triple therapy with parenteral prostanoid as a bridge to balloon pulmonary angioplasty in severe chronic thromboembolic pulmonary hypertension.
ERJ Open Res. 2024;10:00085-2024.
Abstract

VURAN G, Yilmazer MM, Gerceker E, Zihni C, et al
Leukotriene B4 levels in CHD-associated paediatric pulmonary hypertension.
Cardiol Young. 2024 Mar 6:1-5. doi: 10.1017/S1047951124000362.
Abstract

LIU H, Zhang YW, Zhang QQ, Wang YX, et al
[Effects of human umbilical cord mesenchymal stem cells (MSCs)-derived exosomes on pulmonary vascular remodeling in hypoxic pulmonary hypertension].
Sheng Li Xue Bao. 2024;76:33-44.
Abstract

MADDALONI C, Ronci S, De Rose DU, Bersani I, et al
Neonatal persistent pulmonary hypertension related to a novel TBX4 mutation: case report and review of the literature.
Ital J Pediatr. 2024;50:41.
Abstract

ITTERMANN T, Kaczmarek S, Obst A, Konemann R, et al
Metabolic cost of unloading pedalling in different groups of patients with pulmonary hypertension and volunteers.
Sci Rep. 2024;14:5394.
Abstract

ANH NTH, Minh Dien T, Thi Ha L, Thao Nguyen P, et al
Factors in the Neonatal Period Associated With Pulmonary Hypertension at 28 Days of Life in Broncho-Pulmonary Dysplasia.
Glob Pediatr Health. 2024;11:2333794X241234571.
Abstract

TENZING D, Suolang P, Gesang D, Suolang D, et al
Effect of furosemide in the treatment of high-altitude pulmonary edema.
BMC Pulm Med. 2024;24:109.
Abstract

MUNTEANU A, Kundnani NR, Caraba A
Nailfold capillaroscopy abnormalities and pulmonary hypertension in mixed connective tissue disease and systemic sclerosis patients.
Eur Rev Med Pharmacol Sci. 2024;28:1314-1326.
Abstract

CROWLEY AV, Banfield M, Gupta A, Raj R, et al
Role of Surgical and Medical Management of Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review.
Cureus. 2024;16:e53336.
Abstract

PENATE GP, Parra NO, Morera JAD, Menaca AM, et al
Assessing the clinical benefit, safety, and patient-reported outcomes with the use of the PAHcare digital platform in pulmonary arterial hypertension: a pilot study.
Front Public Health. 2024;12:1335072.
Abstract

ZAHID S, Anjali Garg J, Altibi A, Golwala H, et al
Mitral Transcatheter Edge-to-Edge Repair: Advancing Treatment Options for Degenerative Mitral Regurgitation.
Interv Cardiol Clin. 2024;13:155-165.
Abstract

RANGWALA BS, Sohail Rangwala H
Comment on: Severe pulmonary hypertension in pulmonary alveolar microlithiasis: A comprehensive literature review.
Curr Probl Cardiol. 2024 Feb 29:102492. doi: 10.1016/j.cpcardiol.2024.102492.
Abstract

MORA-CUESTA VM, Martinez-Menaca A, Iturbe-Fernandez D, Tello-Mena S, et al
Impact of the New Definition of Pulmonary Hypertension on the Prevalence of Primary Graft Dysfunction in Lung Transplant Recipients.
Heart Lung Circ. 2024 Feb 29:S1443-9506(24)00037.
Abstract

LI J, Xiong J, Liu P, Peng Y, et al
Eye signs as a novel risk predictor in pulmonary arterial hypertension associated with systemic lupus erythematosus.
Adv Rheumatol. 2024;64:15.
Abstract

WHITE RJ, Lachant DJ, Benza RL
Risk scores as a surrogate in pulmonary arterial hypertension: a different lens.
Lancet Respir Med. 2024;12:e9-e10.
Abstract

HARHAY MO, Blette BS, Kawut SM
Risk scores as a surrogate in pulmonary arterial hypertension: a different lens - Authors' reply.
Lancet Respir Med. 2024;12:e11.
Abstract

HODNICK R, Cohen ML, Loehner JB, Mazzanti J, et al
Continuous Positive Airway Pressure in the Treatment of Pediatric High Altitude Pulmonary Edema: A Case Study.
Wilderness Environ Med. 2024;35:78-81.
Abstract

QIAN YL, He JG
[Current status and progress of research on pediatric pulmonary arterial hypertension].
Zhonghua Er Ke Za Zhi. 2024;62:278-281.
Abstract

HIRANO Y, Amano M, Obokata M, Izumo M, et al
Practice guidance for stress echocardiography.
J Echocardiogr. 2024;22:1-15.
Abstract

MATHUR M, Malinowski M, Jazwiec T, Timek TA, et al
Leaflet remodeling reduces tricuspid valve function in a computational model.
J Mech Behav Biomed Mater. 2024;152:106453.
Abstract

SANDEEP B, Cheng H, Yan Y, Huang X, et al
Right ventricle-pulmonary artery coupling in pulmonary artery hypertension its measurement and pharmacotherapy.
Curr Probl Cardiol. 2024;49:102425.
Abstract

SHORT K, McBride M, Anderson S, Miller R, et al
Survival of Infants With Severe Congenital Kidney Disease After ECMO and Kidney Support Therapy.
Pediatrics. 2024 Feb 2:e2023062717. doi: 10.1542/peds.2023-062717.
Abstract

CUETO-ROBLEDO G, Tovar-Benitez D, Alfaro-Cruz A, Gonzalez-Hermosillo LM, et al
Systemic scleroderma: Review and updated approach and case description to addressing pulmonary arterial hypertension and idiopathic pulmonary fibrosis: A dual challenge in treatment.
Curr Probl Cardiol. 2024;49:102404.
Abstract

HAIDER MA, Pearce KJ, Chesler NC, Hill NA, et al
Application and reduction of a nonlinear hyperelastic wall model capturing ex vivo relationships between fluid pressure, area, and wall thickness in normal and hypertensive murine left pulmonary arteries.
Int J Numer Method Biomed Eng. 2024;40:e3798.
Abstract

LI XM, Zhu XJ, Jing ZC
Reverse cardiac remodelling after balloon atrial septostomy for pulmonary arterial hypertension and end-stage heart failure.
Eur Heart J. 2023 Dec 16:ehad822. doi: 10.1093.
Abstract

LI M, Pan W, Tian D, Chen D, et al
Diagnostic Value of Serum Galectin-3 Binding Protein Level in Patients with Pulmonary Arterial Hypertension.
Curr Vasc Pharmacol. 2024;22:67-77.
Abstract

PEREZ-VIZCAINO F, Barbera JA, Rodriguez Chiaradia DA
Vitamin D and Pulmonary Arterial Hypertension.
Arch Bronconeumol. 2024;60:131-132.
Abstract

HEO J, Kang H
Platelet-derived growth factor-stimulated pulmonary artery smooth muscle cells regulate pulmonary artery endothelial cell dysfunction through extracellular vesicle miR-409-5p.
Biol Chem. 2023;405:203-215.
Abstract

ALY S, Qattea I, Othman H, Nguyen HH, et al
Outcomes of atrioventricular septal defects with and without down syndrome: analysis of the national inpatient database.
Cardiol Young. 2024;34:614-623.
Abstract

MATSUMOTO K, Miyawaki Y, Katsuyama T, Nakadoi T, et al
Immunosuppressive Treatment for an anti-U(1) Ribonucleoprotein Antibody-positive Patient with Pulmonary Arterial Hypertension.
Intern Med. 2024;63:671-676.
Abstract

PAVSIC N, Kacar P, Dolenc J, Prokselj K, et al
One-minute sit-to-stand test in patients with pulmonary arterial hypertension associated with congenital heart disease: A single-center prospective study.
Hellenic J Cardiol. 2024;75:41-47.
Abstract

PANAGIOTIDOU E, Betaoutou A, Fouka E, Papakosta D, et al
Phenotyping exercise limitation of patients with Interstitial Fibrosing Lung Disease: the importance of exercise hemodynamics.
Pulmonology. 2024;30:104-112.
Abstract

UNALDI E, Firlatan B, Duzgun SA, Koca SS, et al
Case report: Pulmonary endarterectomy in Takayasu arteritis patient with group IV pulmonary hypertension: A rare clinical scenario.
Int J Rheum Dis. 2024;27:e15119.
Abstract

MONDEN Y, Une D, Mitsumune S, Shimokawahara H, et al
Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension with bronchial obstruction by a carcinoid tumor.
Pulm Circ. 2024;14:e12354.
Abstract

WILSON BK, Sadowski CK, Baeten RG
A clinician's guide to pulmonary hypertension.
JAAPA. 2024 Mar 14. doi: 10.1097/01.JAA.0001007360.09090.
Abstract

CHANG AJ, Goh CH
Resolution of Severe Portopulmonary Hypertension With Inhaled Treprostinil and Liver Transplantation.
Tex Heart Inst J. 2024;51:e238209.
Abstract

GERGES C, Vollmers K, Skoro-Sajer N, Dannenberg V, et al
Efficacy and safety of the Aria pulmonary endovascular device in pulmonary hypertension.
Eur J Heart Fail. 2024 Mar 13. doi: 10.1002/ejhf.3187.
Abstract

BONGIOVANNI G, Tonutti A, Stainer A, Nigro M, et al
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review.
BMJ Open Respir Res. 2024;11:e002161.
Abstract

KITAGHENDA FK, Hidig SM
Improvement in Pulmonary Hypertension Following Metabolic and Bariatric Surgery: a Brief Review and Meta-analysis.
Obes Surg. 2024 Mar 13. doi: 10.1007/s11695-024-07162.
Abstract

BHAGWAT AP, Sharath HV, Seth NH, Puri SN, et al
Persistent Pulmonary Hypertension of Newborns Secondary to Labile Hypoxemia Associated With Cyanosis: A Case Series.
Cureus. 2024;16:e54016.
Abstract

DIALLO TH, Nana Yeboah F, Djafarou Boubacar R, Faraj R, et al
Severe pulmonary hypertension associated with hypothyroidism and mixed aortic valve disease: A case report.
SAGE Open Med Case Rep. 2024;12:2050313X241237405.
Abstract

HU Z, Fan S
Progress in the application of echocardiography in neonatal pulmonary hypertension.
J Matern Fetal Neonatal Med. 2024;37:2320673.
Abstract

MUNKS J, Yogeswaran A, Antoine TK, Blumrich LA, et al
A Novel Rat Model of Mild Pulmonary Hypertension Associated with Pulmonary Venous Congestion Induced by Left Pulmonary Vein Banding.
Int J Mol Sci. 2024;25:2827.
Abstract

WANG MT, Weng KP, Chang SK, Huang WC, et al
Hemodynamic and Clinical Profiles of Pulmonary Arterial Hypertension Patients with GDF2 and BMPR2 Variants.
Int J Mol Sci. 2024;25:2734.
Abstract

RESHMA S J, George S, P SK 5th
Pulmonary hypertension in newly diagnosed obstructive sleep apnea-chronic obstructive pulmonary disease overlap syndrome patients attending a tertiary care centre-a cross-sectional analysis.
Ir J Med Sci. 2024 Mar 12. doi: 10.1007/s11845-024-03657.
Abstract

MORRISROE K, Hansen D, Stevens W, Ross L, et al
Predictors and prognosis of pulmonary hypertension complicating interstitial lung disease in systemic sclerosis.
Rheumatology (Oxford). 2024 Mar 12:keae166. doi: 10.1093.
Abstract

DE JAGER J, Brouwer F, Reijman J, van der Palen RLF, et al
Occurrence of hyperoxia during iNO treatment for persistent pulmonary hypertension of the newborn: a cohort study.
Eur J Pediatr. 2024 Mar 12. doi: 10.1007/s00431-024-05506.
Abstract

PEREZ-PENATE GM, Julia-Serda G, Galvan-Fernandez H, Aleman-Segura D, et al
Safety of inhaled nitric oxide withdrawal in severe chronic pulmonary hypertension.
Pulm Circ. 2024;14:e12344.
Abstract

ALOTAIBI M, Yang JZ, Papamatheakis DG, McGuire WC, et al
Cardiopulmonary exercise test to detect cardiac dysfunction from pulmonary vascular disease.
Respir Res. 2024;25:121.
Abstract

SUNG C, Han S, Yoon S, Han SA, et al
Diagnostic Performance of Perfusion-Only SPECT/CT for Chronic Thromboembolic Pulmonary Hypertension in Comparison With Ventilation-Perfusion Planar, SPECT, and SPECT/CT Imaging.
Clin Nucl Med. 2024 Mar 11. doi: 10.1097/RLU.0000000000005142.
Abstract

HU BZ, Jiang C, Ding YJ, Qin W, et al
The clinical and hemodynamic characteristics of pulmonary hypertension in patients with OSA-COPD overlap syndrome.
Am J Med Sci. 2024 Mar 9:S0002-9629(24)01120-0. doi: 10.1016/j.amjms.2024.
Abstract

JAMOUSSI A, Ben Mrad N, Rachdi E, Jarraya F, et al
Hemodynamic profile of pulmonary arterial hypertension in a Tunisian center.
Tunis Med. 2023;101:751-755.
Abstract

ADACHI T, Adachi S, Nakano Y, Yasuda K, et al
Detrimental Impact of Comorbid Mental Disorders in Chronic Thromboembolic Pulmonary Hypertension?- A Retrospective Observational Study.
Circ Rep. 2024;6:80-85.
Abstract

LONG C, Fan W, Liu Y, Hong K, et al
Stress hyperglycemia is associated with poor outcome in critically ill patients with pulmonary hypertension.
Front Endocrinol (Lausanne). 2024;15:1302537.
Abstract

KHEZERLOUY-AGHDAM N, Toufan Tabrizi M, Seyed Toutounchi K, Jabbaripour Sarmadian A, et al
Challenging in pulmonary thromboembolism diagnosis in patients with disproportionate pulmonary hypertension and severe mitral stenosis: Report of two cases.
Clin Case Rep. 2024;12:e8597.
Abstract

LIU B, Yi D, Xia X, Ramirez K, et al
General Capillary Endothelial Cells Undergo Reprogramming into Arterial Endothelial Cells in Pulmonary Hypertension through HIF-2alpha/Notch4 Pathway.
bioRxiv [Preprint]. 2024 Mar 10:2024.02.13.580227.
Abstract

KUSNER J, Krasuski RA
Pulmonary Hypertension in Adult Congenital Heart Disease-Related Heart Failure.
Heart Fail Clin. 2024;20:209-221.
Abstract

ZHOU S, Zhang Q, Yang H, Zhu Y, et al
Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH.
Life Sci. 2024;342:122538.
Abstract

ZHANG H, Wang X, Liu J, Zhang Y, et al
Role of neutrophil myeloperoxidase in the development and progression of high-altitude pulmonary edema.
Biochem Biophys Res Commun. 2024;703:149681.
Abstract

MANZI G, Mariani MV, Filomena D, Recchioni T, et al
Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysis.
Vascul Pharmacol. 2024;154:107280.
Abstract

LIU C, Lv X, Kong X, Meng L, et al
Ultrasound-mediated HGF Gene Microbubbles Mitigate Hyperkinetic Pulmonary Arterial Hypertension in Rabbits.
Heart Lung Circ. 2024;33:251-259.
Abstract

CHI PL, Cheng CC, Wang MT, Liao JB, et al
Induced pluripotent stem cell-derived exosomes attenuate vascular remodelling in pulmonary arterial hypertension by targeting HIF-1alpha and Runx2.
Cardiovasc Res. 2024;120:203-214.
Abstract

BRADY S, Krishnan U, Saqi A, Vargas D, et al
Twins with alveolar capillary dysplasia with misalignment of pulmonary veins: Strategies for diagnosis and management.
J Neonatal Perinatal Med. 2024;17:147-152.
Abstract

CORRADO A, Mansueto N, Correale M, Rella V, et al
Flow Mediated Dilation in Systemic Sclerosis: Association with clinical findings, capillaroscopic patterns and endothelial circulating markers.
Vascul Pharmacol. 2024;154:107252.
Abstract

DIGNAM JP, Sharma S, Stasinopoulos I, MacLean MR, et al
Pulmonary arterial hypertension: Sex matters.
Br J Pharmacol. 2024;181:938-966.
Abstract

MAMAZHAKYPOV A, Veith C, Schermuly RT, Sydykov A, et al
Surgical protocol for pulmonary artery banding in mice to generate a model of pressure-overload-induced right ventricular failure.
STAR Protoc. 2023;4:102660.
Abstract

POUDEL S, Gautam S, Adhikari P, Zafren K, et al
Physiological Effects of Sildenafil Versus Placebo at High Altitude: A Systematic Review.
High Alt Med Biol. 2024;25:16-25.
Abstract

CHEN CY, Mei-Tzu W, Sung SH, Wu YJ, et al
Exercise capacity-hemodynamics mismatch in elderly patients with pulmonary hypertension: A nationwide multicenter study from Taiwan Society of Cardiology Pulmonary Hypertension Registry (TAIPANS).
Heliyon. 2024;10:e27537.
Abstract

ROMMEL KP, Hobohm L, Rothman AMK, Lurz P, et al
Radiation to Illuminate the Path of Neuromodulation for Pulmonary Hypertension.
JACC Basic Transl Sci. 2024;9:257-259.
Abstract

HORN-OUDSHOORN EJJ, Vermeulen MJ, Knol R, Bout-Rebel R, et al
Multicentre, randomised controlled trial of physiological-based cord clamping versus immediate cord clamping in infants with a congenital diaphragmatic hernia (PinC): statistical analysis plan.
Trials. 2024;25:198.
Abstract

BENZA RL, Grunig E, Sandner P, Stasch JP, et al
The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase.
Eur Respir Rev. 2024;33:230183.
Abstract

KIM MS, Jeon K, Kim EK, Park TK, et al
Usefulness of cardiopulmonary exercise test combined with exercise stress echocardiography in mild chronic thromboembolic pulmonary disease.
Echocardiography. 2024;41:e15795.
Abstract

VALLADALES-RESTREPO LF, Gaviria-Mendoza A, Machado-Duque ME, Vallejos-Narvaez A, et al
Prescription patterns of ambrisentan in some cities of Colombia.
Clin Respir J. 2024;18:e13736.
Abstract

HEMILA H, de Man AME
Vitamin C deficiency can lead to pulmonary hypertension: a systematic review of case reports.
BMC Pulm Med. 2024;24:140.
Abstract

SMUKOWSKA-GORYNIA A, Iwanczyk S, Rzymski P, Wozniak P, et al
Situation of patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension during the COVID-19 pandemic (2020-2022): clinical outcomes, prognostic factors, and response to vaccination.
Pol Arch Intern Med. 2024 Mar 19:16706. doi: 10.20452/pamw.16706.
Abstract

VARIAN F, Dick J, Battersby C, Roman S, et al
Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologies.
Pulm Circ. 2024;14:e12337.
Abstract

BUDHRAM B, Weatherald J, Humbert M
Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis.
Semin Respir Crit Care Med. 2024 Mar 18. doi: 10.1055/s-0044-1782217.
Abstract

HU X, Sun Y, Wang S, Zhao H, et al
CircALMS1 Alleviates Pulmonary Microvascular Endothelial Cell Dysfunction in Pulmonary Hypertension.
J Am Heart Assoc. 2024;13:e031867.
Abstract

DUARTE VE
Women and the Heart: Gender-Related Differences in Cardiovascular Care.
Methodist Debakey Cardiovasc J. 2024;20:1-3.
Abstract

PARK E, Safdar Z
Pulmonary Hypertension in Women.
Methodist Debakey Cardiovasc J. 2024;20:70-80.
Abstract

LIU J, Fang G, Lan C, Qiu C, et al
Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-kappaB Signaling Pathway to Attenuate Vascular Remodeling.
Drug Des Devel Ther. 2024;18:767-780.
Abstract

XIA W, Qian Y, Lin Y, Quan R, et al
Effect of off-label targeted drugs on long-term survival in chronic thromboembolic pulmonary hypertension: Insights from a national multicentre prospective registry.
Respirology. 2024 Mar 17. doi: 10.1111/resp.14700.
Abstract

PROVENCHER S, Arsenault BJ, Bonnet S
Mendelian Randomization in Pulmonary Arterial Hypertension: Unveiling Early Insights With Promise for Future Discoveries.
J Am Heart Assoc. 2024;13:e033446.
Abstract

ALHATHLI E, Julian T, Girach ZUA, Thompson AAR, et al
Mendelian Randomization Study With Clinical Follow-Up Links Metabolites to Risk and Severity of Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2024;13:e032256.
Abstract

GUAN D, Tian L, Li W, Gao H, et al
Using LDDMM and a kinematic cardiac growth model to quantify growth and remodelling in rat hearts under PAH.
Comput Biol Med. 2024;171:108218.
Abstract

TAN JS, Yang Y, Wang J, Wang Y, et al
Diabetes mellitus, glycemic traits, SGLT2 inhibition, and risk of pulmonary arterial hypertension: A Mendelian randomization study.
Biosci Trends. 2024;18:94-104.
Abstract

ZHANG C, Xi Y, Zhang Y, He P, et al
Causal effects between gut microbiota and pulmonary arterial hypertension: A bidirectional Mendelian randomization study.
Heart Lung. 2024;64:189-197.
Abstract

GAWLITZA J, Endres S, Fries P, Graf M, et al
Machine learning assisted feature identification and prediction of hemodynamic endpoints using computed tomography in patients with CTEPH.
Int J Cardiovasc Imaging. 2024;40:569-577.
Abstract

SCHIFFRIN EL, Pollock DM
Endothelin System in Hypertension and Chronic Kidney Disease.
Hypertension. 2023 Dec 7. doi: 10.1161/HYPERTENSIONAHA.123.21716.
Abstract

ZHOU R, Zhao Z, Liu J, Liu M, et al
Efficacy and safety of iloprost in the treatment of pulmonary arterial hypertension: A systematic review and meta-analysis.
Heart Lung. 2024;64:36-45.
Abstract

DWIVEDI K, Sharkey M, Alabed S, Langlotz CP, et al
External validation, radiological evaluation, and development of deep learning automatic lung segmentation in contrast-enhanced chest CT.
Eur Radiol. 2024;34:2727-2737.
Abstract

MEIFANG W, Ying W, Wen C, Kaizu X, et al
Advance in the pharmacological and comorbidities management of heart failure with preserved ejection fraction: evidence from clinical trials.
Heart Fail Rev. 2024;29:305-320.
Abstract

INTERNATIONAL BR
Retracted: Curcumin Improves Pulmonary Hypertension Rats by Regulating Mitochondrial Function.
Biomed Res Int. 2024;2024:9769323.
Abstract

MENG X, Du L, Xu S, Zhou L, et al
Periodontitis exacerbates pulmonary hypertension by promoting IFNgamma(+) T cell infiltration in mice.
Int J Oral Sci. 2024;16:27.
Abstract

GHOFRANI HA, Simonneau G, D'Armini AM, Fedullo P, et al
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Lancet Respir Med. 2024;12:e21-e30.
Abstract

MA RZ, Jin CL, Yang S, Han PP, et al
Evaluating the efficacy of balloon pulmonary angioplasty using quantitative analysis of SPECT pulmonary ventilation/perfusion scintigraphy in patients with chronic thromboembolic pulmonary hypertension.
Quant Imaging Med Surg. 2024;14:2590-2602.
Abstract

NORTON CE
Role of Sensory Nerves in Pulmonary Fibrosis.
Int J Mol Sci. 2024;25:3538.
Abstract

SYKORA M, Szeiffova Bacova B, Andelova K, Egan Benova T, et al
Connexin43, A Promising Target to Reduce Cardiac Arrhythmia Burden in Pulmonary Arterial Hypertension.
Int J Mol Sci. 2024;25:3275.
Abstract

VAIDYA A, Vaidy A, Al-Otaibi M, Zlotshewer B, et al
Pelvic Vein Obstruction in Chronic Thromboembolic Pulmonary Hypertension: A Novel Association.
J Clin Med. 2024;13:1553.
Abstract

LECKA-AMBROZIAK A, Kot K
Pulmonary Hypertension and Hypothyroidism-Still an Important Clinical Coincidence in Paediatric Population, an Endocrinologist's Point of View.
Life (Basel). 2024;14:302.
Abstract

IVANAUSKIENE T, Cesna S, Grigoniene E, Gumbiene L, et al
Balloon Pulmonary Angioplasty for Inoperable Chronic Thromboembolic Pulmonary Hypertension: Insights from a Pilot Low-Volume Centre Study and a Comparative Analysis with Other Centres.
Medicina (Kaunas). 2024;60:461.
Abstract

MOISII P, Jari I, Naum AG, Butcovan D, et al
Takayasu's Arteritis: A Special Case Report and Review of the Literature.
Medicina (Kaunas). 2024;60:456.
Abstract

NAGAI Y, Murayama M, Kaga S, Shima H, et al
Echocardiographic estimation of right ventricular diastolic stiffness based on pulmonary regurgitant velocity waveform analysis in precapillary pulmonary hypertension.
Int J Cardiovasc Imaging. 2024 Mar 27. doi: 10.1007/s10554-024-03083.
Abstract

GARCIA-LUNAR I, Jorge I, Saiz J, Solanes N, et al
Metabolic changes contribute to maladaptive right ventricular hypertrophy in pulmonary hypertension beyond pressure overload: an integrative imaging and omics investigation.
Basic Res Cardiol. 2024 Mar 27. doi: 10.1007/s00395-024-01041.
Abstract

SCHANZ O, Criner GJ, Rali P, Gayen S, et al
Pulmonary Vasodilator Therapy Is Associated with Decreased Mortality in Patients with Chronic Lung Disease and Severe Pulmonary Hypertension.
J Cardiovasc Dev Dis. 2024;11:89.
Abstract

KULARATNE M, Gerges C, Jevnikar M, Humbert M, et al
Updated Clinical Classification and Hemodynamic Definitions of Pulmonary Hypertension and Its Clinical Implications.
J Cardiovasc Dev Dis. 2024;11:78.
Abstract

USMANI SUR, Hasan SU, Ali SH, Ahmed SH, et al
Perioperative sildenafil therapy in pulmonary hypertension associated with congenital cardiac disease: An updated meta-analysis.
Asian J Surg. 2024 Mar 25:S1015-9584(24)00430.
Abstract

YU H, Lee D, Chae Y, Choi M, et al
Myxomatous mitral valve disease and associated pulmonary hypertension might increase serum angiopoietin-2 in dogs.
Am J Vet Res. 2024 Mar 30:1-9. doi: 10.2460/ajvr.23.12.0289.
Abstract

WANG C, Zhu Q, Tan D, Walline J, et al
Acute High-Output Heart Failure with Pulmonary Hypertension and Severe Liver Injury Caused by Amlodipine Poisoning: A Case Report.
Cardiovasc Toxicol. 2024 Mar 26. doi: 10.1007/s12012-024-09849.
Abstract

ZHAO H, Song J, Li X, Xia Z, et al
The role of immune cells and inflammation in pulmonary hypertension: mechanisms and implications.
Front Immunol. 2024;15:1374506.
Abstract

MAI H, Yang X, Xie Y, Zhou J, et al
Identification of the shared hub gene signatures and molecular mechanisms between HIV-1 and pulmonary arterial hypertension.
Sci Rep. 2024;14:7048.
Abstract

WANG LY, Wang BJ, Gao XY
[Research progress on auxiliary indexes and methods of diagnosis and treatment of patent ductus arteriosus in preterm].
Zhonghua Er Ke Za Zhi. 2024;62:381-384.
Abstract

DENG X, Luo H, He J, Deng W, et al
Omentin-1 ameliorates pulmonary arterial hypertension by inhibiting endoplasmic reticulum stress through AMPKalpha signaling.
Clin Exp Hypertens. 2024;46:2332695.
Abstract

KELLIHAN HB, Cutchin E, Sirochman A, Gasper D, et al
Severe Pulmonary Hypertension and Pulmonary Thrombi in a Dog.
CASE (Phila). 2023;8.
Abstract

WAHADNEH OA, Alitter Q, Raju A, Alziadin N, et al
Prevalence and Impact of Pulmonary Hypertension on Acute Decompensated Heart Failure with Preserved Ejection Fraction Hospitalizations: A Five-Year Retrospective Analysis.
Curr Probl Cardiol. 2024 Mar 22:102537. doi: 10.1016/j.cpcardiol.2024.102537.
Abstract

WU J, Ling Y
A review regarding the article 'Impact of tricuspid regurgitation severity on mortality in pulmonary hypertension patients: A comprehensive analysis.
Curr Probl Cardiol. 2024;49:102535.
Abstract

KRZYZEWSKA A, Baranowska-Kuczko M, Galicka A, Kasacka I, et al
Cannabidiol may prevent the development of congestive hepatopathy secondary to right ventricular hypertrophy associated with pulmonary hypertension in rats.
Pharmacol Rep. 2024 Mar 22. doi: 10.1007/s43440-024-00579.
Abstract

STUBBS HD, Cannon J, Knightbridge E, Durrington C, et al
Sendaway capillary NT-proBNP in pulmonary hypertension.
BMJ Open Respir Res. 2024;11:e002124.
Abstract

WEATHERALD J, Nathan SD, El-Kersh K, Argula RG, et al
Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE study.
BMJ Open Respir Res. 2024;11:e002116.
Abstract

HNATJUK MS, Konovalenko SO, Kritsak MY, Gargula TI, et al
Morphometric aspects of remodeling of the arterial bed of the testicles in post- resection portal and pulmonary hypertensions.
Pol Merkur Lekarski. 2024;52:67-72.
Abstract

VILLAS BOAS HJ, Paschoal IA, Pereira MC
Impulse oscillometry in patients with pulmonary arterial hypertension: an exploratory study.
Clinics (Sao Paulo). 2024;79:100313.
Abstract

YAN X, Huang J, Zeng Y, Zhong X, et al
CGRP attenuates pulmonary vascular remodeling by inhibiting the cGAS-STING-NFkappaB pathway in pulmonary arterial hypertension.
Biochem Pharmacol. 2024;222:116093.
Abstract

HOLT MF, Flo A, Ravnestad H, Bjorno V, et al
Invasive haemodynamics at rest and exercise in cardiac amyloidosis.
ESC Heart Fail. 2024;11:1263-1268.
Abstract

SUBRAMANIAN P, Singhal M, Sharma A
Unique segmental branching of right pulmonary artery in association with patent ductus arteriosus and anomalous carotid origin of left vertebral artery.
Pediatr Pulmonol. 2024;59:1092-1094.
Abstract

YANG T, Li X, Luo Q, Zhao Q, et al
Angiographic classification of total occlusion and its implication on balloon pulmonary angioplasty.
ESC Heart Fail. 2024;11:795-804.
Abstract

XUEYUAN L, Yanping X, Jiaoqiong G, Yuehui Y, et al
Autonomic nervous modulation: early treatment for pulmonary artery hypertension.
ESC Heart Fail. 2024;11:619-627.
Abstract

RASHIDI F, Bilehjani E, Mousavi-Aghdas SA, Parvizi R, et al
Massive primary pulmonary artery rhabomyosarcoma: A case report.
Rom J Intern Med. 2024;62:67-74.
Abstract

LI X, Song L, Lu Z, Tong S, et al
Integrative analyses of whole-transcriptome sequencing reveals CeRNA regulatory network in pulmonary hypertension treated with FGF21.
Int Immunopharmacol. 2024;132:111925.
Abstract

ZHANG P, Da Silva Goncalves Bos D, Vang A, Feord J, et al
Reduced exercise capacity occurs before intrinsic skeletal muscle dysfunction in experimental rat models of pulmonary hypertension.
Pulm Circ. 2024;14:e12358.
Abstract

KONG D, Liu J, Lu J, Zeng C, et al
HMGB2 Release Promotes Pulmonary Hypertension and Predicts Severity and Mortality of Patients With Pulmonary Arterial Hypertension.
Arterioscler Thromb Vasc Biol. 2024 Apr 4. doi: 10.1161/ATVBAHA.123.319916.
Abstract

NASSAR GM, Jameson R, Sathiyaraj S, Bidikian N, et al
Recovery from kidney failure associated with chronic thromboembolic pulmonary hypertension following pulmonary thomboendarterectomy.
Clin Kidney J. 2024;17:sfae047.
Abstract

XING Y, Hou Y, Fan T, Gao R, et al
Endothelial phosphodiesterase 4B inactivation ameliorates endothelial-to-mesenchymal transition and pulmonary hypertension.
Acta Pharm Sin B. 2024;14:1726-1741.
Abstract

OKI T, Nagatani Y, Ishida S, Hashimoto M, et al
Right main pulmonary artery distensibility on dynamic ventilation CT and its association with respiratory function.
Eur Radiol Exp. 2024;8:50.
Abstract

GEGENAVA M, Gegenava T
Association of pulmonary hypertension with outcomes in patients with Systemic sclerosis and other connective tissue disorders: review and meta-analysis.
Sarcoidosis Vasc Diffuse Lung Dis. 2024;41:e2024023.
Abstract

PRICE LC, Kouranos V, Baughman R, Bloom C, et al
Use of pulmonary arterial hypertension therapies in patient swith sarcoidosis-associated pulmonary hypertension.
Sarcoidosis Vasc Diffuse Lung Dis. 2024;41:e2024024.
Abstract

JAEGER P, Toskas I, Henes JK, Shcherbyna S, et al
Impact of pulmonary hypertension on outcomes after TEER in patients suffering from mitral regurgitation.
Clin Res Cardiol. 2024 Apr 2. doi: 10.1007/s00392-024-02442.
Abstract

TANG M, Luo J, Liu Q, Song J, et al
Coexistence of pulmonary arterial hypertension and straight back syndrome in a patient with a novel BMPR2 variant affecting cytoplasmic tail domain.
Eur J Med Res. 2024;29:209.
Abstract

HU X, Lv X, Zhang L, Li SS, et al
Noncoding RNA Lipotherapeutics: A Promising Breakthrough in Pulmonary Hypertension Treatment.
Curr Pharm Biotechnol. 2024 Mar 29. doi: 10.2174/0113892010302590240321073509.
Abstract

VAN KALSBEEK D, Anani AR, El-Kersh K
Pulmonary artery vasodilators for treatment of pulmonary hypertension complicating fibrosing mediastinitis.
Respir Med Case Rep. 2024;49:102006.
Abstract

KHEMCHANDANI M, Nasir K, Qureshi R, Dhrolia M, et al
Frequency of Pulmonary Hypertension and Its Associated Risk Factors in End-Stage Renal Disease (ESRD) Patients on Maintenance Hemodialysis.
Cureus. 2024;16:e55206.
Abstract

KOZAILY E, Akdogan ER, Dorsey NS, Tedford RJ, et al
Management of Pulmonary Hypertension in the Context of Heart Failure with Preserved Ejection Fraction.
Curr Hypertens Rep. 2024 Apr 1. doi: 10.1007/s11906-024-01296.
Abstract

WANG S, Li H, Liu Q, Ma H, et al
Hydroxycitric Acid Tripotassium Hydrate Attenuates Monocrotaline and Hypoxia-Induced Pulmonary Hypertension in Rats.
Int Heart J. 2024;65:318-328.
Abstract

ZUO Y, Li B, Gao M, Xiong R, et al
Novel insights and new therapeutic potentials for macrophages in pulmonary hypertension.
Respir Res. 2024;25:147.
Abstract

CRITSER PJ, Buchmiller TL, Gauvreau K, Zalieckas JM, et al
Exercise-induced Pulmonary Hypertension in Long-term Survivors of Congenital Diaphragmatic Hernia.
J Pediatr. 2024 Mar 27:114034. doi: 10.1016/j.jpeds.2024.114034.
Abstract

THE EDITORS OF THE LANCET RESP
Retraction and republication-Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Lancet Respir Med. 2024;12:262-263.
Abstract

WANG J, Liu C, Huang SS, Wang HF, et al
Functions and novel regulatory mechanisms of key glycolytic enzymes in pulmonary arterial hypertension.
Eur J Pharmacol. 2024;970:176492.
Abstract

CHEN Y, Liu J, Zhang Q, Chai L, et al
Activation of CaMKII/HDAC4 by SDF1 contributes to pulmonary arterial hypertension via stabilization Runx2.
Eur J Pharmacol. 2024;970:176483.
Abstract

MARTINEZ-MENACA A, Mora-Cuesta VM, Iturbe-Fernandez D, Sainz-Ezquerra Belmonte B, et al
Quality of Life and the Cardiopulmonary Exercise Test in Pulmonary Arterial Hypertension Patients.
Arch Bronconeumol. 2024;60:253-255.
Abstract

DISTLER O, Ofner C, Huscher D, Jordan S, et al
Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis.
Rheumatology (Oxford). 2024;63:1139-1146.
Abstract

TODOROKI Y, Satoh M, Kubo S, Kosaka S, et al
Anti-survival motor neuron complex antibodies as a novel biomarker for pulmonary arterial hypertension and interstitial lung disease in mixed connective tissue disease.
Rheumatology (Oxford). 2024;63:1068-1075.
Abstract

YOUSSEF M, Boutros Salama M, Rehman N, Hanna C, et al
Pulmonary hypertension survival and hospitalisations in people living with HIV: a systematic review and meta-analysis.
BMJ Open Respir Res. 2024;11:e002318.
Abstract

ALBULUSHI A, Al-Asmi S, Al-Abri M, Al-Farhan H, et al
The Road to Heart Transplant in a Patient With Cardiomyopathy, Shone Complex, and Severe Pulmonary Hypertension.
JACC Case Rep. 2024;29:102323.
Abstract

PAPAGEORGIOU ST, Damdoumis S, Goulis D, Tzikas S, et al
The Effect of Pulmonary Hypertension on Mortality and Intensive Care Unit Admission in Patients With SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.
Heart Lung Circ. 2024 Apr 9:S1443-9506(24)00076.
Abstract

MORALES-CANO D, Barreira B, Callejo M, Olivencia MA, et al
Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human.
Vascul Pharmacol. 2024 Apr 8:107371. doi: 10.1016/j.vph.2024.107371.
Abstract

SAKARIN S, Rungsipipat A, Roytrakul S, Jaresitthikunchai J, et al
Proteomic analysis of the serum in dogs with pulmonary hypertension secondary to myxomatous mitral valve disease: the preliminary study.
Front Vet Sci. 2024;11:1327453.
Abstract

KISKADDON A, Dang T, Mauriello D
Tadalafil in Neonates and Infants With Pulmonary Hypertension Secondary to Bronchopulmonary Dysplasia.
J Pediatr Pharmacol Ther. 2024;29:140-143.
Abstract

WANG T, Zhou D, Chen Y, Kuang S, et al
Non-invasive estimation of pulmonary hypertension and clinical deterioration risk in pediatric congenital heart disease: Development and validation of predictive tools.
Chin Med J (Engl). 2024 Apr 8. doi: 10.1097/CM9.0000000000003070.
Abstract

KOUDSTAAL T, van den Bosch T, Bergen I, Lila K, et al
Predominance of M2 macrophages in organized thrombi in chronic thromboembolic pulmonary hypertension patients.
Eur J Immunol. 2024 Apr 9:e2350670. doi: 10.1002/eji.202350670.
Abstract

CHAUDHARI T, Schmidt Sotomayor N, Maheshwari R
Diagnosis, management and long term cardiovascular outcomes of phenotypic profiles in pulmonary hypertension associated with congenital diaphragmatic hernia.
Front Pediatr. 2024;12:1356157.
Abstract

WEI X, Zou Y, Dong S, Chen Y, et al
Recombinant hirudin attenuates pulmonary hypertension and thrombosis in acute pulmonary embolism rat model.
PeerJ. 2024;12:e17039.
Abstract

UGWENDUM D, Mbome Y, Arrey Agbor DB, Burkhanova U, et al
Methylphenidate-Induced Non-ischemic Heart Failure With Reduced Ejection Fraction and Mild Pulmonary Hypertension.
Cureus. 2024;16:e55604.
Abstract

PASIANA AD, Idrus HH, Purnamasari I
Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-kappaB Signaling Pathway to Attenuate Vascular Remodeling [LETTER].
Drug Des Devel Ther. 2024;18:1023-1024.
Abstract

SHI TY, Wen XH, Meng J, Lu YW, et al
Effect of IL-17 on pulmonary artery smooth muscle cells and connective tissue disease-associated pulmonary arterial hypertension.
Immun Inflamm Dis. 2024;12:e1243.
Abstract

CHAI Y, Gu X, Zhang H, Xu X, et al
Phoenixin 20 ameliorates pulmonary arterial hypertension via inhibiting inflammation and oxidative stress.
Aging (Albany NY). 2024;16:5027-5037.
Abstract

LAU E, Kotlyar E, Makanji Y, Yu DY, et al
Comparative adherence of macitentan versus ambrisentan and bosentan in Australian patients with pulmonary arterial hypertension: a retrospective real-world database study.
J Med Econ. 2024;27:596-604.
Abstract

STEGER M, Canuet M, Enache I, Goetsch T, et al
Survival and response to pulmonary vasodilator therapies in patients with chronic obstructive pulmonary disease and pulmonary vascular phenotype.
Respir Med. 2024;225:107585.
Abstract

NJOKU F, Pugh N, Brambilla D, Kroner B, et al
Mortality in adults with sickle cell disease: Results from the sickle cell disease implementation consortium (SCDIC) registry.
Am J Hematol. 2024;99:900-909.
Abstract

CHALIA M, Seager E, Rao A, Hannam S, et al
Transient abnormal myelopoiesis requiring advanced neonatal intensive care treatment.
Acta Paediatr. 2024 Feb 8. doi: 10.1111/apa.17142.
Abstract

MURPHY SP, Deferm S, Yucel E, Urbut SM, et al
Right Ventricular - Pulmonary Arterial Coupling and All-Cause Mortality in Patients with Mitral Annular Calcification Related Mitral Valve Dysfunction.
J Am Soc Echocardiogr. 2024 Jan 20:S0894-7317(24)00011.
Abstract

YE P, Deng Y, Gu Y, Liu P, et al
GRK2-YAP signaling is implicated in pulmonary arterial hypertension development.
Chin Med J (Engl). 2024;137:846-858.
Abstract

MEGIED MAAE, Abouelhassan MA, Hadwa ESAES
Prognostic and diagnostic utility of interleukin-6 in pediatric pulmonary arterial hypertension - a case-control study.
Eur J Pediatr. 2024;183:1637-1643.
Abstract

BESSA-GONCALVES M, Braganca B, Martins-Dias E, Vinhas A, et al
Blockage of the adenosine A(2B) receptor prevents cardiac fibroblasts overgrowth in rats with pulmonary arterial hypertension.
Purinergic Signal. 2024;20:163-179.
Abstract

SANCHEZ-HOLGADO M, Bravo MC, Alvarez-Garcia P, Lopez-Ortego P, et al
Severe pulmonary hypertension and circulatory failure associated with Congenital syphilis. Case report.
J Neonatal Perinatal Med. 2024 Apr 13. doi: 10.3233/NPM-230133.
Abstract

ZHOU Z, Gu Y, Tian L, Zheng H, et al
Development and Validation of a Nomogram of Persistent Pulmonary Hypertension in Adult Pretricuspid Shunts After Correction.
J Am Heart Assoc. 2024 Apr 19:e032412. doi: 10.1161/JAHA.123.032412.
Abstract

AMERI P, Mercurio V, Pollesello P, Anker MS, et al
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function.
Eur J Heart Fail. 2024 Apr 19. doi: 10.1002/ejhf.3236.
Abstract

YANG L, Peng Z, Gong F, Yan W, et al
TRPC4 Aggravates Hypoxic Pulmonary Hypertension by Promoting Pulmonary Endothelial Cell Apoptosis.
Free Radic Biol Med. 2024 Apr 16:S0891-5849(24)00403.
Abstract

MURAYAMA M, Sugimori H, Yoshimura T, Kaga S, et al
Deep learning to assess right ventricular ejection fraction from two-dimensional echocardiograms in precapillary pulmonary hypertension.
Echocardiography. 2024;41:e15812.
Abstract

LI X, Tan JS, Xu J, Zhao Z, et al
Causal impact of gut microbiota and associated metabolites on pulmonary arterial hypertension: a bidirectional Mendelian randomization study.
BMC Pulm Med. 2024;24:185.
Abstract

BHATTACHARYA S
Emergencies in Pulmonary Hypertension.
Cardiol Clin. 2024;42:273-278.
Abstract

LUO T, Wu H, Zhu W, Zhang L, et al
Emerging therapies: Potential roles of SGLT2 inhibitors in the management of pulmonary hypertension.
Respir Med. 2024 Apr 15:107631. doi: 10.1016/j.rmed.2024.107631.
Abstract

SHIM YD, Chen MC, Ha S, Chang HJ, et al
Multi-scaled temporal modeling of cardiovascular disease progression: An illustration of proximal arteries in pulmonary hypertension.
J Biomech. 2024;168:112059.
Abstract

KHAN SL, Danoff SK, Kulkarni T, Reichuber J, et al
Practice Patterns for Screening and Treating Interstitial Lung Disease-related Pulmonary Hypertension at Specialty Care Centers in the United States.
Ann Am Thorac Soc. 2024 Apr 16. doi: 10.1513/AnnalsATS.202402.
Abstract

MA Y, Guo D, Wang J, Gong J, et al
Effects of right ventricular remodeling in chronic thromboembolic pulmonary hypertension on the outcomes of balloon pulmonary angioplasty: a 2D-speckle tracking echocardiography study.
Respir Res. 2024;25:164.
Abstract

ADRIAN RJ, Alerhand S, Liteplo A, Shokoohi H, et al
Is pulmonary hypertension protective against cardiac tamponade? A systematic review.
Intern Emerg Med. 2024 Apr 15. doi: 10.1007/s11739-024-03566.
Abstract

ZHOU R, Li R, Ding Q, Zhang Y, et al
OPN silencing reduces hypoxic pulmonary hypertension via PI3K-AKT-induced protective autophagy.
Sci Rep. 2024;14:8670.
Abstract

KIM C, Kim S, Kim H, Hwang J, et al
Long-term impact of late pulmonary hypertension requiring medication in extremely preterm infants with severe bronchopulmonary dysplasia.
Sci Rep. 2024;14:8705.
Abstract

BOYLE TA, Ha B, Haq I, Killu A, et al
Atrial Fibrillation Ablation in Patients with Pulmonary Hypertension: Multicenter Experience.
Heart Rhythm. 2024 Apr 13:S1547-5271(24)02383.
Abstract

MORELL E, Colglazier E, Becerra J, Stevens L, et al
A single institution anesthetic experience with catheterization of pediatric pulmonary hypertension patients.
Pulm Circ. 2024;14:e12360.
Abstract

PU Y, Li G, Zhang T, Cui Y, et al
Intravascular ultrasound imaging of pulmonary artery with high-altitude pulmonary hypertension.
Quant Imaging Med Surg. 2024;14:3204-3209.
Abstract

LABYK A, Krakowian M, Mysiorski L, Lichodziejewska B, et al
Refined balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension - reference center experience.
Postepy Kardiol Interwencyjnej. 2024;20:84-88.
Abstract

GAO YH, Zhu YN, Bai JW, Liang S, et al
Severe Pulmonary Hypertension Increased All-cause Mortality in Patients With Bronchiectasis.
Arch Bronconeumol. 2024 Mar 23:S0300-2896(24)00073.
Abstract

WANG L, Liu J, Zhou L, Fu Q, et al
Serum PM20D1 levels in patients with idiopathic pulmonary arterial hypertension and its clinical significance.
BMC Cardiovasc Disord. 2024;24:207.
Abstract

GOHIR Q, Ghosh S, Bosher O, Crawford E, et al
Pleural-based giant solitary fibrous tumour with associated hypoglycaemia: unusual presentation with pulmonary hypertension in a patient with Doege-Potter syndrome.
Clin Med (Lond). 2023;23:518-520.
Abstract

VIRSINSKAITE R, Karia N, Kotecha T, Schreiber BE, et al
Pulmonary hypertension - the latest updates for physicians.
Clin Med (Lond). 2023;23:449-454.
Abstract

SCHULZE KM, Horn AG, Muller-Delp JM, White ZJ, et al
Pulmonary hypertension impairs vasomotor function in rat diaphragm arterioles.
Microvasc Res. 2024 Apr 11:104686. doi: 10.1016/j.mvr.2024.104686.
Abstract

KLEIN F, Dinesh S, Fiedler D, Grun K, et al
Identification of Serum Interleukin-22 as Novel Biomarker in Pulmonary Hypertension: A Translational Study.
Int J Mol Sci. 2024;25:3985.
Abstract

ISRAEL-BIET D, Pastre J, Nunes H
Sarcoidosis-Associated Pulmonary Hypertension.
J Clin Med. 2024;13:2054.
Abstract

KLETZER J, Scharinger B, Demirel O, Kaufmann R, et al
Radiological Parameters for the Detection of Pulmonary Hypertension in Severe Aortic Valve Stenosis and Their Influence on Mortality: Does Sex Matter?
J Clin Med. 2024;13:1999.
Abstract

TATSUOKA Y, Carr ZJ, Jayakumar S, Lin HM, et al
Pulmonary Hypertension and the Risk of 30-Day Postoperative Pulmonary Complications after Gastrointestinal Surgical or Endoscopic Procedures: A Retrospective Propensity Score-Weighted Cohort Analysis.
J Clin Med. 2024;13:1996.
Abstract

ANAND S, Cronin EM
Arrhythmias in Patients with Pulmonary Hypertension and Right Ventricular Failure: Importance of Rhythm Control Strategies.
J Clin Med. 2024;13:1866.
Abstract

BRAUNLICH J, Seyfarth HJ, Wirtz H
Effect of Nasal High Flow (NHF) on Right Heart Function in Stable Patients with Pulmonary Hypertension of Different WHO Classes.
J Clin Med. 2024;13:1862.
Abstract

ARAVAMUDHAN A, Dieffenbach PB, Choi KM, Link PA, et al
Non-canonical IKB kinases regulate YAP/TAZ and pathological vascular remodeling behaviors in pulmonary artery smooth muscle cells.
Physiol Rep. 2024;12:e15999.
Abstract

KUMAR A, Raj S, Singh S, Ghotra GS, et al
Empowering Little Fighters: Post-Cardiotomy Pediatric ECMO and the Journey to Recovery.
Ann Card Anaesth. 2024;27:128-135.
Abstract

ALI AF, Miyasaka R, Jellis CL
It's All About That Right Ventricle.
J Am Heart Assoc. 2024;13:e034711.
Abstract

JOSE A, Rahman N, Opotowsky AR, Glorioso TJ, et al
Association of Cardiopulmonary Hemodynamics and Mortality in Veterans With Liver Cirrhosis: A Retrospective Cohort Study.
J Am Heart Assoc. 2024;13:e033847.
Abstract

ZHOU X, Liang B, Lin W, Zha L, et al
Identification of MACC1 as a potential biomarker for pulmonary arterial hypertension based on bioinformatics and machine learning.
Comput Biol Med. 2024;173:108372.
Abstract

ALMUTAIRI M, Hefnawy A, Almotairy A, Alobaida A, et al
Formulation and evaluation of inhaled Sildenafil-loaded PLGA microparticles for treatment of pulmonary arterial hypertension (PAH): A novel high drug loaded formulation and scalable process via hot melt extrusion technology (Part ?).
Int J Pharm. 2024;655:124044.
Abstract

ORNOWSKA S, Wudarski M, Dziewiecka E, Olesinska M, et al
Naifold capillaroscopy in mixed connective tissue disease patients.
Clin Rheumatol. 2024;43:1703-1709.
Abstract

CARRARO CC, Turck P, Bahr A, Donatti L, et al
Effect of free and nanoemulsified beta-caryophyllene on monocrotaline-induced pulmonary arterial hypertension.
Biochim Biophys Acta Mol Cell Res. 2024;1871:119704.
Abstract

CAMARDA ND, Ibarrola J, Biwer LA, Jaffe IZ, et al
Mineralocorticoid Receptors in Vascular Smooth Muscle: Blood Pressure and Beyond.
Hypertension. 2024;81:1008-1020.
Abstract

HAKGOR A, Dursun A, Kahraman BC, Yazar A, et al
Prognostic impact of main pulmonary artery to ascending aorta diameter ratio in patients with severe aortic stenosis underwent transcatheter aortic valve implantation.
Catheter Cardiovasc Interv. 2024 Feb 28. doi: 10.1002/ccd.31000.
Abstract

LIO KU, Bashir R, Lakhter V, Li S, et al
Impact of reperfusion therapies on clot resolution and long-term outcomes in patients with pulmonary embolism.
J Vasc Surg Venous Lymphat Disord. 2024 Feb 16:101823.
Abstract

AL TABOSH T, Liu H, Koca D, Al Tarrass M, et al
Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors.
Angiogenesis. 2024;27:211-227.
Abstract

LIU H, Zhang Q, Liu C, Zhang Y, et al
Human umbilical cord mesenchymal stromal cell-derived exosomes alleviate hypoxia-induced pulmonary arterial hypertension in mice via macrophages.
Stem Cells. 2023 Dec 28:sxad098. doi: 10.1093.
Abstract

BRENNER R, Drescher T, Locher R, Bilz S, et al
Pulmonary and systemic hemodynamics in patients with hyperthyroidism.
Am J Med. 2023 Dec 15:S0002-9343(23)00760-X. doi: 10.1016/j.amjmed.2023.
Abstract

SURUGA K, Shimokawahara H, Miyagi A, Sugiyama Y, et al
Flow Grade-Based Success Rates, Complication Rates, and Balloon Pulmonary Angioplasty Patency for Total Occlusions.
Can J Cardiol. 2024;40:625-633.
Abstract

HE Y, Li Q, Zhang C, Keller BB, et al
Treprostinil Effectiveness in Higher-Risk Pediatric Patients With Idiopathic and Heritable Pulmonary Arterial Hypertension.
Can J Cardiol. 2024;40:613-621.
Abstract

CORONA LFV, Reyna TSR
Right Ventricle and Autoimmune Diseases.
Curr Rheumatol Rev. 2024;20:127-132.
Abstract

KUBOTA K, Miyanaga S, Akao M, Mitsuyoshi K, et al
Association of delayed diagnosis of pulmonary arterial hypertension with its prognosis.
J Cardiol. 2024;83:365-370.
Abstract

DEBOER EM, Wolter-Warmerdam K, Deterding RR, Marmolejo J, et al
Cardiopulmonary Phenotypes and Protein Signatures in Children With Down Syndrome.
Clin Pediatr (Phila). 2024;63:474-481.
Abstract

NAGUIB M, Aljwaid A, Marella D, Flores RJ, et al
Nitroprusside Combined with Leg Raise at the Time of Right Heart Catheterization to Differentiate Precapillary from Other Hemodynamic Forms of Pulmonary Hypertension: A Single-Center Pilot Study.
J Cardiovasc Dev Dis. 2024;11:124.
Abstract

ZHANG C, Du Q, Zhou X, Qu T, et al
Differential expression and analysis of extrachromosomal circular DNAs as serum biomarkers in pulmonary arterial hypertension.
Respir Res. 2024;25:181.
Abstract

SUN H, Du Z, Zhang X, Gao S, et al
Neutrophil extracellular traps promote proliferation of pulmonary smooth muscle cells mediated by CCDC25 in pulmonary arterial hypertension.
Respir Res. 2024;25:183.
Abstract

HORIKAWA R, Suzuki R, Yuchi Y, Satomi S, et al
Pulmonary thrombotic pulmonary hypertension managed using antithrombotic and pulmonary vasodilator treatment.
J Vet Intern Med. 2024 Apr 25. doi: 10.1111/jvim.17089.
Abstract

PENG W, Zhang ZY, Xiao YB
[Research progress on bioinformatics in pulmonary arterial hypertension].
Zhongguo Dang Dai Er Ke Za Zhi. 2024;26:425-431.
Abstract

ABDULFATTAH A, John S
Navigating Diagnostic Challenges: Severe Pulmonary Hypertension in Acute Exacerbation of Chronic Obstructive Pulmonary Disease vs. Pulmonary Embolism.
Cureus. 2024;16:e56907.
Abstract

FORTMEIER V, Korber MI, Rommel KP, Stolz L, et al
New Diagnostic Criteria for Pulmonary Hypertension: Impact on Survival Prognostication Following Transcatheter Tricuspid Valve Intervention.
JACC Cardiovasc Interv. 2024;17:1073-1075.
Abstract

WANG B, Xu Y, Huang Y, Shao S, et al
miR-210-5p Promotes Pulmonary Hypertension by Blocking ATP2A2.
Cardiovasc Drugs Ther. 2024 Apr 24. doi: 10.1007/s10557-024-07568.
Abstract

SOARES LL, Leite LB, Freitas MO, Ervilha LOG, et al
Effect of experimental pulmonary arterial hypertension on renal and bone parameters of rats submitted to resistance exercise training.
An Acad Bras Cienc. 2024;96:e20230446.
Abstract

XU J, Sun X, Cao Y, Zhu H, et al
Fractional exhaled nitric oxide in idiopathic pulmonary arterial hypertension and mixed connective tissue disease complicating pulmonary hypertension.
BMC Pulm Med. 2024;24:199.
Abstract

HOU Q, Jiang J, Na K, Zhang X, et al
Potential therapeutic targets for COVID-19 complicated with pulmonary hypertension: a bioinformatics and early validation study.
Sci Rep. 2024;14:9294.
Abstract

ALBULUSHI A, Al-Riyami MB, Al-Rawahi N, Al-Mukhaini M, et al
Effectiveness of Mechanical Circulatory Support Devices in Reversing Pulmonary Hypertension Among Heart Transplant Candidates: A Systematic Review.
Curr Probl Cardiol. 2024 Apr 21:102579. doi: 10.1016/j.cpcardiol.2024.102579.
Abstract

SADDOUK FZ, Kuzemczak AP, Saito J, Greif DM, et al
Endothelial HIFalpha-PDGF-B to smooth muscle Beclin1 signaling sustains pathological muscularization in pulmonary hypertension.
JCI Insight. 2024 Apr 23:e162449. doi: 10.1172/jci.insight.162449.
Abstract

PENUMATSA KC, Sharma Y, Warburton RR, Singhal A, et al
Lung-specific interleukin 6 mediated transglutaminase 2 activation and cardiopulmonary fibrogenesis.
Front Immunol. 2024;15:1371706.
Abstract

JIN J, Hao W, Xie D
Meta-analysis of the correlation between pulmonary hypertension and echocardiographic parameters in patients with chronic kidney disease.
PeerJ. 2024;12:e17245.
Abstract

CHEN Y, Zhang S, Lu X, Xie W, et al
Unusual cause of muscle weakness, type II respiratory failure and pulmonary hypertension: a case report of ryanodine receptor type 1(RYR1)-related myopathy.
BMC Pulm Med. 2024;24:194.
Abstract

LENKA J, Foley R, Metersky M, Salmon A, et al
Relationship between obstructive sleep apnea and pulmonary hypertension: past, present and future.
Expert Rev Respir Med. 2024 Apr 24:1-13. doi: 10.1080/17476348.2024.2345684.
Abstract

GOPAGONDANAHALLI KR, Abdul Haium AA, Vora SJ, Sundararaghavan S, et al
Serial tissue Doppler imaging in the evaluation of bronchopulmonary dysplasia-associated pulmonary hypertension among extremely preterm infants: a prospective observational study.
Front Pediatr. 2024;12:1349175.
Abstract

QIU LL, Li Y, Pei LJ, Ma GT, et al
[Successful rescue of postpartum pulmonary hypertension crisis: a multidisciplinary approach in a case report].
Zhonghua Xin Xue Guan Bing Za Zhi. 2024;52:420-424.
Abstract

SMOLICH JJ, Kenna KR, Mynard JP
Extended period of ventilation before delayed cord clamping augments left-to-right shunting and decreases systemic perfusion at birth in preterm lambs.
J Physiol. 2024;602:1791-1813.
Abstract

NOVARA ME, Di Martino E, Stephens B, Nayrouz M, et al
Future Perspectives of Pulmonary Arterial Hypertension: A Review of Novel Pipeline Treatments and Indications.
Drugs R D. 2024;24:13-28.
Abstract

ERDOGAN M, Esatoglu SN, Kilickiran Avci B, Hatemi G, et al
Treatment of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review and meta-analysis.
Intern Emerg Med. 2024;19:731-743.
Abstract

IVY D, Beghetti M, Juaneda-Simian E, Ravindranath R, et al
Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study.
Eur J Pediatr. 2024;183:2141-2153.
Abstract

HUNG JH, Langlois S, Wiebe M, Wild B, et al
Increased Elastase and Matrix Metalloproteinase Levels in the Pulmonary Arteries of Infants With Congenital Diaphragmatic Hernia.
J Pediatr Surg. 2024 Feb 1:S0022-3468(24)00060.
Abstract

PERURENA-PRIETO J, Callejas-Moraga EL, Sanz-Martinez MT, Colobran R, et al
Prognostic value of anti-IFI16 autoantibodies in pulmonary arterial hypertension and mortality in patients with systemic sclerosis.
Med Clin (Barc). 2024;162:370-377.
Abstract

APPADURAI V, Kinno M, Minga I, Slostad B, et al
The value of ultrasound enhancing agents in the echocardiographic acquisition of pulmonary artery systolic pressure: An invasive to non-invasive correlation study.
Int J Cardiovasc Imaging. 2024;40:821-830.
Abstract

DISTLER O, Bonderman D, Coghlan JG, Denton CP, et al
Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines.
Arthritis Rheumatol. 2024;76:777-782.
Abstract

PULIGANDLA P, Skarsgard E, Baird R, Guadagno E, et al
Diagnosis and management of congenital diaphragmatic hernia: a 2023 update from the Canadian Congenital Diaphragmatic Hernia Collaborative.
Arch Dis Child Fetal Neonatal Ed. 2024;109:239-252.
Abstract

GOL D, Vyas A, Visana N, Patel A, et al
Stability Indicating RP-HPLC-DAD method for simultaneous estimation of tadalafil and macitentan in synthetic mixture for treatment of pulmonary arterial hypertension.
Ann Pharm Fr. 2024;82:464-472.
Abstract

WANG J, Lei K, Li J, Zhang Y, et al
Analysis of clinical features and prognostic factors in Takayasu arteritis involving pulmonary hypertension: A retrospective study.
Medicine (Baltimore). 2024;103:e37992.
Abstract

NIKITIN D, Lin GA, Whittington MD, Nhan E, et al
The effectiveness and value of sotatercept for pulmonary arterial hypertension: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory Council.
J Manag Care Spec Pharm. 2024;30:491-495.
Abstract

TOROK RD, Gardner RA, Barker PCA, McCrary AW, et al
Correlating Severity of Pulmonary Hypertension by Echocardiogram with Mortality in Premature Infants with Bronchopulmonary Dysplasia.
Am J Perinatol. 2024 May 2. doi: 10.1055/s-0044-1786544.
Abstract

LIU W, Xu Y, Yang L, Zhan S, et al
Risk factors associated with pulmonary hypertension in patients with active tuberculosis and tuberculous destroyed lung: a retrospective study.
Sci Rep. 2024;14:10108.
Abstract

Sotatercept (Winrevair) for pulmonary arterial hypertension.
Med Lett Drugs Ther. 2024;66:73-75.
Abstract

CAZEIRO DI, Placido R, Raposo MA, Brito J, et al
Pulmonary Arterial Hypertension with Features of Venous Involvement: A Detective's Task.
Arq Bras Cardiol. 2024;121:e20230565.
Abstract

BJORK S, Jain D, Marliere MH, Predescu SA, et al
Obstructive Sleep Apnea, Obesity Hypoventilation Syndrome, and Pulmonary Hypertension: A State-of-the-Art Review.
Sleep Med Clin. 2024;19:307-325.
Abstract

LI H, Li J, Huang J, Jiang D, et al
A review regarding the article 'Effectiveness of Mechanical Circulatory Support Devices in Reversing Pulmonary Hypertension Among Heart Transplant Candidates: A Systematic Review.'.
Curr Probl Cardiol. 2024 Apr 29:102614. doi: 10.1016/j.cpcardiol.2024.102614.
Abstract

YOKOKAWA T, Nishiura K, Katahira M, Sato Y, et al
Collagen triple helix repeat-containing protein 1 is a novel biomarker of right ventricular involvement in pulmonary hypertension.
Can J Cardiol. 2024 Apr 29:S0828-282X(24)00337.
Abstract

FISH A, Wang D, Knight E, Pollak J, et al
Recurrence of Pulmonary Arteriovenous Malformation after Embolization in Patients with Pulmonary Hypertension.
J Vasc Interv Radiol. 2024 Apr 29:S1051-0443(24)00322.
Abstract

SATO M, Saiki H, Saito K, Sato A, et al
Successful Atrial Septal Defect Closure Subsequent to Medical Pulmonary Preconditioning in an Infant With Severe Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia.
Cureus. 2024;16:e57290.
Abstract

ENENCHE AA, Kweki AG, Aiwuyo HO, Akinti OM, et al
Prevalence of Pulmonary Hypertension in Liver Cirrhosis Patients: A Cross-Sectional Analytical Study.
Cureus. 2024;16:e57313.
Abstract

KUMAR S, Mickael C, Kumar R, Prasad RR, et al
Single cell transcriptomic analyses reveal diverse and dynamic changes of distinct populations of lung interstitial macrophages in hypoxia-induced pulmonary hypertension.
Front Immunol. 2024;15:1372959.
Abstract

DALLAPE DE LA RETA N, Oscos M, Pedroni P, Giachello F, et al
Extrinsic compression of left main coronary artery due to pulmonary artery aneurysm and pulmonary hypertension.
Radiol Case Rep. 2024;19:2837-2840.
Abstract

KREMER N, Glocker F, Schafer S, Rako Z, et al
Precision cardiac monitoring: algorithmic real-time assessment of right ventricular function in pulmonary hypertension.
ESC Heart Fail. 2024 Apr 30. doi: 10.1002/ehf2.14833.
Abstract

LAMMI MR, Mukherjee M, Saketkoo LA, Carey K, et al
Sildenafil Versus Placebo for Early Pulmonary Vascular Disease in Scleroderma (SEPVADIS): protocol for a randomized controlled trial.
BMC Pulm Med. 2024;24:211.
Abstract

MORALES-DEMORI R, Coleman R, Mallory GB
Pediatric Pulmonary Hypertension.
Pediatr Rev. 2024;45:251-259.
Abstract

JANG D, Darling R, Choudhary G, Jankowich M, et al
Hemorrhagic Adverse Events of Transthoracic Needle Biopsy of the Lung in Patients with Pulmonary Hypertension: A Systematic Review and Meta-AnalysisPercutaneous.
J Vasc Interv Radiol. 2024 Apr 27:S1051-0443(24)00319.
Abstract

SATO T, Fukui S, Nakano T, Hasegawa K, et al
Balloon pulmonary angioplasty under awake veno-arterial extracorporeal membrane oxygenation in a patient with class III obesity with chronic thromboembolic pulmonary hypertension complicated with multiple serious comorbidities.
Pulm Circ. 2024;14:e12377.
Abstract

KE DYJ, Tso M, Johri AM
The Application of Point of Care Ultrasound to Screen for Pulmonary Hypertension: A Narrative Review.
POCUS J. 2024;9:109-116.
Abstract

MILARA J, Roger I, Montero P, Artigues E, et al
Targeting IL-11 to reduce fibrocyte circulation and lung accumulation in animal models of pulmonary hypertension-associated lung fibrosis.
Br J Pharmacol. 2024 Apr 28. doi: 10.1111/bph.16393.
Abstract

ORBAEK ANDERSEN M, Carlsen J
Continuous heart monitoring in patients with pulmonary hypertension smartwatches and direct transmission to their electronic health records: A trial design.
Contemp Clin Trials. 2024;142:107548.
Abstract

HOBOHM L, Paschke LM, Farmakis IT, Barco S, et al
Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: data from a practice-based longitudinal cohort.
J Thromb Haemost. 2024 Apr 25:S1538-7836(24)00227.
Abstract

JOHNSON CA JR, Cortelli M Jr, Glomp G, Cagnolatti C, et al
A Dynamic Sheep Model to Induce Pulmonary Hypertension and Right Ventricular Failure.
Methods Mol Biol. 2024;2803:239-258.
Abstract

KATZ MG, Hadas Y, Shtraizent N, Ravvin S, et al
Unilateral Lung Removal in Combination with Monocrotaline or SU5416 in Rodents: A Reliable Model to Mimic the Pathology of the Human Pulmonary Hypertension.
Methods Mol Biol. 2024;2803:173-185.
Abstract

BIKOU O, Sassi Y
The Sugen/Hypoxia Rat Model for Pulmonary Hypertension and Right Heart Failure.
Methods Mol Biol. 2024;2803:163-172.
Abstract

ZHANG J, Wen Y, Yin Y, Zhang Y, et al
Impression life with pulmonary hypertension: clinically relevant characteristics and quality of life among patients in Gansu, China.
Ther Adv Respir Dis. 2024;18:17534666241246428.
Abstract

KRIGERE A, Kalejs VR, Kaulins R, Rudzitis A, et al
The Initial Experience of Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in Latvia.
Medicina (Kaunas). 2024;60:568.
Abstract

YE L, Liu R, Li Q, Zhou C, et al
Dysregulated VEGF/VEGFR-2 Signaling and Plexogenic Lesions in the Embryonic Lungs of Chickens Predisposed to Pulmonary Arterial Hypertension.
Int J Mol Sci. 2024;25:4489.
Abstract

CARDOUAT G, Douard M, Bouchet C, Roubenne L, et al
NGF increases Connexin-43 expression and function in pulmonary arterial smooth muscle cells to induce pulmonary artery hyperreactivity.
Biomed Pharmacother. 2024;174:116552.
Abstract

STRICKLAND B, Stuart Harris N
Adapting nitric oxide: A review of its foundation, uses in austere medical conditions, and emerging applications.
Nitric Oxide. 2024;146:58-63.
Abstract

CHEN X, Yu X, Lian G, Tang H, et al
Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension.
Biomed Pharmacother. 2024;174:116505.
Abstract

CHEN YJ, Li HF, Zhao FR, Yu M, et al
Spermidine attenuates monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting purine metabolism and polyamine synthesis-associated vascular remodeling.
Int Immunopharmacol. 2024;132:111946.
Abstract

ZHANG JJ, Mao-Mao, Shao MM, Wang MC, et al
Therapeutic potential of natural flavonoids in pulmonary arterial hypertension: A review.
Phytomedicine. 2024;128:155535.
Abstract

MEYER FJ, Opitz C
Post-Pulmonary Embolism Syndrome: An Update Based on the Revised AWMF-S2k Guideline.
Hamostaseologie. 2024;44:128-134.
Abstract

LEI W, Chen MH, Huang ZF, Chen XY, et al
Salidroside protects pulmonary artery endothelial cells against hypoxia-induced apoptosis via the AhR/NF-kappaB and Nrf2/HO-1 pathways.
Phytomedicine. 2024;128:155376.
Abstract

VOS JL, Lemmers JMJ, El Messaoudi S, Snoeren M, et al
Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis-related pulmonary arterial hypertension.
Eur Heart J Cardiovasc Imaging. 2024;25:708-717.
Abstract

BABA S, Ogawa E, Akagi K, Matsuda K, et al
Hemodynamic and Clinical Response to Liver Transplantation in Children and Young Adults POPH Patients.
Pediatr Cardiol. 2024;45:1142-1150.
Abstract

ZHANG L, Gu X
4-hydroxysesamin protects rat with right ventricular failure due to pulmonary hypertension by inhibiting JNK/p38 MAPK signaling.
Aging (Albany NY). 2024;16.
Abstract

FREIDKIN L, Kramer MR, Rosengarten D, Izhakian S, et al
The acute effect of inhaled nitric oxide on the exercise capacity of patients with advanced interstitial lung disease: a randomized controlled trial.
BMC Pulm Med. 2024;24:226.
Abstract

SHREYAS R, Patteri A, Hayagrivas MB, Singla T, et al
Fatal pulmonary arterial hypertension (PAH): A rare association of anti-MDA-5 positive juvenile dermatomyositis.
Int J Rheum Dis. 2024;27:e15180.
Abstract

WANG D, Huang S, Cao J, Feng Z, et al
A comprehensive study on machine learning models combining with oversampling for bronchopulmonary dysplasia-associated pulmonary hypertension in very preterm infants.
Respir Res. 2024;25:199.
Abstract

LI XC, Zhu XY, Wang YY, Tong SL, et al
Canagliflozin alleviates pulmonary hypertension by activating PPARgamma and inhibiting its S225 phosphorylation.
Acta Pharmacol Sin. 2024 May 8. doi: 10.1038/s41401-024-01286.
Abstract

ORBAEK ANDERSEN M, Diederichsen SZ, Svendsen JH, Carlsen J, et al
Continuous heart monitoring to evaluate treatment effects in pulmonary hypertension.
Open Heart. 2024;11:e002710.
Abstract

SHUFIAN ISHTIAQ AHMED A, Blood AB, Zhang L
Hypoxia-induced pulmonary hypertension in adults and newborns: implications for drug development.
Drug Discov Today. 2024 May 6:104015. doi: 10.1016/j.drudis.2024.104015.
Abstract

ZHANG Y, Wen J, Zeng M, Zhang L, et al
A Nomogram Prediction Model for Persistent Pulmonary Hypertension of the Newborn in Neonates Hospitalized for the First Time After Birth.
Pediatr Emerg Care. 2024 May 9. doi: 10.1097/PEC.0000000000003167.
Abstract

ACAR C, Sahin G, Yuksel HC, Karaca B, et al
Rare immune-related adverse effect of pembrolizumab: pulmonary hypertension.
J Chemother. 2024 May 8:1-6. doi: 10.1080/1120009X.2024.2349858.
Abstract

ZHANG Q, Liu H, Liu C, Wang Y, et al
Tibetan Mesenchymal Stem Cell-derived Exosomes Alleviate Pulmonary Vascular Remodeling in Hypoxic Pulmonary Hypertension Rats.
Stem Cells. 2024 May 8:sxae032. doi: 10.1093.
Abstract

CORDA A, Corda F, Pentcheva P, Puci M, et al
The echocardiographic pulmonary to left atrial ratio: A noninvasive variable for the hemodynamic classification of pulmonary hypertension in dogs.
J Vet Intern Med. 2024 May 7. doi: 10.1111/jvim.17097.
Abstract

MA JI, Owunna N, Jiang NM, Huo X, et al
Sex Differences in Pulmonary Hypertension and Associated Right Ventricular Dysfunction.
medRxiv [Preprint]. 2024 Apr 27:2024.04.25.24306398.
Abstract

LIU Q, Zhao C, Dang P, Li Y, et al
Prognostic value of pulmonary hypertension with a nomogram in acute myocardial infarction patients with reduced left ventricular function.
Front Cardiovasc Med. 2024;11:1368139.
Abstract

ZHANG J, Dong F, Ju G, Pan X, et al
Sodium Houttuyfonate Alleviates MCT-induced Pulmonary Hypertension by Regulating Orai1 and Orai2.
Am J Respir Cell Mol Biol. 2024 May 6. doi: 10.1165/rcmb.2023-0015.
Abstract

SAKARIN S, Rungsipipat A, Roytrakul S, Jaresitthikunchai J, et al
Phosphoproteomics analysis of serum from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease.
PeerJ. 2024;12:e17186.
Abstract

ALMUTAIRY BK, Khafagy ES, Aldawsari MF, Alshetaili A, et al
Tailoring of Bilosomal Nanogel for Augmenting the Off-Label Use of Sildenafil Citrate in Pediatric Pulmonary Hypertension.
ACS Omega. 2024;9:19536-19547.
Abstract

MERRILL K, Davis A, Jackson E, Riker M, et al
Direct prostacyclin transition in pediatric patients with pulmonary hypertension.
Pulm Circ. 2024;14:e12373.
Abstract

[Consensus on the procedure of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension].
Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:404-418.
Abstract

ZHANG S, Gao L, Li S, Luo M, et al
Association of non-insulin-based insulin resistance indices with disease severity and adverse outcome in idiopathic pulmonary arterial hypertension: a multi-center cohort study.
Cardiovasc Diabetol. 2024;23:154.
Abstract

TANG B, Vadgama A, Redmann B, Hong J, et al
Charting the cellular landscape of pulmonary arterial hypertension through single-cell omics.
Respir Res. 2024;25:192.
Abstract

MALIK AA, Saraswati U, Miranda WR, Covington M, et al
Invasive Cardiac Hemodynamics in Apical Hypertrophic Cardiomyopathy.
J Am Heart Assoc. 2024;13:e032520.
Abstract

ZHANG Z, Kutty S, Peng W, Zeng G, et al
Causal association of depression, anxiety, cognitive performance, the brain cortical structure with pulmonary arterial hypertension: A Mendelian randomization study.
J Affect Disord. 2024;356:356-362.
Abstract

YAMAMURA A, Fujiwara M, Kawade A, Amano T, et al
Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension.
Eur J Pharmacol. 2024;973:176564.
Abstract

HIRAKAWA K, Asano R, Ueda J, Aoki T, et al
Calcium channel blockers in patients with pulmonary arterial hypertension receiving PAH-specific treatment.
Int J Cardiol. 2024;406:132043.
Abstract

MANZI G, Recchioni T, Badagliacca R, Papa S, et al
Fixed-dose combination therapy in pulmonary arterial hypertension: Pros & cons.
Int J Cardiol. 2024;406:132003.
Abstract

KINGWELL K
FDA approves Merck & Co's pulmonary arterial hypertension drug sotatercept.
Nat Rev Drug Discov. 2024;23:327.
Abstract

RATWATTE S, Stewart S, Strange G, Playford D, et al
Association of Pulmonary Artery Pressures With Mortality in Adults With Reduced Left Ventricular Ejection Fraction.
JACC Heart Fail. 2024;12:936-945.
Abstract

WANG Z, Zhang YX, Shi JZ, Yan Y, et al
RNA m6A methylation and regulatory proteins in pulmonary arterial hypertension.
Hypertens Res. 2024;47:1273-1287.
Abstract

KNIGHT DS, Virsinskaite R, Karia N, Cole AR, et al
Native myocardial T1 and right ventricular size by CMR predict outcome in systemic sclerosis-associated pulmonary hypertension.
Rheumatology (Oxford). 2024 May 17:keae141. doi: 10.1093.
Abstract

HU T, Mu C, Li Y, Hao W, et al
GPS2 ameliorates cigarette smoking-induced pulmonary vascular remodeling by modulating the ras-Raf-ERK axis.
Respir Res. 2024;25:210.
Abstract

GRATE JC, Reynolds TS, Gordon AC, Dave SB, et al
Infected Thrombosis Leading to Veno-Venous Extracorporeal Membrane Oxygenation Dysfunction in Chronic Thromboembolic Pulmonary Hypertension.
ASAIO J. 2024 May 17. doi: 10.1097/MAT.0000000000002233.
Abstract

MASARONE D, Falco L, Catapano D, Gravino R, et al
Dapagliflozin reverses combined postcapillary and precapillary pulmonary hypertension in a patient with advanced heart failure.
Minerva Cardiol Angiol. 2024 May 16. doi: 10.23736/S2724-5683.24.06592.
Abstract

ZHOU R, Lei Y, Ge L, Mao Q, et al
Accuracy of brain natriuretic peptide and N-terminal brain natriuretic peptide for detecting paediatric pulmonary hypertension: a systematic review and meta-analysis.
Ann Med. 2024;56:2352603.
Abstract

ADHYAPAK SM, Konda A, K T T, Shivakumar, et al
Right heart catheterization in idiopathic pulmonary hypertension: An all-inclusive necessity.
Curr Probl Cardiol. 2024;49:102642.
Abstract

CORVOL F, Hascoet S, Le Bret E, Nathan N, et al
Scimitar syndrome with vein stenosis in an infant.
BMJ Case Rep. 2024;17:e259955.
Abstract

SAINT-MARTIN WILLER A, El Jekmek K, Antigny F
Therapeutic Potential of Sodium Houttuyfonate in Pulmonary Hypertension Through Orai-Ca2+ Channels.
Am J Respir Cell Mol Biol. 2024 May 15. doi: 10.1165/rcmb.2024-0214.
Abstract

ZEDER K, Brittain E, Kovacs G, Maron BA, et al
The Management of Mild Pulmonary Hypertension in Clinical Practice.
Ann Am Thorac Soc. 2024 May 15. doi: 10.1513/AnnalsATS.202312-1079.
Abstract

ZHANG X, Qin H, Ma Q, Zhang J, et al
CircST6GAL1 knockdown alleviates pulmonary arterial hypertension by regulating miR-509-5p/multiple C2 and transmembrane domain containing 2 axis.
Clin Respir J. 2024;18:e13771.
Abstract

BANERJEE S, Onwunyi VRC, Hong J, Martineau S, et al
RV-specific Targeting of Snai1 Rescues Pulmonary Hypertension-induced Right Ventricular Failure by Inhibiting EndMT and Fibrosis via LOXL2 Mediated Mechanism.
bioRxiv [Preprint]. 2024 May 3:2024.04.30.591766. doi: 10.1101/2024.04.30.591766
Abstract

YUAN Y, Li S, Yan M, Yang Y, et al
Genetically determined gut microbiota associates with pulmonary arterial hypertension: a Mendelian randomization study.
BMC Pulm Med. 2024;24:235.
Abstract

GALIS R, Mudura D, Trif P, Diggikar S, et al
Milrinone in persistent pulmonary hypertension of newborn: a scoping review.
Pediatr Res. 2024 May 14. doi: 10.1038/s41390-024-03234.
Abstract

ELSEBAIE A, Enriquez VRB, Baranchuk A, Nahin MA, et al
Atrial Arrhythmias Following Pulmonary Thromboendarterectomy: A Comprehensive Review Of Current Literature.
Port J Card Thorac Vasc Surg. 2024;31:41-46.
Abstract

KANG K, Xiang J, Zhang X, Xie Y, et al
N6-methyladenosine modification of KLF2 may contribute to endothelial-to-mesenchymal transition in pulmonary hypertension.
Cell Mol Biol Lett. 2024;29:69.
Abstract

DESAI R, Katukuri N, Kanagala SG, Ghadge N, et al
Examining prevalence and predictors of pulmonary hypertension in adults with idiopathic pulmonary fibrosis: a population-based analysis in the United States.
J Med Life. 2024;17:35-40.
Abstract

RAWLINGS GH, Gaskell C, Beail N, Thompson A, et al
Exploratory and confirmatory factor analysis of emPHasis-10: The health-related quality-of-life measure in pulmonary hypertension.
Pulm Circ. 2024;14:e12378.
Abstract

VOHRA AS, Olonoff DA, Ip A, Kirtane AJ, et al
Nationwide trends of balloon pulmonary angioplasty and pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension (2012-2019).
Pulm Circ. 2024;14:e12374.
Abstract

ATSUKAWA M, Koyano K, Iwakiri K
[Portopulmonary hypertension (PoPH)].
Nihon Shokakibyo Gakkai Zasshi. 2024;121:382-388.
Abstract

BAE SP, Kim SS, Yun J, Lee H, et al
Neonatal outcomes of preterm infants with pulmonary hypertension: clustering based on prenatal risk factors.
Pediatr Res. 2024 May 11. doi: 10.1038/s41390-024-03232.
Abstract

NEMATI N, Burton T, Fathieh F, Gillins HR, et al
Pulmonary Hypertension Detection Non-Invasively at Point-of-Care Using a Machine-Learned Algorithm.
Diagnostics (Basel). 2024;14:897.
Abstract

RIOU M, Coste F, Meyer A, Enache I, et al
Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review.
Int J Mol Sci. 2024;25:4941.
Abstract

CHATZIDAVID S, Flevari P, Tombrou I, Anastasiadis G, et al
Pulmonary Hypertension in Sickle Cell Disease: Novel Findings of Gene Polymorphisms Related to Pathophysiology.
Int J Mol Sci. 2024;25:4792.
Abstract

BAHI M, Li C, Wang G, Korman BD, et al
Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: From Bedside to Bench and Back Again.
Int J Mol Sci. 2024;25:4728.
Abstract

YAMANO M, Yamano T, Matoba S
Right ventricular dilatation: echocardiographic differential diagnosis.
J Med Ultrason (2001). 2024;51:275-282.
Abstract

KRAMER T, Nattmann P, Gerhardt F, Stafiej P, et al
Impact of rapid sequential combination therapy on distinct haemodynamic measures in newly diagnosed pulmonary arterial hypertension.
ESC Heart Fail. 2024;11:1540-1552.
Abstract

FAVOINO E, Prete M, Liakouli V, Leone P, et al
Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity.
Autoimmun Rev. 2024;23:103514.
Abstract

THOREAU B, Mouthon L
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data.
Autoimmun Rev. 2024;23:103506.
Abstract

OH Y, Park K, Jung S, Choi M, et al
Inhalable Nitric Oxide Delivery Systems for Pulmonary Arterial Hypertension Treatment.
Small. 2024;20:e2308936.
Abstract

KAEMMERER H, Diller GP, Achenbach S, Dahnert I, et al
[Pulmonary hypertension in adults with congenital heart disease in light of the 2022-ESC-PAH guidelines - Part II: Supportive therapy, special situations (pregnancy, contraception, non-cardiac surgery), targeted pharmacotherapy, organ transplantation,
Pneumologie. 2024 May 24. doi: 10.1055/a-2274-1025.
Abstract

SUN Y, Chen C, Yan Q, Wang S, et al
A peripheral system disease-Pulmonary hypertension.
Biomed Pharmacother. 2024;175:116787.
Abstract

CORREALE M, Tricarico L, Bevere EML, Chirivi F, et al
Circulating Biomarkers in Pulmonary Arterial Hypertension: An Update.
Biomolecules. 2024;14:552.
Abstract

BADEA R, Enache R, Predescu LM, Platon P, et al
Left main coronary artery compression in precapillary pulmonary hypertension.
Pulm Circ. 2024;14:e12391.
Abstract

TAKAHASHI M, Murase M
Outcomes of High-Dose Inhaled Nitric Oxide and Oxygen Administration for Severe Pulmonary Hypertension With Bronchopulmonary Dysplasia.
Cureus. 2024;16:e58855.
Abstract

AHMAD A, Zou Y, Zhang P, Li L, et al
Non-invasive imaging techniques for early diagnosis of bilateral cardiac dysfunction in pulmonary hypertension: current crests, future peaks.
Front Cardiovasc Med. 2024;11:1393580.
Abstract

WU J, Jiang Y
A review regarding the article 'Right heart catheterization in idiopathic pulmonary hypertension: An all-inclusive necessity.'.
Curr Probl Cardiol. 2024 May 21:102673. doi: 10.1016/j.cpcardiol.2024.102673.
Abstract

CRUZ NC, Pham E, Ali H, Nanavati J, et al
How severity and classification of pulmonary hypertension affect pregnancy outcomes: a systematic review and timeline.
Int J Obstet Anesth. 2024;59:104210.
Abstract

KUMAR R, Kumar S, Mickael C, Fonseca Balladares D, et al
Interstitial macrophage phenotypes in Schistosoma-induced pulmonary hypertension.
Front Immunol. 2024;15:1372957.
Abstract

FORIS V, Olschewski A
Editorial: Pulmonary hypertension: from bench to bedside.
Front Physiol. 2024;15:1421654.
Abstract

GONG J, Ding Y, Wang J, Wang W, et al
Insufficiency of quality of life as the treatment endpoint for balloon pulmonary angioplasty in inoperable chronic thromboembolic pulmonary hypertension.
J Transl Int Med. 2024;12:148-156.
Abstract

ZHANG T, Guo L, Liang S, Liu H, et al
Direct Oral Anticoagulants in Chronic Thromboembolic Pulmonary Hypertension: First Meta-Analysis of Prospective Studies.
Clin Appl Thromb Hemost. 2024;30:10760296241257931.
Abstract

NIYOGI SG, Singh A, Kumar B, Mishra AK, et al
Right Atrial Strain in Pediatric Pulmonary Hypertension-A Prospective Observational Study.
Pediatr Cardiol. 2024 May 22. doi: 10.1007/s00246-024-03523.
Abstract

DULER L, Visser L, Nguyen N, Johnson LR, et al
Platelet hyperresponsiveness and increased platelet-neutrophil aggregates in dogs with myxomatous mitral valve disease and pulmonary hypertension.
J Vet Intern Med. 2024 May 21. doi: 10.1111/jvim.17067.
Abstract

HASHIM AS, Al-Obaidi MN, Al-Obaidi AD, Saleh SA, et al
"An unprecedented occurrence: a case report of pulmonary hypertension manifestation in Donohue syndrome".
BMC Pediatr. 2024;24:327.
Abstract

SHAMS KA, Ellahony DM, Halima AF, Elzayat RS, et al
Effect of phosphodiesterase type 5 inhibitors on surgical outcome of ventricular septal defect and pulmonary hypertension patients.
Egypt Heart J. 2024;76:60.
Abstract

JOHNSON SW, Wang RS, Winter MR, Gillmeyer KR, et al
Cluster analysis identifies novel real-world lung disease-pulmonary hypertension subphenotypes: implications for treatment response.
ERJ Open Res. 2024;10:00959-2023.
Abstract

MOUILLOT P, Favrolt N, Khouri C, Grandvuillemin A, et al
Characteristics and outcomes of gemcitabine-associated pulmonary hypertension.
ERJ Open Res. 2024;10:00654-2023.
Abstract

KUMAR D, Raju N, Prajapati B, Moinuddin I, et al
Management and Outcomes of Kidney Transplant Candidates With Severe Pulmonary Hypertension: A Single-center Strategy and Experience.
Transplant Direct. 2024;10:e1640.
Abstract

YU C, Qian J, Ma J, Zhou Y, et al
Case report: Pulmonary artery hypertension secondary to SAPHO syndrome.
Int J Rheum Dis. 2024;27:e15140.
Abstract

LESLIE E, Gonzalez Bosc LV, Specht J, McKenna ZJ, et al
Impact of Maternal Exercise on Mice Offspring Development, Pulmonary Hypertension, and Vascular Remodeling in Chronic Hypoxia.
Med Sci Sports Exerc. 2024 May 15. doi: 10.1249/MSS.0000000000003479.
Abstract

QI R, Zhang Y, Yan F
Exosomes enriched by miR-429-3p derived from ITGB1 modified Telocytes alleviates hypoxia-induced pulmonary arterial hypertension through regulating Rac1 expression.
Cell Biol Toxicol. 2024;40:32.
Abstract

LIN JL, Hsu CH
Pulmonary Arterial Hypertension Therapy in Pulmonary Hypertension Associated With Lung Diseases.
JACC Asia. 2024;4:418-420.
Abstract

TANABE N, Kumamaru H, Tamura Y, Kondoh Y, et al
Pulmonary Hypertension With Interstitial Pneumonia: Initial Treatment Effectiveness and Severity in a Japan Registry.
JACC Asia. 2024;4:403-417.
Abstract

CARLOZZI LN, Lin CH, Steinberg ZL
Balloon Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension.
Methodist Debakey Cardiovasc J. 2024;20:57-64.
Abstract

KREMER N, Roller FC, Kremer S, Schafer S, et al
Native hepatic T1-time as a non-invasive predictor of diastolic dysfunction and a monitoring tool for disease progression and treatment response in patients with pulmonary hypertension.
Int J Cardiol. 2024 May 16:132189. doi: 10.1016/j.ijcard.2024.132189.
Abstract

WESOLOWSKI R, Pleimes D, Specker E, Bader M, et al
TPT-004, a Next-Generation Inhibitor of Tryptophan Hydroxylase, Ameliorates Pulmonary Arterial Hypertension in Rats.
J Am Heart Assoc. 2024;13:e034240.
Abstract

TAO R, Dharmavaram N, El Shaer A, Heffernan S, et al
Relationship of TAPSE Normalized by Right Ventricular Area With Pulmonary Compliance, Exercise Capacity, and Clinical Outcomes.
Circ Heart Fail. 2024;17:e010826.
Abstract

CHOUDHURY P, Dasgupta S, Kar A, Sarkar S, et al
Bioinformatics analysis of hypoxia associated genes and inflammatory cytokine profiling in COPD-PH.
Respir Med. 2024;227:107658.
Abstract

SARI A, Satis H, Ayan G, Kucuksahin O, et al
Survival in systemic sclerosis associated pulmonary arterial hypertension in the current treatment era-results from a nationwide study.
Clin Rheumatol. 2024;43:1919-1925.
Abstract

ZHANG S, Gao L, Zhao Z, Zhao Q, et al
Blood urea nitrogen to serum albumin ratio as a new indicator of disease severity and prognosis in idiopathic pulmonary artery hypertension.
Respir Med. 2024;227:107643.
Abstract

PAPAIOANNOU I, Dritsoula A, Kang P, Baliga RS, et al
NKX2-5 regulates vessel remodeling in scleroderma-associated pulmonary arterial hypertension.
JCI Insight. 2024;9:e164191.
Abstract

WAXMAN AB, Systrom DM, Manimaran S, de Oliveira Pena J, et al
SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension.
Circ Heart Fail. 2024 Apr 4:e011227. doi: 10.1161/CIRCHEARTFAILURE.123.011227.
Abstract

LIU H, Jiang Y, Shi R, Hao Y, et al
Super enhancer-associated circRNA-circLrch3 regulates hypoxia-induced pulmonary arterial smooth muscle cells pyroptosis by formation of R-loop with host gene.
Int J Biol Macromol. 2024;268.
Abstract

CULLIVAN S, Cronin E, Gaine S
Pulmonary Hypertension in Systemic Sclerosis.
Semin Respir Crit Care Med. 2024;45:411-418.
Abstract

RUTZ T, Aubert JD, Beghetti M, Eeckhout E, et al
Atrial Septal Defect, Pulmonary Arterial Hypertension, and Diastolic Left Heart Failure: When 3 Players Come into the Game.
Circ Heart Fail. 2024 Mar 21:e010545. doi: 10.1161/CIRCHEARTFAILURE.123.010545.
Abstract

BOUCLY A, Gerges C, Savale L, Jais X, et al
Pulmonary arterial hypertension.
Presse Med. 2023;52:104168.
Abstract

JOSHI S, Quinones Cardona V, Poletto E, Menktiti OR, et al
Bleeding complications in Neonates receiving Extracorporeal Membrane Oxygenation and Controlled Hypothermia.
Am J Perinatol. 2022 Mar 3. doi: 10.1055/a-1786-8688.
Abstract

BEARZI P, Navarini L, Currado D, Marino A, et al
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis.
Clin Exp Rheumatol. 2024 May 28. doi: 10.55563.
Abstract

TORRES ARRESE M, Barbera Rausell P, Lago Gancedo H, Mata Martinez A, et al
Usefulness of the pulsed wave doppler flow pattern in the common femoral vein to detect high probability of pulmonary hypertension in patients attended in the emergency department.
Emergencias. 2024;36:234.
Abstract

YANG L, Luo D, Huang T, Li X, et al
New risk model by right ventricle - pulmonary arterial coupling and inferior vena cava from echocardiography in patients with conventional low-intermediate risk pulmonary artery hypertension under targeted treatment.
Echocardiography. 2024;41:e15850.
Abstract

LIN J, Chen R, Liao H, Zhang Y, et al
Mechanisms of cordycepin in the treatment of pulmonary arterial hypertension in rats based on metabonomics and transcriptomics.
Sci Rep. 2024;14:12431.
Abstract

MOORE J, Altschul E, Remy-Jardin M, Raoof S, et al
Chronic Thromboembolic Pulmonary Hypertension: Clinical and Imaging Evaluation.
Clin Chest Med. 2024;45:405-418.
Abstract

HERNANDEZ BS, Shinozaki RM, Grady RM, Drussa A, et al
Improvement in Echocardiographic and Diagnostic Biomarkers after Systemic Glucocorticoid Therapy in Infants with Pulmonary Hypertension.
J Pediatr. 2024 May 28:114116. doi: 10.1016/j.jpeds.2024.114116.
Abstract

CHEN Z, Cui J, Chen Z, Wang J, et al
Pulmo-protection of long-term swimming exercise via improving insulin sensitivity in monocrotaline-induced pulmonary hypertensive rats.
Biochem Biophys Res Commun. 2024;723:150159.
Abstract

JHENG JR, DesJardin JT, Chen YY, Huot JR, et al
Plasma Proteomics Identifies B2M as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction.
Arterioscler Thromb Vasc Biol. 2024 May 30. doi: 10.1161/ATVBAHA.123.320270.
Abstract

KOIKE H, Nishimura T, Morikawa M
Quantitative evaluation of pulmonary hypertension using 4D flow MRI: A retrospective study.
Heliyon. 2024;10:e31177.
Abstract

MAEDER MT, Weber L, Pohle S, Chronis J, et al
Impact of the 2022 pulmonary hypertension definition on haemodynamic classification and mortality in patients with aortic stenosis undergoing valve replacement.
Eur Heart J Open. 2024;4:oeae037.
Abstract

GELE RR, Burnotte P, Valcke A, Walker TG, et al
Retrospective evaluation of a right heart parameter score in the assessment of precapillary pulmonary hypertension in dogs (2017-2021): 135 cases.
J Vet Emerg Crit Care (San Antonio). 2024 May 29. doi: 10.1111/vec.13394.
Abstract

JERMAKOW M, Danielewicz K, Dudzinska K, Bienias P, et al
Transient severe precapillary pulmonary hypertension caused by eosinophilic granulomatosis with polyangiitis in a patient diagnosed with asthma.
Pol Arch Intern Med. 2024 May 24:16758. doi: 10.20452/pamw.16758.
Abstract

FERREIRA EVM, Lucena JS, Oliveira RKF
The role of the pulmonary function laboratory to assist in disease management: pulmonary hypertension.
J Bras Pneumol. 2024;50:e20240033.
Abstract

CSAKI R, Nagaraj C, Almassy J, Khozeimeh MA, et al
The TREK-1 potassium channel is a potential pharmacological target for vasorelaxation in pulmonary hypertension.
Br J Pharmacol. 2024 May 28. doi: 10.1111/bph.16426.
Abstract

BA H, Guo Y, Jiang Y, Li Y, et al
Unveiling the metabolic landscape of pulmonary hypertension: insights from metabolomics.
Respir Res. 2024;25:221.
Abstract

EVANS RA
The Rationale, Evidence, and Adaptations to Pulmonary Rehabilitation for Chronic Respiratory Diseases Other Than COPD.
Respir Care. 2024;69:697-712.
Abstract

AGRAWAL A, Bajaj S, Bhagat U, Yesilyaprak A, et al
Cardiovascular Complications With Delivery Hospitalizations in Patients With Pulmonary Hypertension: A Nationwide Study From 2011 to 2020.
J Am Heart Assoc. 2024 May 28:e031632. doi: 10.1161/JAHA.123.031632.
Abstract

HERSI K, Ramani GV, Law JY, Sadek AS, et al
Diagnosis and management of chronic thromboembolic pulmonary hypertension (CTEPH) in sickle cell disease: A review.
Pulm Circ. 2024;14:e12362.
Abstract

BAJWA EK, Cislak D, Kumar A, Li D, et al
Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease.
Int J Chron Obstruct Pulmon Dis. 2024;19:1105-1121.
Abstract

LI Y, Qian J, Dong X, Zhao J, et al
The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines.
Arthritis Res Ther. 2024;26:109.
Abstract

LIN K, Sarnari R, Gordon DZ, Markl M, et al
Radiomics features of the cardiac blood pool to indicate hemodynamic changes in pulmonary hypertension (PH) due to heart failure with preserved ejection fraction (PH-HFpEF).
Int J Cardiovasc Imaging. 2024 May 27. doi: 10.1007/s10554-024-03131.
Abstract

ACUNA B, Bello-Zepeda J, Montenegro G, Reyes RV, et al
[Pulmonary hypertension: calcium channel-mediated signaling, present and future pharmacological targets].
Rev Med Chil. 2023;151:753-763.
Abstract

HIGGINS M, Cullivan S, McCullagh B, Gaine S, et al
Characteristics of sarcoidosis-associated pulmonary hypertension at the National Pulmonary Hypertension Unit.
Ir Med J. 2024;117:955.
Abstract

SIREGAR FM, Hartopo AB, Haryana SM
Recent progress in the roles of microRNAs in pulmonary arterial hypertension associated with congenital heart disease.
Narra J. 2024;4:e579.
Abstract

ALJANABI MA, Alrabadi N, Mahmoud SH, Haddad R, et al
Sildenafil Effect on Atrial Natriuretic Peptide Level in Pulmonary Hypertensive Rats.
Cardiovasc Hematol Agents Med Chem. 2024.
Abstract

LI X, Ma S, Wang Q, Li Y, et al
A new integrative analysis of histopathology and single cell RNA-seq reveals the CCL5 mediated T and NK cell interaction with vascular cells in idiopathic pulmonary arterial hypertension.
J Transl Med. 2024;22:502.
Abstract

KASHAKI M, Mohazzab A, Radgoudarzi M, Bordbar A, et al
Study on the comparison between Bosentan and Macitentan in the treatment of persistent pulmonary hypertension of the newborns, simultaneously on sildenafil: A randomized double-blinded non-inferiority parallel clinical trial.
Pediatr Neonatol. 2024 May 22:S1875-9572(24)00077.
Abstract

NISHII T, Horinouchi H, Namboku T, Sofue K, et al
Laterality of CT-measured hepatic extracellular volume fraction in patients with chronic thromboembolic pulmonary hypertension.
Int J Cardiovasc Imaging. 2024 May 26. doi: 10.1007/s10554-024-03119.
Abstract

KADOGLOU NPE, Khattab E, Velidakis N, Gkougkoudi E, et al
The Role of Echocardiography in the Diagnosis and Prognosis of Pulmonary Hypertension.
J Pers Med. 2024;14:474.
Abstract

RUDIENE V, Kapleriene L, Laukyte-Sleniene M, Zebrauskiene D, et al
The Impact of COVID-19 Infection on Patients with Severe Chronic Pulmonary Hypertension: A Prospective Study from a Single Referral Center.
Medicina (Kaunas). 2024;60:750.
Abstract

BALCAN B, Akdeniz B, Peker Y, The Turcosact Collaborators, et al
Obstructive Sleep Apnea and Pulmonary Hypertension: A Chicken-and-Egg Relationship.
J Clin Med. 2024;13:2961.
Abstract

BERTICI RA, Bertici NS, Ridichie A, Fira-Mladinescu O, et al
Comorbidities, Treatment and Survival Rates of Chronic Thromboembolic Pulmonary Hypertension in a Regional Centre.
J Clin Med. 2024;13:2754.
Abstract

AWAD KS, Wang S, Dougherty EJ, Keshavarz A, et al
BMPR2 Loss Activates AKT by Disrupting DLL4/NOTCH1 and PPARgamma Signaling in Pulmonary Arterial Hypertension.
Int J Mol Sci. 2024;25:5403.
Abstract

SCHROEDER L, Soltesz L, Leyens J, Strizek B, et al
Vasoactive Management of Pulmonary Hypertension and Ventricular Dysfunction in Neonates Following Complicated Monochorionic Twin Pregnancies: A Single-Center Experience.
Children (Basel). 2024;11:548.
Abstract

YANG Q, Lai B, Xie H, Deng M, et al
Identification of differentially expressed ER stress-related genes and their association with pulmonary arterial hypertension.
Respir Res. 2024;25:220.
Abstract

EICHSTAEDT CA, Shaukat M, Grunig E
[Heritable pulmonary arterial hypertension].
Inn Med (Heidelb). 2024;65:560-565.
Abstract

PLATZ E, Systrom D, Leopold JA
Pulmonary congestion in patients with pulmonary arterial hypertension? New insights from lung ultrasound.
Eur J Heart Fail. 2024;26:825-828.
Abstract

PALAZZUOLI A, Dini FL, Agostoni P, Cartocci A, et al
Right ventricular dysfunction in chronic heart failure: clinical laboratory and echocardiographic characteristics. (the RIVED-CHF registry).
J Cardiovasc Med (Hagerstown). 2024;25:457-465.
Abstract

LIU B, Azfar M, Legchenko E, West JA, et al
ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport.
Cardiovasc Res. 2024;120:756-768.
Abstract

GUTOR SS, Richmond BW, Agrawal V, Brittain EL, et al
Pulmonary vascular disease in Veterans with post-deployment respiratory syndrome.
Cardiovasc Pathol. 2024;71:107640.
Abstract

FUKUOKA S, Kaku N, Nagata H, Nagatomo Y, et al
Extracorporeal membrane oxygenation support for balloon atrial septostomy in a BMPR2 variant-associated pulmonary arterial hypertension.
Pediatr Pulmonol. 2024;59:1789-1791.
Abstract

D'ALTO M, Di Maio M, Argiento P, Romeo E, et al
Right heart failure as a cause of pulmonary congestion in pulmonary arterial hypertension.
Eur J Heart Fail. 2024 Feb 26. doi: 10.1002/ejhf.3172.
Abstract

COUTO-MALLON D, Enriquez-Vazquez D, Calvino-Santos R, Velasco-Garcia de Sierra C, et al
Usefulness of remote pulmonary arterial pressure monitoring in patients with advanced heart failure listed for HT.
Rev Esp Cardiol (Engl Ed). 2024;77:493-495.
Abstract

MINHAS J, Moutchia J, Al-Naamani N, Mazurek JA, et al
Electrocardiographic Abnormalities and Their Association with Outcomes in Randomized Clinical Trials of Pulmonary Arterial Hypertension.
Ann Am Thorac Soc. 2024;21:858-865.
Abstract

GOWDA SH, Patel N
"Heart of the Matter": Cardiac Dysfunction in Congenital Diaphragmatic Hernia.
Am J Perinatol. 2023 Apr 3. doi: 10.1055/a-2067-7925.
Abstract

PITRE T, Weatherald J, Humbert M
Treatments for pulmonary arterial hypertension: navigating through a network of choices.
Eur Heart J. 2024 Mar 5:ehae106. doi: 10.1093.
Abstract

MOUTCHIA J, McClelland RL, Al-Naamani N, Appleby DH, et al
Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis.
Eur Heart J. 2024 Feb 28:ehae049. doi: 10.1093.
Abstract

WANG S, Xue Z, Su D, Ji L, et al
Association between preoperative albumin and length of hospital stay in non-cardiac surgery patients with pulmonary hypertension: A secondary retrospective analysis.
Medicine (Baltimore). 2024;103:e38442.
Abstract

TAN JS, Wei Y, Chong L, Yang Y, et al
SGLT2 inhibitors as a potential therapeutic option for pulmonary hypertension: mechanisms and clinical perspectives.
Crit Rev Clin Lab Sci. 2024 Jun 7:1-17. doi: 10.1080/10408363.2024.2361012.
Abstract

JYOTHI RAMACHANDRAN NAIR DP, Zachariah S, Abraham A, Sacks D, et al
Anomalous Bronchial Artery Origin - Canary in the Coal Mine - For Diagnosing Chronic Thromboembolic Pulmonary Hypertension.
Eur J Case Rep Intern Med. 2024;11:004616.
Abstract

WEINSTEIN N, Carlsen J, Schulz S, Stapleton T, et al
A Lifelike guided journey through the pathophysiology of pulmonary hypertension-from measured metabolites to the mechanism of action of drugs.
Front Cardiovasc Med. 2024;11:1341145.
Abstract

CAPUTO A, Scoccia G
Reply to: Correlation Between Right Ventricular Echocardiography Measurements and Functional Capacity in Patients With Pulmonary Arterial Hypertension.
Tex Heart Inst J. 2024;51:e248451.
Abstract

GAO L, Skinner J, Nath T, Lin Q, et al
Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension.
Respir Res. 2024;25:235.
Abstract

DABRAL S, Noh M, Werner F, Krebes L, et al
C-type natriuretic peptide/cGMP/FoxO3 signaling attenuates hyperproliferation of pericytes from patients with pulmonary arterial hypertension.
Commun Biol. 2024;7:693.
Abstract

MOOERS EA, Johnson HM, Michalkiewicz T, Rana U, et al
Aberrant PGC-1alpha signaling in a lamb model of persistent pulmonary hypertension of the newborn.
Pediatr Res. 2024 Jun 6. doi: 10.1038/s41390-024-03223.
Abstract

KIEU V, Handler SS, Mitchell M, Pan AY, et al
Multimodal Assessment and Intramodal Comparison of Imaging Techniques for Pediatric Pulmonary Vein Stenosis with Pulmonary Hypertension.
Pediatr Cardiol. 2024 Jun 6. doi: 10.1007/s00246-024-03531.
Abstract

ZHOU Y, Tabib T, Huang M, Yuan K, et al
Molecular Changes Implicate Angiogenesis and Arterial Remodeling in Systemic Sclerosis-Associated and Idiopathic Pulmonary Hypertension.
Arterioscler Thromb Vasc Biol. 2024 Jun 6. doi: 10.1161/ATVBAHA.123.320005.
Abstract

THENAPPAN T
Asymmetric Dimethylarginine in Pulmonary Arterial Hypertension: A Liquid Biopsy to Assess Pulmonary Vascular Endothelial Health.
JACC Heart Fail. 2024;12:1098-1100.
Abstract

LOU YX, Shi ED, Yang R, Yang Y, et al
Exploring the mechanisms of glycolytic genes involvement in pulmonary arterial hypertension through integrative bioinformatics analysis.
J Cell Mol Med. 2024;28:e18447.
Abstract

BORLAUG BA, Larive B, Frantz RP, Hassoun P, et al
Pulmonary hypertension across the spectrum of left heart and lung disease.
Eur J Heart Fail. 2024 Jun 4. doi: 10.1002/ejhf.3302.
Abstract

KOZAILY E, Akdogan ER, Dorsey NS, Tedford RJ, et al
Correction to: Management of Pulmonary Hypertension in the Context of Heart Failure with Preserved Ejection Fraction.
Curr Hypertens Rep. 2024 Jun 5. doi: 10.1007/s11906-024-01305.
Abstract

BEIJK MAM, Winkelman JA, Eckmann HM, Samson DA, et al
Notch ratio in pulmonary flow predicts long-term survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
Heart Vessels. 2024 Jun 5. doi: 10.1007/s00380-024-02422.
Abstract

MAO C, Huang J, Liu H, Liu Y, et al
Nur77 induced by HIF-1alpha mediates vascular remodeling in hypoxic pulmonary hypertension.
Cell Mol Biol (Noisy-le-grand). 2024;70:233-237.
Abstract

MARTIN DE MIGUEL I, Lopez-Gude MJ, Martinez Menaca A, Revilla Ostolaza Y, et al
Chronic Thromboembolic Pulmonary Hypertension: When Thrombus Mandates Definite Diagnosis to Occur in the Operating Room.
Circ Cardiovasc Imaging. 2024 Jun 5:e016543. doi: 10.1161/CIRCIMAGING.123.016543
Abstract

JAIN H, Odat RM, Ahmed M, Jain J, et al
Safety and Outcomes with Direct Oral Anticoagulants Versus Vitamin-K Antagonists in Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review, Meta-Analysis, and Meta-Regression.
Cardiol Rev. 2024 Jun 4. doi: 10.1097/CRD.0000000000000735.
Abstract

DENG J, Wei RQ, Zhang WM, Shi CY, et al
Crocin's role in modulating MMP2/TIMP1 and mitigating hypoxia-induced pulmonary hypertension in mice.
Sci Rep. 2024;14:12716.
Abstract

ALRAHIMI JS, Ismail YM, Aljubairi NA, Kutob NW, et al
Assessing the correlation between the degree of tricuspid regurgitation and pulmonary hypertension: A comprehensive study.
Saudi Med J. 2024;45:572-577.
Abstract

SEDLAR A, Vrbata D, Pokorna K, Holzerova K, et al
Glycopolymer Inhibitors of Galectin-3 Suppress the Markers of Tissue Remodeling in Pulmonary Hypertension.
J Med Chem. 2024 Jun 3. doi: 10.1021/acs.jmedchem.4c00341.
Abstract

NEBEL Y, Williams K, Lyons LA, Reinero C, et al
Developmental lung disease in a cat associated with high probability of severe pulmonary hypertension: natural history, histopathology and genetic analysis.
JFMS Open Rep. 2024;10:20551169241249003.
Abstract

ZHANG S, Li Y, Yang Y, Gong S, et al
The management pattern and outcomes of chronic thromboembolic pulmonary hypertension: rationale and design for a Chinese real-world study.
BMC Pulm Med. 2024;24:265.
Abstract

RUCKER JA, Beinfeld MT, Enright DE, Germack HD, et al
US commercial health plan coverage dynamics in pulmonary arterial hypertension therapies.
J Manag Care Spec Pharm. 2024;30:541-548.
Abstract

TSOI SM, Steurer M, Nawaytou H, Cheung S, et al
Defining the Typical Course of Persistent Pulmonary Hypertension of the Newborn (PPHN): when to think beyond reversible causes.
J Pediatr. 2024 May 30:114131. doi: 10.1016/j.jpeds.2024.114131.
Abstract

LAWSON AA, Franklin WH, Porta NFM, Nugent A, et al
An Infant with High-Output Heart Failure and Pulmonary Hypertension Resulting from a Giant Cutaneous Hemangioma.
Pediatr Cardiol. 2024 Jun 1. doi: 10.1007/s00246-024-03528.
Abstract

YOGESWARAN A, da Rocha BB, Rako ZA, Kaufmann SJ, et al
Physiological mechanisms behind respiratory variations in right atrial pressure in pulmonary hypertension.
Sci Rep. 2024;14:12547.
Abstract

HUBESCH G, Dewachter C, Chomette L, Hupkens E, et al
Early Alteration of Right Ventricle-Pulmonary Artery Coupling in Experimental Heart Failure With Preserved Ejection Fraction.
J Am Heart Assoc. 2024;13:e032201.
Abstract

SUN XY, Xu CF, Li HY, Zhang HL, et al
[Application of cardiopulmonary exercise test in children with respiratory system diseases].
Zhonghua Er Ke Za Zhi. 2024;62:586-589.
Abstract

RACHEDI NS, Tang Y, Tai YY, Zhao J, et al
Dietary intake and glutamine-serine metabolism control pathologic vascular stiffness.
Cell Metab. 2024;36:1335-1350.
Abstract

SHAFRAN I, Probst V, Panzenbock A, Sadushi-Kolici R, et al
Asymmetric Dimethylarginine and NT-proBNP Levels Provide Synergistic Information in Pulmonary Arterial Hypertension.
JACC Heart Fail. 2024;12:1089-1097.
Abstract

TAN XL, Deng Y, Lan WF, Dai P, et al
Right ventricular dyssynchrony for the prediction of prognosis in patients with systemic lupus erythematosus-aaociated pulmonary arterial hypertension: a study with two-dimensional speckle tracking.
Int J Cardiovasc Imaging. 2024;40:967-979.
Abstract

KARAKASIS P, Patoulias D, Giannakoulas G, Rosenkranz S, et al
Effect of sodium-glucose cotransporter-2 inhibitors on pulmonary arterial wedge pressure.
Eur J Intern Med. 2024;124:147-149.
Abstract

KUCIRKA LM, Desai S, LeVarge B, Conklin JL, et al
Unilateral Absent Pulmonary Artery in Pregnancy: A Case Report and Systematic Literature Review.
Am J Perinatol. 2024;41.
Abstract

DE ANGELIS R, Riccieri V, Cipolletta E, Del Papa N, et al
Significant nailfold capillary loss and late capillaroscopic pattern are associated with pulmonary arterial hypertension in systemic sclerosis.
Rheumatology (Oxford). 2024;63:1616-1623.
Abstract

SHOKROLLAHI F, Pazoki A, Allami A, Aliakbari S, et al
Bosentan and Pulmonary Hypertension Caused by COVID-19: A Pilot Randomized Double-blind Clinical Study.
Curr Vasc Pharmacol. 2024 Jun 13. doi: 10.2174/0115701611299843240607061547.
Abstract

GINTING MUNTE FA, Elen E, Lelya O, Rudiktyo E, et al
Right ventricular fibrosis in adults with uncorrected secundum atrial septal defect and pulmonary hypertension: a cardiovascular magnetic resonance study with late gadolinium enhancement, native T1 and extracellular volume.
Front Cardiovasc Med. 2024;11:1395382.
Abstract

SMITH MA, Cheng G, Phelan R, Brazauskas R, et al
Pulmonary hypertension in the intensive care unit after pediatric allogeneic hematopoietic stem cell transplant: incidence, risk factors, and outcomes.
Front Oncol. 2024;14:1415984.
Abstract

LAWRIE A, Chin K, Fong YL, Gargano C, et al
Two prospective, multicenter studies for the identification of biomarker signatures for early detection of pulmonary hypertension (PH): The CIPHER and CIPHER-MRI studies.
Pulm Circ. 2024;14:e12386.
Abstract

HUANG P, Wang Y, Liu C, Zhang Q, et al
Exploring the Mechanism of Zhishi-Xiebai-Guizhi Decoction for the Treatment of Hypoxic Pulmonary Hypertension Based on Network Pharmacology and Experimental Analyses.
Curr Pharm Des. 2024 Jun 11. doi: 10.2174/0113816128293601240523063527.
Abstract

KANG K, Sun C, Li H, Liu X, et al
N6-methyladenosine-driven miR-143/145-KLF4 circuit orchestrates the phenotypic switch of pulmonary artery smooth muscle cells.
Cell Mol Life Sci. 2024;81:256.
Abstract

DENG L, Cao C, Cai Z, Wang Z, et al
STING Contributes to Pulmonary Hypertension by Targeting the Interferon and BMPR2 Signaling through Regulating F2RL3.
Am J Respir Cell Mol Biol. 2024 Jun 12. doi: 10.1165/rcmb.2023-0308.
Abstract

MANSOURI P, Rashidi AM, Mansouri MH, Sadeghi M, et al
Assessment of lytic therapy effect in patients with intermediate-high risk pulmonary embolism for prevention of chronic thromboembolic pulmonary hypertension: A randomized, double-blind trial.
Health Sci Rep. 2024;7:e2093.
Abstract

ZHOU D, Liu C, Wang L, Li J, et al
Prediction of clinical risk assessment and survival in chronic obstructive pulmonary disease with pulmonary hypertension.
Clin Transl Med. 2024;14:e1702.
Abstract

XU J, Wang JJ, Zhao QH, Gong SG, et al
Pulmonary vascular resistance predicts the mortality in patients with bronchiectasis-associated pulmonary hypertension.
J Hypertens. 2024 May 28. doi: 10.1097/HJH.0000000000003782.
Abstract

KANAZAWA Y, Goda A, Mohri T, Takeuchi S, et al
Exercise pulmonary hypertension in patients with systemic sclerosis based on updated guidelines.
Sci Rep. 2024;14:13358.
Abstract

KOUREK C, Zachariou A, Karatzanos E, Antonopoulos M, et al
Effects of combined aerobic, resistance and inspiratory training in patients with pulmonary hypertension: A systematic review.
World J Crit Care Med. 2024;13:92585.
Abstract

XU WJ, Wang S, Zhao QH, Xu JY, et al
Serum ASGR2 level: an efficacy biomarker for balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
Front Immunol. 2024;15:1402250.
Abstract

SUN L, Zhao X, Guo Y, Hou X, et al
Predictive Value of Smoking Index Combined with NT-proBNP for Patients with Pulmonary Hypertension Due to Chronic Lung Disease: A Retrospective Study.
Int J Chron Obstruct Pulmon Dis. 2024;19:1233-1245.
Abstract

VADDORIYA V, Khan SZ, Simonson JL, Gumpeni R, et al
Abnormal Heart Rate Recovery and Chronotropic Incompetence With Exercise in Patients With Interstitial Lung Disease With and Without Pulmonary Hypertension.
Cureus. 2024;16:e60056.
Abstract

NEELAKANTAN S, Vang A, Mehdi RR, Phelan H, et al
Right ventricular stiffening and anisotropy alterations in pulmonary hypertension: Mechanisms and relations to function.
bioRxiv [Preprint]. 2024 May 29:2024.05.24.592212.
Abstract

CHOUDHURY P, Dasgupta S, Bhattacharyya P, Roychowdhury S, et al
Understanding pulmonary hypertension: the need for an integrative metabolomics and transcriptomics approach.
Mol Omics. 2024 Jun 10. doi: 10.1039/d3mo00266.
Abstract

CORREALE M, Rotondo C, Bevere EML, Tricarico L, et al
Combined peripheral and central ultrasound for the diagnosis of PAH-SSc patients.
Echocardiography. 2024;41:e15853.
Abstract

COOL CJ, Khalid AF, Sukmadi N, Akbar MR, et al
The association of right ventricular-pulmonary arterial coupling and pulmonary vascular resistance in adult patients with uncorrected atrial septal defect.
BMC Cardiovasc Disord. 2024;24:297.
Abstract

GUO S, Wang D
Novel insights into the potential applications of stem cells in pulmonary hypertension therapy.
Respir Res. 2024;25:237.
Abstract

LIU Q, Luo Q, Zhong B, Xiong Y, et al
Preparation of the new peptide drug ACTY116-loaded in situ forming implants and evaluation of its efficacy in pulmonary arterial hypertension and right ventricular hypertrophy induced by SU5416/hypoxia in mice.
Basic Clin Pharmacol Toxicol. 2024;135:60-70.
Abstract

LI J, Shi S, Yan W, Shen Y, et al
Preliminary Mechanism of Glial Maturation Factor beta on Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
Adv Biol (Weinh). 2024;8:e2300623.
Abstract

SUZUKI K, Yagi T, Kawakami J
Long-term efficacies of selective vasodilators in pulmonary arterial hypertension: a comprehensive comparison using a spontaneous reporting database.
Naunyn Schmiedebergs Arch Pharmacol. 2024;397:4981-4992.
Abstract

WANG Y, Ye Q, Cui Y, Wu Y, et al
Impact and mechanisms of drag-reducing polymers on shear stress regulation in pulmonary hypertension.
Clin Hemorheol Microcirc. 2024 Jun 19. doi: 10.3233/CH-242281.
Abstract

XIONG T, Li Y, Yang M, Huo B, et al
Metallothionein 3 Potentiates Pulmonary Artery Smooth Muscle Cell Proliferation by Promoting Zinc-MTF1-ATG5 Axis-mediated Autophagosome Formation.
Int J Biol Sci. 2024;20:2904-2921.
Abstract

GATTERER H, Villafuerte FC, Ulrich S, Bhandari SS, et al
Altitude illnesses.
Nat Rev Dis Primers. 2024;10:43.
Abstract

[Guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (2024 edition)].
Zhonghua Yi Xue Za Zhi. 2024;104:2200-2221.
Abstract

ZHAO M, Wu Q, Duanmu W, Shen J, et al
Clinical Analysis of Myocardial Injury in Highlanders with Pulmonary Hypertension.
High Alt Med Biol. 2024 Jun 20. doi: 10.1089/ham.2023.0075.
Abstract

TUTTLE M, Sarnak MJ, Navaneethan SD
Therapeutic approaches for pulmonary hypertension in patients with chronic kidney disease.
Curr Opin Nephrol Hypertens. 2024 Jun 20. doi: 10.1097/MNH.0000000000001008.
Abstract

HEBERT A, McNamara PJ, Carvalho Nunes G, Maltais-Bilodeau C, et al
PDA management strategies and pulmonary hypertension in extreme preterm infants with bronchopulmonary dysplasia.
Pediatr Res. 2024 Jun 19. doi: 10.1038/s41390-024-03321.
Abstract

WANG G, Wen B, Guo M, Li E, et al
Identification of endothelial and mesenchymal FOXF1 enhancers involved in alveolar capillary dysplasia.
Nat Commun. 2024;15:5233.
Abstract

GAO H, Song Y, Liu K, Lu X, et al
The Impact of Different Smoking Behavior on Pulmonary Function and Pulmonary Hypertension Among Chinese Male Patients with Chronic Obstructive Pulmonary Disease.
Int J Chron Obstruct Pulmon Dis. 2024;19:1315-1331.
Abstract

BRUCK O, Pandit LM
Pulmonary Hypertension and Hyperglycemia-Not a Sweet Combination.
Diagnostics (Basel). 2024;14:1119.
Abstract

NATIONS JA, Lin J, Park AB, Shriver CD, et al
Pulmonary Hypertension and Survival among Non-Small Cell Lung Cancer Patients: A Retrospective Cohort Study in the U.S. Military Health System.
J Clin Med. 2024;13:3217.
Abstract

WINICKI NM, Puerta C, Besse CE, Zhang Y, et al
NOTCH3 and Pulmonary Arterial Hypertension.
Int J Mol Sci. 2024;25:6248.
Abstract

BROSINSKY P, Heger J, Sydykov A, Weiss A, et al
Does Cell-Type-Specific Silencing of Monoamine Oxidase B Interfere with the Development of Right Ventricle (RV) Hypertrophy or Right Ventricle Failure in Pulmonary Hypertension?
Int J Mol Sci. 2024;25:6212.
Abstract

ZHANG H, Li M, Hu CJ, Stenmark KR, et al
Fibroblasts in Pulmonary Hypertension: Roles and Molecular Mechanisms.
Cells. 2024;13:914.
Abstract

MAHAJAN A, Gunewardena S, Morris A, Clauss M, et al
Analysis of MicroRNA Cargo in Circulating Extracellular Vesicles from HIV-Infected Individuals with Pulmonary Hypertension.
Cells. 2024;13:886.
Abstract

ZEDER K, Siew ED, Kovacs G, Brittain EL, et al
Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes.
Nat Rev Nephrol. 2024 Jun 18. doi: 10.1038/s41581-024-00857.
Abstract

LUO A, Hao R, Zhou X, Jia Y, et al
Transcriptomic profiling highlights cell proliferation in the progression of experimental pulmonary hypertension in rats.
Sci Rep. 2024;14:14056.
Abstract

HABEDANK D, Ittermann T, Kaczmarek S, Stubbe B, et al
Cardiopulmonary exercise testing and the 2022 definition of pulmonary hypertension.
Pulm Circ. 2024;14:e12398.
Abstract

JERJES-SANCHEZ C, Ramirez-Rivera A, Hernandez NZ, Cueto Robledo G, et al
Demographic, hemodynamic characteristics, and therapeutic trends of pulmonary hypertension patients: The Pulmonary Hypertension Mexican registry (REMEHIP).
Pulm Circ. 2024;14:e12395.
Abstract

MARTINEZ MANZANO JM, Prendergast A, John T, Leguizamon R, et al
Association of mildly elevated pulmonary vascular resistance with major cardiovascular events in pulmonary hypertension and chronic kidney disease: A retrospective cohort analysis.
Pulm Circ. 2024;14:e12401.
Abstract

ZHENG X, Zhang C, Yang T, Luo Z, et al
Integrative bioinformatics approach for identifying key genes and potential therapeutic targets in the concurrent manifestation of hypertrophic cardiomyopathy and pulmonary hypertension.
J Thorac Dis. 2024;16:3152-3169.
Abstract

YANG Y, Zhang H, Wang Y, Xu J, et al
Promising dawn in the management of pulmonary hypertension: The mystery veil of gut microbiota.
Imeta. 2024;3:e159.
Abstract

ZHOU Q, Tang C, Xu X, Hu J, et al
Serum metabolic profiling implicates mTOR activation and insulin resistance in the development of pulmonary hypertension in a rat model of pressure overload-induced heart failure.
Genes Dis. 2023;11:101097.
Abstract

[Chinese expert advisory on percutaneous pulmonary artery denervation for the treatment of pulmonary hypertension].
Zhonghua Xin Xue Guan Bing Za Zhi. 2024;52:647-658.
Abstract

CAJAS SANTANA LJ, Correa Giraldo A, Torres MC
Cardiopulmonary phenotype in systemic sclerosis associated pulmonary hypertension.
Reumatol Clin (Engl Ed). 2024;20:243-248.
Abstract

SINITCA AM, Lyanova AI, Kaplun DI, Hassan H, et al
Microscopy Image Dataset for Deep Learning-Based Quantitative Assessment of Pulmonary Vascular Changes.
Sci Data. 2024;11:635.
Abstract

LIU Y, Tang B, Wang H, Lu M, et al
Otud6b induces pulmonary arterial hypertension by mediating the Calpain-1/HIF-1alpha signaling pathway.
Cell Mol Life Sci. 2024;81:258.
Abstract

YOKOKAWA T, Boucherat O, Martineau S, Lemay SE, et al
Prognostic Significance of Proteomics-Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2024;13:e032888.
Abstract

SINGH N, Al-Naamani N, Brown MB, Long GM, et al
Extrapulmonary manifestations of pulmonary arterial hypertension.
Expert Rev Respir Med. 2024;18.
Abstract

TAMIMI O, Ejikeme C, Nisar T, Gotur D, et al
Clinical impact of pulmonary arterial hypertension on SARS-CoV-2 outcomes: U.S. pre-vaccination analysis.
Curr Probl Cardiol. 2024;49:102672.
Abstract

LI X, Zhang Y, Zhao Q, Yang T, et al
Usefulness of risk assessment tools in predicting hemodynamic outcome after balloon pulmonary angioplasty: a comparative analysis.
Postgrad Med. 2024;136:446-455.
Abstract

SCHLUETER BC, Quanz K, Baldauf J, Petrovic A, et al
The diverging roles of insulin-like growth factor binding proteins in pulmonary arterial hypertension.
Vascul Pharmacol. 2024;155:107379.
Abstract

DONG J, Meng X, Xu H, Yang H, et al
Cluster analysis of clinical phenotypes in idiopathic inflammatory myopathy patients complicated with cardiac involvement.
Clin Rheumatol. 2024;43:2237-2244.
Abstract

D'ALTO M, Badagliacca R, Airo E, Ameri P, et al
Gaps in evidence in the management of patients with intermediate-risk pulmonary arterial hypertension: Considerations following the ESC/ERS 2022 guidelines.
Vascul Pharmacol. 2024;155:107374.
Abstract

GIGANTE A, Papa S, Rosato E, Badagliacca R, et al
When pulmonary arterial hypertension complicates connective tissue diseases: we still have not found what we are looking for.
Intern Emerg Med. 2024;19:883-884.
Abstract

CABEZUDO BALLESTEROS S, Sanabria Carretero P, Reinoso Barbero F
Review of electrical impedance tomography in the pediatric patient.
Rev Esp Anestesiol Reanim (Engl Ed). 2024;71:479-485.
Abstract

BECERRA-MUNOZ VM, Gomez Saenz JT, Escribano Subias P
The importance of data in Pulmonary Arterial Hypertension: from international registries to Machine Learning.
Med Clin (Barc). 2024;162:591-598.
Abstract

YALTA K, Zorkun C, Yetkin E
Bleomycin-induced pulmonary hypertension: an underrated phenomenon with important implications in the setting of high-risk clinical scenarios.
Sarcoidosis Vasc Diffuse Lung Dis. 2024;41:e2024012.
Abstract

IVY DD, Frank BS
Treat and Repair for Congenital Heart Disease and Pulmonary Hypertension: Not a Panacea.
JACC Adv. 2024;3:100891.
Abstract

ANAND V, Scott CG, Lee AT, Rigolin VH, et al
Prevalence and Prognostic Implications of Pulmonary Hypertension in Patients With Severe Aortic Regurgitation.
JACC Adv. 2024;3:100827.
Abstract

SANZ J, Nelson KF
Prognosis in Chronic Aortic Regurgitation: Does Pulmonary Hypertension Play a Role?
JACC Adv. 2024;3:100831.
Abstract

ARKADIEVICH OD
Retrospective analysis of dogs and cats with a mixed form of pulmonary hypertension and suspected pulmonary capillary hemangiomatosis in comparison to animals with predomination of precapillary pulmonary hypertension.
Open Vet J. 2024;14:1216-1223.
Abstract

LIN C, Ge Q, Wang L, Zeng P, et al
Predictors, prevalence and prognostic role of pulmonary hypertension in patients with chronic kidney disease: a systematic review and meta-analysis.
Ren Fail. 2024;46:2368082.
Abstract

GENTLE SJ, Singh A, Travers CP, Nakhmani A, et al
Achieved oxygen saturations and risk for bronchopulmonary dysplasia with pulmonary hypertension in preterm infants.
Arch Dis Child. 2024 Jun 27:archdischild-2024-327014.
Abstract

CHONG LT, Hu S, Guo TT, Gao X, et al
Direct oral anticoagulants in the treatment of chronic thromboembolic pulmonary hypertension patients: a retrospective cohort study.
Respir Med. 2024 Jun 25:107722. doi: 10.1016/j.rmed.2024.107722.
Abstract

ESSAYAGH B, Benfari G, Antoine C, Grigioni F, et al
Reappraisal of the Concept and Implications of Pulmonary Hypertension in Degenerative Mitral Regurgitation.
JACC Cardiovasc Imaging. 2024 Jun 14:S1936-878X(24)00195.
Abstract

TANG L, Niu S, Xu J, Lu W, et al
miR-221-3p is upregulated in acute pulmonary embolism complicated with pulmonary hypertension and promotes pulmonary arterial smooth muscle cells proliferation and migration by inhibiting PTEN.
Cytotechnology. 2024;76:453-463.
Abstract

WALKER M, Moore H, Ataya A, Pham A, et al
A perfectly imperfect engine: Utilizing the digital twin paradigm in pulmonary hypertension.
Pulm Circ. 2024;14:e12392.
Abstract

GUAZZI M
When the heart and lung play in concert and pulmonary hypertension is the common 'musical leitmotif' of cardiopulmonary diseases.
Eur J Heart Fail. 2024 Jun 26. doi: 10.1002/ejhf.3358.
Abstract

WIETESKA-MILEK M, Witowicz A, Szmit S, Florczyk M, et al
Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension after the Removal of COVID-19 Pandemic Restrictions.
J Clin Med. 2024;13:3532.
Abstract

PESCATORE J, Bittner M, D'Alonzo G, Weaver S, et al
Predictors of Mortality in Pulmonary Hypertension-Associated Chronic Lung Disease.
J Clin Med. 2024;13:3472.
Abstract

VARGHESE NP, Altit G, Gubichuk MM, Siddaiah R, et al
Navigating Diagnostic and Treatment Challenges of Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia.
J Clin Med. 2024;13:3417.
Abstract

CHEN S, Guo J, Huang X, He W, et al
Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in Patients with Lupus Nephritis.
Medicina (Kaunas). 2024;60:988.
Abstract

MINDUBAYEVA F, Akhmaltdinova L, Ospanova M, Tukbekova B, et al
Identifying Key Biomarkers in Pediatric Pulmonary Hypertension: An Investigative Approach.
Children (Basel). 2024;11:737.
Abstract

KRISHNAN AV, Freniere V, Sahni R, Vargas Chaves DP, et al
Safety and Tolerability of Continuous Inhaled Iloprost Therapy for Severe Pulmonary Hypertension in Neonates and Infants.
Children (Basel). 2024;11:703.
Abstract

SANKARAN D, Li JRA, Lakshminrusimha S
Meconium Aspiration Syndrome, Hypoxic-Ischemic Encephalopathy and Therapeutic Hypothermia-A Recipe for Severe Pulmonary Hypertension?
Children (Basel). 2024;11:673.
Abstract

WEI F, Yaowen C, Wenhui W
Embolization treatment of right pulmonary artery agenisis with patent ductus arteriosus causing pulmonary hypertension and hemoptysis: a case report and literature review.
J Cardiothorac Surg. 2024;19:391.
Abstract

HE B, Shao B, Cheng C, Ye Z, et al
miR-21-Mediated Endothelial Senescence and Dysfunction Are Involved in Cigarette Smoke-Induced Pulmonary Hypertension through Activation of PI3K/AKT/mTOR Signaling.
Toxics. 2024;12:396.
Abstract

MANOURAS A, Lund LH, Nagy AI, Johnson J, et al
Insights into RC time curve fit analysis of pulmonary artery pressure decay.
BMC Pulm Med. 2024;24:295.
Abstract

MWAKYULA IH, Makarius E, Maro H, Ngatunga C, et al
Pneumoconiosis among artisanal miners in Chunya district, Mbeya, Tanzania.
BMJ Case Rep. 2024;17:e260481.
Abstract

TSUJINO I, Kitahara K, Omura J, Iwahori T, et al
A PrOsPective Cohort Study on Interstitial Lung Disease-Associated Pulmonary Hypertension with a ParticulaR Focus on the Subset with Pulmonary Arterial Hypertension Features (POPLAR Study).
Pulm Ther. 2024 Jun 24. doi: 10.1007/s41030-024-00264.
Abstract

LEMAY SE, Provencher S, Bonnet S, Potus F, et al
A HIF-2alpha-dependent KMT2E-AS1/KMT2E axis orchestrates endothelial epigenetic and metabolic dysfunction in pulmonary hypertension.
Ann Transl Med. 2024;12:55.
Abstract

RAGNARSDOTTIR H, Ozkan E, Michel H, Chin-Cheong K, et al
Deep Learning Based Prediction of Pulmonary Hypertension in Newborns Using Echocardiograms.
Int J Comput Vis. 2024;132:2567-2584.
Abstract

BRAKSATOR M, Jachymek M, Rahmani A, Widecka K, et al
Nonsurgical treatment of a patient with decompensated right ventricular failure due to chronic thromboembolic pulmonary hypertension with proximal clot location-A case report.
Pulm Circ. 2024;14:e12400.
Abstract

PICCARI L, Kovacs G, Jones S, Skaara H, et al
The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatments.
Pulm Circ. 2024;14:e12405.
Abstract

SUN L, Zhao X, Hou X, Zhang Y, et al
The role of serum sodium in poor prognosis evaluation of pulmonary hypertension associated with left heart disease.
Am J Med Sci. 2024 Jun 21:S0002-9629(24)01317.
Abstract

DENG ZH, Chen YX, Xue-Gao, Yang JY, et al
Mesenchymal stem cell-derived exosomes ameliorate hypoxic pulmonary hypertension by inhibiting the Hsp90aa1/ERK/pERK pathway.
Biochem Pharmacol. 2024 Jun 21:116382. doi: 10.1016/j.bcp.2024.116382.
Abstract

LI B, Zhu H, Jia M, Song J, et al
Venous retrograde approach for endovascular angioplasty in chronic total pulmonary vein occlusion -a case report.
BMC Cardiovasc Disord. 2024;24:315.
Abstract

TENES A, Garcia-Sanchez A, Pintado-Cort B, Gonzalez-Castro S, et al
Chronic thromboembolic pulmonary hypertension treatment and sex: Systematic review and meta-analysis.
Med Clin (Barc). 2024 Jun 21:S0025-7753(24)00275.
Abstract

LI X, Li H, Feng B, Chen X, et al
Post-treatment with Resolvin D1 attenuates pulmonary hypertension by inhibiting endothelial-to-mesenchymal transition.
Biomed Pharmacother. 2024;177:117023.
Abstract

PENG W, Jiang C, Cai G, Liu L, et al
Preparation of polyclonal antibody against thrombospondin 2 recombinant protein and its functional verification in pulmonary hypertension syndrome in broilers.
Int J Biol Macromol. 2024;274.
Abstract

ZHANG H, Chen L, Li J, Sun J, et al
STAT3 phosphorylation at Tyr705 affects DRP1 (dynamin-related protein 1) controlled-mitochondrial fission during the development of apoptotic-resistance in pulmonary arterial endothelial cells.
Genes Genomics. 2024;46:751-762.
Abstract

LI W, Quigley K
Bone morphogenetic protein signalling in pulmonary arterial hypertension: revisiting the BMPRII connection.
Biochem Soc Trans. 2024;52:1515-1528.
Abstract

FRANTZ RP, McLaughlin VV, Sahay S, Escribano Subias P, et al
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial.
Lancet Respir Med. 2024;12:523-534.
Abstract

SERAFIN A, Kosmala W, Marwick TH
Evolving Applications of Echocardiography in the Evaluation of Left Atrial and Right Ventricular Strain.
Curr Cardiol Rep. 2024;26:593-600.
Abstract

LIU X, Liu B, Luo X, Liu Z, et al
Research progress on the role of p53 in pulmonary arterial hypertension.
Respir Investig. 2024;62:541-550.
Abstract

BROWN Z, Hansen D, Stevens W, Ferdowsi N, et al
Evaluation of the European Society of Cardiology Risk Assessment Score in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
Arthritis Care Res (Hoboken). 2024;76:973-983.
Abstract

YANG X, Han X, Liang M, Wang Y, et al
The role of neutrophil to lymphocyte ratio in patients with COPD-OSA overlap syndrome.
Sleep Breath. 2024;28:1329-1335.
Abstract

CHEN X, Yan Z, Pan Q, Zhang C, et al
Bibliometric analysis of T-cells immunity in pulmonary hypertension from 1992 to 2022.
Immun Inflamm Dis. 2024;12:e1280.
Abstract

ELHAGE HASSAN M, Vinales J, Perkins S, Sandesara P, et al
Pathogenesis, Diagnosis, and Management of Chronic Thromboembolic Pulmonary Hypertension.
Interv Cardiol Clin. 2023;12.
Abstract

NASRI A, Bashir R, Lakhter V
Management of Complications of Balloon Pulmonary Angioplasty.
Interv Cardiol Clin. 2023;12.
Abstract

IMAI R, Adachi S, Yoshida M, Shimokata S, et al
Clinical usefulness of endothelial progenitor cells in predicting the efficacy of riociguat in chronic thromboembolic pulmonary hypertension.
Nagoya J Med Sci. 2024;86:292-303.
Abstract

KIKO T, Asano R, Endo H, Nishi N, et al
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary disease without pulmonary hypertension.
Pulm Circ. 2024;14:e12409.
Abstract

AVITABILE CM, Mota JP, Yeaman KM, Andrieux SJ, et al
Creating a digital approach for promoting physical activity in pediatric pulmonary hypertension: A framework for future interventions.
Pulm Circ. 2024;14:e12402.
Abstract

COLAK A, Kumral Z, Sezgin D, Simsek GO, et al
The prognostic value of right ventricular outflow tract velocity time integral in patients with pulmonary hypertension.
ESC Heart Fail. 2024 Jul 3. doi: 10.1002/ehf2.14934.
Abstract

SONAGLIONI A, Caminati A, Zompatori M, Cassandro R, et al
TAPSE/sPAP ratio can be used to predict pulmonary hypertension in fibrosing interstitial lung disease.
Int J Tuberc Lung Dis. 2024;28:362-364.
Abstract

LE BOZEC A, Korb-Savoldelli V, Boiteau C, Dechartres A, et al
Medication adherence, related factors and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: a systematic review.
Eur Respir Rev. 2024;33:240006.
Abstract

YUAN S, Li S, Ruan J, Liu H, et al
Chronic kidney disease and pulmonary hypertension: progress in diagnosis and treatment.
Transl Res. 2024 Jul 1:S1931-5244(24)00138-5. doi: 10.1016/j.trsl.2024.
Abstract

FRANCOIS P, Sebastien B
Collagen Triple Helix Repeat-Containing Protein 1: More Than Just a Novel Biomarker for Right Ventricular Involvement in Pulmonary Hypertension.
Can J Cardiol. 2024 Jul 1:S0828-282X(24)00514-2. doi: 10.1016/j.cjca.2024.
Abstract

TANG XG, Wei ZD, Wang X, Zhang R, et al
Letter to the Editor: T-Wave Inversion in Leads V1-V3 as a Crucial Indicator of High-Altitude Pulmonary Hypertension among Young Chinese Males at 4,820 m: A Report of Two Cases.
High Alt Med Biol. 2024 Jul 3. doi: 10.1089/ham.2024.0093.
Abstract

KHALIL S, Tabowei G, Kaur M, Dadzie SK, et al
Effect of Pulmonary Hypertension on Survival Outcomes in Patients With Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.
Cureus. 2024;16:e58540.
Abstract

MICHEL-MACIAS C, Hebert A, Altit G
Optimizing management of chronic pulmonary hypertension in preterm infants: strategies for a complex population.
Curr Opin Pediatr. 2024 Jun 27. doi: 10.1097/MOP.0000000000001383.
Abstract

SAMI H, Sami F, Razok A, Dasgupta M, et al
Pulmonary arterial hypertension in systemic sclerosis: a national inpatient analysis.
ARP Rheumatol. 2024;3:95-100.
Abstract

REDDY YNV, Miranda WR, Jain CC, Borlaug BA, et al
Haemodynamic contributors to pulmonary hypertension across the spectrum of adult congenital heart disease.
Eur J Heart Fail. 2024 Jul 2. doi: 10.1002/ejhf.3366.
Abstract

PARK TK, Chang SA, Yang JH, Kwon W, et al
Programmed Follow-up and Quality Control of Treatment Techniques Enhance Chronic Thromboembolic Pulmonary Hypertension Management: Lessons From a Multidisciplinary Team.
Korean Circ J. 2024 Jun 3. doi: 10.4070/kcj.2024.0021.
Abstract

HOLDA MK, Razny U, Sordyl M, Goralska J, et al
Autophagy and ubiquitin-dependent proteolysis processes in left ventricular mass loss in pulmonary arterial hypertension.
Sci Rep. 2024;14:15133.
Abstract

BOTONI FA, Lambertucci JR, Santos RAS, Muller J, et al
Functional autoantibodies against G protein-coupled receptors in hepatic and pulmonary hypertensions in human schistosomiasis.
Front Immunol. 2024;15:1404384.
Abstract

MAHDAVI M, Shahzadi H, Ghasemnezhad M, Hoseinzadeh Moghadam S, et al
Pulmonary Capillary Hemangiomatosis as a Rare Underlying Cause of Primary Pulmonary Hypertension: A Case Report in an Adolescent.
Iran J Med Sci. 2024;49:394-398.
Abstract

LIU Z, Fu Q, Yu Q, Ma X, et al
Assessing causal associations of blood counts and biochemical indicators with pulmonary arterial hypertension: a Mendelian randomization study and results from national health and nutrition examination survey 2003-2018.
Front Endocrinol (Lausanne). 2024;15:1418835.
Abstract

OKNINSKA M, Paterek A, Grzanka M, Zajda K, et al
Myo-inositol trispyrophosphate prevents right ventricular failure and improves survival in monocrotaline-induced pulmonary hypertension in the rat.
Br J Pharmacol. 2024 Jul 1. doi: 10.1111/bph.16482.
Abstract

DING YJ, Zhang L, Li QY
[Advances in early diagnosis of non-thromboembolic tumor related pulmonary vascular disease].
Zhonghua Nei Ke Za Zhi. 2024;63:712-715.
Abstract

SKORO-SAJER N, Sheares K, Forfia P, Heresi GA, et al
Treatment and management of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross-sectional scientific survey (CLARITY).
Pulm Circ. 2024;14:e12406.
Abstract

MAIA PD, Abman SH, Mandell E
Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: Basing Care on Physiology.
Neoreviews. 2024;25:e415-e433.
Abstract

KILICKIRAN AVCI B, Seyahi E, Polat F, Kolak Z, et al
Role of Optical Coherence Tomography in Vasculitis-Associated Pulmonary Hypertension and Chronic Thromboembolic Pulmonary Hypertension.
Circ J. 2024 Jun 28. doi: 10.1253/circj.CJ-24-0254.
Abstract

BOMMENA S, Fallon MB
Pulmonary Complications of Portal Hypertension.
Clin Liver Dis. 2024;28:467-482.
Abstract

INACIO CAZEIRO D, Azaredo Raposo M, Guimaraes T, Lousada N, et al
Chronic thromboembolic pulmonary hypertension: A comprehensive review of pathogenesis, diagnosis, and treatment strategies.
Rev Port Cardiol. 2024 Jun 28:S0870-2551(24)00187.
Abstract

YANG L, Luo D, Huang T, Li X, et al
Echocardiographic assessment for cardiopulmonary function in patients with congenital heart disease-related pulmonary arterial hypertension.
BMC Pulm Med. 2024;24:306.
Abstract

COLUNGA A, Carlson B, Olufsen MS
The importance of incorporating ventricular-ventricular interaction (VVI) in the study of pulmonary hypertension.
Math Biosci. 2024 Jun 27:109242. doi: 10.1016/j.mbs.2024.109242.
Abstract

NING S, Guo X, Zhu Y, Li C, et al
The mechanism of NRF2 regulating cell proliferation and mesenchymal transformation in pulmonary hypertension.
Int J Biol Macromol. 2024 Jun 27:133514. doi: 10.1016/j.ijbiomac.2024.133514.
Abstract

WU D, Lin Y, Yang M, Li H, et al
Tissue factor regulates autophagy in pulmonary artery endothelial cells from chronic thromboembolic pulmonary hypertension rats via the p38 MAPK-FoxO1 pathway.
Respir Res. 2024;25:261.
Abstract

MATHAI SC
Pulmonary Hypertension Associated with Connective Tissue Disease.
Rheum Dis Clin North Am. 2024;50:359-379.
Abstract

WANG X, Cui L, Wang Y, Zeng Z, et al
Mechanistic investigation of wogonin in delaying the progression of endothelial mesenchymal transition by targeting the TGF-beta1 pathway in pulmonary hypertension.
Eur J Pharmacol. 2024;978:176786.
Abstract

DAI X, Liu Y, Wu Y, Wang S, et al
DYZY01 alleviates pulmonary hypertension via inhibiting endothelial cell pyroptosis and rescuing endothelial dysfunction.
Eur J Pharmacol. 2024;978:176785.
Abstract

FREIRE TC, Ferreira MS, De Angelis K, Paula-Ribeiro M, et al
Respiratory, cardiovascular and musculoskeletal mechanisms involved in the pathophysiology of pulmonary hypertension: An updated systematic review of preclinical and clinical studies.
Heart Lung. 2024;68:81-91.
Abstract

MA H, Gao JM, Wang J, Huang LY, et al
Pulmonary tumor thrombotic microangiopathy: Two case reports and literature review.
Medicine (Baltimore). 2024;103:e38618.
Abstract

LOKHORST C, van der Werf S, Berger RMF, Douwes JM, et al
Prognostic Value of Serial Risk Stratification in Adult and Pediatric Pulmonary Arterial Hypertension: A Systematic Review.
J Am Heart Assoc. 2024;13:e034151.
Abstract

USMAN PP AS, Sekar D
microRNA-based electrochemical biosensor for early detection of pulmonary arterial hypertension.
Hypertens Res. 2024;47:2000-2002.
Abstract

MOHAMMAD M, Hartmann JP, Carlsen J, Greve AM, et al
Prognostic value of pulmonary diffusing capacity for carbon monoxide and ventilation-perfusion SPECT findings in pulmonary arterial hypertension.
Exp Physiol. 2024;109:1040-1050.
Abstract

RECCHIONI T, Manzi G, Mihai A, Vizza CD, et al
Is Cardiopulmonary Exercise Test Really Representative of Pulmonary Arterial Hypertension Patients' Quality of Life?
Arch Bronconeumol. 2024;60:458-459.
Abstract

RIBEUZ HL, Willer AS, Chevalier B, Sancho M, et al
Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction.
Am J Respir Cell Mol Biol. 2024;71:95-109.
Abstract

ROLDAN GOMEZ FJ, Aranda Fraustro A, Gomez Soto L, Pulido Zamudio T, et al
Heritable pulmonary arterial hypertension in rats with spontaneous systemic hypertension.
Rev Esp Cardiol (Engl Ed). 2024;77:587-588.
Abstract

GARZA-GARZA LA, Villarreal-Martinez P, Garza-Leon M
Untreated combined persistent fetal vasculature with "coralliform" cataract in a Hispanic 21 year-old male.
Arch Soc Esp Oftalmol (Engl Ed). 2024;99:300-303.
Abstract

VALDEOLMILLOS E, Sakhi H, Tortigue M, Audie M, et al
4D flow cardiac MRI to assess pulmonary blood flow in patients with pulmonary arterial hypertension associated with congenital heart disease.
Diagn Interv Imaging. 2024;105.
Abstract

ZHANG J, Huang WQ, Zhang YR, Liang N, et al
Upregulation of eIF2alpha by m(6)A modification accelerates the proliferation of pulmonary artery smooth muscle cells in MCT-induced pulmonary arterial hypertension rats.
J Cardiovasc Transl Res. 2024;17:598-608.
Abstract

MORIYA H, Kato M, Hisada R, Ninagawa K, et al
The chest CT signs for pulmonary veno-occlusive disease correlate with pulmonary haemodynamics in systemic sclerosis.
Rheumatology (Oxford). 2024;63:1868-1873.
Abstract

LICHTBLAU M, Saxer S, Muller J, Appenzeller P, et al
Effect of 5 weeks of oral acetazolamide on patients with pulmonary vascular disease: A randomized, double-blind, cross-over trial.
Pulmonology. 2024;30:362-369.
Abstract

MICHEL SG, Hanuna M, Pattathu J, Pabst von Ohain J, et al
Case report: Paracorporeal lung assist device for 215 days as a bridge-to-lung transplantation in a patient with bronchopulmonary dysplasia and severe pulmonary hypertension.
Front Transplant. 2023;2:1197906.
Abstract

AXELSEN JS, Andersen S, Ringgaard S, Smal R, et al
Right ventricular diastolic adaptation to pressure overload in different rat strains.
Physiol Rep. 2024;12:e16132.
Abstract

WAN JJ, Yi J, Wang FY, Li X, et al
Role of mitophagy in pulmonary hypertension: Targeting the mechanism and pharmacological intervention.
Mitochondrion. 2024 Jul 9:101928. doi: 10.1016/j.mito.2024.101928.
Abstract

HERESI G, Dean B, Wu B, Lee H, et al
Burden of illness in patients with pulmonary hypertension due to interstitial lung disease: a real-world analysis.
BMC Pulm Med. 2024;24:335.
Abstract

PARSAEE M, Saedi S, Behrooj S, Emami E, et al
A rare association of the absence of left pulmonary artery with ventricular septal defect, pulmonary hypertension, and more interestingly, patent ductus arteriosus in an adult patient: Case report and literature review.
Clin Case Rep. 2024;12:e9138.
Abstract

YU X, Huang J, Liu X, Li J, et al
LncRNAH19 acts as a ceRNA of let-7 g to facilitate endothelial-to-mesenchymal transition in hypoxic pulmonary hypertension via regulating TGF-beta signalling pathway.
Respir Res. 2024;25:270.
Abstract

GANTA A, Merrell LA, Esper GW, Gibbons K, et al
Under pressure: symptomatic pulmonary hypertension is a predictor of poor outcome following hip fracture.
Eur J Orthop Surg Traumatol. 2024 Jul 11. doi: 10.1007/s00590-024-04028.
Abstract

MADONNA R, Alberti M, Biondi F, Morganti R, et al
Chronic thromboembolic disease: Association with exercise-induced pulmonary hypertension and right ventricle deterioration.
Vascul Pharmacol. 2024;155:107291.
Abstract

AGGARWAL K, Valleru PS, Anamika FNU, Aggarwal P, et al
Unraveling the Complex Relationship-Atrial Fibrillation and Pulmonary Hypertension.
Curr Cardiol Rep. 2024 Jul 10. doi: 10.1007/s11886-024-02089.
Abstract

ZHANG Z, Liu J, Zhen Y, Liu X, et al
Riociguat as bridging therapy to pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a retrospective cohort study.
J Thorac Dis. 2024;16:3540-3552.
Abstract

TODESCO A, Grynblat J, Akoumia KKF, Bonnet D, et al
Pulmonary Hypertension Induced by Right Pulmonary Artery Occlusion: Hemodynamic Consequences of Bmpr2 Mutation.
J Am Heart Assoc. 2024 Jul 9:e034621. doi: 10.1161/JAHA.124.034621.
Abstract

SHARP-DIMITRI D, Pourriahi M, Zhou C, Jandarov R, et al
Mortality Risk Assessment Using the REVEAL 2.0 Score in Pulmonary Hypertension Secondary to Left Heart Disease.
Res Sq [Preprint]. 2024 Jun 25:rs.3.rs-4474171. doi: 10.21203/rs.3.rs-4474171.
Abstract

MONTANI D, Cifrian JM, Rojo RP, Nunes H, et al
Unmet need in pulmonary hypertension-associated interstitial lung disease (PH-ILD): a clinician survey of real-world management of PH-ILD in Europe.
ERJ Open Res. 2024;10:00039-2024.
Abstract

SEIDINGER A, Roberts R, Bai Y, Muller M, et al
Pharmacological Gq inhibition induces strong pulmonary vasorelaxation and reverses pulmonary hypertension.
EMBO Mol Med. 2024 Jul 8. doi: 10.1038/s44321-024-00096.
Abstract

AGYEMAN WY, Hawkins J, Chishinga N, Addo B, et al
Challenges and Insights: Severe Acute Right Ventricular Dysfunction in Pulmonary Hypertension.
Cureus. 2024;16:e61696.
Abstract

HOYOS R, Lichtblau M, Cajamarca E, Mayer L, et al
Characteristics and risk profiles of patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension living permanently at >2500 m of high altitude in Ecuador.
Pulm Circ. 2024;14:e12404.
Abstract

LIU B, Yi D, Ma X, Ramirez K, et al
A Novel Animal Model for Pulmonary Hypertension: Lung Endothelial-Specific Deletion of Egln1 in Mice.
J Respir Biol Transl Med. 2024;1:10007.
Abstract

HAVRANEK S, Fingrova Z, Dusik M, Dytrych V, et al
Benefits from catheter ablation in patients with pulmonary hypertension: Recent advances.
Kardiol Pol. 2024;82:602-608.
Abstract

DAY AL, Katzenbach J, Manchester AC, Figueroa R, et al
Mycoplasma spp. pneumonia and subsequent pulmonary hypertension in a domestic ferret (Mustela putorius furo).
Top Companion Anim Med. 2024 Jul 5:100891. doi: 10.1016/j.tcam.2024.100891.
Abstract

BOUCLY A, Bertoletti L, Fauvel C, Dewavrin MG, et al
Evidence and unresolved questions in pulmonary hypertension: Insights from the 5th French Pulmonary Hypertension Network Meeting.
Respir Med Res. 2024;86:101123.
Abstract

ILONZE OJ, Ebong IA, Guglin M, Nair A, et al
Considerations in the Diagnosis and Management of Pulmonary Hypertension Associated With Left Heart Disease.
JACC Heart Fail. 2024 Jun 24:S2213-1779(24)00436.
Abstract

GONZALEZ-VELA J, Tore-Melendez F, Bravo-Marques R
[The role of nursing in right heart catheterization. Advantages from peripheral venous access].
J Healthc Qual Res. 2024;39:241-246.
Abstract

VERMA A, Jaiswal S, Mahawar A, Lal M, et al
Managing Patients With Sympathetic Crashing Acute Pulmonary Edema (SCAPE) Using the SCAPE Treatment Protocol: A Case Series.
Perm J. 2024;28:116-120.
Abstract

ATSUMI T, Tan JY, Chiang AP, Yu DY, et al
Prevalence, patient characteristics and treatment patterns among systemic lupus erythematosus-pulmonary arterial hypertension patients in real-world clinical practice: A retrospective analysis of Medical Data Vision Database in Japan.
Mod Rheumatol. 2024;34:741-749.
Abstract

WANG Z, Zhang Z, Zhu L, Hou J, et al
Identification of risk factors for acute exacerbation of idiopathic pulmonary fibrosis based on baseline high-resolution computed tomography: a prospective observational study.
BMC Pulm Med. 2024;24:352.
Abstract

GARCIA MVF, Souza R, Caruso P
A Machine Learning Approach for Phenotyping Acute Decompensated Pulmonary Hypertension Patients Admitted to the ICU.
Am J Med Sci. 2024 Jul 17:S0002-9629(24)01358.
Abstract

VERWERFT J, Stassen J, Falter M, Bekhuis Y, et al
Clinical Significance of Exercise Pulmonary Hypertension With a Negative Diastolic Stress Test for Suspected Heart Failure With Preserved Ejection Fraction.
J Am Heart Assoc. 2024 Jul 19:e032228. doi: 10.1161/JAHA.123.032228.
Abstract

Correction to "Cardiopulmonary exercise testing and the 2022 definition of pulmonary hypertension".
Pulm Circ. 2024;14:e12417.
Abstract

XANTHOULI P, Uesbeck P, Lorenz HM, Blank N, et al
Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study.
Arthritis Res Ther. 2024;26:136.
Abstract

CARVALHO ES, Penha JG, Maeda NY, Abud KCO, et al
Down syndrome and postoperative hemodynamics in patients undergoing surgery for congenital cardiac communications.
Sci Rep. 2024;14:16612.
Abstract

WENG Z, Zhang L, Lin D, Yang L, et al
Long-term follow-up in outpatients with mildly elevated pulmonary artery systolic pressure on echocardiography: a single-centre retrospective cohort study in Shanghai, China.
BMJ Open. 2024;14:e086516.
Abstract

FELDMAN WB, Mahesri M, Sarpatwari A, Huybrechts KF, et al
Removing the FDA's Boxed Hepatotoxicity Warning and Liver Function Testing Requirement for Ambrisentan.
JAMA Netw Open. 2024;7:e2419873.
Abstract

SINGERER I, Tempel L, Gruen K, Heiss J, et al
Extra-domain A containing fibronectin in pulmonary hypertension and treatment effects of a function-blocking antibody.
Cardiovasc Res. 2024 Jul 18:cvae146. doi: 10.1093.
Abstract

POOJARY G, Morris N, Joshi MB, Babu AS, et al
Role of Exercise in Pulmonary Hypertension: Evidence from Bench to Bedside.
Pulse (Basel). 2024;12:66-75.
Abstract

SAHIN O, Gok NR, Colak D, Oner T, et al
Risk Factors and Mortality in Newborns with Persistent Pulmonary Hypertension: A Six-Year Single-Center Experience.
Sisli Etfal Hastan Tip Bul. 2024;58:165-170.
Abstract

WANG G, Liu S, Kong X, Jiao H, et al
Lipocalin-2 induced LDHA expression promotes vascular remodelling in pulmonary hypertension.
Cell Prolif. 2024 Jul 18:e13717. doi: 10.1111/cpr.13717.
Abstract

HOLDEN KI, Rintoul NE, McNamara PJ, Harting MT, et al
Congenital diaphragmatic hernia-associated pulmonary hypertension.
Semin Pediatr Surg. 2024;33:151437.
Abstract

INTAN RE, Balti DR, Nugraha RA, Alkaff FF, et al
Angiotensin converting enzyme inhibitor and coenzyme Q10 as adjunctive treatment for patients with ventricular septal rupture following late onset myocardial infarction: a case report.
J Pak Med Assoc. 2024;74.
Abstract

BATTAGLIA E, Compalati E, Mapelli L, Lax A, et al
Pulmonary hypertension in patients affected by sleep-related breathing disorders: up to date from the literature.
Minerva Med. 2024 Jul 17. doi: 10.23736/S0026-4806.24.09112.
Abstract

PROENCA I, Turck P, Ortiz V, Campos-Carraro C, et al
Right Ventricular Function and Oxidative Stress Improve with the Administration of Thyroid Hormones and Grape Juice in a Pulmonary Hypertension Model.
Arq Bras Cardiol. 2024;121:e20230602.
Abstract

WANG DD, Cheng M, Chen CY
Intervention control of aerobic exercise in maintaining quality of life and pulmonary hypertension in hemodialysis patients.
World J Clin Cases. 2024;12:4217-4229.
Abstract

XIE O, Li SS, Luo Y, Wang L, et al
[Protective effects of 2-methoxyestradiol against hypoxic pulmonary hypertension in neonatal rats].
Zhongguo Dang Dai Er Ke Za Zhi. 2024;26:757-764.
Abstract

SOBIECKA M, Siemion-Szczesniak I, Burakowska B, Kurzyna M, et al
Sarcoidosis-associated pulmonary hypertension due to pulmonary arteries stenosis - a case report.
BMC Pulm Med. 2024;24:346.
Abstract

WANG P, Zuo Z, Wu J, Wang J, et al
Short-term changes in chest CT images among individuals at low altitude after entering high-altitude environments.
Front Public Health. 2024;12:1392696.
Abstract

ALBULUSHI A, Kashoub M, Al-Saidi K, Al-Farhan H, et al
Iron Deficiency in Pulmonary Hypertension.
Int Heart J. 2024 Jul 13. doi: 10.1536.
Abstract

WANG G, Wang Z
Investigation into the role of H2-Ab1 in vascular remodeling in pulmonary arterial hypertension via Bioinformatics.
BMC Pulm Med. 2024;24:342.
Abstract

INOUE N, Yamamoto N, Ohtomo Y, Ohtomo Y, et al
[Inhaled Nitric Oxide Therapy Using High-flow Nasal Cannula in Adults After Open Heart Surgery].
Kyobu Geka. 2024;77:409-414.
Abstract

MA W, Zhang P, Vang A, Zimmer A, et al
Reduction in activity and abundance of mitochondrial electron transport chain supercomplexes in pulmonary hypertension-induced right ventricular dysfunction.
bioRxiv [Preprint]. 2024 Mar 13:2024.03.08.584016.
Abstract

MATSUBARA H
Multidisciplinary Team Approach for the Management of Chronic Thromboembolic Pulmonary Hypertension.
Korean Circ J. 2024;54:422-424.
Abstract

CHEN W, Chen A, Lian G, Yan Y, et al
Zinc attenuates monocrotaline-induced pulmonary hypertension in rats through upregulation of A20.
J Mol Cell Cardiol. 2024 Jul 11:S0022-2828(24)00111.
Abstract

SUAREZ-CASTILLEJO C, Calvo N, Preda L, Cordova Diaz R, et al
Cardiopulmonary Complications after Pulmonary Embolism in COVID-19.
Int J Mol Sci. 2024;25:7270.
Abstract

TORRES-ARRESE M, Barbera-Rausell P, Li-Zhu JO, Salas-Duenas R, et al
The Cardiac Pulsed Wave Doppler Pattern of the Common Femoral Vein in Diagnosing the Likelihood of Severe Pulmonary Hypertension: Results from a Prospective Multicentric Study.
J Clin Med. 2024;13:3860.
Abstract

FALCON-CORDON S, Falcon-Cordon Y, Caro-Vadillo A, Costa-Rodriguez N, et al
Association between Thoracic Radiographic Changes and Indicators of Pulmonary Hypertension in Dogs with Heartworm Disease.
Animals (Basel). 2024;14:1900.
Abstract

ZHAO B, Liu C, Qi Y, Zhang T, et al
Preliminary study of identified novel susceptibility loci for HAPE risk in a Chinese male Han population.
Per Med. 2024;21:227-241.
Abstract

WANG L, Mu M, Guo Y, Huang J, et al
PD-1/PD-L1 Provides Protective Role in Hypoxia-Induced Pulmonary Vascular Remodeling.
Hypertension. 2024;81:1822-1836.
Abstract

MAO Z, Wang C, Liu J, Li X, et al
Superoxide dismutase 1-modified dental pulp stem cells alleviate high-altitude pulmonary edema by inhibiting oxidative stress through the Nrf2/HO-1 pathway.
Gene Ther. 2024 Jun 4. doi: 10.1038/s41434-024-00457.
Abstract

WANG J, Shen Y, Zhang Y, Lin D, et al
Smooth Muscle Ythdf2 Abrogation Ameliorates Pulmonary Vascular Remodeling by Regulating Myadm Transcript Stability.
Hypertension. 2024;81:1785-1798.
Abstract

SATO T, Ogihara Y, Kitagawa K, Ogura T, et al
Diagnostic performance of fluoroscopic video analysis for pulmonary embolism: a prospective observational study.
Int J Cardiovasc Imaging. 2024;40:1445-1453.
Abstract

LAZCANO-DIAZ EA, Encarnacion-Martinez U, Gaytan-Garcia CJ, Manzur-Sandoval D, et al
[Circulatory support with venovenous ECMO in a patient with reperfusion pulmonary edema after pulmonary artery thromboendarterectomy].
Arch Cardiol Mex. 2024;94:361-365.
Abstract

REDDY YNV, Dubrock H, Hassoun PM, Hemnes A, et al
Non-invasive prediction of pulmonary vascular disease-related exercise intolerance and survival in non-group 1 pulmonary hypertension.
Eur J Heart Fail. 2024 Jul 26. doi: 10.1002/ejhf.3396.
Abstract

FAUVEL C, Damy T, Berthelot E, Bauer F, et al
Post-capillary pulmonary hypertension in heart failure: impact of current definition in the PH-HF multicentre study.
Eur Heart J. 2024 Jul 26:ehae467. doi: 10.1093.
Abstract

KIKO T, Asano R, Ishibashi T, Endo H, et al
Prevalence and Clinical Characteristics of Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension.
J Am Heart Assoc. 2024 Jul 26:e035009. doi: 10.1161/JAHA.124.035009.
Abstract

WANG H, Zhu CF, Han FZ
[Characteristics and maternal-fetal outcomes of pregnant women with critical congenital heart disease from a single center in China].
Zhonghua Fu Chan Ke Za Zhi. 2024;59:513-521.
Abstract

FRANKE M, Safdar Z
Acute Myocardial Infarction in the Setting of Pulmonary Hypertension due to a Patent Foramen Ovale and Paradoxical Embolism.
Case Rep Pulmonol. 2024;2024:6725308.
Abstract

ZHAI Y, Li A, Tao X, Gao Q, et al
Predicting high-risk pre-capillary pulmonary hypertension: an echocardiographic multiparameter scoring index.
BMC Cardiovasc Disord. 2024;24:384.
Abstract

GELLER A, Martinez Manzano JM, Jarrett SA, Wattanachayakul P, et al
Major Adverse Cardiovascular Outcomes within Distinct Pulmonary Hypertension Patterns in Advanced Chronic Kidney Disease: A Retrospective Cohort Analysis.
Respir Med. 2024 Jul 23:107743. doi: 10.1016/j.rmed.2024.107743.
Abstract

RIZZO C, Camarda F, La Barbera L, Guggino G, et al
Successful management of pulmonary hypertension with baricitinib in a dermatomyositis patient.
Clin Exp Rheumatol. 2024 Jul 25. doi: 10.55563.
Abstract

BERTUCCIO FR, Baio N, Montini S, Ferroni V, et al
Adjuvant surgical treatment of non-tuberculous mycobacterial lung disease in chronic thromboembolic pulmonary hypertension: A first case report.
J Clin Tuberc Other Mycobact Dis. 2024;36:100462.
Abstract

CERESER L, Zussino G, Ciccio C, Tullio A, et al
Impact of an expert-derived, quick hands-on tool on classifying pulmonary hypertension in chest computed tomography: a study on inexperienced readers using RAPID-CT-PH.
Radiol Med. 2024 Jul 24. doi: 10.1007/s11547-024-01852.
Abstract

CHASE BINION C, Agala CB, Ebanks AH, Marzinsky A, et al
Fetal biophysical predictors of pulmonary hypertension severity, management, and treatment in infants born with congenital diaphragmatic hernia.
Am J Surg. 2024;236:115821.
Abstract

MENG H, Deng Y, Liao J, Wu DD, et al
beta-catenin mediates monocrotaline-induced pulmonary hypertension via glycolysis in rats.
BMC Cardiovasc Disord. 2024;24:381.
Abstract

CHAIWANGYEN N, Vijarnsorn C, Chungsomprasong P, Chanthong P, et al
Contemporary survival outcomes of congenital systemic-to-pulmonary shunt in children with borderline pulmonary vascular resistant index compared to Eisenmenger syndrome.
Sci Rep. 2024;14:16867.
Abstract

CHEN W, Long Y, Chen D, Hao S, et al
Pulmonary hypertension exacerbated by hereditary hemorrhagic telangiectasia combined with pulmonary arteriovenous fistula and pregnancy status: A case report.
Int J Cardiol Cardiovasc Risk Prev. 2024;22:200300.
Abstract

RAN C, Lu M, Zhao F, Hao Y, et al
Ginsenoside Rg1 alleviates vascular remodeling in hypoxia-induced pulmonary hypertension mice through the calpain-1/STAT3 signaling pathway.
J Ginseng Res. 2024;48:405-416.
Abstract

HAN SA, Han S, Lee J, Kang DY, et al
Semi-Quantitative Analysis of Lung Perfusion SPECT/CT for Evaluation of Response to Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension.
Nucl Med Mol Imaging. 2024;58:291-299.
Abstract

CHOI MH, Greathouse F, Darki A
Medical Management of Isolated Partial Anomalous Pulmonary Venous Connection With Symptomatic Right Ventricular Failure and Pulmonary Hypertension.
Cureus. 2024;16:e62779.
Abstract

HE W, Liu C, Li X, Zhong B, et al
Integrated approach of network pharmacology, molecular docking, and clinical observations in evaluating the efficacy and safety of Bufei Huoxue capsules for pulmonary hypertension associated with chronic obstructive pulmonary disease.
Pulm Circ. 2024;14:e12414.
Abstract

UDJUS C, Halvorsen B, Kong XY, Sagen EL, et al
Alveolar hypoxia induces organ-specific inflammasome-related inflammation in male mouse lungs.
Physiol Rep. 2024;12:e16143.
Abstract

HONG KT, Shin SH, Kim EK, Kim HS, et al
Clinical phenotype of pulmonary vascular disease requiring treatment in extremely preterm infants.
BMC Pediatr. 2024;24:467.
Abstract

ENNIS S, Bruce J, Sandhu H, Ratna M, et al
Protocol update for a multi-centre randomised controlled trial of exercise rehabilitation for people with pulmonary hypertension: the SPHERe trial.
Trials. 2024;25:495.
Abstract

CHAO HY, Yee BJ, Hsu CH, Chen HM, et al
Sleep-related disorders in patients with precapillary pulmonary hypertension.
Sleep Med Rev. 2024;77:101972.
Abstract

RAMINENI A, Faateh M, Mehdizadeh-Shrifi A, Hayes D Jr, et al
Outcomes of Concomitant Cardiac Surgical Procedures Performed During Pediatric Lung Transplantation in the United States.
Lung. 2024;202:459-464.
Abstract

AMERI P, Toma M, Stolfo D
The pathophysiological approach: the best for phenotyping patients with pulmonary arterial hypertension: reply.
Clin Res Cardiol. 2024;113:1278-1279.
Abstract

MANZI G, Badagliacca R, Filomena D, D'Alto M, et al
The pathophysiological approach: the best for phenotyping patients with pulmonary arterial hypertension.
Clin Res Cardiol. 2024;113:1276-1277.
Abstract

PAPOLOS AI, Kenigsberg BB, Austin DR, Barnett CF, et al
Management of the peri-intubation period in patients with pulmonary arterial hypertension and respiratory failure.
Curr Cardiol Rep. 2024;26:815-820.
Abstract

MCGINN R, McCluskey SA, Sayed BA, Goto T, et al
Intraoperative hemodialysis with supra- and infradiaphragmatic catheters for liver transplantation.
Can J Anaesth. 2024;71:1165-1171.
Abstract

DAVID N, Lakha S, Walsh S, Fried E, et al
Novel inhaled pulmonary vasodilators in adult cardiac surgery: a scoping review.
Can J Anaesth. 2024 May 23. doi: 10.1007/s12630-024-02770.
Abstract

MADONNA R, Biondi F, Ghelardoni S, D'Alleva A, et al
Pulmonary hypertension associated to left heart disease: Phenotypes and treatment.
Eur J Intern Med. 2024 Aug 1:S0953-6205(24)00326.
Abstract

ABOZEID SF, Elkholy RA, Elbedewy TA, Seliem MF, et al
EXPRESS: Soluble Fms-Like Tyrosine Kinase-1 as an Endothelial Dysfunction Biomarker Associated with Pulmonary Hypertension in Adult Patients with Beta-Thalassemia Major.
J Investig Med. 2024 Aug 2:10815589241270616. doi: 10.1177/10815589241270616.
Abstract

ABDULELAH M, Abdulelah ZA, Azzam M, Ghalayni R, et al
Analysis of Terminated Pulmonary Hypertension Clinical Trials. What Are We Doing Wrong?
Curr Probl Cardiol. 2024 Jul 30:102775. doi: 10.1016/j.cpcardiol.2024.102775.
Abstract

CHENG K, Zhai Q, Song J, Liu B, et al
The Co-pathogenic Target Gene CNTN1 Involved in Coronary Artery Disease and Pulmonary Arterial Hypertension Has Potential for Diagnosis of Coronary Artery Disease.
Anatol J Cardiol. 2024;28:381-392.
Abstract

OGUZ MS, Bingol Z, Pihtili A, Karaca Ozer P, et al
Oxygen saturation recovery after 6-minute walk test in patients with idiopathic pulmonary fibrosis.
BMC Pulm Med. 2024;24:373.
Abstract

TSUNEMATSU H, Imanishi M, Uemura Y, Higaki Y, et al
Indigo Leaves-Induced Pulmonary Arterial Remodeling without Right Ventricular Hypertrophy in Rats.
Biol Pharm Bull. 2024;47:1350-1359.
Abstract

GRANADOS L, John M, Edelman JD
New Therapies in Outpatient Pulmonary Medicine.
Med Clin North Am. 2024;108:843-869.
Abstract

ZHONG YF, Liang BB, Zhang XF, Ji-Wu, et al
The Correlation between Lung Ultrasound and Pathology in Rat Model of Monocrotaline-Induced Pulmonary Hypertension.
Can Respir J. 2024;2024:6619471.
Abstract

ZHANG S, Li S, Gao L, Zhao Q, et al
Effects of malnutrition on disease severity and adverse outcomes in idiopathic pulmonary arterial hypertension: a retrospective cohort study.
Respir Res. 2024;25:292.
Abstract

JIANG Q, Yang Q, Zhang C, Hou C, et al
Nephrectomy and high-salt diet inducing pulmonary hypertension and kidney damage by increasing Ang II concentration in rats.
Respir Res. 2024;25:288.
Abstract

WU D, Liang H, Kaisaier W, Li J, et al
The use of non-vitamin K antagonist oral anticoagulants in chronic thromboembolic pulmonary hypertension: an updated meta-analysis.
J Thromb Thrombolysis. 2024 Jul 30. doi: 10.1007/s11239-024-03021.
Abstract

LEIVA O, Beaty W, Soo S, Agarwal MA, et al
Cancer Therapy-Associated Pulmonary Hypertension and Right Ventricular Dysfunction: Etiologies and Prognostic Implications.
Rev Cardiovasc Med. 2024;25:87.
Abstract

XU H, Song W, Zheng S, Huyan Y, et al
Association of Prolonged Nocturnal Hypoxemia with Clinical Worsening in Patients with Chronic Thromboembolic Pulmonary Hypertension Undergoing Pulmonary Endarterectomy.
Rev Cardiovasc Med. 2023;24:240.
Abstract

SCHIAVO A, Bellino M, Moreo A, Casadei F, et al
Exercise Pulmonary Hypertension in Heart Valve Disease.
Rev Cardiovasc Med. 2024;25:131.
Abstract

LIU T, Xu S, Yang J, Xing X, et al
Roles of LncRNAs in the Pathogenesis of Pulmonary Hypertension.
Rev Cardiovasc Med. 2024;25:217.
Abstract

ZHUANG B, Chen Y, Han S
Neonatal lupus erythematosus with severe persistent pulmonary hypertension.
QJM. 2024 Jul 29:hcae134. doi: 10.1093.
Abstract

AHMED ASI, Blood AB, Zhang L
MicroRNA-210 mediates hypoxia-induced pulmonary hypertension by targeting mitochondrial bioenergetics and mtROS flux.
Acta Physiol (Oxf). 2024 Jul 29:e14212. doi: 10.1111/apha.14212.
Abstract

CAO W, Wang L, Mo Q, Peng F, et al
Disease-associated gut microbiome and metabolome changes in rats with chronic hypoxia-induced pulmonary hypertension.
Front Cell Dev Biol. 2024;12:1022181.
Abstract

SUMARLI A, Choi J, Wong V, Aluzri N, et al
Cesarean Section in a Group 1 Pulmonary Hypertension Parturient Patient: A Case Report.
Cureus. 2024;16:e63390.
Abstract

LIANG PQ, Xu BN, Pan YX, Huang HY, et al
[Clinical features of pulmonary hypertension in lymphangioleiomyomatosis].
Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:746-753.
Abstract

SULLIVAN RT, Austin ED
Pulmonary Hypertension in Children.
Clin Chest Med. 2024;45:685-693.
Abstract

VENKATESHVARAN A, Bohlin J, Kjellstrom B, Bergstrom E, et al
Left ventricular dysfunction in pulmonary arterial hypertension is attributed to underfilling rather than intrinsic myocardial disease: a CMR 2D phase contrast study.
Sci Rep. 2024;14:17280.
Abstract

YOSHIKAWA K, Nishiyama O, Yamazaki R, Kunita Y, et al
Selexipag for patients with pulmonary hypertension associated with lung disease: A preliminary study.
Respir Investig. 2024;62:850-855.
Abstract

KARYOFYLLIS P, Demerouti E, Tsetika EG, Apostolopoulou S, et al
Haemolytic Anaemia-Related Pulmonary Hypertension.
Life (Basel). 2024;14:876.
Abstract

KOSANOVIC D, Avdeev SN, Milovanov AP, Chernyaev AL, et al
Northern Pulmonary Hypertension: A Forgotten Kind of Pulmonary Circulation Pathology.
Life (Basel). 2024;14:875.
Abstract

OLAH A, Barta BA, Ruppert M, Sayour AA, et al
A Comparative Investigation of the Pulmonary Vasodilating Effects of Inhaled NO Gas Therapy and Inhalation of a New Drug Formulation Containing a NO Donor Metabolite (SIN-1A).
Int J Mol Sci. 2024;25:7981.
Abstract

TOBAL R, Potjewijd J, van Doorn D, van Empel V, et al
High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary Hypertension.
Diagnostics (Basel). 2024;14:1471.
Abstract

ZHANG M, Li L, Zhang W, Li M, et al
TG2 participates in pulmonary vascular remodelling by regulating the senescence of pulmonary artery smooth muscle cells.
Cell Signal. 2024;121:111296.
Abstract

HUANG W, Zhou H, He Y, Wang A, et al
A novel PDGFR inhibitor WQ-C-401 prevents pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension.
Exp Cell Res. 2024;441:114154.
Abstract

KANG C
Sotatercept: First Approval.
Drugs. 2024;84:857-862.
Abstract

PITRE T, Desai K, Mah J, Zeraatkar D, et al
Comparative Effectiveness of Sotatercept and Approved Add-On Pulmonary Arterial Hypertension Therapies: A Systematic Review and Network Meta-Analysis.
Ann Am Thorac Soc. 2024;21:1194-1203.
Abstract

BRAVO-MARQUES R, Becerra-Munoz V, Espildora-Hernandez F, Recio-Mayoral A, et al
Effectiveness of a Prostacyclin IP Receptor Agonist in Patients With Pulmonary Arterial Hypertension in the Real-world Andalusian Setting: The RAMPHA Study.
Clin Ther. 2024;46:509-514.
Abstract

CARMAN BL, Qin S, Predescu DN, Jana M, et al
Dysregulation of the Long Noncoding RNA X-Inactive-Specific Transcript Expression in Male Patients with Pulmonary Arterial Hypertension.
Am J Pathol. 2024;194:1592-1606.
Abstract

MACCALLINI M, Barge-Caballero G, Barge-Caballero E, Lopez-Perez M, et al
Prognostic value of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio in cardiac amyloidosis.
Rev Esp Cardiol (Engl Ed). 2024;77:634-644.
Abstract

LI Q, Liao H, Ren Y, Yang D, et al
Right Ventricular Function in Takayasu's Arteritis Patients With Pulmonary Artery Involvement Using MRI Feature Tracking.
J Magn Reson Imaging. 2023 Dec 1. doi: 10.1002/jmri.29143.
Abstract

WAWRZYNIAK R, Gresner P, Lewicka E, Macioszek S, et al
Metabolomics Meets Clinics: A Multivariate Analysis of Plasma and Urine Metabolic Signatures in Pulmonary Arterial Hypertension.
J Proteome Res. 2024;23:2795-2804.
Abstract

GLENTHOJ A, Grace RF, Lander C, van Beers EJ, et al
Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak Registry.
Br J Haematol. 2024;205:613-623.
Abstract

NAM HS, Oh YI
Sildenafil-induced priapism in a dog : an unusual case report.
BMC Vet Res. 2024;20:352.
Abstract

WOJCIAK-STOTHARD B, Gupte S, Bossone E
Disease mechanisms and therapeutic targets in pulmonary hypertension: Key insights from the special issue of vascular pharmacology on pulmonary hypertension.
Vascul Pharmacol. 2024 Aug 6:107415. doi: 10.1016/j.vph.2024.107415.
Abstract

MALIN J, Khan R, Manzano JMM, Wattanachayakul P, et al
Association of arteriovenous fistulae with precapillary pulmonary hypertension - A single center retrospective analysis of invasive hemodynamic parameters.
Heart Lung. 2024;68:260-264.
Abstract

LI X, Tan J, Wan J, Cheng B, et al
Cell Death in Pulmonary Arterial Hypertension.
Int J Med Sci. 2024;21:1840-1851.
Abstract

CHEN D, Jin Q, Yang L, Zhang X, et al
Mendelian randomization study on causal association of TEF and circadian rhythm with pulmonary arterial hypertension.
Respir Res. 2024;25:301.
Abstract

WANG L, Tang T, Tian X, Peng C, et al
Animal models of pulmonary arterial hypertension associated with atrial septal defect.
Sci Rep. 2024;14:18287.
Abstract

BERTAZZO B, Cicolini A, Fanilla M, Favaloro L, et al
Extracorporeal Mechanical Circulatory Support after Pulmonary Thromboendarterectomy: Experience of One Center.
Ann Thorac Cardiovasc Surg. 2024;30.
Abstract

ZUIN M, Badagliacca R, Harder E, McGonagle B, et al
Pulmonary hypertension-related deaths in patients with acute pulmonary embolism in the United States, 2003 to 2020.
Vasc Med. 2024 Aug 7:1358863X241257165. doi: 10.1177/1358863X241257165.
Abstract

YOGESWARAN A, Grimminger J, Tello K, Becker L, et al
Air travel in patients suffering from pulmonary hypertension-A prospective, multicentre study.
Pulm Circ. 2024;14:e12397.
Abstract

WU D, Wang S, Wang F, Zhang Q, et al
Lactate dehydrogenase A (LDHA)-mediated lactate generation promotes pulmonary vascular remodeling in pulmonary hypertension.
J Transl Med. 2024;22:738.
Abstract

WANG X, Guan X, Zhu X, Zhang L, et al
CircNAP1L4 regulates pulmonary artery smooth muscle cell proliferation via the NAP1L4-mediated super-enhancer-driven glycolysis gene hexokinase II (HK II) in pulmonary hypertension.
FASEB J. 2024;38:e23868.
Abstract

ZENG MN, Zhang YH, Guo PL, Zhang ZY, et al
[Effect of 2-phenylethyl-beta-glucopyranoside isolated from Huaizhong No. 1 Rehmannia glutinosa on hypoxic pulmonary hypertension by regulating PI3K/Akt/m TOR/HIF-1alpha pathway].
Zhongguo Zhong Yao Za Zhi. 2024;49:3857-3867.
Abstract

YANG C, Liu YH, Zheng HK
Identification of TFRC as a biomarker for pulmonary arterial hypertension based on bioinformatics and experimental verification.
Respir Res. 2024;25:296.
Abstract

FRANK BS, Gentzler ER, Avitabile CM, Miller-Reed K, et al
Safety and Effectiveness of Selexipag in Pediatric Pulmonary Hypertension: A Retrospective Multi-Center Cohort Study.
J Pediatr. 2024 Aug 1:114221. doi: 10.1016/j.jpeds.2024.114221.
Abstract

LISKE J, Patel N, Makowski C, Awdish R, et al
Risk evaluation and mitigation strategy compliance for pulmonary hypertension medications after policy implementation with computerized provider order entry support.
Am J Health Syst Pharm. 2024 Aug 3:zxae228. doi: 10.1093.
Abstract

HU Y, Zhao C, Tan W, Li M, et al
Discovery and Optimization of Hsp110 and sGC Dual-Target Regulators for the Treatment of Pulmonary Arterial Hypertension.
J Med Chem. 2024;67:13474-13490.
Abstract

BREWER J, Wilson M, Coons JC, Schmit A, et al
Practical management of oral treprostinil in patients with pulmonary arterial hypertension: Lessons from ADAPT, EXPEDITE, and expert consensus.
Respir Med. 2024;231:107734.
Abstract

CHAUHAN K, Yashavarddhan MH, Gogia A, Ranjan V, et al
Unraveling the genetic landscape of pulmonary arterial hypertension in Indian patients: A transcriptome study.
Respir Med. 2024;231:107716.
Abstract

MA X, Cao Y, Yang D, Dong Z, et al
Inhibition of RUNX1 slows the progression of pulmonary hypertension by targeting CBX5.
Biomol Biomed. 2024 Aug 16. doi: 10.17305/bb.2024.10720.
Abstract

JAN K, Pavel J, Renata C, Daniela D, et al
The incidence of the thrombophilic SNPs rs6025, rs1799963, rs2066865, rs2289252, and rs8176719 in chronic thromboembolic pulmonary hypertension.
Clin Appl Thromb Hemost. 2024;30:10760296241271369.
Abstract

LIAO MZ, Xiao YB
[Research progress of right ventricular strain imaging evaluation technology in pulmonary arterial hypertension].
Zhongguo Dang Dai Er Ke Za Zhi. 2024;26:887-892.
Abstract

KOTHARI SS, Shah J, Sharma V, Charaniya R, et al
Severe pulmonary arterial hypertension in congenital sideroblastic anemia from PUS1 mutation - a case report.
BMC Med Genomics. 2024;17:213.
Abstract

EL LABBAN M, Mir MR, Abruzzo A, Boike S, et al
The impact of group II pulmonary hypertension on congestive heart failure patients admitted with ST elevation myocardial infarction, a nationwide study.
J Thorac Dis. 2024;16:4120-4127.
Abstract

RAFIKOV R, de Jesus Perez V, Dekan A, Kudryashova TV, et al
Deciphering the Complexities of Pulmonary Hypertension: The Emergent Role of Single-Cell Omics.
Am J Respir Cell Mol Biol. 2024 Aug 14. doi: 10.1165/rcmb.2024-0145.
Abstract

DE LIYIS BG, Suastika LOS, Sutedja JC, Jagannatha GNP, et al
Prognostic values of right ventricular echocardiography functional parameters for mortality prediction in precapillary pulmonary hypertension: a systematic review and meta-analysis.
Egypt Heart J. 2024;76:105.
Abstract

CARVALHO AA, Carvalho WA, Martins ER, Medeiros Neto AH, et al
New Incremental Model for Predicting Mortality in Pre-Capillary Pulmonary Hypertension.
Arq Bras Cardiol. 2024;121:e20230669.
Abstract

ZHANG H, Li G, Li Q, Zuo Y, et al
Impact of Pulmonary Artery Banding in Patients with Congenital Heart Disease and Pulmonary Hypertension.
Rev Cardiovasc Med. 2024;25:253.
Abstract

GONZALEZ-GARCIA M, Conde-Camacho R, Diaz K, Rodriguez-Cortes C, et al
Differences in Exercise Capacity, Ventilatory Efficiency, and Gas Exchange between Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Residing at High Altitude.
Rev Cardiovasc Med. 2024;25:247.
Abstract

HOU J, Nie Y, Wen Y, Hua S, et al
The role and mechanism of AMPK in pulmonary hypertension.
Ther Adv Respir Dis. 2024;18:17534666241271990.
Abstract

BANJADE P, Subedi A, Acharya S, Itani A, et al
The Role of Cardiac MRI in Pulmonary Hypertension- Is it Still an Underutilized Tool.
Open Respir Med J. 2024;18:e18743064288565.
Abstract

WANG L, Li F, Hu S, Xu Y, et al
Decreased plasma docosahexaenoic acid concentration in chronic obstructive pulmonary disease patients with pulmonary Hypertension: Findings from human lipidomics and transcriptomics analysis.
Clin Chim Acta. 2024;563:119899.
Abstract

JAVED R, Hodson J, Gowda H
Prevalence of Pulmonary Hypertension During Therapeutic Hypothermia for Hypoxic Ischemic Encephalopathy and Evaluation of Short-Term Outcomes.
Ther Hypothermia Temp Manag. 2024 Aug 12. doi: 10.1089/ther.2024.0023.
Abstract

ROSENKRANZ S, Hoeper MM, Maron BA
Pulmonary hypertension in heart failure: the good, the bad, and the ugly.
Eur Heart J. 2024 Aug 12:ehae518. doi: 10.1093.
Abstract

LABRANDERO C, Deiros L, Abelleira C, Arreo V, et al
Hemodynamic Monitoring of Pediatric Patients With Heart Failure and Pulmonary Hypertension Using CardioMEMS.
J Soc Cardiovasc Angiogr Interv. 2024;3:101933.
Abstract

MICHAUD E, Pan M, Lakhter V, Reddy Maligireddy A, et al
Anatomical Variations in Pulmonary Arterial Branches in Patients Undergoing Evaluation for Chronic Thromboembolic Pulmonary Hypertension.
J Soc Cardiovasc Angiogr Interv. 2023;2:101108.
Abstract

ELFAKI YA, Ibrahim AS, Merghani TH
Prevalence of Pulmonary Hypertension among Sudanese Patients with Sickle Cell Disease.
Open Respir Med J. 2024;18:e18743064292252.
Abstract

FERRARI E, Tamura H
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Any technical improvements are welcome.
Int J Cardiol. 2024;414:132433.
Abstract

ZHANG Y, Li X, Li S, Zhou Y, et al
Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management.
Int J Mol Sci. 2024;25:8427.
Abstract

HE X, Wu Z, Jiang J, Xu W, et al
Urolithin A Protects against Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Smooth Muscle Cell Pyroptosis via AMPK/NF-kappaB/NLRP3 Signaling.
Int J Mol Sci. 2024;25:8246.
Abstract

BOXHAMMER E, Paar V, Kopp K, Gharibeh SX, et al
Insulin-like Growth Factor-Binding Protein 2 in Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Gender-Based Perspective.
Int J Mol Sci. 2024;25:8220.
Abstract

LOTSIOS NS, Keskinidou C, Dimopoulou I, Kotanidou A, et al
Effects of Modulating BMP9, BMPR2, and AQP1 on BMP Signaling in Human Pulmonary Microvascular Endothelial Cells.
Int J Mol Sci. 2024;25:8043.
Abstract

SANTOS-GOMES J, Mendes-Ferreira P, Adao R, Maia-Rocha C, et al
Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular Function.
Int J Mol Sci. 2024;25:8054.
Abstract

PORRES-AGUILAR M, Rivera-Lebron B, Kim NH, Solomon AL, et al
Post-pulmonary embolism syndrome, CTEPD, and CTEPH.
Vasc Med. 2024;29:457-461.
Abstract

ALTIT G, Lapointe A, Kipfmueller F, Patel N, et al
Cardiac function in congenital diaphragmatic hernia.
Semin Pediatr Surg. 2024;33:151438.
Abstract

LIU B, Wen CJ, Zhou G, Wei YP, et al
Identification of Noncoding Functional Regulatory Variants of STIM1 Gene in Idiopathic Pulmonary Arterial Hypertension.
Hypertension. 2024 Jul 11. doi: 10.1161/HYPERTENSIONAHA.124.22766.
Abstract

GILLEY J, Hanneman SK, Ottosen MJ, Shivanna B, et al
Endothelial-to-Mesenchymal Transition in Human and Murine Models of Congenital Diaphragmatic Hernia.
Neonatology. 2024 Apr 8:1-7. doi: 10.1159/000537802.
Abstract

LI B, Qu SS, Li LX, Zhou N, et al
Risk factors and clinical outcomes of pulmonary hypertension associated with bronchopulmonary dysplasia in extremely premature infants: A systematic review and meta-analysis.
Pediatr Pulmonol. 2024 Aug 23. doi: 10.1002/ppul.27220.
Abstract

FUENDERICH MT, Krieb P, Seeger W, Majeed RW, et al
Data Integration for a Global Deep-Phenotyping Registry for Pulmonary Hypertension - Lessons Learned.
Stud Health Technol Inform. 2024;316:334-338.
Abstract

STAAL DP, Hendriks PM, van Thor MCJ, van de Groep LD, et al
Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies.
Pulm Circ. 2024;14:e12419.
Abstract

YUN X, Niedermeyer S, Andrade MR, Jiang H, et al
Aquaporin 1 confers apoptosis resistance in pulmonary arterial smooth muscle cells from the SU5416 hypoxia rat model.
Physiol Rep. 2024;12:e16156.
Abstract

SMITS AJ, Isebia K, Combee-Duffy C, van der Wal S, et al
Low nailfold capillary density in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: biomarker of clinical outcome?
Sci Rep. 2024;14:19467.
Abstract

LATIMER K, Layne M, Payne M
Pulmonary Hypertension.
Am Fam Physician. 2024;110:183-191.
Abstract

WACKER J, Joye R, Genecand L, Lador F, et al
The evolution of clinical trials for pediatric pulmonary hypertension: are the needs of patients and their caregivers being met?
Expert Rev Clin Pharmacol. 2024 Aug 22. doi: 10.1080/17512433.2024.2396119.
Abstract

SIMEONE B, Maggio E, Schirone L, Rocco E, et al
Chronic Thromboembolic Pulmonary Hypertension: the therapeutic assessment.
Front Cardiovasc Med. 2024;11:1439411.
Abstract

JACOBS S, Payne C, Shaboodien S, Kgatla T, et al
Pulmonary hypertension and the potential of 'drug' repurposing: A case for African medicinal plants.
Afr J Thorac Crit Care Med. 2024;30:e1352.
Abstract

BIKOU O, Schafer K
Selective Inhibition of Peripheral Serotonin Synthesis in Pulmonary Hypertension.
JACC Basic Transl Sci. 2024;9:903-905.
Abstract

ATSUMI K, Fukushima Y, Tanaka Y, Nishima S, et al
Novel evaluation of pulmonary hypertension associated with chronic lung disease using perfusion SPECT/CT: A pilot study.
Pulm Circ. 2024;14:e12423.
Abstract

GUO T, Zeng XM, Huang HQ, Wu XF, et al
ECG changes following balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a retrospective study.
J Cardiothorac Surg. 2024;19:484.
Abstract

MEWADA V, Shah J, Jacob S, Shah H, et al
Improvement of Bioavailability of Sildenafil Citrate Through Taste Masked Orodispersible Film for Pulmonary Hypertension Management.
AAPS PharmSciTech. 2024;25:194.
Abstract

SHIMOMIYA Y, Nagao M, Kogure T, Asagai S, et al
Right Ventricular Strain With 4-Dimensional Computed Tomography Identifies Pulmonary Hypertension in Adults With Repaired Tetralogy of Fallot.
Circ J. 2024 Aug 22. doi: 10.1253/circj.CJ-24-0386.
Abstract

PERKINS SJ, Funes M, Cheah D, Argenti C, et al
Safety Window for Effective Lesion Crossing in Patients With Chronic Thromboembolic Pulmonary Hypertension.
J Soc Cardiovasc Angiogr Interv. 2024;3:102142.
Abstract

KASHIMURA T, Tsuchiya H, Sawaguchi G, Ikesugi H, et al
The effects of bolus isosorbide dinitrate on pulmonary hypertension with cardiopulmonary comorbidities.
Heart Vessels. 2024 Aug 21. doi: 10.1007/s00380-024-02451.
Abstract

WU D, Jansen-van Vuuren RD, Dasgupta A, Al-Qazazi R, et al
Novel Drp1 GTPase Inhibitor, Drpitor1a: Efficacy in Pulmonary Hypertension.
Hypertension. 2024 Aug 20. doi: 10.1161/HYPERTENSIONAHA.124.22822.
Abstract

SHARMA S, Singh N
Editorial on "Characteristics and risk profiles of patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension living permanently at >2500 m of high altitude in Ecuador".
Pulm Circ. 2024;14:e12428.
Abstract

WU C, Wu W, Luo C, Qiu H, et al
Obesity paradox in pulmonary hypertension secondary to chronic lung diseases.
Chin Med J (Engl). 2024 Aug 20. doi: 10.1097/CM9.0000000000003263.
Abstract

XIAO R, Liu J, Shi L, Zhang T, et al
Au-modified ceria nanozyme prevents and treats hypoxia-induced pulmonary hypertension with greatly improved enzymatic activity and safety.
J Nanobiotechnology. 2024;22:492.
Abstract

MENG Q, Song L, Wang H, Wang G, et al
Levosimendan mediates the BMP/Smad axis through upregulation of circUSP34-targeted miR-1298 to alleviate pulmonary hypertension.
Respir Res. 2024;25:316.
Abstract

MANGESHKAR S, Borkowski P, Singh N, Zoumpourlis P, et al
Sex differences in Chronic Thromboembolic Pulmonary Hypertension.
Future Cardiol. 2024 Aug 19:1-10. doi: 10.1080/14796678.2024.2385872.
Abstract

SAFAIE QAMSARI E, Stewart DJ
Cellular senescence in the pathogenesis of pulmonary arterial hypertension: the good, the bad and the uncertain.
Front Immunol. 2024;15:1403669.
Abstract

ZHOU YP, Liu C, Jing ZC
Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: 10 Years to Sharpen a Sword.
JACC Asia. 2024;4:590-593.
Abstract

MASAKI K, Hosokawa K, Funakoshi K, Taniguchi Y, et al
Outcomes of Chronic Thromboembolic Pulmonary Hypertension After Balloon Pulmonary Angioplasty and Pulmonary Endarterectomy.
JACC Asia. 2024;4:577-589.
Abstract

MAGOON R, Jose J
Characterizing pulmonary hypertension: to err on either side of the capillary!
Indian J Thorac Cardiovasc Surg. 2024;40:648-650.
Abstract

LIU R, Zhou T, Li X, Zou Q, et al
A Non-Metallic Nanozyme Ameliorates Pulmonary Hypertension Through Inhibiting ROS/TGF-beta1 Signaling.
Adv Healthc Mater. 2024 Aug 18:e2401909. doi: 10.1002/adhm.202401909.
Abstract

DING S, Cui J, Yan L, Ru C, et al
Safflower Alleviates Pulmonary Arterial Hypertension by Inactivating NLRP3: A Combined Approach of Network Pharmacology and Experimental Verification.
Clin Respir J. 2024;18:e13826.
Abstract

ZENG H, Lan B, Li B, Xie H, et al
The role and mechanism of thrombospondin-4 in pulmonary arterial hypertension associated with congenital heart disease.
Respir Res. 2024;25:313.
Abstract

YUAN MN, Liu T, Cai AQ, Zhan Z, et al
Emerging connectivity of programmed cell death pathways and pulmonary vascular remodelling during pulmonary hypertension.
J Cell Mol Med. 2024;28:e70003.
Abstract

LOGTENBERG ME, Boerman S, Hofman FN, van Es HW, et al
A rare aneurysm of the brachiocephalic vein causing chronic thromboembolic pulmonary hypertension.
Eur Heart J Cardiovasc Imaging. 2024 Aug 17:jeae221. doi: 10.1093.
Abstract

LI J, Zhang Z, Zhu C, Zheng X, et al
Salidroside enhances NO bioavailability and modulates arginine metabolism to alleviate pulmonary arterial hypertension.
Eur J Med Res. 2024;29:423.
Abstract

LV J, Shi S, Fu Z, Wang Y, et al
Exploring the inflammation-related mechanisms of Lingguizhugan decoction on right ventricular remodeling secondary to pulmonary arterial hypertension based on integrated strategy using UPLC-HRMS, systems biology approach, and experimental validation.
Phytomedicine. 2024;132:155879.
Abstract

TSAI S, Castillo N, Stevenson LW, Zalawadiya S, et al
Home Hemodynamic Monitoring to Guide Reduction of Persistently High Pulmonary Artery Pressures in Chronic Heart Failure.
Circ Heart Fail. 2024 Jul 11:e011946. doi: 10.1161/CIRCHEARTFAILURE.124.011946.
Abstract

ZHANG Z, Chen J, Su S, Xie X, et al
Luteolin ameliorates hypoxic pulmonary vascular remodeling in rat via upregulating K(V)1.5 of pulmonary artery smooth muscle cells.
Phytomedicine. 2024;132:155840.
Abstract

GU N, Shen Y, He Y, Li C, et al
Loss of m6A demethylase ALKBH5 alleviates hypoxia-induced pulmonary arterial hypertension via inhibiting Cyp1a1 mRNA decay.
J Mol Cell Cardiol. 2024;194:16-31.
Abstract

AIT-OUDHIA S, Jaworowicz D, Hu Z, Bihorel S, et al
Population pharmacokinetic modeling of sotatercept in healthy participants and patients with pulmonary arterial hypertension.
CPT Pharmacometrics Syst Pharmacol. 2024;13:1380-1393.
Abstract

EMANUELLI G, Zhu J, Li W, Morrell NW, et al
Functional validation of EIF2AK4 (GCN2) missense variants associated with pulmonary arterial hypertension.
Hum Mol Genet. 2024;33:1495-1505.
Abstract

LI HT, Yuan P, Jiang R, Zhao QH, et al
Sleep-disordered breathing and nocturnal hypoxemia in chronic thromboembolic pulmonary disease.
Intern Med J. 2024;54:1292-1301.
Abstract

ERDOGAN M, Kilickiran Avci B, Ebren C, Ersoy Y, et al
Screening for pulmonary arterial hypertension in patients with systemic sclerosis in the era of new pulmonary arterial hypertension definitions.
Clin Exp Rheumatol. 2024;42:1590-1597.
Abstract

SAKAIDA E, Yamashita Y, Muro Y, Sawa M, et al
A case of anti-Th/To antibody-positive interstitial lung disease and pulmonary arterial hypertension that does not meet the classification criteria of systemic sclerosis. Comment on the article by Moschetti et al.
Clin Exp Rheumatol. 2024;42:1701-1702.
Abstract

SUN D, Hu Y, Li Y, Yu X, et al
Chamber Attention Network (CAN): Towards interpretable diagnosis of pulmonary artery hypertension using echocardiography.
J Adv Res. 2024;63:103-115.
Abstract

ISMAIL R, Vorhies E, Mohammad K, Soraisham A, et al
Persistent pulmonary hypertension and short-term neurological outcomes in infants with moderate to severe hypoxic ischemic encephalopathy.
J Neonatal Perinatal Med. 2024;17:597-605.
Abstract

MICKAEL C, Sanders LA, Lee MH, Kumar R, et al
Classical dendritic cells contribute to hypoxia-induced pulmonary hypertension.
FASEB J. 2024;38:e70015.
Abstract

TORRES-CASTRO R, Hinojosa W, Martinez-Menaca A, Sala Llinas E, et al
Epidemiology of supplemental oxygen in patients with pulmonary hypertension.
Respirology. 2024 Aug 29. doi: 10.1111/resp.14821.
Abstract

WANG R, Wang R, Zhou S, Liu T, et al
Ubiquitination of angiotensin-converting enzyme 2 contributes to the development of pulmonary arterial hypertension mediated by neural precursor cell-expressed developmentally down-regulated gene 4-Like.
Respir Res. 2024;25:326.
Abstract

CREMER PC, Guduguntla V
Pulmonary Hypertension in Mitral Regurgitation: Silent, But Deadly.
JACC Cardiovasc Imaging. 2024 Aug 14:S1936-878X(24)00300.
Abstract

PIRNAT M, Lesjak V, Suran D, Lovrec Orthaber T, et al
A Case of Secondary Pulmonary Hypertension in a Patient With Atrial Septal Defect and Fetal Alcohol Syndrome.
Cureus. 2024;16:e65611.
Abstract

ABOUZAID A, Ali K, Jatoi S, Ahmed M, et al
Cardiac Arrhythmias in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Mechanistic Insights, Pathophysiology, and Outcomes.
Ann Noninvasive Electrocardiol. 2024;29:e70010.
Abstract

IANCU DG, Varga A, Cristescu L, Dumbrava RA, et al
Kidney Dysfunction, Hepatic Impairment, and Lipid Metabolism Abnormalities in Patients with Precapillary Pulmonary Hypertension.
Diagnostics (Basel). 2024;14:1824.
Abstract

HARTLEY A, Singh H, Jani C, Salciccioli JD, et al
Mortality from pulmonary hypertension in Europe 2001-2019.
BMC Pulm Med. 2024;24:415.
Abstract

SAKAO S, Kondoh Y, Kinoshita H, Nishiyama O, et al
Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease.
Respir Investig. 2024;62:980-986.
Abstract

KHASSAFI F, Chelladurai P, Valasarajan C, Nayakanti SR, et al
Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertension.
Nat Cardiovasc Res. 2023;2:917-936.
Abstract

JURIDA L, Werner S, Knapp F, Niemann B, et al
A common gene signature of the right ventricle in failing rat and human hearts.
Nat Cardiovasc Res. 2024;3:819-840.
Abstract

CUTTONE G, Minardi C, Baronti G, Zanza C, et al
Intravenous magnesium sulfate in pulmonary hypertension of the newborn: a systematic review.
Eur Rev Med Pharmacol Sci. 2024;28:4060-4066.
Abstract

LUO K, Tang J, Chen H, Zhang X, et al
Vasodilators for persistent pulmonary hypertension of the newborn: A network meta-analysis.
Pediatr Pulmonol. 2024 Aug 28. doi: 10.1002/ppul.27234.
Abstract

MOKHA SA, Lakshminrusimha S
Prostaglandin E1 in neonatal pulmonary hypertension: Need for randomized trials based on physiology.
Pediatr Pulmonol. 2024 Aug 28. doi: 10.1002/ppul.27227.
Abstract

CHEN M, Wu Q, Shao N, Lai X, et al
The significance of CD16+ monocytes in the occurrence and development of chronic thromboembolic pulmonary hypertension: insights from single-cell RNA sequencing.
Front Immunol. 2024;15:1446710.
Abstract

ZHAO M, Song L, Zhu J, Zhou T, et al
Non-contrasted computed tomography (NCCT) based chronic thromboembolic pulmonary hypertension (CTEPH) automatic diagnosis using cascaded network with multiple instance learning.
Phys Med Biol. 2024 Aug 27. doi: 10.1088/1361-6560/ad7455.
Abstract

KASHIZAKI F, Matsumoto S, Miyasaka A, Tsuchiya N, et al
Effectiveness of upfront triple oral combination therapy with additional pirfenidone in a patient with severe pulmonary hypertension associated with lung diseases.
Respirol Case Rep. 2024;12:e70010.
Abstract

WANG W, Wang J, Yang S, Kuang T, et al
Better efficacy of sequential combination with balloon pulmonary angioplasty after long-term riociguat for patients with inoperable chronic thromboembolic pulmonary hypertension.
Pulm Circ. 2024;14:e12429.
Abstract

CHEN Y, Liang J, Li Q, Zhou J, et al
Clinical outcome of lung transplantation for chronic thromboembolic pulmonary hypertension.
BMC Pulm Med. 2024;24:410.
Abstract

ALHUMAID S, Alnaim AA, Al Ghamdi MA, Alahmari AA, et al
International treatment outcomes of neonates on extracorporeal membrane oxygenation (ECMO) with persistent pulmonary hypertension of the newborn (PPHN): a systematic review.
J Cardiothorac Surg. 2024;19:493.
Abstract

AKANGIRE GG, Manimtim W, Agarwal A, Alexiou S, et al
Outcomes of infants and children with bronchopulmonary dysplasia-associated pulmonary hypertension who required home ventilation.
Pediatr Res. 2024 Aug 24. doi: 10.1038/s41390-024-03495.
Abstract

HORVAT D, Agoston-Coldea L
A spotlight on the aged pulmonary artery.
Adv Clin Chem. 2024;123:157-177.
Abstract

CEKAY M, Arndt PF, Franken JK, Wilhelm J, et al
Non-invasive surrogate markers of pulmonary hypertension are associated with poor survival in patients with cancer.
BMJ Open Respir Res. 2024;11:e001916.
Abstract

LIU W, Men C, Liu Z, Li Q, et al
The Impact of Highly Selective Thoracic Sympathectomy on the Progression of Monocrotaline-induced Pulmonary Arterial Hypertension in Rats.
J Physiol Investig. 2024;67:207-214.
Abstract

WANG Y, Han D, Chai L, Qiu Y, et al
MFN2-dependent mitochondrial dysfunction contributes to Relm-beta-induced pulmonary arterial hypertension via USP18/Twist1/miR-214 pathway.
Eur J Pharmacol. 2024 Jul 31:176828. doi: 10.1016/j.ejphar.2024.176828.
Abstract

LANGE TJ, Escribano-Subias P, Muller A, Fernandes CC, et al
Four-Strata Risk Assessment in Patients with Pulmonary Arterial Hypertension Treated with Selexipag in Real-World Settings (EXPOSURE Study).
Adv Ther. 2024;41:3645-3663.
Abstract

VINICIUS DE PAULA DA SILVA M, Vieira Alves I, Rodrigues Pereira Alves A, Soares Lemos V, et al
Crosstalk between cytokines, inflammation and pulmonary arterial hypertension in heart transplant patients.
Cytokine. 2024;182:156709.
Abstract

LU M, Baima YJ, Ni Z, Yang L, et al
Advances in the potential of nebulized inhalation for the treatment of pulmonary arterial hypertension.
Curr Probl Cardiol. 2024;49:102752.
Abstract

WANG H, Gao Y, Bai J, Liu H, et al
CircLMBR1 inhibits phenotypic transformation of hypoxia-induced pulmonary artery smooth muscle via the splicing factor PUF60.
Eur J Pharmacol. 2024;980:176855.
Abstract

CHEN YC, Dai HL, Liu CL, Li J, et al
Real-world effectiveness and safety of macitentan in patients with pulmonary artery hypertension: a multicenter, retrospective, observational study in China.
Curr Med Res Opin. 2024;40:1455-1464.
Abstract

MELENDRES-GROVES L, Tang W, Germack HD, Liu Z, et al
Racial disparities in treatment patterns, healthcare resource use, and outcomes in patients with pulmonary arterial hypertension in the United States.
Curr Med Res Opin. 2024;40:1465-1475.
Abstract

AMBADE AS, Naranjo M, Tuhy T, Yu R, et al
Collagen 18A1/Endostatin Expression in the Progression of Right Ventricular Remodeling and Dysfunction in Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol. 2024;71:343-355.
Abstract

SANTOS RT, de Sa Freire Onofre ME, de Assis Fernandes Caldeira D, Klein AB, et al
Pharmacological Agents and Potential New Therapies in Pulmonary Arterial Hypertension.
Curr Vasc Pharmacol. 2024;22:155-170.
Abstract

BIENER L, Kohli J, Marggraf V, Nickenig G, et al
Intravenous iron supplementation in pulmonary hypertension groups 1 to 4.
Int J Med Sci. 2024;21:2011-2020.
Abstract

BRITO J, Alves da Silva P, Inacio Cazeiro D, Azaredo Raposo M, et al
Multidimensional CT approach to predict hemodynamics in pulmonary hypertension.
Clin Radiol. 2024 Aug 10:S0009-9260(24)00424-0. doi: 10.1016/j.crad.2024.
Abstract

MA X, Liu Y, Lei L, Wang L, et al
Smooth Muscle Cell-Specific LKB1 Protects Against Sugen5416/Hypoxia-Induced Pulmonary Hypertension through Inhibition of BMP4.
Am J Respir Cell Mol Biol. 2024 Sep 5. doi: 10.1165/rcmb.2023-0430.
Abstract

LOPES SOARES L, Portes AMO, Costa SFF, Leite LB, et al
Autonomic Dysregulation in Pulmonary Hypertension: Role of Physical Exercise.
Hypertension. 2024 Sep 5. doi: 10.1161/HYPERTENSIONAHA.124.23573.
Abstract

ISSARD J, Fadel E, Dolidon S, Gerardin B, et al
Balloon pulmonary angioplasty for proximal chronic thromboembolic pulmonary hypertension in patients ineligible for pulmonary endarterectomy.
Pulm Circ. 2024;14:e12432.
Abstract

ALKOBY-MESHULAM L, Amir J, Lubin D, Klinger G, et al
Congenital cytomegalovirus and pulmonary hypertension.
Congenit Anom (Kyoto). 2024 Sep 4. doi: 10.1111/cga.12580.
Abstract

NEELAKANTAN S, Mendiola EA, Vang A, Myers KJ, et al
Dissecting contributions of pulmonary arterial remodeling to right ventricular afterload in pulmonary hypertension.
bioRxiv [Preprint]. 2024 Aug 19:2024.08.18.608471.
Abstract

LIN DW, Weng ZL, Fan JN, Long YL, et al
Outcome of Transcatheter Aortic Valve Replacement for Pure Native Aortic Regurgitation in Patients with Pulmonary Hypertension.
Rev Cardiovasc Med. 2024;25:307.
Abstract

LI H, Liu Y, Zhang H, Shi X, et al
Identification of potential diagnostic biomarkers and therapeutic targets in patients with hypoxia pulmonary hypertension.
Int Immunopharmacol. 2024;142.
Abstract

YAN L, Luo X, Hang C, YuWang, et al
Unraveling the Mfn2-Warburg effect nexus: a therapeutic strategy to combat pulmonary arterial hypertension arising from catch-up growth after IUGR.
Respir Res. 2024;25:328.
Abstract

DU Q, Zhang C, Qu T, Zhou X, et al
METTL3-Driven m6A Modification of RBPJ Promotes Vascular Remodeling in Pulmonary Hypertension.
Am J Pathol. 2024 Aug 31:S0002-9440(24)00326.
Abstract

ALBULUSHI A, De Silva TD, Kashoub M, Tawfek A, et al
Expanding Horizons in Pulmonary Hypertension Management: A Systematic Review and Meta-Analysis of Non-Pharmacological Interventions.
Curr Probl Cardiol. 2024 Aug 31:102825. doi: 10.1016/j.cpcardiol.2024.102825.
Abstract

WOO IS, Kim JH
Predictive value of left atrial volumes assessed using real-time three-dimensional echocardiography for pulmonary hypertension in dogs with myxomatous mitral valve disease.
Front Vet Sci. 2024;11:1441839.
Abstract

WANG C, Yang B, Luo S, Zheng S, et al
Gender-Dependent Association of Pulmonary Hypertension with Adverse Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
Int J Gen Med. 2024;17:3755-3764.
Abstract

WANG Y, Fan Y, Zhou Y, Chen T, et al
Oroxylin A, a broad?spectrum anticancer agent, relieves monocrotaline?induced pulmonary arterial hypertension by inhibiting the Warburg effect in rats.
Mol Med Rep. 2024;30:195.
Abstract

MUNOZ FA, Kim A, Kelly B, Jackson EO, et al
Biomarker screening for pulmonary hypertension in VLBW infants at risk for bronchopulmonary dysplasia.
Pediatr Res. 2024 Aug 31. doi: 10.1038/s41390-024-03517.
Abstract

SOUZA NSC, Barenco-Marins T, Ferraz AP, Barbosa RAQ, et al
Low Thyroid Hormones Level Attenuates Mitochondrial Dysfunction and Right Ventricular Failure in Pulmonary Hypertensive Rats.
Cardiovasc Drugs Ther. 2024 Aug 31. doi: 10.1007/s10557-024-07618.
Abstract

BROWN Z, Morrisroe K, Hansen D, Stevens W, et al
Predictive accuracy of the ASIG algorithm in a prospective systemic sclerosis cohort undergoing annual screening for pulmonary arterial hypertension.
Intern Med J. 2024;54:1561-1566.
Abstract

GONZALEZ-HERMOSILLO LM, Cueto-Robledo G, Navarro-Vergara DI, Garcia-Cesar M, et al
Post-pulmonary embolism syndrome: A reminder for clinicians.
Asian Cardiovasc Thorac Ann. 2024;32:336-344.
Abstract

LIU DD, Liu XL, Zheng TF, Li X, et al
Dapagliflozin alleviates right heart failure by promoting collagen degradation by reducing ROS levels.
Eur J Pharmacol. 2024;981:176875.
Abstract

FAN C, Liu X, Liu R, Zhang Y, et al
Pregnancy conditions and outcomes of Chinese women with mild, moderate and severe pulmonary arterial hypertension.
Hypertens Res. 2024;47:2561-2573.
Abstract

LUKS AM, Grissom CK
Evaluation and Management of the Individual with Recurrent High Altitude Pulmonary Edema.
High Alt Med Biol. 2024;25:238-246.
Abstract

LI X, Pu Z, Xu G, Yang Y, et al
Hypoxia-Induced Myocardial Hypertrophy Companies with Apoptosis Enhancement and p38-MAPK Pathway Activation.
High Alt Med Biol. 2024;25:186-196.
Abstract

PAPADIMITRIOU TI, Lemmers JMJ, van Caam APM, Vos JL, et al
Systemic sclerosis-associated pulmonary arterial hypertension is characterized by a distinct peripheral T helper cell profile.
Rheumatology (Oxford). 2024;63:2525-2534.
Abstract

HANAOKA M, Kobayashi T, Droma Y, Ota M, et al
Clinical and Pathophysiological Features of High-altitude Pulmonary Edema in the Japanese Population: A Review of Studies on High-altitude Pulmonary Edema in Japan.
Intern Med. 2024;63:2355-2366.
Abstract

DHONT S, Verwerft J, Bertrand PB
Exercise-Induced Pulmonary Hypertension: Rationale for Correcting Pressures for Flow and Guide to Non-Invasive Diagnosis.
Eur Heart J Cardiovasc Imaging. 2024 Sep 12:jeae239. doi: 10.1093.
Abstract

GENTLE SJ, Ambalavanan N
Home is where the right ventricle lives: bronchopulmonary dysplasia-associated pulmonary hypertension and home ventilation.
Pediatr Res. 2024 Sep 12. doi: 10.1038/s41390-024-03550.
Abstract

NAGAMOTO K, Maruyama H, Ishuguro A, Ito Y, et al
Alveolar capillary dysplasia complicated by subglottic stenosis.
BMJ Case Rep. 2024;17:e261004.
Abstract

YAO Y, Song L, Zuo Z, Chen Z, et al
Parthenolide attenuates hypoxia-induced pulmonary hypertension through inhibiting STAT3 signaling.
Phytomedicine. 2024;134:155976.
Abstract

LI X, Wang J, Chen Y, Li P, et al
Estrogen Oppositely Regulates Pulmonary Hypertension via METTL3/PFKFB3 Under Normoxia and Hypoxia.
Am J Respir Cell Mol Biol. 2024 Sep 12. doi: 10.1165/rcmb.2024-0042.
Abstract

LI H, Liu Q, Liu C, Wang S, et al
Identification of SNHG11 as a Therapeutic Target in Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2024 Sep 12. doi: 10.1165/rcmb.2023-0428.
Abstract

YAN T, Ma Q, Li X, Shen Q, et al
Establishment of a prediction model of pulmonary artery hypertension in patients with hyperthyroidism.
Ann Noninvasive Electrocardiol. 2024;29:e13133.
Abstract

DONG R, Shui X, Zhang J, Dun Z, et al
Analysis of clinical characteristics of patients with pulmonary hypertension in Chaya County, Chamdo, Tibet.
Cardiovasc Diagn Ther. 2024;14:462-477.
Abstract

ADACHI T, Adachi S, Nakano Y, Nishiyama I, et al
Controlling Nutritional Status Score Predicts 1-Year Outcomes in Chronic Thromboembolic Pulmonary Hypertension.
Circ Rep. 2024;6:381-388.
Abstract

KOYUN E, Sahin A, Yilmaz A, Dindas F, et al
Electrocardiographic Prognostic Marker in Pulmonary Arterial Hypertension: RS Time.
Arq Bras Cardiol. 2024;121:e20240083.
Abstract

NAMAZI M, Eftekhar SP, Mosaed R, Shiralizadeh Dini S, et al
Pulmonary Hypertension and Right Ventricle: A Pathophysiological Insight.
Clin Med Insights Cardiol. 2024;18:11795468241274744.
Abstract

WU Y, Sun X, Cui G, Wang S, et al
Mir-150-5p distinguishes acute pulmonary embolism, predicts the occurrence of pulmonary arterial hypertension, and regulates ox-LDL-induced endothelial cell injury.
Hereditas. 2024;161:33.
Abstract

ZHANG J, Yan H, Wang Y, Yue X, et al
Emerging insights into pulmonary hypertension: the potential role of mitochondrial dysfunction and redox homeostasis.
Mol Cell Biochem. 2024 Sep 10. doi: 10.1007/s11010-024-05096.
Abstract

HU J, Deng Y, Dai P, Xie DW, et al
Prognostic impact of right atrial strain in systemic lupus erythematosus with pulmonary arterial hypertension.
Echocardiography. 2024;41:e15921.
Abstract

SHIRAZI SP, Negretti NM, Jetter CS, Sharkey AL, et al
Bronchopulmonary Dysplasia with Pulmonary Hypertension Associates with Loss of Semaphorin Signaling and Functional Decrease in FOXF1 Expression.
bioRxiv [Preprint]. 2024 Sep 1:2024.08.27.609955. doi: 10.1101/2024.08.27.609955
Abstract

ICHIMURA K, Celestin BE, Bagherzadeh SP, Zamanian RT, et al
Tricuspid annular plane systolic excursion in pulmonary hypertension-Moving beyond the sector plane.
Pulm Circ. 2024;14:e12416.
Abstract

KUSAKA K, Takeda K, Kawashima M, Morio Y, et al
New diagnostic criteria and current issues for pulmonary hypertension.
Respir Investig. 2024;62:1034-1036.
Abstract

ARCHAMBAULT JL, Hernandez TL, Nozik ES, Palmer C, et al
Relationship Between Urine Serotonin and Persistent Pulmonary Hypertension of the Newborn.
J Pediatr. 2024 Sep 4:114290. doi: 10.1016/j.jpeds.2024.114290.
Abstract

PARK CM, Jeon S, Yang MJ, Kim MS, et al
Differences in impact on disease or lung injury depending on the physicochemical characteristics of harmful chemicals in the PAH model.
Ecotoxicol Environ Saf. 2024;283:116838.
Abstract

WANG G, Wang C, Zhu P, Tian J, et al
The protective mechanism of sevoflurane in pulmonary arterial hypertension via downregulation of TRAF6.
Toxicol Appl Pharmacol. 2024;491:117065.
Abstract

LISBOA CD, Maciel de Souza JL, Gaspar CJ, Turck P, et al
Melatonin effects on oxidative stress and on TLR4/NF-kbeta inflammatory pathway in the right ventricle of rats with pulmonary arterial hypertension.
Mol Cell Endocrinol. 2024;592:112330.
Abstract

HIGUCHI S, Horinouchi H, Nakayama S, Aoki T, et al
Feasibility of revascularization after gelatin sponge embolization for hemoptysis during balloon pulmonary angioplasty.
Int J Cardiol. 2024;413:132343.
Abstract

GRIFFITHS K, Grand RJ, Horan I, Certo M, et al
Fluorinated perhexiline derivative attenuates vascular proliferation in pulmonary arterial hypertension smooth muscle cells.
Vascul Pharmacol. 2024;156:107399.
Abstract

CALIS KARANFIL F, Bingol Kiziltunc P, Ozdemir Zeydanli E, Atilla H, et al
Reappearance of excentric persistent fetal vasculature stalk following laser treatment in a patient with type 1 retinopathy of prematurity.
Eur J Ophthalmol. 2024 May 6:11206721241249771. doi: 10.1177/11206721241249771.
Abstract

KERSTEIN JS, Valencia E, Collins S, Ferraro AM, et al
Transcatheter Ductus Arteriosus Stenting for Acute Pediatric Pulmonary Arterial Hypertension is Associated with Improved Right Ventricular Echocardiography Strain.
Pediatr Cardiol. 2024;45:1573-1580.
Abstract

KLOK FA, Vago E, Horvath-Puho E, Barco S, et al
Incidence and clinical course of chronic thromboembolic pulmonary hypertension with or without a history of venous thromboembolism in Denmark.
J Thromb Haemost. 2024 Sep 19:S1538-7836(24)00546.
Abstract

WANG X, Wang Y, Yuan T, Wang H, et al
Network pharmacology provides new insights into the mechanism of traditional Chinese medicine and natural products used to treat pulmonary hypertension.
Phytomedicine. 2024;135:156062.
Abstract

LEGUIZAMON R, McLaren I, John T, Khan R, et al
Pulmonary vasodilators in patients with advanced chronic kidney disease and pre-capillary pulmonary hypertension-A case series.
Respirol Case Rep. 2024;12:e70027.
Abstract

HENNINGS E, Aeschbacher S, Coslovsky M, Paladini RE, et al
BMP10 reflects pre-capillary pulmonary hemodynamics: association of biomarkers and hemodynamic parameters in pulmonary hypertension.
Clin Res Cardiol. 2024 Sep 19. doi: 10.1007/s00392-024-02546.
Abstract

TAKEICHI T, Morimoto Y, Yamada A, Tanaka T, et al
A case of the effective inhalation of nitric oxide therapy for caused severe pulmonary hypertension with protamine neutralization of systemic heparinization during totally endoscopic minimally invasive cardiac surgery.
J Extra Corpor Technol. 2024;56:120-124.
Abstract

ZHANG S, Wang J, Wen J, Xin Q, et al
MSC-derived exosomes attenuates pulmonary hypertension via inhibiting pulmonary vascular remodeling.
Exp Cell Res. 2024 Sep 17:114256. doi: 10.1016/j.yexcr.2024.114256.
Abstract

SHENOY S, Deekshit VK, Rao SS, Ashwini PS, et al
Clinical profile and thiamine transporter gene (SLC19A2 and SLC19A3) variations in infants with thiamine-responsive pulmonary hypertension and acute respiratory infection.
J Trop Pediatr. 2024;70:fmae030.
Abstract

AMENDOLIA B, Bhat V, Poletto E, Jaspreet A, et al
Vein of Galen Aneurysmal Malformation Presenting As Persistent Pulmonary Hypertension in a Newborn: A Case Report.
Cureus. 2024;16:e67191.
Abstract

OJOPI EPB, Tonon CR, Okoshi K, Okoshi MP, et al
Pulmonary Arterial Hypertension and Cardioprotective Interventions.
Arq Bras Cardiol. 2024;121:e20240445.
Abstract

GROBS Y, Potus F
From Data Mining to Discovery: SNHG11 as a Therapeutic Target in Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2024 Sep 17. doi: 10.1165/rcmb.2024-0415.
Abstract

SUN G, Zhao F, Feng Y, Liu F, et al
Exosomes derived from hypoxic alveolar epithelial cells promote the phenotypic transformation of pulmonary artery smooth muscle cells via the Rap1 pathway.
Exp Lung Res. 2024;50:160-171.
Abstract

DU D, Qiu JY, Zhao J, Yuan YD, et al
Causal relationship between immune cells and pulmonary arterial hypertension: Mendelian randomization analysis.
Medicine (Baltimore). 2024;103:e39670.
Abstract

GRAFF K, Ross JR, Morella K, Chowdhury SM, et al
Echocardiographic Predictors of Hospital Outcomes in Preterm Neonates with Patent Ductus Arteriosus and Clinical Suspicion of Pulmonary Hypertension.
J Neonatol. 2023;37:384-389.
Abstract

LEBLANC CA, Higgins ME, Sirois MG, Tanguay JF, et al
Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia using Pulmonary Artery Banding.
J Vis Exp. 2024;.
Abstract

ARANT CB, Arant CN, Bobbitt DE
Chronic thromboembolic pulmonary hypertension: A great mimic.
Respir Med Case Rep. 2024;51:102099.
Abstract

GUO YZ, Cui HY, Cai MY, Wang D, et al
SOX9 promotes hypoxic pulmonary hypertension through stabilization of DPP4 in pulmonary artery smooth muscle cells.
Exp Cell Res. 2024;442:114254.
Abstract

PEREIRA SS, Jacquemyn X, Kutty S
Echocardiographic markers at diagnosis of persistent pulmonary hypertension of the newborn.
J Perinat Med. 2024 Sep 16. doi: 10.1515/jpm-2023-0346.
Abstract

MALIK M, Malik S, Karur GR, Mafeld S, et al
Cardiothoracic Imaging for Outcome Prediction in Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Endarterectomy or Balloon Pulmonary Angioplasty: A Scoping Review.
J Clin Med. 2024;13:5045.
Abstract

TOTARO P, Tirelli C, De Amici M, Grosjean F, et al
Circulating Endothelin 1 but Not Transforming Growth Factor-beta Levels Are Reduced after Pulmonary Endarterectomy in Subjects Affected by Chronic Thromboembolic Pulmonary Hypertension: A Prospective Cohort Study.
J Clin Med. 2024;13:4977.
Abstract

OGOSHI T, Yatera K, Mukae H, Tsutsui M, et al
Role of Nitric Oxide Synthases in Respiratory Health and Disease: Insights from Triple Nitric Oxide Synthases Knockout Mice.
Int J Mol Sci. 2024;25:9317.
Abstract

FONSECA BALLADARES DC, Kassa B, Mickael C, Kumar R, et al
Intrapulmonary T Cells Are Sufficient for Schistosoma-Induced Pulmonary Hypertension.
Int J Mol Sci. 2024;25:9202.
Abstract

FALCON-CORDON S, Falcon-Cordon Y, Costa-Rodriguez N, Matos JI, et al
Assessment of Thoracic Radiographic Alterations in Dogs with Heartworm and Their Correlation with Pulmonary Hypertension, Pre- and Post-Adulticide Treatment.
Animals (Basel). 2024;14:2551.
Abstract

EMERY L, Hughes A, Oji-Mmuo C, Silveyra P, et al
Omic-signature of bronchopulmonary dysplasia associated pulmonary hypertension in <1500g-birth-weight-infants with hemodynamically significant intracardiac shunt.
Pediatr Res. 2024 Sep 13. doi: 10.1038/s41390-024-03541.
Abstract

IZHAKIAN S, Gorenshtein A, Engelstein H, Freidkin L, et al
Utility of serum uric acid levels in excluding pulmonary hypertension in severe chronic lung disease: insights from a tertiary care center.
Clin Exp Med. 2024;24:220.
Abstract

BAO W, Cheng M, Chen X, Wang T, et al
Effect of fasudil on clinical outcomes of pulmonary hypertension: a systematic review and meta-analysis.
Expert Rev Clin Pharmacol. 2024 Sep 13. doi: 10.1080/17512433.2024.2404688.
Abstract

YU Q, Zhang Q
Pulmonary Hypertension in Hemodialysis Patients and Its Determinants: A Hospital Based Cross-Sectional Study.
Int J Gen Med. 2024;17:3919-3926.
Abstract

LIU A, Wang Y, Zheng S, Bao Z, et al
Endonuclear Circ-calm4 regulates ferroptosis via a circR-Loop of the COMP gene in pulmonary artery smooth muscle cells.
Eur J Pharmacol. 2024;982:176944.
Abstract

EGENLAUF B, Weinstock KF, Marra AM, Eichstaedt CA, et al
Association between right heart size and right ventricular output reserve in patients with pulmonary arterial hypertension.
Int J Cardiol. 2024;416:132466.
Abstract

SHI X, Ma Q, Huo Y, Su Y, et al
5-Aminoimidazole-4-carboxamide ribonucleotide formyltransferase/inosine monophosphate cyclohydrolase promotes pulmonary arterial smooth muscle cell proliferation via the Ras signaling pathway.
Am J Physiol Cell Physiol. 2024;327:C901-C912.
Abstract

GE YL, Li PJ, Bu YR, Zhang B, et al
TNF-alpha and RPLP0 drive the apoptosis of endothelial cells and increase susceptibility to high-altitude pulmonary edema.
Apoptosis. 2024;29.
Abstract

PAUL LD, Moinul S, Urina-Jassir M, Gopal DM, et al
Expanding pulmonary artery pressure monitoring to racially and socially diverse populations: A pilot CardioMEMS program.
Am J Med Sci. 2024;368:408-410.
Abstract

WANG E, Zhang B, Huang L, Li P, et al
LncRNA MIR210HG promotes phenotype switching of pulmonary arterial smooth muscle cells through autophagy-dependent ferroptosis pathway.
Apoptosis. 2024;29.
Abstract

MU C, Li Q, Niu Y, Hu T, et al
Chronic diesel exhaust exposure induced pulmonary vascular remodeling a potential trajectory for traffic related pulmonary hypertension.
Respir Res. 2024;25:348.
Abstract

CASCINO TM, Maron BA, Vachiery JL, McLaughlin VV, et al
Highlights for the heart failure cardiologist from the 7(th) World Symposium on Pulmonary Hypertension: Are we out of the woods yet?
J Card Fail. 2024 Sep 26:S1071-9164(24)00414.
Abstract

LAWRENCE A, Myall KJ, Mukherjee B, Marino P, et al
Converging Pathways: A Review of Pulmonary Hypertension in Interstitial Lung Disease.
Life (Basel). 2024;14:1203.
Abstract

HOJDA SE, Chis IC, Clichici S
Magnesium Sulfate, Rosuvastatin, Sildenafil and Their Combination in Chronic Hypoxia-Induced Pulmonary Hypertension in Male Rats.
Life (Basel). 2024;14:1193.
Abstract

FTIKOS P, Gkantinas G, Karageorgos V, Smirli A, et al
Intravenous Levosimendan versus Inhalational Milrinone in the Management of Pulmonary Hypertension during Adult Cardiac Surgery: A Randomized Clinical Trial.
Life (Basel). 2024;14:1164.
Abstract

JANG JH, Jang HJ, Lee JH
A Case of Interstitial Lung Disease-Related Pulmonary Hypertension Successfully Treated with Inhaled Iloprost.
Life (Basel). 2024;14:1068.
Abstract

NTILOUDI D, Kasinos N, Kalesi A, Vagenakis G, et al
Diagnosis and Management of Pulmonary Hypertension: New Insights.
Diagnostics (Basel). 2024;14:2052.
Abstract

ROMERO OROZCO R, Mohammed TA, Carter K, Brown S, et al
Association of Right Ventricular Dysfunction with Risk of Neurodevelopmental Impairment in Infants with Pulmonary Hypertension.
Children (Basel). 2024;11:1121.
Abstract

MENG ZY, Lu CH, Li J, Liao J, et al
Identification and experimental verification of senescence-related gene signatures and molecular subtypes in idiopathic pulmonary arterial hypertension.
Sci Rep. 2024;14:22157.
Abstract

ZHOU D, Li X, Xu J, Wang Y, et al
Active Left Atrial Ejection Fraction as a Non-Invasive Marker in Pulmonary Hypertension Secondary to Heart Failure.
J Cardiovasc Magn Reson. 2024 Sep 25:101105. doi: 10.1016/j.jocmr.2024.101105.
Abstract

OLIVEROS E, Ibrahim M, Romero CM, Navo P, et al
Novel Computed Tomography Angiography Parameter Is Associated with Low Cardiac Index in Patients with Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Analysis.
J Cardiovasc Dev Dis. 2024;11:281.
Abstract

RAJAGOPAL NAIR A, Asadi M, Arshad S, Jain SP, et al
Graves' Disease Associated With Pulmonary Hypertension and Cardiac Arrest.
J Med Cases. 2024;15:267-271.
Abstract

LI Q, Fang F, Yang C, Yu D, et al
Whole transcriptome landscape in HAPE under the stress of environment at high altitudes: new insights into the mechanisms of hypobaric hypoxia tolerance.
Front Immunol. 2024;15:1444666.
Abstract

CHEN L, Chen X, Huang Y, Ma Z, et al
Establishment of mouse models for severe pulmonary hypertension through 'double-hit' strategies.
Exp Physiol. 2024 Sep 27. doi: 10.1113/EP091833.
Abstract

BENJAMIN N, Echampati I, Harutyunova S, Eichstaedt CA, et al
Long-term oxygen therapy in precapillary pulmonary hypertension - SOPHA study.
Sci Rep. 2024;14:22038.
Abstract

LIU X, Wu D, Bao C, Huang Z, et al
Identification of fatty acid metabolism signature genes in patients with pulmonary arterial hypertension using WGCNA and machine learning.
J Int Med Res. 2024;52:3000605241277740.
Abstract

PUPIALES-DAVILA KA, Sanchez-Amaya DJ, Zebadua-Torres R, Lopez-Reyes JC, et al
Pulmonary hypertension secondary to arteriovenous fistula: a case report.
Br J Cardiol. 2024;31:004.
Abstract

MCCORMACK C, Kehoe B, McCullagh B, Gaine S, et al
The impact of gas transfer on responses to exercise training in patients with pulmonary hypertension.
Pulm Circ. 2024;14:e12438.
Abstract

SATO S, Ito T, Todani S, Nonaka S, et al
Chronic thromboembolic pulmonary hypertension and iodine allergy successfully treated using gadolinium contrast and pressure catheter.
Cardiovasc Interv Ther. 2024 Sep 25. doi: 10.1007/s12928-024-01047.
Abstract

FARMAKIS IT, Hobohm L, Valerio L, Keller K, et al
Prevalence and significance of pulmonary hypertension among hospitalized patients with left heart disease.
Respir Med. 2024;234:107817.
Abstract

LICHTENBERGER J, Cote E, Forney SD, Barrett KA, et al
Cardiac biomarker profiles in dogs with naturally occurring precapillary pulmonary hypertension.
J Vet Cardiol. 2024;56:56-64.
Abstract

NIIHORI M, James J, Varghese MV, McClain N, et al
Mitochondria as a primary determinant of angiogenic modality in pulmonary arterial hypertension.
J Exp Med. 2024;221:e20231568.
Abstract

KLOUDA T, Tsikis ST, Hirsch TI, Kim Y, et al
Smooth muscle Cxcl12 activation is associated with vascular remodeling in flow-induced pulmonary hypertension.
bioRxiv [Preprint]. 2024 Sep 10:2024.09.10.611870.
Abstract

DUAN A, Huang Z, Zhao Z, Zhao Q, et al
Pulmonary hypertension associated with anomalous left coronary artery originating from the pulmonary artery.
ESC Heart Fail. 2024 Sep 23. doi: 10.1002/ehf2.15094.
Abstract

CHEN Z, Wang J, Qin X, Di N, et al
Long-term swimming exercise attenuates right ventricular hypertrophy via modulating meta-inflammation in monocrotaline-induced pulmonary hypertensive rats.
Biochem Biophys Res Commun. 2024;733:150710.
Abstract

GRANTON J, Coghlan G
Novel Approach to Evaluate the Role of Selexipag in Pulmonary Arterial Hypertension.
JAMA Netw Open. 2024;7:e2434644.
Abstract

BURGER CD, Tang W, Tsang Y, Panjabi S, et al
Early Addition of Selexipag to Double Therapy for Pulmonary Arterial Hypertension.
JAMA Netw Open. 2024;7:e2434691.
Abstract

CINAROGLU S, Karakus K, Keles H, Kacmaz M, et al
EVALUATION OF PATIENTS WITH COVID-19 IN THE EARLY HYPOXEMIC STAGE AND PATIENTS WITH VIRAL RESPIRATORY TRACT INFECTION IN TERMS OF PULMONARY HYPERTENSION.
Acta Clin Croat. 2023;62:478-485.
Abstract

SIMEONE B, Maggio E, Schirone L, Rocco E, et al
Chronic thromboembolic pulmonary hypertension: the diagnostic assessment.
Front Cardiovasc Med. 2024;11:1439402.
Abstract

SULASTOMO H, Dinarti LK, Hariawan H, Haryana SM, et al
MicroRNA expression alteration in chronic thromboembolic pulmonary hypertension: A systematic review.
Pulm Circ. 2024;14:e12443.
Abstract

KRZYZEWSKA A, Kurakula K
Sex Dimorphism in Pulmonary Arterial Hypertension Associated With Autoimmune Diseases.
Arterioscler Thromb Vasc Biol. 2024;44:2169-2190.
Abstract

KAZIMIERCZYK R, Szumowski P, Nekolla SG, Malek LA, et al
What is the meaning of late gadolinium enhancement at right ventricular insertion points in pulmonary arterial hypertension?
Pol Arch Intern Med. 2024;134:16806.
Abstract

SAVONITTO G, Barbisan D, Ameri P, Lombardi CM, et al
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension.
ESC Heart Fail. 2024;11:3146-3154.
Abstract

CALVO-ASENSIO M, Buendia Fuentes F, Arnau Vives MA, Andres Lalaguna L, et al
Pulmonary arterial hypertension associated with pretricuspid shunts: risk profile and survival.
Rev Esp Cardiol (Engl Ed). 2024;77:868-870.
Abstract

WAGNER LE, Rosa GH, Plachi F, da Silva AB, et al
Impact of Real-Time Assessment of Pulse Oximetry on the 6-Min Walk Distance in Patients With Chronic Respiratory Disease.
Respir Care. 2024;69:1294-1304.
Abstract

WU X, Wang X, Zhang L, Pan Z, et al
Pulmonary artery denervation versus conventional therapies for PAH: a systematic review and updated network meta-analysis.
ESC Heart Fail. 2024;11:2889-2900.
Abstract

AHMED HF, Morales DLS, Hayes D Jr
ECMO Bridge to Lung Transplant in Children with Idiopathic Pulmonary Arterial Hypertension.
Lung. 2024;202:753-755.
Abstract

AKAGI S
Risk Assessment in Pulmonary Arterial Hypertension.
Circ J. 2024;88:1618-1619.
Abstract

LI Q, Zhang Y, Cui X, Lu W, et al
Optimal combination of right ventricular functional parameters using echocardiography in pulmonary arterial hypertension.
ESC Heart Fail. 2024;11:2694-2706.
Abstract

ISHII S, Hatano M, Minatsuki S, Hirose K, et al
Comprehensive Risk Assessment in Patients With Pulmonary Arterial Hypertension Referred for Lung Transplantation.
Circ J. 2024;88:1610-1617.
Abstract

ZHENG Q, Zhang B, Lu N, Li X, et al
Diagnostic values of serum BNP, PTX3, and VEGF in acute pulmonary embolism complicated by pulmonary artery hypertension and their correlations with severity of pulmonary artery hypertension.
Immun Inflamm Dis. 2023;11:e986.
Abstract

GAO RJ, Aikeremu N, Cao N, Chen C, et al
Quercetin regulates pulmonary vascular remodeling in pulmonary hypertension by downregulating TGF-beta1-Smad2/3 pathway.
BMC Cardiovasc Disord. 2024;24:535.
Abstract

RICKS WA, Rackauskas M, Weir WB, Emtiazjoo AM, et al
ProtekDuo Cannula for Pre-, Intra-, and Postoperative Lung Transplantation Management.
Ann Card Anaesth. 2024;27:375-378.
Abstract

NATHAN SD, Lacasse V, Bell H, Sista P, et al
COPD associated pulmonary hypertension: A post hoc analysis of the PERFECT study.
Pulm Circ. 2024;14:e12430.
Abstract

DING Z, Qi F, Liu L, Wang Z, et al
Circulating extracellular vesicles as novel biomarkers for pulmonary arterial hypertension in patients with systemic lupus erythematosus.
Front Immunol. 2024;15:1374100.
Abstract

TSOI SM, Keller RL
Prostaglandin E1 in neonatal pulmonary hypertension: Need for randomized trials based on physiology-Response.
Pediatr Pulmonol. 2024 Oct 3. doi: 10.1002/ppul.27312.
Abstract

LIU C, Chen J, Huang X, Xia Q, et al
lncRNA VELRP Modulates Pulmonary Arterial Smooth Muscle Cell Proliferation and Promotes Vascular Remodeling in Pulmonary Hypertension.
Arterioscler Thromb Vasc Biol. 2024 Oct 3. doi: 10.1161/ATVBAHA.124.321416.
Abstract

CITAK S, Saribas E, Halis AN, Alkilic FF, et al
Expanding horizons: lung transplantation for non-IPF interstitial lung diseases.
BMC Pulm Med. 2024;24:482.
Abstract

FERREIRA EVM, Lucena JS, Oliveira RKF
The role of the exercise physiology laboratory in disease management: pulmonary arterial hypertension.
J Bras Pneumol. 2024;50:e20240240.
Abstract

LI Z, Ma J, Wang X, Zhu L, et al
The role of immune cells in the pathogenesis of connective tissue diseases-associated pulmonary arterial hypertension.
Front Immunol. 2024;15:1464762.
Abstract

GUAN X, Du H, Wang X, Zhu X, et al
CircSSR1 regulates pyroptosis of pulmonary artery smooth muscle cells through parental protein SSR1 mediating endoplasmic reticulum stress.
Respir Res. 2024;25:355.
Abstract

WANG X, Wang S, Shen R, Lu Z, et al
The effects of standardized intravenous treprostinil in pulmonary arterial hypertension patients after total cavo-pulmonary connection procedure.
Eur J Med Res. 2024;29:479.
Abstract

MANCUSO FJN
Electrocardiogram as a Predictor of Mortality in Individuals with Pulmonary Hypertension.
Arq Bras Cardiol. 2024;121:e20240548.
Abstract

HE S, Bai J, Zhang L, Yuan H, et al
Superenhancer-driven circRNA Myst4 involves in pulmonary artery smooth muscle cell ferroptosis in pulmonary hypertension.
iScience. 2024;27:110900.
Abstract

QUINTERO G, Mourad S, Kovacs T, Iyyani MK, et al
Pulmonary Arterial Hypertension in Adult-Onset Still's Disease: A Rare but Severe Complication.
Am J Case Rep. 2024;25:e943591.
Abstract

SERRA W, Botti A, Vignali L, Chetta A, et al
Potential use of sPAP /PAAT ratio in Severe Functional Tricuspid Regurgitation with Pulmonary Hypertension.
Cardiology. 2024 Sep 30:1-13. doi: 10.1159/000541529.
Abstract

WANG F, Li C, Li X, Li S, et al
Autoantibodies in systemic sclerosis overlap syndrome and their correlation with organ damage and survival.
Ann Med. 2024;56:2407526.
Abstract

LI Q, Xu Z, Gong Q, Shen X, et al
Clinical characteristics and a diagnostic model for high-altitude pulmonary edema in habitual low altitude dwellers.
PeerJ. 2024;12:e18084.
Abstract

MALDONADO-VELEZ G, Mickler EA, Cook TG, Aldred MA, et al
Loss of Tbx4 Affects Postnatal Lung Development and Predisposes to Pulmonary Hypertension.
bioRxiv [Preprint]. 2024 Sep 22:2024.09.18.613783.
Abstract

FANG X, Chen J, Hu Z, Shu L, et al
Carotid Baroreceptor Stimulation Ameliorates Pulmonary Arterial Remodeling in Rats With Hypoxia-Induced Pulmonary Hypertension.
J Am Heart Assoc. 2024;13:e035868.
Abstract

JIANG Y, Liu H, Shi R, Hao Y, et al
Methyltransferase-Like 3-Mediated N6-Methyladenosine RNA Methylation Regulates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Pyroptosis by Targeting PTEN.
J Am Heart Assoc. 2024;13:e034470.
Abstract

CHEN W, Liu X, Zhang Z, Yuan Y, et al
Sinomenine Hydrochloride Regulates the Apoptosis of Endothelial Cells through PPAR-gamma to Alleviate PAH.
Int Heart J. 2024;65:929-938.
Abstract

TANGCHAROEN T, Ngernsritrakul T, Chandavimol M, Kamsorn C, et al
Discordance between the European and the United States Guideline Criteria for Atrial Septal Defect closure in adult patients with pulmonary hypertension and its clinical impact.
Curr Probl Cardiol. 2024 Sep 27:102869. doi: 10.1016/j.cpcardiol.2024.102869.
Abstract

SIGNORETTI C, Matsumura S, Fatehi S, D'Silva M, et al
G6pd(N126D) Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker-Induced Pulmonary Vascular Disease.
J Am Heart Assoc. 2024;13:e035174.
Abstract

OLIVEIRA LFTS, Arakaki JSO, Vieira EB, Lopes JL, et al
Sexual function, health functionality, and quality of life in females with pulmonary arterial hypertension: a cross-sectional study.
J Sex Med. 2024;21:897-903.
Abstract

BARNES H, Niewodowski D, Doi A, Marasco S, et al
Current surgical management of chronic thromboembolic pulmonary disease.
Intern Med J. 2024;54:1616-1625.
Abstract

HEWES JL, Bhadra A, Schreck E, Goodman JT, et al
Novel Hemodynamic, Vascular Lesion, and Cytokine/Chemokine Differences Regarding Sex in a Pulmonary Arterial Hypertension Model.
Am J Respir Cell Mol Biol. 2024;71:453-463.
Abstract

KHAN CF, Kamran Ikram M, Terzikhan N, Brusselle GG, et al
Revisiting the Clinical Interpretation of CT-Measured Pulmonary Artery-to-Aorta Ratio-The Rotterdam Study.
Acad Radiol. 2024;31:3837-3843.
Abstract

DING KL, Smith C, Seedorf G, Abman SH, et al
Nintedanib preserves lung growth and prevents pulmonary hypertension in a hyperoxia-induced lung injury model.
Pediatr Res. 2024 Oct 11. doi: 10.1038/s41390-024-03562.
Abstract

RODRIGUEZ GARCIA C, Lopez Valdivia C, Ferrer Lozano J, Mancheno Franch N, et al
Alveolar capillary dysplasia with misalignment of the pulmonary veins: A surgical lung biopsy and autopsy in a full-term newborn.
Rev Esp Patol. 2024;57:305-308.
Abstract

ZOU X, Yuan M, Zhou W, Cai A, et al
SOX17 Prevents Endothelial-Mesenchymal Transition of Pulmonary Arterial Endothelial Cells in Pulmonary Hypertension through Mediating TGF-beta/Smad2/3 Signaling.
Am J Respir Cell Mol Biol. 2024 Oct 11. doi: 10.1165/rcmb.2023-0355.
Abstract

LEE DH, Kim M, Chang SS, Lee R, et al
PPARgamma/ETV2 axis regulates endothelial-to-mesenchymal transition in pulmonary hypertension.
Pulm Circ. 2024;14:e12448.
Abstract

CORBOZ MR, Nguyen TL, Stautberg A, Cipolla D, et al
Current Overview of the Biology and Pharmacology in Sugen/Hypoxia-Induced Pulmonary Hypertension in Rats.
J Aerosol Med Pulm Drug Deliv. 2024;37:241-283.
Abstract

FERNANDEZ-GONZALEZ A, Mukhia A, Nadkarni J, Willis GR, et al
Immunoregulatory Macrophages Modify Local Pulmonary Immunity and Ameliorate Hypoxic Pulmonary Hypertension.
Arterioscler Thromb Vasc Biol. 2024 Oct 10. doi: 10.1161/ATVBAHA.124.321264.
Abstract

TAN X, Zhang N, Zhang G, Xu S, et al
Exploring the diagnostic and immune infiltration roles of disulfidptosis related genes in pulmonary hypertension.
Respir Res. 2024;25:365.
Abstract

ARVANITAKI A, Diller GP, Gatzoulis MA, McCabe C, et al
Noninvasive diagnostic modalities and prediction models for detecting pulmonary hypertension associated with interstitial lung disease: a narrative review.
Eur Respir Rev. 2024;33:240092.
Abstract

LANG IM, Gojic V
Risk scoring in pulmonary hypertension: One size fits all?
Eur J Heart Fail. 2024 Oct 9. doi: 10.1002/ejhf.3459.
Abstract

HA FJ, Brown Z, Stevens W, Prior D, et al
N-terminal pro-brain natriuretic peptide is associated with pulmonary hypertension or diastolic dysfunction in patients with systemic sclerosis: An Australian prospective cross-sectional study.
J Scleroderma Relat Disord. 2024;9:178-184.
Abstract

ALOUAZEN O, Chetoui A, Meqor A, Amar AO, et al
Ortner's syndrome: Hoarseness of voice revealing severe secondary pulmonary hypertension.
Radiol Case Rep. 2024;19:6618-6620.
Abstract

KATZ MG, Ohad DG, Putter P, Shtraizent N, et al
Metabolic gene therapy in a canine with pulmonary hypertension secondary to degenerative mitral valve disease.
Front Vet Sci. 2024;11:1415030.
Abstract

KHAN E, Nawaz S, Inam K, Alali M, et al
Anesthesia Strategies for the Perioperative Management of Severe Pulmonary Hypertension in Emergency Orthopedic Surgery: A Case Report.
Cureus. 2024;16:e68836.
Abstract

CHOI HJ
Usefulness and importance of echocardiography in the diagnosis of pediatric pulmonary hypertension.
J Cardiovasc Imaging. 2024;32:33.
Abstract

YANG JZ, Poch DS, Ang L, Mahmud E, et al
Tricuspid annular plane systolic excursion to pulmonary artery systolic pressure ratio in chronic thromboembolic pulmonary hypertension improves with balloon pulmonary angioplasty.
Pulm Circ. 2024;14:e12452.
Abstract

DEBI U, Devkota S, Choudhary SR, Sagar S, et al
Computed Tomography Spectrum of Complications in Usual Interstitial Pneumonia Pattern in a Tertiary Care Hospital: A Descriptive Cross- sectional Study.
JNMA J Nepal Med Assoc. 2024;62:511-515.
Abstract

KULNGAMNETR I, Pongmee P, Losty PD, Aeesoa S, et al
Utility of the oxygenation index in management of congenital diaphragmatic hernia: a report from a Thai University Surgical Centre.
Pediatr Surg Int. 2024;40:264.
Abstract

VIZZA CD, Klok R, Small M, Castellano G, et al
Predictive factors of right heart catheterization to diagnose pulmonary arterial hypertension using least absolute shrinkage selection operator (LASSO) regression.
Curr Med Res Opin. 2024;40:1667-1672.
Abstract

SONG J, Cheng J, Ju W, Hu D, et al
High relative humidity environment alleviates hypoxia-induced pulmonary arterial hypertension in mice.
Biochem Biophys Res Commun. 2024;733:150681.
Abstract

WERNZ MM, Voskrebenzev A, Muller RA, Zubke M, et al
Feasibility, Repeatability, and Correlation to Lung Function of Phase-Resolved Functional Lung (PREFUL) MRI-derived Pulmonary Artery Pulse Wave Velocity Measurements.
J Magn Reson Imaging. 2024 Mar 9. doi: 10.1002/jmri.29337.
Abstract

BALAKRISHNAN B, Azar J, Farha S, Goyanes AM, et al
Efficacy and Determinants of Response to Inhaled Treprostinil in Pulmonary Hypertension - Interstitial Lung Disease.
Respir Med. 2024 Oct 17:107835. doi: 10.1016/j.rmed.2024.107835.
Abstract

ARIOKA M, Nakamura S, Nishioka K, Inoue K, et al
ASXL1-related Bohring-Optiz Syndrome complicated by Persistent Neonatal Pulmonary Hypertension and Abnormal Alveoli Formation.
Eur J Med Genet. 2024 Oct 16:104978. doi: 10.1016/j.ejmg.2024.104978.
Abstract

CHEN M, Li H, Li Y, Luo Y, et al
Glycolysis modulation: New therapeutic strategies to improve pulmonary hypertension (Review).
Int J Mol Med. 2024;54:115.
Abstract

LI W, Pang X, Chen J, Ren X, et al
Prostacyclin pathway vasodilators in patients with chronic thromboembolic pulmonary hypertension (CTEPH): A systemic review and meta-analysis of randomized controlled trials.
Pulm Circ. 2024;14:e70001.
Abstract

AVITABILE CM, O'Brien C, Dureja D, Albizem D, et al
Barriers to and facilitators of physical activity in pediatric pulmonary hypertension.
Pulm Circ. 2024;14:e70000.
Abstract

GENCOGLU F, Yesiltas MA, Koyuncu O, Mert AM, et al
The effect of pulmonary hypertension and right ventricular dysfunction on early mortality and morbidity in patients undergoing mitral valve replacement.
BMC Cardiovasc Disord. 2024;24:568.
Abstract

AMIKISHIYEV S, Yalcinkaya Y, Mammadova K, Aliyeva N, et al
Mortality and Associated Factors in Patients with Systemic Sclerosis Associated Pulmonary Hypertension with and without Interstitial Lung Disease: A Long-Term Follow-up Study.
Mod Rheumatol. 2024 Oct 17:roae095. doi: 10.1093.
Abstract

GARRY JD, Kundu S, Annis J, Alcorn C, et al
Incidence of Pulmonary Hypertension in the Echocardiography Referral Population.
medRxiv [Preprint]. 2024 Oct 8:2024.10.08.24315117.
Abstract

REINDERS S, Didden EM, Ong R
Survival, morbidity, and quality of life in pulmonary arterial hypertension patients: a systematic review of outcomes reported by population-based observational studies.
Respir Res. 2024;25:373.
Abstract

Correction: Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE study.
BMJ Open Respir Res. 2024;11:e002116corr1.
Abstract

MARTIN G, Cavaliere C, Pandya N, Balasubramanian K, et al
Collapse of an early adolescent girl. Syncope? Simple or sinister?
BMJ Case Rep. 2024;17:e259246.
Abstract

DAVULURI S, Kapoor P, Nandyala S, Li S, et al
Lipodermatosclerosis and Pulmonary Hypertension in Systemic Sclerosis.
JAMA Dermatol. 2024 Oct 16. doi: 10.1001/jamadermatol.2024.3929.
Abstract

ZHANG X, Zhou Y, Zhang H
Clinical significance of HIF-1alpha, ET-1, and NO as biomarkers in chronic obstructive pulmonary disease patients with pulmonary hypertension.
Biomol Biomed. 2024 Oct 15. doi: 10.17305/bb.2024.11078.
Abstract

DELIU N, Das R, May A, Newman J, et al
StratosPHere 2: study protocol for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2.
Trials. 2024;25:680.
Abstract

FU S, Wu RX, Liu CL, Zhou Y, et al
[Progress in health-related quality of life in patients with pulmonary hypertension].
Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:978-983.
Abstract

LYHNE MD, Hansen JV, Andersen S, Schultz JG, et al
Right ventricular to pulmonary artery coupling in chronic thromboembolic pulmonary hypertension.
Int J Cardiol. 2024;418:132639.
Abstract

CHOI YJ, Choi JY, Lee J, Choi BG, et al
Prognostic Value of Pulmonary Artery Systolic Pressure in Severe Rheumatic Mitral Stenosis.
Circ Cardiovasc Imaging. 2024;17:e016302.
Abstract

CERRONE E, Hameed AG, Kiely DG, Condliffe R, et al
Do Hemodynamic Definitions of Chronic Thromboembolic Pulmonary Hypertension Distinguish Between Distinct Phenotypes of Chronic Thromboembolic Pulmonary Disease?
Ann Am Thorac Soc. 2024 Oct 15. doi: 10.1513/AnnalsATS.202405.
Abstract

PENG Z, Luo XY, Li X, Li Y, et al
Cathepsin L Promotes Pulmonary Hypertension via BMPR2/GSDME-Mediated Pyroptosis.
Hypertension. 2024 Oct 15. doi: 10.1161/HYPERTENSIONAHA.124.22903.
Abstract

DING L, Zhang H, Dai C, Weng S, et al
The impact of right atrial volume on ablation outcomes in patients with pulmonary hypertension and atrial flutter.
BMC Pulm Med. 2024;24:516.
Abstract

GAI X, Xia Q, Wang H, Bi H, et al
Study on the mechanism of echinacoside in preventing and treating hypoxic pulmonary hypertension based on proteomic analyses.
Pharmacol Res Perspect. 2024;12:e70025.
Abstract

ISMAIL NR, Makhlouf HA, Hassan A, Elshahat A, et al
An in-depth evaluation of the efficacy and safety of various treatment modalities for chronic thromboembolic pulmonary hypertension: A systematic review and network meta-analysis.
Am Heart J Plus. 2024;46:100466.
Abstract

GURUSAMY K, V R, P S, Velu KB, et al
Burden of Pulmonary Hypertension in End-Stage Renal Disease Patients Receiving Maintenance Hemodialysis: Evaluation Factors and Treatment Strategies.
Cureus. 2024;16:e69123.
Abstract

ZAMPIEROLLO-JARAMILLO G, Abed A, El Shaer A, Garcia-Arango M, et al
Ventricular interdependent phenotype of mixed Cpc-pulmonary hypertension and HFpEF with normal left atrium: Impact on CPET metrics and clinical outcomes.
Pulm Circ. 2024;14:e12449.
Abstract

YANG H, Feng Q, Su Z, Chen S, et al
The increased longitudinal basal-to-apical strain ratio in the right ventricular free wall is associated with neonatal pulmonary hypertension.
Eur J Pediatr. 2024 Oct 14. doi: 10.1007/s00431-024-05814.
Abstract

EGBE AC, Reddy YNV, Miranda WR, Jain CC, et al
Clinical features, hemodynamics, and outcomes of pulmonary hypertension in adults with coarctation of aorta.
Int J Cardiol. 2024 Oct 10:132634. doi: 10.1016/j.ijcard.2024.132634.
Abstract

SAENGSIN K, Khuwuthayakorn V, Prongprot Y, Sittiwangkul R, et al
Longitudinal echocardiographic parameters for evaluation of pulmonary hypertension in preterm infants with very low birth weight.
Cardiol Young. 2024 Oct 10:1-10. doi: 10.1017/S1047951124026040.
Abstract

CHEN X, Zhai Z, Lin L, Xue D, et al
The role of anticoagulation on the long-term survival of patients with pulmonary arterial hypertension: A meta-analysis of 15 cohort studies.
Thromb Res. 2024;243:109173.
Abstract

AREGULLIN OE, Girgis RE, Krishnan S
Atrial flow regulators for the treatment of pulmonary arterial hypertension: what does the future hold?
Expert Rev Med Devices. 2024;21:889-891.
Abstract

IKUTANI M, Shimizu S, Okada K, Imami K, et al
Characterization of long-term interleukin-33 administration as an animal model of pulmonary arterial hypertension.
Biochem Biophys Res Commun. 2024;734:150750.
Abstract

CHIN KM, Channick R, Kim NH, MacDonald G, et al
Macitentan and Tadalafil Combination Therapy in Incident and Prevalent Pulmonary Arterial Hypertension: Real-World Evidence from the OPUS/OrPHeUS Studies.
Adv Ther. 2024;41:4205-4227.
Abstract

TAN Y, Chen Y, Wang T, Li J, et al
Serum uric acid and pulmonary arterial hypertension: A two-sample Mendelian randomization study.
Heart Lung. 2024;68:337-341.
Abstract

HONDA S, Kawakita I, Okumura K, Ara M, et al
Unusual rapid development of portopulmonary hypertension after shunt closure for congenital portosystemic shunt.
J Paediatr Child Health. 2024 Aug 6. doi: 10.1111/jpc.16636.
Abstract

MASSARO M, Quarta S, Calabriso N, Carluccio MA, et al
Omega-3 polyunsaturated fatty acids and pulmonary arterial hypertension: Insights and perspectives.
Eur J Clin Invest. 2024;54:e14277.
Abstract

FANG W, Wang E, Liu P, Gao X, et al
The relativity analysis of hypoxia inducible factor-1alpha in pulmonary arterial hypertension (ascites syndrome) in broilers: a review.
Avian Pathol. 2024;53:441-450.
Abstract

TOKUSHIGE N, Hayashi Y, Omura J, Jinnai T, et al
Patient characteristics, diagnostic testing, and initial treatment profiles of patients with connective tissue disease-associated pulmonary arterial hypertension using a Japanese claims database.
Mod Rheumatol. 2024;34:1202-1212.
Abstract

PLUNKETT MJ, Paton JFR, Fisher JP
Autonomic control of the pulmonary circulation: Implications for pulmonary hypertension.
Exp Physiol. 2024 Oct 25. doi: 10.1113/EP092249.
Abstract

GANIPINENI VDP, Jitta SR, Gudiwada MCVB, Jasti JR, et al
High-Sensitivity Cardiac Troponin [hs-cTn] as a Valuable Biomarker for Pulmonary Hypertension Risk Stratification: A Contemporary Review of the Literature.
Healthcare (Basel). 2024;12:2037.
Abstract

LIANG R, Liu D, Li H, Yan Y, et al
The efficacy and safety of herbal formulas for adults with pulmonary hypertension combined with chronic obstructive pulmonary disease: a systematic review and meta-analysis involving 1,865 participants.
J Thorac Dis. 2024;16:5923-5935.
Abstract

HU X, Liu J, Song X, Yuan P, et al
Stem cells in pulmonary hypertension: Current understanding and future challenges.
Animal Model Exp Med. 2024 Oct 22. doi: 10.1002/ame2.12482.
Abstract

TAKEUCHI D, Fujii T, Nishimura T, Inai K, et al
His-Bundle Pacing for Pulmonary Hypertension With Bradycardia in Congenital Heart Disease: A Case Report.
Pacing Clin Electrophysiol. 2024 Oct 22. doi: 10.1111/pace.15098.
Abstract

YIN L, Wen Y, Liang Z, Guan Z, et al
Lung function and blood gas of rats after different protocols of hypobaric exposure.
Med Gas Res. 2025;15:180-187.
Abstract

IKEDA N, Yamashita Y, Morimoto T, Chatani R, et al
Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry-2.
J Am Heart Assoc. 2024 Oct 22:e035997. doi: 10.1161/JAHA.124.035997.
Abstract

OGO T
Does the Use of Direct Oral Anticoagulants Influence the Incidence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism?
J Am Heart Assoc. 2024 Oct 22:e037730. doi: 10.1161/JAHA.124.037730.
Abstract

ALGHAMDI AI, Shah MA, Alkhodair AM
A case report of systemic lupus erythematosus with severe pulmonary hypertension presenting as large pericardial effusion with early signs of cardiac tamponade: a diagnostic and therapeutic challenge.
Eur Heart J Case Rep. 2024;8:ytae521.
Abstract

TANG Y, Shi YP, Chen L, Suo YF, et al
[Prognosis of different hemodynamic classifications in patients with pulmonary hypertension due to left heart disease].
Zhonghua Xin Xue Guan Bing Za Zhi. 2024;52:1177-1185.
Abstract

ZHU MM, Dai J, Dai Z, Peng Y, et al
GCN2 kinase activation mediates pulmonary vascular remodeling and pulmonary arterial hypertension.
JCI Insight. 2024;9:e177926.
Abstract

LEWIS CV, Garcia AM, Burciaga SD, Posey JN, et al
Redistribution of SOD3 expression due to R213G polymorphism affects pulmonary interstitial macrophage reprogramming in response to hypoxia.
Physiol Genomics. 2024;56:776-790.
Abstract

EL AMROUSY D, Hashem M, Hassan H, Hodeib H, et al
Predictive value of red cell distribution width in children with pulmonary arterial hypertension associated with CHD.
Cardiol Young. 2024;34:1589-1593.
Abstract

NATARAJAN RK, Rodgers N, Narasimhan S, Ambrose M, et al
Invasive haemodynamics predict outcomes in paediatric pulmonary artery hypertension.
Cardiol Young. 2024;34:1563-1570.
Abstract

LIN J, Zhang Y, Lin S, Ding H, et al
Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Cordycepin against Pulmonary Arterial Hypertension in Rats.
Comb Chem High Throughput Screen. 2024;27:2776-2789.
Abstract

KAN J, Zhang H, Xie D, Wei Y, et al
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial.
EuroIntervention. 2023;19:684-694.
Abstract

ZHAO Y, Li X, Wang L, Xu W, et al
Phenotypes of patients with lupus-associated pulmonary hypertension in the Chinese Han population: a cluster analysis.
Clin Rheumatol. 2024 Nov 1. doi: 10.1007/s10067-024-07216.
Abstract

AN HX, Zhang QK, Wei XF, Feng YF, et al
[Analysis of Incidence Rate, Risk Factors and Prognosis of Pulmonary Hypertension in Ph(-)MPNs Patients].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024;32:1463-1471.
Abstract

MONTERO-CABEZAS JM, Delgado V
The Promise and Challenges of Pressure-Guided Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension.
JACC Cardiovasc Interv. 2024;17:2408-2410.
Abstract

SATOH T, Yaoita N, Higuchi S, Nochioka K, et al
Improving Balloon Pulmonary Angioplasty Through Target Endpoint Optimization With Pressure Catheter and Angiographic Lung Perfusion.
JACC Cardiovasc Interv. 2024;17:2394-2407.
Abstract

MACASAET R, Khalid F, Bhide PP, Fish P, et al
Pulmonary hypertension with severe sepsis in ehrlichiosis: what you should know before you hike.
BMJ Case Rep. 2024;17:e260202.
Abstract

LIN YT, Lu JW, Wu CH, Ho YJ, et al
Molecular Hydrogen Therapy in Sjogren's Syndrome With Pulmonary Arterial Hypertension and Right-sided Heart Failure: A Case Report of Improved Immune Markers Including Treg, B Cells and Plasma Cell.
In Vivo. 2024;38:3117-3124.
Abstract

BAEZ GUTIERREZ N, Rodriguez Ramallo H, Mendoza-Zambrano EM, Brown Arreola B, et al
Smartphone Apps for Pulmonary Hypertension: Systematic Search and Content Evaluation.
JMIR Mhealth Uhealth. 2024;12:e57289.
Abstract

PROENCA ICT, Turck P, Ortiz VD, Proenca CC, et al
Treatment with thyroid hormones and grape juice in a model of pulmonary hypertension: the response of apoptosis and inflammation.
An Acad Bras Cienc. 2024;96:e20240338.
Abstract

STOLZ L, Kresoja KP, von Stein J, Fortmeier V, et al
Impact of Pulmonary Hypertension on Outcomes after Transcatheter Tricuspid Valve Edge-to-Edge Repair.
JACC Cardiovasc Interv. 2024 Oct 16:S1936-8798(24)01409.
Abstract

BASIRI R, Davoodian J, Baniasad A
Rheumatoid arthritis presenting by combined pulmonary fibrosis and emphysema with clubbing and pulmonary hypertension: A rare case report.
Clin Case Rep. 2024;12:e9535.
Abstract

ZENG X, Zhong B
Investigating the causal relationship between human blood metabolites and pulmonary hypertension: a two-sample Mendelian randomization study.
Front Cardiovasc Med. 2024;11:1304986.
Abstract

PAN Z, Yao Y, Liu X, Wang Y, et al
Nr1d1 inhibition mitigates intermittent hypoxia-induced pulmonary hypertension via Dusp1-mediated Erk1/2 deactivation and mitochondrial fission attenuation.
Cell Death Discov. 2024;10:459.
Abstract

ZHANG X, Dai Z
Guarding the Endothelium: SOX17's Crucial Role in Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2024 Oct 29. doi: 10.1165/rcmb.2024-0490.
Abstract

MCMASTER MW, Shah A, Hassid Y, Garg J, et al
Pulmonary Artery Denervation: An Emerging Treatment for Pulmonary Hypertension.
Cardiol Rev. 2024 Oct 10. doi: 10.1097/CRD.0000000000000800.
Abstract

DE MANNA ND, Aburahma K, Kruszona S, Wand P, et al
Single Lung Transplantation in a Highly Selected Patient With End-Stage Chronic Thromboembolic Pulmonary Hypertension.
Clin Transplant. 2024;38:e15483.
Abstract

DE PINTO M, Coppi F, Spinella A, Pagnoni G, et al
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension.
Front Cardiovasc Med. 2024;11:1430903.
Abstract

FLYNN S, Chen H, Kerbel R, Gupta S, et al
Management and outcomes in pulmonary arterial hypertension patients with sepsis.
BMC Pulm Med. 2024;24:538.
Abstract

ZHANG S, Gao L, Li S, Luo M, et al
Is pulmonary vascular remodeling an intermediate link between hyperglycemia and adverse outcomes in patients with idiopathic pulmonary arterial hypertension? Insights from a multi-center cohort study.
Cardiovasc Diabetol. 2024;23:384.
Abstract

NAKANO Y, Adachi S, Hirose M, Adachi T, et al
Monitoring anti-factor Xa activity in patients with chronic thromboembolic pulmonary hypertension treated with factor Xa inhibitors.
Sci Rep. 2024;14:25762.
Abstract

YAROVOY SY, Danilov NM, Shchelkova GV, Dinevich EO, et al
[Metabolic disorders in patients with chronic thromboembolic pulmonary hypertension].
Ter Arkh. 2024;96:879-884.
Abstract

WEN Y, Zheng Y, Hua S, Li T, et al
Mechanisms of Bone Morphogenetic Protein 2 in Respiratory Diseases.
Curr Allergy Asthma Rep. 2024;25:1.
Abstract

LYU S, Liao M
Carbon dioxide narcosis following cesarean section in a patient with severe pulmonary hypertension: A case report.
Medicine (Baltimore). 2024;103:e39857.
Abstract

JUANEDA E, Catalfamo D, Fregapani JP, Guevara A, et al
Magnetic resonance lymphangiography abnormalities as extracardiac biomarkers of pulmonary hypertension and functional phenotype in Fontan-Kreutzer univentricular circulation.
Cardiol Young. 2024 Oct 28:1-5. doi: 10.1017/S1047951124026362.
Abstract

NEMEH C, Schmoke N, Patten W, Clark E, et al
Extracorporeal membrane oxygenation (ECMO) support for children with pulmonary hypertension: A single-institutional experience of outcomes.
Pulm Circ. 2024;14:e12442.
Abstract

KAPLISH D, Vagha JD, Rathod S, Jain A, et al
Current Pharmaceutical Strategies in the Management of Persistent Pulmonary Hypertension of the Newborn (PPHN): A Comprehensive Review of Therapeutic Agents.
Cureus. 2024;16:e70307.
Abstract

WU R, Zhang G, Guo M, Li Y, et al
Assessing personalized molecular portraits underlying endothelial-to-mesenchymal transition within pulmonary arterial hypertension.
Mol Med. 2024;30:189.
Abstract

VON VISGER TT, Parikh V, Sese DG, Gibbons WJ, et al
Effects of A Web-based Multiple Component Mindfulness Meditation for Pulmonary Hypertension (MMPH) Program on Symptoms and Health-related Quality of Life: A Pilot Randomized Controlled Trial.
J Card Fail. 2024 Oct 24:S1071-9164(24)00886.
Abstract

YAN Q, Li P, Liu S, Sun Y, et al
Dihydromyricetin treats pulmonary hypertension by modulating CKLF1/CCR5 axis-induced pulmonary vascular cell pyroptosis.
Biomed Pharmacother. 2024;180:117614.
Abstract

TSAI J, Malik S, Tjen-A-Looi SC
Pulmonary Hypertension: Pharmacological and Non-Pharmacological Therapies.
Life (Basel). 2024;14:1265.
Abstract

FLORES K, Almeida C, Arriaza K, Pena E, et al
mTOR in the Development of Hypoxic Pulmonary Hypertension Associated with Cardiometabolic Risk Factors.
Int J Mol Sci. 2024;25:11023.
Abstract

ATIAKSHIN D, Kostin A, Alekhnovich A, Volodkin A, et al
The Role of Mast Cells in the Remodeling Effects of Molecular Hydrogen on the Lung Local Tissue Microenvironment under Simulated Pulmonary Hypertension.
Int J Mol Sci. 2024;25:11010.
Abstract

YANG C, Liu YH, Zheng HK
Identification of metabolic biomarkers in idiopathic pulmonary arterial hypertension using targeted metabolomics and bioinformatics analysis.
Sci Rep. 2024;14:25283.
Abstract

XU S, Li X, Li X, Ma R, et al
Impact of MIR137HG rs7554283 on susceptibility to high-altitude pulmonary edema in the Chinese population.
Per Med. 2024;21:295-302.
Abstract

SONG Y, Jia H, Ma Q, Zhang L, et al
The causes of pulmonary hypertension and the benefits of aerobic exercise for pulmonary hypertension from an integrated perspective.
Front Physiol. 2024;15:1461519.
Abstract

GUIMARAES-ERVILHA LO, Soares LL, Assis MQ, Bento IPDS, et al
Pulmonary Arterial Hypertension Affects Sperm Quality and Epididymis Function in Sedentary and Exercised Wistar Rats.
Reprod Sci. 2024;31:3485-3497.
Abstract

SITBON O, Skride A, Feldman J, Sahay S, et al
Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial.
Lancet Respir Med. 2024;12:865-876.
Abstract

ZHAO C, Wu Y, Li M, Tan W, et al
Allosteric site identification, virtual screening and discovery of a sulfonamide Hsp110-STAT3 interaction inhibitor for the treatment of hypoxic pulmonary arterial hypertension.
Eur J Med Chem. 2024;279:116855.
Abstract

LIANG X, Zhou J, Wang H, Zhang Z, et al
miR-30d Attenuates Pulmonary Arterial Hypertension via Targeting MTDH and PDE5A and Modulates the Beneficial Effect of Sildenafil.
Adv Sci (Weinh). 2024;11:e2407712.
Abstract

SMISETH OA, Wang TKM, Klein AL, Nagueh SF, et al
Left ventricular diastolic dysfunction in non-myocardial disorders.
Eur Heart J Cardiovasc Imaging. 2024;25:1554-1565.
Abstract

TITZ A, Schneider S, Mueller J, Mayer L, et al
Symposium review: high altitude travel with pulmonary vascular disease.
J Physiol. 2024;602:5505-5513.
Abstract

SLINGO ME
Oxygen-sensing pathways and the pulmonary circulation.
J Physiol. 2024;602:5619-5629.
Abstract

XU J, Yin D, Zhang W, Xu Y, et al
The role and mechanism of FTO in pulmonary vessels.
Biotechnol Genet Eng Rev. 2024;40:4284-4299.
Abstract

DURLAK W, Thebaud B
The vascular phenotype of BPD: new basic science insights-new precision medicine approaches.
Pediatr Res. 2024;96:1162-1171.
Abstract

TANGMAHAKUL N, Rungsipipat A, Surachetpong SD
Investigation of pulmonary artery and circulating endothelin-1 expression in dogs with pulmonary hypertension secondary to myxomatous mitral valve disease.
Vet World. 2024;17:2144-2151.
Abstract

ATLAN L, Berthomieu L, Karsenty C, Gascoin G, et al
Neurodevelopmental outcome in children between one and five years after persistent pulmonary hypertension of term and near-term newborns.
Front Pediatr. 2024;12:1450916.
Abstract

PENTIKAINEN M, Simonen P, Leskela P, Harju T, et al
Economic burden of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in Finland.
Int J Cardiol Heart Vasc. 2024;55:101534.
Abstract

MONTOVANO M, Scheel PJ 3rd, Cubero Salazar IM, Hassoun PM, et al
Hemodynamic markers independent of pulmonary capillary wedge pressure can discriminate between pre and postcapillary exercise-induced pulmonary hypertension.
Pulm Circ. 2024;14:e70002.
Abstract

KOIRALA T, Burger CD, Chaudhry R, Benitez P, et al
Impact of a Disease-Focused Electronic Health Record Dashboard on Clinical Staff Efficiency in Previsit Patient Review in an Ambulatory Pulmonary Hypertension Care Clinic.
Appl Clin Inform. 2024;15:928-938.
Abstract

SANTOS-MARTINEZ LE
[Pulmonary Hypertension Centers].
Rev Med Inst Mex Seguro Soc. 2024;62:1-3.
Abstract

SATO BOKU A, So M, Fujikake K, Tanaka M, et al
Perioperative Management of a Patient With Idiopathic Pulmonary Hypertension and a History of Syncope: A Case Report.
Anesth Prog. 2024;71:29-33.
Abstract

LOPEZ MESEGUER M, Saez Gimenez B
New Phenotypes of Pulmonary Hypertension Associated With Respiratory Diseases: Towards Traits to Treat.
Arch Bronconeumol. 2024 Oct 22:S0300-2896(24)00411.
Abstract

ZHENG X, Xu M, Zhang Z, Yang L, et al
Microbial signatures in chronic thromboembolic pulmonary hypertension thrombi: Insights from metagenomic profiling of fresh and organized thrombi.
Thromb Res. 2024;244:109204.
Abstract

STEC M, Pachcinski O, Dziadosz D, Banka P, et al
Misfortune never comes singly: an unusual case of a patient with type 1 diabetes mellitus and widespread cardiac fibrosis with restrictive phenotype, mitral stenosis and postcapillary pulmonary hypertension.
Pol Arch Intern Med. 2024 Nov 5:16879. doi: 10.20452/pamw.16879.
Abstract

EDEL GG, van Kempen M, Munck AB, Huisman CN, et al
The molecular consequences of FOXF1 missense mutations associated with alveolar capillary dysplasia with misalignment of pulmonary veins.
J Biomed Sci. 2024;31:100.
Abstract

HIRAIDE T, Tsuda N, Momoi M, Shinya Y, et al
CXCL12/CXCR4 pathway as a novel therapeutic target for RNF213-associated pulmonary arterial hypertension.
Sci Rep. 2024;14:26604.
Abstract

TOBAL R, Potjewijd J, de Vries F, van Doorn DPC, et al
Dephosphorylated uncarboxylated Matrix-Gla-Protein as candidate biomarker for immune-mediated vascular remodeling and prognosis in pulmonary hypertension.
Sci Rep. 2024;14:26633.
Abstract

GE H, Zhang L, Zhang W, Yuan Q, et al
Neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with chronic kidney disease-related pulmonary hypertension: A retrospective study.
Medicine (Baltimore). 2024;103:e40161.
Abstract

WILLIAMS J, Iheagwam FN, Maroney SP, Schmitt LR, et al
A bovine model of hypoxia-induced pulmonary hypertension reveals a gradient of immune and matrisome response with a complement signature found in circulation.
Am J Physiol Cell Physiol. 2024 Nov 4. doi: 10.1152/ajpcell.00274.2024.
Abstract

WANG X, Zhu X, Huang W, Wang Z, et al
Super-Enhancer-Driven Syndecan-4 Regulates Intercellular Communication in Hypoxic Pulmonary Hypertension.
J Am Heart Assoc. 2024;13:e036757.
Abstract

NAKA Y, Inami T, Takeuchi K, Kikuchi H, et al
Efficacy of Balloon Pulmonary Angioplasty in Patients with Chronic Thromboembolic Pulmonary Disease and Exercise Pulmonary Hypertension.
Respir Med. 2024 Oct 25:107848. doi: 10.1016/j.rmed.2024.107848.
Abstract

KALLIMATH A, Deshpande S, Singh P, Garegrat R, et al
Oral sildenafil versus bosentan for treatment of persistent pulmonary hypertension of the newborn: a randomized controlled trial.
BMC Pediatr. 2024;24:698.
Abstract

ZHANG W, Hua Y, Zheng D, Wang W, et al
Expression and Diagnostic Value of miR-3591-5p in Patients with Congenital Heart Disease-Associated Pulmonary Arterial Hypertension.
Lung. 2024;202:831-843.
Abstract

MENSON KE, Dowman L
Pulmonary Rehabilitation for Diseases Other Than COPD.
J Cardiopulm Rehabil Prev. 2024;44:425-431.
Abstract

OZDEMIR ZEYDANLI E, Ucgul AY, Atalay HT, Hartnett ME, et al
Overlapping clinical features of persistent fetal vasculature and combined hamartoma of the retina and retinal pigment epithelium.
J AAPOS. 2024;28:104012.
Abstract

STUMP B, Waxman AB
Pulmonary Arterial Hypertension and TGF-beta Superfamily Signaling: Focus on Sotatercept.
BioDrugs. 2024;38:743-753.
Abstract

CUETO-ROBLEDO G, Roldan-Valadez E, Garcia-Lezama M, Garcia-Cesar M, et al
Updated review on pulmonary arterial hypertension: Differences between down syndrome and non-down syndrome populations.
Curr Probl Cardiol. 2024;49:102840.
Abstract

KRAJEWSKA K, Ejdys K, Jadczak K, Lisowska A, et al
Right-ventricle heart failure in PAH vs. HFrEF with secondary PH: Hemodynamic, ergospirometric, and organ function correlations.
Adv Med Sci. 2024;69:421-427.
Abstract

LABAN H, Siegmund S, Schlereth K, Trogisch FA, et al
Nuclear factor of activated T-cells 5 is indispensable for a balanced adaptive transcriptional response of lung endothelial cells to hypoxia.
Cardiovasc Res. 2024;120:1590-1606.
Abstract

LI Y, Zhang YT, Han B, Xue L, et al
Single-cell sequencing analysis confirms the association of ANRIL with the increased smooth muscle cell proliferation and migration gene signatures in pulmonary artery hypertension in silico.
Adv Med Sci. 2024;69:217-223.
Abstract

CHEN C, Zhou H, Fu F, Huang R, et al
Genetic burden in neonatal and pediatric-onset pulmonary hypertension: A single-center retrospective study using exome sequencing in a Chinese population.
Pediatr Neonatol. 2024 Nov 4:S1875-9572(24)00194.
Abstract

SHEN QL, Zhao QH, Li HT, Deng J, et al
Improvements in Hemodynamics and Right Heart Remodeling Following Balloon Pulmonary Angioplasty Treatment in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Study.
Health Sci Rep. 2024;7:e70159.
Abstract

SHIMBO M, Hatano M, Katsushika S, Kodera S, et al
Deep Learning to Detect Pulmonary Hypertension from the Chest X-Ray Images of Patients with Systemic Sclerosis.
Int Heart J. 2024 Nov 14. doi: 10.1536.
Abstract

DENIZ S, Uludag B, Demirci F
Correlation between vascular endothelial growth factor, soluble urokinase plasminogen activator receptor, and tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio in group E chronic obstructive lung disease.
Rev Assoc Med Bras (1992). 2024;70:e20240589.
Abstract

URUNO K, Iwano H, Hayashi T, Hatano R, et al
Carfilzomib-induced pulmonary hypertension in a patient with multiple myeloma.
J Cardiol Cases. 2024;30:172-175.
Abstract

FUKUCHI Y, Watanabe T, Utsumi A, Hashimoto Y, et al
An autopsy case of constrictive pericarditis following open chest surgery with severe pulmonary hypertension treated as HFpEF.
J Cardiol Cases. 2024;30:154-156.
Abstract

HANSEN JV, Poulsen MW, Nielsen-Kudsk JE, Kalra MK, et al
Quantitative pulmonary perfusion in acute pulmonary embolism and chronic thromboembolic pulmonary hypertension.
Pulm Circ. 2024;14:e12445.
Abstract

BESSE CE, Winicki NM, Puerta C, Hernandez M, et al
Delta-like ligand 4 inhibitor drug treatment induces pulmonary hypertension in cancer clinical trials.
Pulm Circ. 2024;14:e12450.
Abstract

ACHARYA S, Manchandani U, Mehta V, Thapa S, et al
Unveiling the enigma: Pulmonary hypertension in marginal zone non-Hodgkin's lymphoma: A singular case illuminating an obscure nexus.
Radiol Case Rep. 2024;20:252-255.
Abstract

JIN YS, Yang B, Ding L, Jiang B, et al
[Mechanism of vitamin D deficiency involvement in the development of pulmonary arterial hypertension related to monocrotaline-induced connective tissue disease in rats].
Zhonghua Yi Xue Za Zhi. 2024;104:3972-3979.
Abstract

YU HR, Qian YL, Xia WY, Xiong CM, et al
[Survival status and prognostic factors analysis in patients with hereditary hemorrhagic telangiectasia-associated pulmonary arterial hypertension].
Zhonghua Yi Xue Za Zhi. 2024;104:3910-3915.
Abstract

ZHANG WM, Guo W, Zhang M, Li H, et al
[Impact of the 2022 ESC/ERS revised hemodynamic definition on the diagnosis of pulmonary hypertension].
Zhonghua Yi Xue Za Zhi. 2024;104:3903-3909.
Abstract

LUO Q, Liu ZH, Xiong CM
[Pay attention to the impact of cardiopulmonary comorbidities on the management strategies of pulmonary arterial hypertension].
Zhonghua Yi Xue Za Zhi. 2024;104:3861-3866.
Abstract

CAO Z, Liu Y, Sun B, Zhou G, et al
A High-Stability Pressure-Sensitive Implantable Memristor for Pulmonary Hypertension Monitoring.
Adv Mater. 2024 Nov 12:e2411659. doi: 10.1002/adma.202411659.
Abstract

KAY D, Bernardo R, Elwing J
Pulmonary Vascular Disease in Chronic Obstructive Pulmonary Disease.
Semin Respir Crit Care Med. 2024;45:574-581.
Abstract

VAN DE SANDE MJA, Slaghekke F, Te Pas AB, Witlox RSGM, et al
Increased risk of persistent pulmonary hypertension of the newborn in twin anaemia polycythaemia sequence donors.
Fetal Diagn Ther. 2024 Nov 12:1-19. doi: 10.1159/000542493.
Abstract

CHEN C, Qin S, Song X, Wen J, et al
PI3K p85alpha/HIF-1alpha accelerates the development of pulmonary arterial hypertension by regulating fatty acid uptake and mitophagy.
Mol Med. 2024;30:208.
Abstract

TANG J, Yang R, Li H, Wei X, et al
Derivation and internal validation of prediction models for pulmonary hypertension risk assessment in a cohort inhabiting Tibet, China.
Elife. 2024;13:RP98169.
Abstract

ORIHARA Y, Min KD, Eguchi A, Okuhara Y, et al
Novel Noninvasive Index Combining Echocardiography and Computed Tomography for Screening for Pulmonary Hypertension in Patients With Systemic Sclerosis.
CJC Open. 2024;6:1050-1057.
Abstract

KHOR J, Jamie Hong Im T
Pancytopenia, Cholestatic Jaundice, and Pulmonary Hypertension: Rare Extrathyroidal Manifestations of Graves' Disease.
Cureus. 2024;16:e71175.
Abstract

SHELBURNE NJ, Nian H, Beck GJ, Casanova NG, et al
Association of Male Sex With Worse Right Ventricular Function and Survival in Pulmonary Hypertension in the Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics Cohort.
CHEST Pulm. 2024;2:100046.
Abstract

CALLEJO M, Morales-Cano D, Olivencia MA, Mondejar-Parreno G, et al
Vitamin D receptor and its antiproliferative effect in human pulmonary arterial hypertension.
Sci Rep. 2024;14:27445.
Abstract

WANG L, Bian F, Ma F, Fang S, et al
[Activation of ALDH2 alleviates hypoxic pulmonary hypertension in mice by upregulating the SIRT1/PGC-1alpha signaling pathway].
Nan Fang Yi Ke Da Xue Xue Bao. 2024;44:1955-1964.
Abstract

SUN ZY, Lu GQ, Sun HY, Jiang WD, et al
Salidroside ameliorates hypoxic pulmonary hypertension by regulating the two-pore domain potassium TASK-1 channel.
Phytomedicine. 2024;135:156206.
Abstract

KIM NH, D'Armini AM, Howard LS, Jenkins DP, et al
Long-Term Safety and Efficacy of Macitentan in Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from MERIT and its Open-Label Extension.
Pulm Ther. 2024 Nov 9. doi: 10.1007/s41030-024-00276.
Abstract

LI M, McKeon BA, Gu S, Prasad RR, et al
Honokiol and Nicotinamide Adenine Dinucleotide Improve Exercise Endurance in Pulmonary Hypertensive Rats Through Increasing SIRT3 Function in Skeletal Muscle.
Int J Mol Sci. 2024;25:11600.
Abstract

COLOMBO CNJ, Corradi F, Dammassa V, Colombo D, et al
Time Interval Between Right Ventricular Early Diastolic Velocity by Tissue and Pulse Wave Doppler: An Index of Right Atrial Pressure in Pulmonary Hypertension Patients.
J Clin Med. 2024;13:6349.
Abstract

YANG J, Chen S, Chen K, Wu J, et al
Exploring IRGs as a Biomarker of Pulmonary Hypertension Using Multiple Machine Learning Algorithms.
Diagnostics (Basel). 2024;14:2398.
Abstract

KOSMAS K, Papathanasiou AE, Spyropoulos F, Rehman R, et al
Stress Granule Assembly in Pulmonary Arterial Hypertension.
Cells. 2024;13:1796.
Abstract

KAEMMERER H, Diller GP, Dahnert I, Achenbach S, et al
Pulmonary hypertension in adults with congenital heart defects (ACHDs) in light of the 2022 ESC PAH guidelines-part II: supportive therapy, special situations (pregnancy, contraception, non-cardiac surgery), targeted pharmacotherapy, organ transplanta
Cardiovasc Diagn Ther. 2024;14:921-934.
Abstract

KAEMMERER H, Diller GP, Dahnert I, Achenbach S, et al
Pulmonary hypertension in adults with congenital heart defects (ACHDs)-in light of the 2022 ESC PAH guidelines-part I: definition, epidemiology, classification, diagnostics, genetics, risk stratification and follow-up, gender aspects.
Cardiovasc Diagn Ther. 2024;14:935-948.
Abstract

RALLIS D, El-Shibiny H, Szakmar E, Garvey A, et al
Impact of persistent pulmonary hypertension on cerebral oxygenation in infants with neonatal encephalopathy.
Pediatr Res. 2024 Nov 7. doi: 10.1038/s41390-024-03718.
Abstract

YANAGISAWA A, Kim JD, Naito A, Kobayashi T, et al
Deciphering the inhibitory effects of trimetazidine on pulmonary hypertension development via decreasing fatty acid oxidation and promoting glucose oxidation.
Sci Rep. 2024;14:27069.
Abstract

TANG SY, Lin C, Ma HP, Chen TY, et al
Implication of heart rhythm complexity in predicting long-term outcomes in pulmonary hypertension.
J Formos Med Assoc. 2024 Nov 6:S0929-6646(24)00516.
Abstract

HUANG D, Wang Y, Pei C, Zhang X, et al
Pre-treatment with notoginsenoside R1 from Panax notoginseng protects against high-altitude-induced pulmonary edema by inhibiting pyroptosis through the NLRP3/caspase-1/GSDMD pathway.
Biomed Pharmacother. 2024;180:117512.
Abstract

AYIK S, Gunata M, Ozhan O, Yildiz A, et al
Alamandin and especially melatonin attenuate pulmonary arterial hypertension induced by monocrotalin.
Fundam Clin Pharmacol. 2024;38:1143-1154.
Abstract

DEMIRCI M, Sayar N, Oguz M, Kalandarov I, et al
Right ventricular outflow tract fractional shortening: a novel diagnostic parameter for pulmonary hypertension.
Int J Cardiovasc Imaging. 2024 Nov 22. doi: 10.1007/s10554-024-03288.
Abstract

HUNGERFORD SL, Kearney K, Li C, Song N, et al
Pulsatile Vascular Afterload Measurement Improves Prediction of Right-Sided Heart Dysfunction in Undifferentiated and Left-Sided Pulmonary Hypertension.
J Am Heart Assoc. 2024 Nov 22:e034684. doi: 10.1161/JAHA.124.034684.
Abstract

BHOSLE S, Bagali S, Parvatikar PP, Das KK, et al
Effect of bioactive compounds of Mucuna pruriens on proteins of Wnt/beta catenin pathway in pulmonary hypertension by in silico approach.
In Silico Pharmacol. 2024;12:110.
Abstract

BRANESCU I, Alexandru DO, Vladareanu S, Kulkarni A, et al
Two-Year Outcomes in Preterm Infants Suffering from Moderate to Severe Bronchopulmonary Dysplasia with or without Associated Pulmonary Hypertension.
Curr Health Sci J. 2024;50:436-443.
Abstract

MADONNA R, Biondi F
Sotatercept: New drug on the horizon of pulmonary hypertension.
Vascul Pharmacol. 2024 Nov 19:107442. doi: 10.1016/j.vph.2024.107442.
Abstract

OGUZ M, Uzun M, Yilmaz I, Erdem A, et al
Pulmonary arterial stiffness and vascular tone in pulmonary hypertension: Insights from waveform-derived reflection index and hemodynamic correlations.
Heart Lung. 2024;70:50-56.
Abstract

AGUIRRE-CAMACHO A
Patients' perspectives on the challenges associated with receiving non-oral pulmonary arterial hypertension treatment: a mixed methods study.
Ther Adv Respir Dis. 2024;18:17534666241289807.
Abstract

VAIDYA A, Sketch MR, Broderick M, Shlobin OA, et al
Parenteral prostacyclin utilization in patients with pulmonary arterial hypertension in the intermediate-risk strata: a retrospective chart review and cross-sectional survey.
BMC Pulm Med. 2024;24:574.
Abstract

CHEN Y, Tang Y, Zhu T, Li F, et al
Dynamic PAH-Related Changes: A Dataset of tRNA-Derived Small RNA Transcriptome Across Multiple Organs.
Sci Data. 2024;11:1257.
Abstract

SALINAS P, Alvarez ABC, Perez PJ, Vazquez-Alvarez ME, et al
Catheter-directed interventions in acute pulmonary embolism. Position statement of SEC-Interventional Cardiology Association/SEC-Ischemic Heart Disease and Acute Cardiovascular Care Association/SEC-GT Pulmonary Hypertension Working Group.
Rev Esp Cardiol (Engl Ed). 2024 Nov 18:S1885-5857(24)00333.
Abstract

KNOEPP F, Kraut S, Veith C
Endothelial Dysfunction in Pulmonary Hypertension: Does ADP-ribosylation Factor 6-mediated HIF-2alpha Stabilization Matter?
Am J Respir Cell Mol Biol. 2024 Nov 20. doi: 10.1165/rcmb.2024-0465.
Abstract

WU H, Xi L, Hao Y, Liu M, et al
Effects of inlet boundary conditions on blood flow and thrombosis modelling in patients with chronic thromboembolic pulmonary hypertension.
Comput Methods Biomech Biomed Engin. 2024.
Abstract

XIE L, Fu S, Xu Y, Ran L, et al
Baseline triglyceride-glucose, body mass index, end-diastolic internal diameter of the left atria and creatinine are independent predictors for pulmonary hypertension in coronary artery disease patients after percutaneous coronary intervention treatme
Biomark Med. 2024 Nov 20:1-11. doi: 10.1080/17520363.2024.2422807.
Abstract

GILL NK, Sohi SK, Joseph G, Bhatti N, et al
Hormone Replacement Therapy and Pulmonary Hypertension: A Review of the Literature.
Cureus. 2024;16:e71908.
Abstract

POTNURU PP, Jefferies H, Lei R, Igwe P, et al
Maternal pulmonary hypertension and cardiopulmonary outcomes during delivery hospitalization in the United States: A nationwide study from 2016-2020.
Pregnancy Hypertens. 2024;38:101170.
Abstract

NASER A
Risk Factors of Pulmonary Hypertension in Patients on Hemodialysis; Mitral Regurgitation is a Classic Cause of Secondary Pulmonary Hypertension [Letter].
Int J Nephrol Renovasc Dis. 2024;17:287-288.
Abstract

TAKEOKA M, Sawada H, Mitani Y, Ohashi H, et al
Persistent pulmonary hypertension in children after apparent resolution of ultrasound-defined pulmonary hypertension associated with bronchopulmonary dysplasia.
Eur J Pediatr. 2024;184:26.
Abstract

YEE W, Crombie R, Bailey W, Sage MD, et al
Deceptive scan results in a man with pulmonary hypertension and jaundice.
Am J Med. 2024 Nov 16:S0002-9343(24)00758-7. doi: 10.1016/j.amjmed.2024.
Abstract

Atrial Fibrillation, Acute Pericarditis, GBS Colonization During Labor, Rosacea, Carpal Tunnel, Pulmonary Hypertension.
Am Fam Physician. 2024;110:463.
Abstract

JOHNSON SW, Wan ES, San Jose Estepar R, Nardelli P, et al
Chest Computed Tomography to Improve Phenotyping in Pulmonary Hypertension Associated with COPD.
Ann Am Thorac Soc. 2024 Nov 18. doi: 10.1513/AnnalsATS.202408.
Abstract

TSUBOYA N, Sawada H, Mitani Y, Oshita H, et al
C-C motif chemokine receptor-2 blockade ameliorates pulmonary hypertension in rats and synergizes with a pulmonary vasodilator.
Cardiovasc Res. 2024 Nov 18:cvae244. doi: 10.1093.
Abstract

DIAB SG, Ebata R, Mroczek D, Hui W, et al
Asymmetric right ventricular myocardial work correlates with gold standard measurements of cardiac function in pulmonary hypertension.
Pulm Circ. 2024;14:e70014.
Abstract

CHANNGAM P, Sakcamduang W, Chanmongkolpanit K, Kaenchan P, et al
Alteration of clinical parameters before mortality and prognostic outcomes of pulmonary hypertension in dogs with myxomatous mitral valve disease.
Open Vet J. 2024;14:2237-2249.
Abstract

FERIEL B, Alessandra C, Deborah GJ, Corinne N, et al
Exploring the Endothelin-1 pathway in chronic thromboembolic pulmonary hypertension microvasculopathy.
Sci Rep. 2024;14:28308.
Abstract

ZHOU G, Yu R, Luo C, Li P, et al
Association between comorbid COPD or chronic bronchitis and the prognosis of patients with Dilated cardiomyopathy.
Ann Med. 2024;56:2428857.
Abstract

DMYTRIIEV K, Stickland MK, Weatherald J
Cardiopulmonary Exercise Testing in Pulmonary Hypertension.
Heart Fail Clin. 2025;21:51-61.
Abstract

VANAKEN G, Rubick D, Wieczorek D, Chatterjee S, et al
Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Heart Fail Clin. 2025;21:137-148.
Abstract

MILLER A, Vanderpool RR
Cardiopulmonary Exercise Testing in Research.
Heart Fail Clin. 2025;21:111-117.
Abstract

FERRARA F, Carbone A, Polito MV, Sasso C, et al
Normal Hemodynamic Response to Exercise.
Heart Fail Clin. 2025;21:1-14.
Abstract

ELROSASY A, Maher A, Ramadan A, Hamam NG, et al
A Network Meta-Analysis of Vasodilator Therapies in Pulmonary Hypertension Patients Undergoing Mitral Valve Replacement Surgery: Insights for Optimizing Hemodynamics.
Clin Drug Investig. 2024 Nov 16. doi: 10.1007/s40261-024-01404.
Abstract

LUPPINO-ASSAD AP, Alves Junior JL, Figueiredo Neves Yuki E, Seguro LPC, et al
Reversibility of pulmonary hypertension in systemic lupus erythematosus after induction immunosuppressive therapy: An inflammatory manifestation?
Lupus. 2024 Nov 15:9612033241301183. doi: 10.1177/09612033241301183.
Abstract

CRUZ-BAQUERO L, Molano-Gonzalez N, Garcia-Vargas D, Torres AG, et al
VSD Surgical Closure in Colombia in Children with Secondary Pulmonary Hypertension. Does Altitude Influence Postoperative Pulmonary Pressure?
Pediatr Cardiol. 2024 Nov 15. doi: 10.1007/s00246-024-03697.
Abstract

RAHMAN M, Jakkoju A, Mohsen AM, Vaidya A, et al
Interobserver reliability and accuracy of the visual assessment of interventricular septal flattening in pulmonary hypertension.
Respir Med. 2024;235:107858.
Abstract

SCHROEDER L, Ebach F, Melaku T, Strizek B, et al
Longitudinal evaluation of hemodynamic blood and echocardiographic biomarkers for the prediction of BPD and BPD-related pulmonary hypertension in very-low-birth-weight preterm infants.
Eur J Pediatr. 2024;184:15.
Abstract

KELLENBERGER CJ
Magnetic resonance imaging of pulmonary hypertension.
Pediatr Radiol. 2024 Nov 15. doi: 10.1007/s00247-024-06099.
Abstract

COQUOZ N, Lechartier B, Yerly P, Bridevaux PO, et al
[Post-pulmonary embolism syndrome: Litterature review 2024].
Rev Med Suisse. 2024;20:2099-2103.
Abstract

FADON-PADILLA L, Miranda-Perez de Alejo C, Miguel-Coello AB, Beraza M, et al
Magnetic nanoradiotracers for targeted neutrophil detection in pulmonary arterial hypertension.
J Nanobiotechnology. 2024;22:709.
Abstract

JIANG L, Tao W, Liu J, Yang A, et al
microRNA-637/661 ameliorate hypoxic-induced pulmonary arterial hypertension by targeting TRIM29 signaling pathway.
Sci Rep. 2024;14:27971.
Abstract

ALI M, Kumar KG, Singh K, Rabyang S, et al
Evaluation of the cell death markers for aberrated cell free DNA release in high altitude pulmonary edema.
Clin Sci (Lond). 2024;138:1467-1480.
Abstract

PI H, Xia L, Boucherat O, Suresh K, et al
Proteomic Signatures of Right Ventricular Outcomes in Pulmonary Arterial Hypertension.
Circ Heart Fail. 2024 Oct 22:e012067. doi: 10.1161/CIRCHEARTFAILURE.124.012067.
Abstract

AZZUHDI MZ, Krevani CK, Kino K
Short-term exercise training benefits pulmonary arterial hypertension patients.
Asian Cardiovasc Thorac Ann. 2024;32.
Abstract

ESCAL J, Poenou G, Delavenne X, Bezzeghoud S, et al
Tailoring oral anticoagulant treatment in the era of multi-drug therapies for PAH and CTEPH.
Blood Rev. 2024;68:101240.
Abstract

LU T, Guo L, Ma Y, Yao L, et al
Identification and Analysis of Differentially Expressed Genes Associated with Ferroptosis and HIV in PASMCs Based on Bioinformatics.
Curr HIV Res. 2024;22:308-317.
Abstract

MI YM, Hu WL, Chao HM, Hua CZ, et al
Pediatric high-altitude pulmonary edema and acute mountain sickness: Clinical features and risk determinants.
Pediatr Pulmonol. 2024;59:2614-2620.
Abstract

ILONZE C, Echefu GC, Broadnax AL, Johnson A, et al
Cardiovascular complications of sickle cell disease: A primer for the general clinician.
J Natl Med Assoc. 2024;116:517-525.
Abstract

TONG J, Wan C, Wang A, Chen M, et al
Causal association between epigenetic age acceleration and two pulmonary vascular diseases: pulmonary arterial hypertension and pulmonary embolism-a bidirectional Mendelian study.
Clin Epigenetics. 2024;16:172.
Abstract

RUFFENACH G, Medzikovic L, Aryan L, Sun W, et al
Intestinal IFNalpha4 promotes 15-HETE diet-induced pulmonary hypertension.
Respir Res. 2024;25:419.
Abstract

ZHANG M, Li H, Ma S, Li X, et al
Serum proteome profiling reveals HGFA as a candidate biomarker for pulmonary arterial hypertension.
Respir Res. 2024;25:418.
Abstract

LI W, Zhang Y, Cui X, Ji Q, et al
Quadricuspid pulmonary valve with pulmonary hypertension: a case report.
Eur Heart J Case Rep. 2024;8:ytae408.
Abstract

LIU M, Huang Y
The association of quality of life and fear of progression in patients with pulmonary hypertension: a cross-sectional network analysis.
BMC Psychol. 2024;12:702.
Abstract

ONO Y, Mogami A, Saito R, Seki N, et al
Interleukin-17A is a potential therapeutic target predicted by proteomics for systemic sclerosis patients at high risk of pulmonary arterial hypertension.
Sci Rep. 2024;14:29484.
Abstract

MOMOI M, Katsumata Y, Kunimoto H, Inami T, et al
Clonal Hematopoiesis in Chronic Thromboembolic Pulmonary Hypertension.
J Am Heart Assoc. 2024 Nov 27:e035498. doi: 10.1161/JAHA.124.035498.
Abstract

MASCARENHAS D, Al-Balushi M, Al-Sabahi A, Weisz DE, et al
Pulmonary hypertension in preterm neonates with bronchopulmonary dysplasia: a meta-analysis.
Arch Dis Child Fetal Neonatal Ed. 2024 Nov 27:fetalneonatal-2024-327547.
Abstract

MULLEN MP, Ivy DD, Varghese NP, Winant AJ, et al
SOX17 - Associated Pulmonary Hypertension in Children: A Distinct Developmental and Clinical Syndrome.
J Pediatr. 2024 Nov 25:114422. doi: 10.1016/j.jpeds.2024.114422.
Abstract

LEE D
Treprostinil Use in the NICU.
Adv Neonatal Care. 2024;24:554-560.
Abstract

CHEN T, Ni M, Wang H, Xue F, et al
The Reparative Effect of FOXM1 in Pulmonary Disease.
Lung. 2024;203:1.
Abstract

MASARONE D, Valente F, Verrengia M, Contaldi C, et al
Pharmacologic Treatment of Pulmonary Hypertension Due to Heart Failure with Preserved Ejection Fraction: Are There More Arrows on Our Bow?
J Clin Med. 2024;13:6867.
Abstract

VARGA A, Cristescu L, Iancu DG, Dumbrava RA, et al
Relationships Among the EmPHasis-10 Questionnaire, the Simplified Four-Strata Risk Assessment Tool, and Echocardiographic Parameters in Patients with Precapillary Pulmonary Hypertension.
J Clin Med. 2024;13:6782.
Abstract

LUCA AC, Stoica C, Diaconescu C, Tarca E, et al
The Role of Early Child Nutrition in Pulmonary Hypertension-A Narrative Review.
Children (Basel). 2024;11:1307.
Abstract

ALHUMAID S, Alabdulqader M, Al Alawi Z, Al Ghamdi MA, et al
Clinical Characteristics and Outcomes of SARS-CoV-2 Infection in Neonates with Persistent Pulmonary Hypertension of the Newborn (PPHN): A Systematic Review.
Children (Basel). 2024;11:1305.
Abstract

BACAKOVA L, Sedlar A, Musilkova J, Eckhardt A, et al
Mechanisms Controlling the Behavior of Vascular Smooth Muscle Cells in Hypoxic Pulmonary Hypertension.
Physiol Res. 2024;73.
Abstract

THENAPPAN T, Weir EK
Gut Microbiome and Pulmonary Arterial Hypertension - A Novel and Evolving Paradigm.
Physiol Res. 2024;73.
Abstract

SHAIKH P, Rivera MR, Beal MA, Schill MR, et al
Giant Left Atrial Myxoma Presenting with Severe Pulmonary Hypertension.
US Cardiol. 2024;18:e19.
Abstract

LU G, Du R, Lu L, Wang Q, et al
Macrophage-specific kappa-OR knockout exacerbates inflammation in hypoxic pulmonary hypertension.
Eur J Pharmacol. 2024 Nov 23:177152. doi: 10.1016/j.ejphar.2024.177152.
Abstract

SWARRAY-DEEN A, Adana MY, Alao MA, Agyen-Frimpong VAA, et al
Screening for pulmonary hypertension in pregnant women with sickle cell disease in sub-Saharan Africa.
AJOG Glob Rep. 2024;4:100413.
Abstract

HUANG WC, Cheng YY, Hsu CH, Wu YJ, et al
2023 TSOC-TACVPR-TACPAH Consensus Statement of the Rehabilitation on Patients with Pulmonary Hypertension.
Acta Cardiol Sin. 2024;40:716-728.
Abstract

ATAYA A, Mitchel S, Carey B, Sippel J, et al
Pulmonary hypertension during high-dose GM-CSF therapy of autoimmune pulmonary alveolar proteinosis.
Pulm Circ. 2024;14:e70020.
Abstract

SUMMAR M
Potential therapeutic uses of L-citrulline beyond genetic urea cycle disorders.
J Inherit Metab Dis. 2024;47:1260-1268.
Abstract

DENG X, You Y, Lv S, Liu Y, et al
MMP8-mediated vascular remodeling in pulmonary hypertension.
Biochim Biophys Acta Mol Basis Dis. 2024;1871:167582.
Abstract

KOBALAVA S, Tsverava M, Tsetskhladze E
CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICLE EJECTION FRACTION (HFPEF) AND RIGHT VENTRICLE INVOLVEMENT IN PATIENTS WITH NORMAL SINUS RHYTHM AND ATRIAL FIBRILLATION; A SMALL OBSERVATIONAL STUDY: RELEVANCE OF THE PROBLEM, DIAGNOSTIC APPROACH, ECH
Georgian Med News. 2024;:66-74.
Abstract

GARCIA MVF, Nanah A, Caruso P
Acute decompensated pulmonary hypertension outcomes in pulmonary arterial hypertension patients: systematic review and meta-analysis of proportions.
Heart Lung. 2024;70:57-64.
Abstract

ZHANG QL, Liu YN, Zeng YT, Zheng YR, et al
Experience of patent ductus arteriosus ligation during extracorporeal membrane oxygenation treatment in newborns with severe respiratory failure due to persistent pulmonary hypertension: a single-center retrospective study.
Ital J Pediatr. 2024;50:250.
Abstract

YU J, Hong S, Yang L, Ye S, et al
Promotor Hypomethylation Mediated Upregulation of VCAN Targets Twist1 to Promote EndMT in Hypoxia-Induced Pulmonary Hypertension.
J Am Heart Assoc. 2024 Nov 22:e036969. doi: 10.1161/JAHA.124.036969.
Abstract

BOLAYIR HA, Karasu M, Gelen MA, Akin Y, et al
Inflammatory and cardiac biomarkers in pulmonary arterial hypertension: The prognostic role of IL-34.
Heart Lung. 2025;69:202-207.
Abstract

FERRER R, Castro P, Lorencio C, Monclou J, et al
Ten take-home messages on vasopressin use in critically ill patients.
Med Intensiva (Engl Ed). 2024;48:704-713.
Abstract

SHEN YH, Ding D, Lian TY, Qiu BC, et al
Panorama of artery endothelial cell dysfunction in pulmonary arterial hypertension.
J Mol Cell Cardiol. 2024;197:61-77.
Abstract

PILGRIM-MORRIS JH, Collier GJ, Takigawa M, Strickland S, et al
Mapping the amplitude and phase of dissolved (129)Xe red blood cell signal oscillations with keyhole spectroscopic lung imaging.
Magn Reson Med. 2025;93:584-596.
Abstract

IRENE G, Nadia C, Marzia L, Iovino P, et al
Appraisal and evaluation of the quality of life in pulmonary arterial hypertension instruments: A systematic review using COSMIN methodology.
Respir Med. 2024;234:107829.
Abstract

CASTILLO-GALAN S, Parra V, Cuenca J
Unraveling the pathogenesis of viral-induced pulmonary arterial hypertension: Possible new therapeutic avenues with mesenchymal stromal cells and their derivatives.
Biochim Biophys Acta Mol Basis Dis. 2025;1871:167519.
Abstract

MUNAWAR M, Wickerson L, Gottesman C, Braun A, et al
Pulmonary rehabilitation in lung transplant candidates with pulmonary arterial hypertension.
Respir Med. 2024;234:107816.
Abstract

PETROW E, Feng C, Frazer-Abel A, Marangoni RG, et al
Utility of factor D and other alternative complement factors as biomarkers in systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH).
Semin Arthritis Rheum. 2024;69:152554.
Abstract

CHORNEY SR, Beams DR, Nadar A, Afolabi F, et al
Bronchopulmonary dysplasia and ventilation-associated outcomes after pediatric tracheostomy.
Pediatr Pulmonol. 2024;59:3530-3539.
Abstract

LI J, Meng ZY, Wen H, Lu CH, et al
beta-sitosterol alleviates pulmonary arterial hypertension by altering smooth muscle cell phenotype and DNA damage/cGAS/STING signaling.
Phytomedicine. 2024;135:156030.
Abstract

BROWN JT, Virsinskaite R, Kotecha T, Steeden JA, et al
Prognostic utility of exercise cardiovascular magnetic resonance in patients with systemic sclerosis-associated pulmonary arterial hypertension.
Eur Heart J Cardiovasc Imaging. 2024;25:1712-1720.
Abstract

FARSHBAFNADI M, Ghannadzadeh Kermani Pour R, Sattarzadeh Badkoubeh R, Geraiely B, et al
Kidney transplantation in the presence of pulmonary hypertension: A clinical dilemma.
Heliyon. 2024;10:e39074.
Abstract

LANCELLOTTI P, Dulgheru R
Advancing strategies for valvular heart disease and pulmonary hypertension: insights and perspectives.
Acta Cardiol. 2024 Dec 5:1-5. doi: 10.1080/00015385.2024.2436769.
Abstract

HA S, Han S
The Role of Lung Ventilation/Perfusion Scan in the Management of Chronic Thromboembolic Pulmonary Hypertension.
Nucl Med Mol Imaging. 2024;58:449-458.
Abstract

FRANTZ RP, Desai SS, Ewald G, Franco V, et al
SOPRANO: Macitentan in patients with pulmonary hypertension following left ventricular assist device implantation.
Pulm Circ. 2024;14:e12446.
Abstract

PENG B, Zhou Y, Fu X, Chen L, et al
THBS1 mediates hypoxia driven EndMT in pulmonary hypertension.
Pulm Circ. 2024;14:e70019.
Abstract

ZHANG X, Fu Z, Wang H, Sheng L, et al
Metabolic pathways, genomic alterations, and post-translational modifications in pulmonary hypertension and cancer as therapeutic targets and biomarkers.
Front Pharmacol. 2024;15:1490892.
Abstract

COULIS A, Levanon S, Randhawa G, Brailovsky Y, et al
Cardiopulmonary exercise testing in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Front Sports Act Living. 2024;6:1477562.
Abstract

LI C, Liu P, Zhu H, Yang H, et al
T follicular helper cell is essential for M2 macrophage polarization and pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension.
Respir Res. 2024;25:428.
Abstract

SUN X, Wang J, Xiao Y, Li D, et al
Skeletal muscle-derived musclin attenuates glycolysis, oxidative stress, and pulmonary hypertension through the NPR3/AKT/mTORC1 pathway.
Acta Biochim Biophys Sin (Shanghai). 2024 Dec 5. doi: 10.3724/abbs.2024214.
Abstract

HEINE A, Obst A, Opitz CF, Halank M, et al
[Combination drug therapy in pulmonary hypertension: switch from selexipaq to intravenous trepostinil].
Pneumologie. 2024 Dec 4. doi: 10.1055/a-2472-0694.
Abstract

GOPAGONDANAHALLI KR, Sundararaghavan S, Tan TH, Yeo KT, et al
Characterizing the role of left ventricular indices and biventricular interaction in bronchopulmonary dysplasia-associated pulmonary hypertension in extreme prematurity.
Neonatology. 2024 Dec 4:1-17. doi: 10.1159/000542980.
Abstract

RATWATTE S, Playford D, Strange G, Celermajer DS, et al
Prevalence and prognostic significance of pulmonary hypertension in adults with left ventricular diastolic dysfunction.
Open Heart. 2024;11:e003049.
Abstract

TANG F, Ma Q, Liu Y, Yang X, et al
Risk of respiratory, thoracic, and mediastinal disorders associated with endothelin receptor antagonists and prostacyclin-related drugs in pulmonary hypertension: a disproportionality analysis based on FAERS.
Expert Opin Drug Saf. 2024 Dec 3:1-12. doi: 10.1080/14740338.2024.2436077.
Abstract

SCHULZE KM, Weber RE, Horn AG, Hageman KS, et al
Skeletal and respiratory muscle blood flow redistribution during submaximal exercise in pulmonary hypertensive rats.
J Physiol. 2024 Dec 3. doi: 10.1113/JP287549.
Abstract

KAKSONEN M, Simonen P, Lassila R, Pentikainen M, et al
Venous thromboembolism treatment failure during use of factor Xa inhibitors-association with thoracic outlet syndrome and development of chronic thromboembolic pulmonary hypertension.
Ann Med. 2024;56:2404549.
Abstract

HARDER EM, Rahaghi FN, Leopold JA, Systrom DM, et al
Vasoreactivity and inhaled treprostinil response in interstitial lung disease pulmonary hypertension.
ERJ Open Res. 2024;10:00201-2024.
Abstract

DING H, Zhang F, Zhong J, Pan J, et al
A combination of clinical, electrocardiographic, and echocardiographic parameters predicts pulmonary hypertension occurrence in patients with end-stage renal disease.
Front Cardiovasc Med. 2024;11:1337243.
Abstract

ZHANG N, Han GH
[An excerpt for the management of congenital portosystemic shunts and their complications: EASL expert consensus (2023)].
Zhonghua Gan Zang Bing Za Zhi. 2024;32:965-969.
Abstract

SENGSIM J, Vijarnsorn C, Chanthong P, Chungsomprasong P, et al
Survival comparison in adults with congenital systemic to pulmonary shunt and borderline elevated pulmonary vascular resistance versus Eisenmenger syndrome.
Sci Rep. 2024;14:29891.
Abstract

ZHU H, Li C, Hu F, Wu L, et al
RO4929097 inhibits NICD3 to alleviate pulmonary hypertension via blocking Notch3/HIF-2alpha/FoxM1 signaling pathway.
In Vitro Cell Dev Biol Anim. 2024 Dec 2. doi: 10.1007/s11626-024-00976.
Abstract

KHALILIAN MR, Hekmat M, Sadr S, Tavallai-Zavvareh A, et al
Isolated Left Subclavian Artery, Multiple Ventricular Septal Defects, and Pulmonary Hypertension in a Child: A Case Report.
CJC Pediatr Congenit Heart Dis. 2024;3:221-224.
Abstract

SHAHIDI P, Mentzel L, Blazek S, Sulimov D, et al
From Pulmonary Embolism to Chronic Thromboembolic Pulmonary Hypertension: A Pathophysiological Approach.
Rev Cardiovasc Med. 2024;25:402.
Abstract

LIN D, Hu L, Wei D, Li Y, et al
Peli1 Deficiency in Macrophages Attenuates Pulmonary Hypertension by Enhancing Foxp1-Mediated Transcriptional Inhibition of IL-6.
Hypertension. 2024 Dec 2. doi: 10.1161/HYPERTENSIONAHA.124.23542.
Abstract

XIE Y, Qiu X, Zhang Y, Liu Y, et al
Predictive Value of Cardiopulmonary Exercise Testing Parameters for Pulmonary Arterial Hypertension in Peritoneal Dialysis Patients-A Retrospective Study.
Br J Hosp Med (Lond). 2024;85:1-13.
Abstract

BAXAN N, Zhao L, Ashek A, Niglas M, et al
Deep phenotyping the right ventricle to establish translational MRI biomarkers for characterization of adaptive and maladaptive states in pulmonary hypertension.
Sci Rep. 2024;14:29774.
Abstract

DONG H, Li P, Wang X, Zhang Y, et al
Effect of elastin on abnormal proliferation of pulmonary artery smooth muscle cells at an early stage of hypoxic exposure.
J Recept Signal Transduct Res. 2024;44:129-139.
Abstract

GRAM MA, Laksafoss A, Hviid A
Antidepressant exposure patterns during pregnancy and risk of adverse newborn outcomes.
Psychiatry Res. 2024;342:116274.
Abstract

SUMI MP, Tupta B, Song K, Mavrakis L, et al
Expression of soluble guanylate cyclase (sGC) and its ability to form a functional heterodimer are crucial for reviving the NO-sGC signaling in PAH.
Free Radic Biol Med. 2024;225:846-855.
Abstract

PRASAD JD, Williams TJ, Whitford HM
Pulmonary arterial hypertension: updates and perspective with newer therapies.
Intern Med J. 2024;54:1944-1951.
Abstract

LI M, Zhao C, Xiang H, Wang Y, et al
Design, synthesis and optimization of pyrazolo[3,4-b] pyridine derivatives as Hsp110-STAT3 interaction disruptors for the treatment of pulmonary arterial hypertension.
Bioorg Chem. 2024;153:107888.
Abstract

IMANO H, Hayashi T, Nomura A, Tanaka S, et al
Suppressing the expression of steroidogenic acute regulatory protein (StAR) in the myocardium by spironolactone contributes to the improvement of right ventricular remodeling in pulmonary arterial hypertension.
Hypertens Res. 2024;47:3423-3433.
Abstract

AZAREDO RAPOSO M, Inacio Cazeiro D, Guimaraes T, Lousada N, et al
Pulmonary arterial hypertension: Navigating the pathways of progress in diagnosis, treatment, and patient care.
Rev Port Cardiol. 2024;43:699-719.
Abstract

LI S, Huang S, Feng Y, Mao Y, et al
White blood cell-to-haemoglobin ratio as a predictor of 30-day mortality in ICU patients with pulmonary hypertension: a MIMIC-IV database study.
BMC Cardiovasc Disord. 2024;24:729.
Abstract

NIIJIMA R, Otani K, Kodama T, Okada M, et al
Minocycline prevents monocrotaline-induced pulmonary hypertension through the attenuation of endothelial dysfunction and vascular wall thickening.
J Pharmacol Sci. 2025;157:39-44.
Abstract

LI HT, Zhang FX, Gong SG, Zhao QH, et al
Diagnostic Efficacy of Ventilation-Perfusion Single Photo Emission Computed Tomography/Computed Tomography for Pulmonary Hypertension due to Fibrinous Mediastinitis.
Acad Radiol. 2024 Dec 18:S1076-6332(24)00872-9. doi: 10.1016/j.acra.2024.
Abstract

HUANG P, Wang YX, Zhang QQ, Ma YG, et al
[Effect of Zhishi Xiebai Guizhi Decoction on phenotypic transformation of pulmonary artery smooth muscle cells in rats with hypoxic pulmonary hypertension].
Zhongguo Zhong Yao Za Zhi. 2024;49:5297-5306.
Abstract

TEIXEIRA-FONSECA JL, Orts DJBY, Silva PLD, Conceicao MRL, et al
In Vivo Anti-Inflammatory Activity of D-Limonene in a Rat Model of Monocrotaline-Induced Pulmonary Hypertension: Implications to the Heart Function.
Arq Bras Cardiol. 2024;121:e20240195.
Abstract

HEI H, Zhao W, Dong N, Duan X, et al
Quantitative assessment of pulmonary blood flow redistribution in the classification of group 1 and group 4 pulmonary hypertension.
Quant Imaging Med Surg. 2024;14:8658-8671.
Abstract

FU M, Li Y, Liu J, Liu J, et al
Zhishi Xiebai Guizhi Decoction modulates hypoxia and lipid toxicity to alleviate pulmonary vascular remodeling of pulmonary hypertension in rats.
Chin Med. 2024;19:173.
Abstract

CHEN Y, Liu N, Yang Y, Yang L, et al
NCAM1 modulates the proliferation and migration of pulmonary arterial smooth muscle cells in pulmonary hypertension.
Respir Res. 2024;25:435.
Abstract

KENDREW R, Ajraoui S, Beaudet A, Kelly K, et al
Relevance of patient-centered actigraphy measures in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a qualitative interview study.
BMC Pulm Med. 2024;24:608.
Abstract

YOU Q, Song H, Zhu Z, Wang J, et al
Decoding the enigmatic estrogen paradox in pulmonary hypertension: delving into estrogen metabolites and metabolic enzymes.
Cell Mol Biol Lett. 2024;29:155.
Abstract

YAO Y, Jiang H, Xu D, Zhang B, et al
The extracellular CIRP as a predictive marker for the endothelial dysfunction in chronic obstructive pulmonary disease combined with pulmonary hypertension.
BMC Pulm Med. 2024;24:615.
Abstract

POSEY J, Jordan M, Lewis CV, Sul C, et al
Nbeal2 Knockout Mice Are Not Protected Against Hypoxia-Induced Pulmonary Vascular Remodeling and Pulmonary Hypertension.
Blood Adv. 2024 Dec 18:bloodadvances.2024013880.
Abstract

GAZDA AJ, Pan D, Erdos K, Abu-Zeinah G, et al
High Pulmonary Hypertension Risk by Echocardiogram Shortens Survival in Polycythemia Vera.
Blood Adv. 2024 Dec 18:bloodadvances.2024013970.
Abstract

MUKHERJEE M, Mathai SC, Jellis C, Freed BH, et al
Defining Echocardiographic Degrees of Right Heart Size and Function in Pulmonary Vascular Disease from the PVDOMICS Study.
Circ Cardiovasc Imaging. 2024;17:e017074.
Abstract

ALBULUSHI A, Al-Abri U, Al Matrooshi N, Alsabti H, et al
Pulmonary hypertension as a prognostic marker in low-flow low-gradient aortic stenosis: Insights from invasive hemodynamics and post-TAVR outcomes.
Int J Cardiol. 2024;421:132910.
Abstract

SIMPKIN CT, Ivy DD, Friedberg MK, Burkett DA, et al
Use of Right Ventricular Free-Wall Strain in a Multivariable Estimate of Right Ventricular-Arterial Coupling in Pediatric Pulmonary Arterial Hypertension.
Circ Cardiovasc Imaging. 2024;17:e016882.
Abstract

ARGIENTO P, D'Agostino A, Castaldo R, Franzese M, et al
A pulmonary hypertension targeted algorithm to improve referral to right heart catheterization: A machine learning approach.
Comput Struct Biotechnol J. 2024;24:746-753.
Abstract

JASINSKA-STROSCHEIN M, Glajzner P
Searching for Old and New Small-Molecule Protein Kinase Inhibitors as Effective Treatments in Pulmonary Hypertension-A Systematic Review.
Int J Mol Sci. 2024;25:12858.
Abstract

DEVAUGHN H, Rich HE, Shadid A, Vaidya PK, et al
Complement Immune System in Pulmonary Hypertension-Cooperating Roles of Circadian Rhythmicity in Complement-Mediated Vascular Pathology.
Int J Mol Sci. 2024;25:12823.
Abstract

SUZUKI Y, Kawasaki T, Tatsumi K, Okaya T, et al
Transcriptome Analysis of Fibroblasts in Hypoxia-Induced Vascular Remodeling: Functional Roles of CD26/DPP4.
Int J Mol Sci. 2024;25:12599.
Abstract

GARRY JD, Kundu S, Annis J, Alcorn C, et al
Incidence of Pulmonary Hypertension in the Echocardiography Referral Population.
Ann Am Thorac Soc. 2024 Dec 16. doi: 10.1513/AnnalsATS.202407.
Abstract

HAN L, Lin C, Lan Y, Hua Y, et al
Metagenomic Analysis of Gut Microbiome of Persistent Pulmonary Hypertension of the Newborn.
Cardiovasc Toxicol. 2024 Dec 16. doi: 10.1007/s12012-024-09949.
Abstract

SATOH T, Yaoita N, Higuchi S, Nochioka K, et al
Impact of Sodium-Glucose Co-Transporter-2 Inhibitors on Exercise-Induced Pulmonary Hypertension.
Pulm Circ. 2024;14:e70026.
Abstract

CSOSZA G, Valko L, Dinya E, Losonczy G, et al
Right ventricular stroke work index in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A retrospective observational study.
Pulm Circ. 2024;14:e12433.
Abstract

XIE D, Sun X, Cao Y
Malignant pheochromocytoma associated with pulmonary hypertension.
Eur Heart J. 2024 Dec 6:ehae842. doi: 10.1093.
Abstract

XU Y, Liang W, Huo J, Zhang T, et al
Effect of dapagliflozin on pulmonary vascular remodeling in rats with chronic hypoxic pulmonary arterial hypertension.
J Recept Signal Transduct Res. 2024;44.
Abstract

LUI JK, Cozzolino M, Winburn M, Trojanowski MA, et al
Clustering regional patterns of left ventricular longitudinal strain in systemic sclerosis-related pulmonary hypertension.
Int J Cardiol. 2024;421:132891.
Abstract

MAT BAH MN, Zahari N, Abdullah NA, Sapian MH, et al
Survival and Risk Factor for Mortality of Infants with Trisomy-21 and Pulmonary Hypertension: A Population-Based Study from a Middle-Income Country.
Pediatr Cardiol. 2024 Dec 11. doi: 10.1007/s00246-024-03732.
Abstract

MAHAJAN AK, Collar N, Muldowney F, Gorka P, et al
Echocardiography Findings for Pulmonary Hypertension During Workup for Bronchoscopic Lung Volume Reduction.
J Bronchology Interv Pulmonol. 2024;32:e0997.
Abstract

NIE C, Zhu Y, Xiao M, Zhu C, et al
Sex differences in the prevalence and survival of pulmonary hypertension in obstructive hypertrophic cardiomyopathy following septal myectomy.
Int J Cardiol Heart Vasc. 2024;56:101569.
Abstract

KASSE T, Elias A, Lonsako AA, Agegnehu Y, et al
Prevalence of pulmonary hypertension and its associated factors among chronic obstructive pulmonary diseases patients at public hospitals of Addis Ababa, Ethiopia, 2024: a facility-based cross-sectional study.
Front Public Health. 2024;12:1456235.
Abstract

VITULO P, Piccari L, Wort SJ, Shlobin OA, et al
Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH-CLD): A consensus statement from the pulmonary vascular research institute's innovative drug development initiative-group 3 pulmonary hypertension.
Pulm Circ. 2024;14:e70005.
Abstract

PADTE S, Mehta P, Bansal V, Singh N, et al
Impact of diabetes mellitus on mortality in pulmonary hypertension: A systematic review and meta-analysis.
World J Crit Care Med. 2024;13:99564.
Abstract

DHAYYAT A, Mykland Hilde J, Jervan O, Rashid D, et al
Exercise pulmonary hypertension in chronic thromboembolic pulmonary disease: A right heart catheterization study.
Pulm Circ. 2024;14:e70018.
Abstract

DORR O, Keranov S, van Wickern P, Nef H, et al
SPARCL1 and NT-proBNP as biomarkers of right ventricular-to-pulmonary artery uncoupling in pulmonary hypertension.
ESC Heart Fail. 2024 Dec 9. doi: 10.1002/ehf2.15159.
Abstract

ZHANG YW, Yu YZ, Qiu YY, Liu XQ, et al
[Pulmonary capillary hemangiomatosis: a case report].
Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:1144-1147.
Abstract

LAN R, Zhang MJ, Liu K, Meng FF, et al
Cytochrome P450-derived Epoxyeicosatrienoic Acid, the Regulation of Cardiovascular-related Diseases, and the Implication for Pulmonary Hypertension.
Cardiovasc Drugs Ther. 2024 Dec 9. doi: 10.1007/s10557-024-07655.
Abstract

O'HALLORAN KD
Exercise intolerance in pulmonary hypertension: robbing Peter to pay Paul.
J Physiol. 2024 Dec 9. doi: 10.1113/JP288081.
Abstract

POOJARY G, Vasishta S, Thomas RH, Satyamoorthy K, et al
Exercise improves systemic metabolism in a monocrotaline model of pulmonary hypertension.
Sports Med Health Sci. 2024;7:37-47.
Abstract

HOPPER RK, Hansmann G, Hollander SA, Dipchand AI, et al
Clinical Management and Transplant Considerations in Pediatric Pulmonary Hypertension Due to Left Heart Disease: A Scientific Statement From the American Heart Association.
Circ Heart Fail. 2024 Dec 9:e000086. doi: 10.1161/HHF.0000000000000086.
Abstract

MIRZA H, Garcia J, Zussman M, Wadhawan R, et al
Inhaled Nitric Oxide Treatment of Early Pulmonary Hypertension to Reduce the Risk of Death or Bronchopulmonary Dysplasia in Infants Born Extremely Preterm: A Masked Randomized Controlled Trial.
J Pediatr. 2024 Dec 4:114427. doi: 10.1016/j.jpeds.2024.114427.
Abstract

TAKEDA K, Shigeta A, Inagaki T, Hayama N, et al
The utility and safety of one-minute sit-to-stand test in pulmonary hypertension: A prospective study.
Respir Investig. 2024;63:61-66.
Abstract

XIONG P, Huang Q, Mao Y, Qian H, et al
Identification of an immune-related gene panel for the diagnosis of pulmonary arterial hypertension using bioinformatics and machine learning.
Int Immunopharmacol. 2025;144:113694.
Abstract

GE Q, Zhang T, Yu J, Lu X, et al
A new perspective on targeting pulmonary arterial hypertension: Programmed cell death pathways (Autophagy, Pyroptosis, Ferroptosis).
Biomed Pharmacother. 2024;181:117706.
Abstract

AXELSEN LN, Kummel A, Perez Ruixo JJ, Russu A, et al
Population pharmacokinetics of selexipag for dose selection and confirmation in pediatric patients with pulmonary arterial hypertension.
CPT Pharmacometrics Syst Pharmacol. 2024;13:2185-2195.
Abstract

DOMINONI M, Melito C, Schirinzi S, Ghio S, et al
When pulmonary arterial hypertension and pregnancy meet: a multidisciplinary clinical experts review.
Arch Gynecol Obstet. 2024;310:2839-2852.
Abstract

SONG J, Shao J, Yu S, Zhang H, et al
LncRNA MEG3 aggravates acute pulmonary embolism-induced pulmonary arterial hypertension by regulating miR-34a-3p/DUSP1 axis.
Int J Biol Macromol. 2024;283.
Abstract

CHEN Y, Li Y, Leng B, Cao C, et al
LncRNA MYOSLID contributes to PH via targeting BMPR2 signaling in pulmonary artery smooth muscle cell.
Vascul Pharmacol. 2024;157:107439.
Abstract

CAMPOS DE ANDRADE OG, Goncalves de Castro LC, Amado VM
Unveiling the metabolic challenges in pulmonary arterial hypertension: Insights into thyroid, glycemic, lipid, and bone disorders.
Respir Med. 2024;235:107859.
Abstract

LEE HN, Kim HC, Lee JB, Lee JS, et al
Prognostic significance of right atrial volume and interval changes in patients with idiopathic pulmonary arterial hypertension.
Respir Med. 2024;235:107857.
Abstract

VACHIERY JL, Belge C, Cools B, Damen A, et al
A Belgian consensus on sotatercept for the treatment of pulmonary arterial hypertension.
Acta Cardiol. 2024;79:978-983.
Abstract

VON HAEHLING S
[Iron deficiency in cardiovascular disease].
Inn Med (Heidelb). 2024;65:1273-1282.
Abstract

LINDHOLM A, Kjellstrom B, Radegran G, Arheden H, et al
Right ventricular dyssynchrony predicts outcome in pulmonary arterial hypertension when assessed in multiple cardiac magnetic resonance views.
J Cardiovasc Magn Reson. 2024;26:101103.
Abstract

PEI C, Shen Z, Wu Y, Zhao S, et al
Eleutheroside B Pretreatment Attenuates Hypobaric Hypoxia-Induced High-Altitude Pulmonary Edema by Regulating Autophagic Flux via the AMPK/mTOR Pathway.
Phytother Res. 2024;38:5657-5671.
Abstract

DE JESUS FERREIRA H, Ferreira Borges JA, Simoes Galini Schwarz De Andrade N, De Castro JT, et al
A Rare Case of Pulmonary Artery Trunk Aneurysm.
Vasc Endovascular Surg. 2025;59:211-217.
Abstract

MANZI G, Benza RL, Argiento P, Casu G, et al
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus.
Vascul Pharmacol. 2024;157:107432.
Abstract

SHAH NR, Burgi K, Lotakis DM, Olive MK, et al
Patterns and Outcomes of Epoprostenol Use in Infants with Congenital Diaphragmatic Hernia Requiring Extracorporeal Life Support.
J Pediatr. 2024 Sep 2:114286. doi: 10.1016/j.jpeds.2024.114286.
Abstract

MCLAUGHLIN VV, Sitbon O, Chin KM, Galie N, et al
Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbidities.
Eur J Heart Fail. 2024;26:2379-2391.
Abstract

HUANG Y, Zhang J, Zhao Q, Hu X, et al
Impact of reduced apolipoprotein A-I levels on pulmonary arterial hypertension.
Hellenic J Cardiol. 2024;80:31-46.
Abstract

BELPERIO JA, Fishbein MC, Abtin F, Channick J, et al
Pulmonary sarcoidosis: A comprehensive review: Past to present.
J Autoimmun. 2024;149:103107.
Abstract

GONZALEZ-HERMOSILLO LM, Cueto-Robledo G, Navarro-Vergara DI, Torres-Rojas MB, et al
Molecular Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: A Clinical Update from a Basic Research Perspective.
Adv Respir Med. 2024;92:485-503.
Abstract

SATIJA D, Gouchoe DA, Monasterio J, Cui EY, et al
Transcatheter versus Surgical Aortic Valve Replacement for Patients With Pulmonary Hypertension.
J Surg Res. 2024;305:222-230.
Abstract

LIN J, Pan Z, Sun J, Wang X, et al
PCSK9 inhibitor alleviates experimental pulmonary fibrosis-induced pulmonary hypertension via attenuating epithelial-mesenchymal transition by suppressing Wnt/beta-catenin signaling in vivo and in vitro.
Front Med (Lausanne). 2024;11:1509168.
Abstract

HE M, Zeng Q
Comment on "Implication of heart rhythm complexity in predicting long-term outcomes in pulmonary hypertension".
J Formos Med Assoc. 2024 Dec 24:S0929-6646(24)00584.
Abstract

OUCHI K, Sakuma T, Akao R, Nojiri A, et al
Determining pulmonary artery diameter on CT scans as basis for performing transthoracic echocardiography to screen for pulmonary hypertension in patients with pulmonary artery enlargement.
J Echocardiogr. 2024 Dec 25. doi: 10.1007/s12574-024-00674.
Abstract

GERTZ RJ, Lennartz S, Kaya K, Wawer Matos Reimer RP, et al
Dual-layer dual-energy CT characterization of thrombus composition in acute pulmonary embolism and chronic thromboembolic pulmonary hypertension.
Int J Cardiovasc Imaging. 2024 Dec 25. doi: 10.1007/s10554-024-03309.
Abstract

LIU Y, He C, Zhong Q, Shi X, et al
Tadalafil Enhances the Therapeutic Efficacy of Mesenchymal Stem Cells-Derived Exosomes in Pulmonary Hypertension by Upregulating miR-29a-3p.
Int J Nanomedicine. 2024;19:13525-13546.
Abstract

ALISHA A K, Jenny Z Y, Timothy M F
Stroke Volume Augmentation Improves with PH-Targeted Therapy in Patients with Exercise-Induced Pulmonary Hypertension.
Respir Med. 2024 Dec 21:107921. doi: 10.1016/j.rmed.2024.107921.
Abstract

ZEDER K, Sassmann T, Foris V, Douschan P, et al
Severe pulmonary hypertension in chronic obstructive pulmonary disease - From clinical perspective to histological evidence.
Int J Cardiol Congenit Heart Dis. 2024;17:100519.
Abstract

ABUHALAWEH N, Wort SJ, Dunbar J, Kempny A, et al
A rare presentation of pulmonary hypertension.
Int J Cardiol Congenit Heart Dis. 2024;17:100531.
Abstract

RATWATTE S, Celermajer DS
The latest definition and classification of pulmonary hypertension.
Int J Cardiol Congenit Heart Dis. 2024;17:100534.
Abstract

BARAL T, Malakapogu P, Shyma Z, Kurian SJ, et al
Efficacy of iron replacement in pulmonary hypertension: A systematic review.
Nutr Health. 2024 Dec 23:2601060241303814. doi: 10.1177/02601060241303814.
Abstract

TANG SY, Lin YT, Tsai CH, Lin YH, et al
Reply to the comment to "Implication of heart rhythm complexity in predicting long-term outcomes in pulmonary hypertension".
J Formos Med Assoc. 2024 Dec 21:S0929-6646(24)00606.
Abstract

ZHU Q, Mao X, Zhu X, Xiao Y, et al
Hypoxia-Induced and Glucuronic Acid-Modified Extracellular Vesicles from Mesenchymal Stromal Cells Treat Pulmonary Arterial Hypertension by Improving Vascular Remodeling.
Nano Lett. 2024;24:16342-16350.
Abstract

ZHANG B, Zou ZK, Cai JF, Tan WM, et al
Discovery and Optimization of Dihydroquinolin-2(1H)-ones as Novel Highly Selective and Orally Bioavailable Phosphodiesterase 5 Inhibitors for the Treatment of Pulmonary Arterial Hypertension.
J Med Chem. 2024;67:22134-22144.
Abstract

AOKI-KAMIYA C, Katsuragi S, Shiina Y, Hasegawa J, et al
Maternal Death Due to Pulmonary Arterial Hypertension?- A Nationwide Survey in Japan.
Circ J. 2024;89:77-82.
Abstract

MOINUDDIN SM, Ibrahim M, Sarkar T, Hossain MS, et al
Protocol for quantum dot-based cell counting and immunostaining of pulmonary arterial cells from patients with pulmonary arterial hypertension.
STAR Protoc. 2024;5:103319.
Abstract

GOKHALE T, Harinstein ME
Challenging the Paradigm of Post-Capillary Pulmonary Hypertension.
Am J Cardiol. 2023 Dec 30:S0002-9149(23)01445.
Abstract

PATARROYO APONTE MM
When Bad and Worse Collide: Venous Thromboembolic Disease and Pulmonary Hypertension.
Am J Cardiol. 2024 Jan 9:S0002-9149(23)00252.
Abstract

CELESKI M, Segreti A, Polito D, Valente D, et al
Traditional and Advanced Echocardiographic Evaluation in Chronic Obstructive Pulmonary Disease: The Forgotten Relation.
Am J Cardiol. 2024;217:102-118.
Abstract

MALIGIREDDY A, Jabri A, Zghouzi M, Rojulpote C, et al
Maternal and Fetal Outcomes in Pulmonary Hypertension During Pregnancy: A Contemporary Nationwide Analysis.
Am J Cardiol. 2024 Apr 23:S0002-9149(24)00277.
Abstract

CORREALE M, Tricarico L, Chirivi F, Bevere EML, et al
Endothelial function correlates with pulmonary pressures in subjects with clinically suspected pulmonary hypertension.
Am J Cardiol. 2024 Jun 17:S0002-9149(24)00454.
Abstract

VAN DISSEL AC, D'Alto M, Farro A, Mathijssen H, et al
Improved Risk Prediction Using a Refined European Guidelines Instrument in Pulmonary Arterial Hypertension Related to Congenital Heart Disease.
Am J Cardiol. 2024 Sep 2:S0002-9149(24)00627.
Abstract

MASIERO G, Arturi F, Soramio EB, Fovino LN, et al
Impact of Updated Invasive Right Ventricular and Pulmonary Hemodynamics on Long-Term Outcomes in Patients With Mitral Valve Transcatheter Edge-to-Edge Repair.
Am J Cardiol. 2024 Nov 20:S0002-9149(24)00799.
Abstract

HANSEN TS, Karimi Galougahi K, Tang O, Tsang M, et al
The FXYD1 protein plays a protective role against pulmonary hypertension and arterial remodelling via redox and inflammatory mechanisms.
Am J Physiol Heart Circ Physiol. 2023 Dec 22. doi: 10.1152/ajpheart.00090.2023.
Abstract

ARADHYULA V, Vyas R, Dube P, Haller ST, et al
Novel Insights into the Pathobiology of Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction.
Am J Physiol Heart Circ Physiol. 2024 Apr 19. doi: 10.1152/ajpheart.00068.2024.
Abstract

FUKUMITSU M, Kawada T, Nishikawa T, Yokota S, et al
Effects of nitric oxide inhalation on pulmonary arterial impedance: Differences between normal and pulmonary hypertension male rats.
Am J Physiol Heart Circ Physiol. 2024 May 31. doi: 10.1152/ajpheart.00108.2024.
Abstract

BURGHAZE MG, Gorr MW
Understanding the estrogen paradox of pulmonary arterial hypertension in the context of right ventricular function.
Am J Physiol Heart Circ Physiol. 2024;327:H349-H350.
Abstract

KWAN ED, Hardie BA, Garcia KM, Mu H, et al
Sex-dependent remodeling of right ventricular function in a rat model of pulmonary arterial hypertension.
Am J Physiol Heart Circ Physiol. 2024;327:H351-H363.
Abstract

PIELES GE, Dorobantu DM, Caterini JE, Cifra B, et al
Biventricular responses to exercise and their relation to cardiorespiratory fitness in pediatric pulmonary hypertension.
Am J Physiol Heart Circ Physiol. 2024 Jul 26. doi: 10.1152/ajpheart.00096.2024.
Abstract

SMITH MA, Chiacchia S, Boehme J, Datar SA, et al
MicroRNA Profiling to Inform Disease Classification, Severity, and Treatment Response in Pediatric Pulmonary Hypertension.
Am J Physiol Heart Circ Physiol. 2024 Nov 26. doi: 10.1152/ajpheart.00622.2024.
Abstract

PHILIP N, Yun X, Pi H, Murray S, et al
Fatty acid metabolism promotes TRPV4 activity in lung microvascular endothelial cells in pulmonary arterial hypertension.
Am J Physiol Lung Cell Mol Physiol. 2024;326:L252-L265.
Abstract

HATABAH D, De Marco T, McGlothlin DP, Malloy M, et al
Low global arginine bioavailability: a common phenomenon in pulmonary hypertension.
Am J Physiol Lung Cell Mol Physiol. 2024;326:L514-L515.
Abstract

ALI M, Choudhary R, Singh K, Kumari S, et al
Hypobaric hypoxia modulated structural characteristics of circulating cell-free DNA in high-altitude pulmonary edema.
Am J Physiol Lung Cell Mol Physiol. 2024;326:L496-L507.
Abstract

GUTOR SS, Salinas RI, Nichols DS, Bazzano JMR, et al
Repetitive sulfur dioxide exposure in mice models post-deployment respiratory syndrome.
Am J Physiol Lung Cell Mol Physiol. 2024;326:L539-L550.
Abstract

NIEDERMEYER S, Yun X, Trujillo M, Jiang H, et al
A novel interaction between aquaporin 1 and caspase-3 in pulmonary arterial smooth muscle cells.
Am J Physiol Lung Cell Mol Physiol. 2024;326:L638-L645.
Abstract

MUTGAN AC, Radic N, Valzano F, Crnkovic S, et al
A comprehensive map of proteoglycan expression and deposition in the pulmonary arterial wall in health and pulmonary hypertension.
Am J Physiol Lung Cell Mol Physiol. 2024 May 21. doi: 10.1152/ajplung.00022.2024
Abstract

SUN XQ, Klouda T, Barnasconi S, Schalij I, et al
Pneumonectomy combined with SU5416 or monocrotaline pyrrole does not cause severe pulmonary hypertension in mice.
Am J Physiol Lung Cell Mol Physiol. 2024 May 29. doi: 10.1152/ajplung.00105.2024
Abstract

KUDRYASHOVA TV, Zaitsev SV, Jiang L, Buckley BJ, et al
PAI-1 Deficiency Drives Pulmonary Vascular Smooth Muscle Remodeling and Pulmonary Hypertension.
Am J Physiol Lung Cell Mol Physiol. 2024 Jun 11. doi: 10.1152/ajplung.00110.2024
Abstract

COURSEN JC, Tuhy T, Naranjo M, Woods A, et al
Aberrant long-chain fatty acid metabolism associated with evolving systemic sclerosis-associated pulmonary arterial hypertension.
Am J Physiol Lung Cell Mol Physiol. 2024;327:L54-L64.
Abstract

HEISE EL, Salman J, Webs KS, Hoffler K, et al
Hypoxic perfusion of pulmonary arterial vasa vasorum increases pulmonary arterial pressure.
Am J Physiol Lung Cell Mol Physiol. 2024;327:L79-L85.
Abstract

STEPPAN J, Wang H, Nandakumar K, Gadkari M, et al
LOXL2 inhibition ameliorates pulmonary artery remodeling in pulmonary hypertension.
Am J Physiol Lung Cell Mol Physiol. 2024 Jul 16. doi: 10.1152/ajplung.00327.2023
Abstract

CHOVANEC M, Durisova J, Vajnerova O, Banasova A, et al
Simple model of pulmonary hypertension secondary to left heart pressure overload induced by partial intravascular occlusion of the ascending aorta.
Am J Physiol Lung Cell Mol Physiol. 2024 Jul 16. doi: 10.1152/ajplung.00243.2023
Abstract

MENEZES TCF, Fonseca Balladares DC, Nolan K, Graham BB, et al
Two hits strike out causing persistent pulmonary hypertension in mice.
Am J Physiol Lung Cell Mol Physiol. 2024 Jul 16. doi: 10.1152/ajplung.00198.2024
Abstract

TUINEAU MN, Herbert LM, Garcia SM, Resta TC, et al
Enhanced glycolysis causes extracellular acidification and activates acid-sensing ion channel 1a in hypoxic pulmonary hypertension.
Am J Physiol Lung Cell Mol Physiol. 2024 Aug 6. doi: 10.1152/ajplung.00083.2024.
Abstract

BROWNSTEIN AJ, Mura M, Ruffenach G, Channick RN, et al
"Dissecting the Lung Transcriptome of Pulmonary Fibrosis-associated Pulmonary Hypertension".
Am J Physiol Lung Cell Mol Physiol. 2024 Aug 13. doi: 10.1152/ajplung.00166.2024
Abstract

VALUPARAMPIL VARGHESE M, James J, Bharti D, Rischard F, et al
Circulating free heme induces cytokine storm and pulmonary hypertension through the MKK3/p38 axis.
Am J Physiol Lung Cell Mol Physiol. 2024 Aug 28. doi: 10.1152/ajplung.00422.2022
Abstract

MICKAEL C, Jordan M, Posey JN, Tuder RM, et al
Activation of Platelets and the Complement System in Mice with Schistosoma-Induced Pulmonary Hypertension.
Am J Physiol Lung Cell Mol Physiol. 2024 Sep 10. doi: 10.1152/ajplung.00165.2024
Abstract

WANG S, Awad KS, Chen LY, Siddique MAH, et al
Endothelial PHD2 deficiency induces apoptosis resistance and inflammation via AKT activation and AIP1 loss independent of HIF2alpha.
Am J Physiol Lung Cell Mol Physiol. 2024;327:L503-L519.
Abstract

ZHENG Q, Cabrera JTO, Tsuji-Hosokawa A, Ramirez FJ, et al
Enhanced lung endothelial glycolysis is implicated in the development of severe pulmonary hypertension in type 2 diabetes.
Am J Physiol Lung Cell Mol Physiol. 2024 Oct 22. doi: 10.1152/ajplung.00305.2023
Abstract

MARINHO Y, Villarreal ES, Loya O, Oliveira SD, et al
Mechanisms of lung endothelial cell injury and survival in pulmonary arterial hypertension.
Am J Physiol Lung Cell Mol Physiol. 2024;327:L972-L983.
Abstract

RAJAGOPAL S, Yu YR
Determining the Architecture of Inflammation in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2024;209:131-133.
Abstract

FERRIAN S, Cao A, McCaffrey EF, Saito T, et al
Single-Cell Imaging Maps Inflammatory Cell Subsets to Pulmonary Arterial Hypertension Vasculopathy.
Am J Respir Crit Care Med. 2024;209:206-218.
Abstract

NAEIJE R, Tonelli AR
Pulmonary Artery Wedge Pressure in the Diagnosis of Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2024;209:242-244.
Abstract

HARDER EM, Divo MJ, Washko GR, Leopold JA, et al
Implications of Mean Pulmonary Arterial Wedge Pressure Trajectories in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2024;209:316-324.
Abstract

KUDRYASHOVA TV, Jiang L, Goncharova EA
What Is All of the Hype About? Hypusine Signaling as a Driver of Pulmonary Hypertension.
Am J Respir Crit Care Med. 2024 Feb 27. doi: 10.1164/rccm.202401-0195.
Abstract

LILEY J, Newnham M, Bleda M, Bunclark K, et al
Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Embolism.
Am J Respir Crit Care Med. 2024 Mar 12. doi: 10.1164/rccm.202307-1236.
Abstract

HARDER E, Abtin F, Nardelli P, Brownstein A, et al
Pulmonary Hypertension in Idiopathic Interstitial Pneumonia Is Associated with Small Vessel Pruning.
Am J Respir Crit Care Med. 2024 Mar 19. doi: 10.1164/rccm.202312-2343.
Abstract

JAIN A, Epelbaum O
Synchronous Pulmonary Arterial and Pulmonary Venous Thrombosis in Pancreatic Cancer.
Am J Respir Crit Care Med. 2024;209:751-752.
Abstract

BJORKMAN KR, Miles KG, Bellew LE, Schneider KA, et al
Patent Ductus Arteriosus and Lung MRI Phenotype in Moderate and Severe Bronchopulmonary Dysplasia-Pulmonary Hypertension.
Am J Respir Crit Care Med. 2024 Apr 3. doi: 10.1164/rccm.202310-1733.
Abstract

VILLAMOR E, Gonzalez-Luis GE
Pulmonary Hypertension and Lung Damage Associated with Prolonged Exposure to Patent Ductus Arteriosus in Very Preterm Infants.
Am J Respir Crit Care Med. 2024 May 3. doi: 10.1164/rccm.202404-0694.
Abstract

KAWUT SM, Feng R, Ellenberg SS, Zamanian R, et al
Pulmonary Hypertension and Anastrozole (PHANTOM): A Randomized, Double-Blind, Placebo-Controlled Trial.
Am J Respir Crit Care Med. 2024 May 15. doi: 10.1164/rccm.202402-0371.
Abstract

OLDROYD SH, Manek G, Bhardwaj A, Zamanian RT, et al
Constructing the Framework for Disease Modification in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2024;209:1189-1195.
Abstract

SCOTT JV, Moutchia J, McClelland RL, Al-Naamani N, et al
Novel Liver Injury Phenotypes and Outcomes in Clinical Trial Participants with Pulmonary Hypertension.
Am J Respir Crit Care Med. 2024 May 31. doi: 10.1164/rccm.202311-2196.
Abstract

LEMAY SE, Grobs Y, Romanet C, Martineau S, et al
Hypusine Signaling Promotes Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2024;209:1376-1391.
Abstract

EICHSTAEDT CA
Genetically Identifying the "Thrombo-embolic" in CTEPH.
Am J Respir Crit Care Med. 2024 Mar 27. doi: 10.1164/rccm.202402-0471.
Abstract

TOSHNER M
Searching for an Elusive Phantom - Targeting Oestrogen in Pulmonary Hypertension.
Am J Respir Crit Care Med. 2024 Jun 26. doi: 10.1164/rccm.202405-1029.
Abstract

BADAGLIACCA R, Ghio S, D'Alto M, Ameri P, et al
Relevance of Echocardiography-derived Phenotyping in Patients with Pulmonary Arterial Hypertension Treated with Initial Oral Combination Therapy: An Italian Pulmonary Hypertension Network (iPHNET) Study.
Am J Respir Crit Care Med. 2024;210:362-365.
Abstract

TUDER RM, Gandjeva A, Williams S, Kumar S, et al
Digital Spatial Profiling Identifies Distinct Molecular Signatures of Vascular Lesions in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2024;210:329-342.
Abstract

SAHAY S, Chakinala MM, Kim NH, Preston IR, et al
Contemporary Treatment of Pulmonary Arterial Hypertension: A U.S. Perspective.
Am J Respir Crit Care Med. 2024;210:581-592.
Abstract

KOVACS G, Moutchia J, Zeder K, Maron BA, et al
Clinical Response to Pulmonary Arterial Hypertension Treatment Does Not Depend on Pulmonary Arterial Wedge Pressure: A Meta-Analysis Using Individual Participant Data from Randomized Clinical Trials.
Am J Respir Crit Care Med. 2024;210:844-847.
Abstract

XU Z, Li Q, Zhang C, Wang Q, et al
Viscosity-Corrected Pulmonary Vascular Resistance Index in Pediatric Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2024;210:831-834.
Abstract

RAYNER SG, Tedford RJ, Leary PJ, Mak S, et al
"This Patient Needs a Doctor, Not a Guideline!" The Zone of Uncertainty in Pulmonary Arterial Wedge Pressure Measurement.
Am J Respir Crit Care Med. 2024;210:712-714.
Abstract

KREMER N, Schaefer S, Yogeswaran A, Rako Z, et al
Exercise Limitation in Pulmonary Hypertension - Physiological Insights into the Six-Minute Walk Test.
Am J Respir Crit Care Med. 2024 Oct 15. doi: 10.1164/rccm.202407-1397.
Abstract

ZEDER K
Beyond the Lung: Viewing Treatment Response through the Liver in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2024;210:976-978.
Abstract

HAYES D JR, Jennerich AL, Coleman RD, Abston E, et al
Interventional Strategies for Children with Progressive Pulmonary Hypertension Despite Optimal Therapy. An Official American Thoracic Society Clinical Practice Guideline.
Am J Respir Crit Care Med. 2024 Nov 12. doi: 10.1164/rccm.202410-1901.
Abstract

HAKIM A, Fricker ZP, Feuerstein JD, Farber HW, et al
Recurrent Gastrointestinal Bleeding in a Patient With Pulmonary Arterial Hypertension Treated With Sotatercept.
Ann Intern Med. 2024;177:115-117.
Abstract

MADANI MM
Acute Kidney Injury Post Pulmonary Thromboendarterectomy: Is It a Valid Concern? A Word of Caution.
Ann Thorac Surg. 2024;117:318-319.
Abstract

MADANI MM, Wiedenroth CB, Jenkins DP, Fadel E, et al
Pulmonary Thromboendarterectomy: The Potentially Curative Treatment of Choice for Chronic Thromboembolic Pulmonary Hypertension.
Ann Thorac Surg. 2024 Sep 10:S0003-4975(24)00763.
Abstract

TUCKER DL, Gupta S, Pande A, Mahboubi R, et al
Mitral Valve Intervention, Pulmonary Hypertension, and Survival in 219 Shone's Syndrome Patients.
Ann Thorac Surg. 2023 Oct 28:S0003-4975(23)01131.
Abstract

FRANTZ RP, Swift AJ
Advancing Risk Stratification in Pulmonary Arterial Hypertension Through Cardiac MRI: The Need for Collaboration and Standardization.
Chest. 2024;165:12-13.
Abstract

CELANT LR, Wessels JN, Marcus JT, Meijboom LJ, et al
Toward the Implementation of Optimal Cardiac Magnetic Resonance Risk Stratification in Pulmonary Arterial Hypertension.
Chest. 2024;165:181-191.
Abstract

BALASUBRAMANIAN A, Larive B, Horn EM, DuBrock HM, et al
Health-Related Quality of Life Across the Spectrum of Pulmonary Hypertension.
Chest. 2024 Feb 12:S0012-3692(24)00155-7. doi: 10.1016/j.chest.2024.
Abstract

FAUVEL C, White RJ, Vanderpool RR, Badagliacca R, et al
Risk Stratification in Pulmonary Arterial Hypertension: Perhaps Simple Is Not Best?
Chest. 2024;165:431-436.
Abstract

MOORE J, Remy J, Altschul E, Chusid J, et al
Thoracic Applications of Spectral CT Scan.
Chest. 2024;165:417-430.
Abstract

O'MEARA K, Stone G, Buch E, Brownstein A, et al
Atrial Arrhythmias in Patients with Pulmonary Hypertension.
Chest. 2024 Mar 5:S0012-3692(24)00291-5. doi: 10.1016/j.chest.2024.
Abstract

PROVENCHER S, Mai V, Bonnet S
Managing Pulmonary Arterial Hypertension With Cardiopulmonary Comorbidities.
Chest. 2024;165:682-691.
Abstract

OROZCO-LEVI M, de Jesus Perez V
Precision Solutions: A Strategy to Improve Medical Care for Patients With Pulmonary Hypertension in Latin America.
Chest. 2024;165:669-672.
Abstract

SAHAY S
Counterpoint: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? No.
Chest. 2024;165:494-496.
Abstract

WEATHERALD J, Sitbon O
POINT: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? Yes.
Chest. 2024;165:492-494.
Abstract

YOGESWARAN A, Gall H, Funderich M, Wilkins MR, et al
Comparison of contemporary risk scores in all groups of pulmonary hypertension - a PVRI GoDeep meta-registry analysis.
Chest. 2024 Mar 18:S0012-3692(24)00309-X. doi: 10.1016/j.chest.2024.
Abstract

AL-NAAMANI N, Thenappan T
Left Heart Disease Phenotype in Pulmonary Arterial Hypertension: Considerations for Therapy.
Chest. 2024;165:766-768.
Abstract

KEARNEY K, Brown K, Celermajer DS, Collins N, et al
Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy.
Chest. 2024;165:967-977.
Abstract

GENECAND L, Lador F, Montani D, Perneger T, et al
Is Higher Dose of Inhaled Treprostinil Truly Superior to Lower Dose of Inhaled Treprostinil in Patients With Pulmonary Hypertension Associated With Interstitial Lung Diseases?
Chest. 2024;165:e161.
Abstract

CHEN Y, Li J, Li F, Chen Z, et al
Impact of Epicardial Adipose Tissue on Right Cardiac Function and Prognosis in Pulmonary Arterial Hypertension.
Chest. 2024;165:1211-1223.
Abstract

RICE JL, Austin ED, Mathai SC, Sahay S, et al
Genetic Testing in Pulmonary Arterial Hypertension Evaluation: A Patient and Clinician Survey.
Chest. 2024;165:1224-1227.
Abstract

ANG HL, Schulte M, Chan RK, Tan HH, et al
Pulmonary hypertension in interstitial lung disease: a systematic review and meta-analysis.
Chest. 2024 May 29:S0012-3692(24)00661-5. doi: 10.1016/j.chest.2024.
Abstract

LAMMI MR, Agrawal V, Mathai SC
Does the Left Heart Know What the Right Heart Is Doing in Patients With Systemic Sclerosis and Pulmonary Hypertension?
Chest. 2024;165:1288-1290.
Abstract

COLALILLO A, Hachulla E, Pellicano C, Smith V, et al
DLco and echocardiographic parameters in identifying mild pulmonary hypertension in the EUSTAR cohort of systemic sclerosis patients.
Chest. 2024 Jun 5:S0012-3692(24)00683-4. doi: 10.1016/j.chest.2024.
Abstract

CHAROENPONG P, Hall NM, Keller CM, Ram AK, et al
Overview of Methamphetamine-Associated Pulmonary Arterial Hypertension.
Chest. 2024;165:1518-1533.
Abstract

STRICK DJ, Farber HW, Hill NS, Preston IR, et al
Group 5 Pulmonary Hypertension Associated With T-Cell Large Granular Lymphocytic Leukemia: Hemodynamics and Treatment.
Chest. 2024;166:e1-e3.
Abstract

NOSSENT EJ, Smits JA, Seegers C, Meijboom LJ, et al
Clinical Correlates of a Nonplexiform Vasculopathy in Patients With a Diagnosis of Idiopathic Pulmonary Arterial Hypertension.
Chest. 2024;166:190-200.
Abstract

BAGHERZADEH SP, Celestin BE, Santana EJ, Salerno M, et al
Novel Reference Equations for Pulmonary Artery Size and Pulsatility Using Echocardiography and their Diagnostic Value in Pulmonary Hypertension.
Chest. 2024 Jul 16:S0012-3692(24)04615-4. doi: 10.1016/j.chest.2024.06.3805.
Abstract

SAHAY S, Villasmil Hernandez N, Wang F, Wooten M, et al
Comparison Between REVEAL Lite 2 and COMPERA 2.0 for Risk Stratification in Pulmonary Arterial Hypertension.
Chest. 2024;166:373-387.
Abstract

GUGLIN M, Munshi K, Volz E, Bennett M, et al
Misclassification of Pulmonary Hypertension with Current Hemodynamic Criteria.
Chest. 2024 Aug 27:S0012-3692(24)05067-0. doi: 10.1016/j.chest.2024.
Abstract

TELLO K, Yogeswaran A, Majeed RW, Kiely DG, et al
Phosphodiesterase-5 Inhibitor Treatment is Associated with Improved Survival in Pulmonary Hypertension Associated with COPD in the PVRI GoDeep Meta-Registry.
Chest. 2024 Aug 23:S0012-3692(24)05046-3. doi: 10.1016/j.chest.2024.
Abstract

JOSE A, Kumar SS, Gorelik L, Friedman SH, et al
Association of Cardiopulmonary Hemodynamics and Outcomes in Pulmonary Hypertension Following Kidney Transplant: A Multicenter Retrospective Cohort Study.
Chest. 2024 Aug 22:S0012-3692(24)04938-9. doi: 10.1016/j.chest.2024.
Abstract

FAUVEL C, Gomberg-Maitland M, Benza RL
Risk Stratification in Pulmonary Hypertension: We Need to "GoDeeper"!
Chest. 2024;166:420-422.
Abstract

PRESTON IR, Lewis D, Gomberg-Maitland M
Using Sotatercept in the Care of Patients With Pulmonary Arterial Hypertension.
Chest. 2024;166:604-611.
Abstract

GIGANTE A, Ciurzynski M
Are There Any New, Useful Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in Patients With Systemic Sclerosis?
Chest. 2024;166:668-670.
Abstract

MOUNSEY LA, Alape Moya D, Wright C, Langer N, et al
Association between thrombus histopathology and hemodynamic outcomes among patients with chronic thromboembolic pulmonary hypertension undergoing pulmonary endarterectomy.
Chest. 2024 Oct 23:S0012-3692(24)05395-9. doi: 10.1016/j.chest.2024.
Abstract

HAO L, Xue J
Improving Diagnosis and Management of Pulmonary Hypertension in Interstitial Lung Disease.
Chest. 2024;166:e175-e176.
Abstract

BALANESCU DV, Kane GC
Redefining Echocardiographic Pulmonary Artery Measurements: Insights Into the Presence of Pulmonary Hypertension.
Chest. 2024;166:919-920.
Abstract

GERGES C, Beurnier A, Jais X, Herve P, et al
Role of Exercise Hemodynamics in the Prediction of Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers.
Chest. 2024;166:1173-1183.
Abstract

POISSON C, Hlavaty A, Favrolt N, Chaumais MC, et al
Pulmonary hypertension associated with Trastuzumab-Emtansine: an analysis of French PH registry and WHO pharmacovigilance database.
Chest. 2024 Nov 19:S0012-3692(24)05562-4. doi: 10.1016/j.chest.2024.
Abstract

GRIFFITHS M, Simpson CE, Yang J, Vaidya D, et al
Equivalency of Multiple Biomarkers to Clinical Pulmonary Arterial Hypertension Survival Risk Models.
Chest. 2024;166:1511-1531.
Abstract

MURUGESAN P, Zhang Y, Huang Y, Chengong Zong N, et al
Reversal of Pulmonary Hypertension in a Human-Like Model: Therapeutic Targeting of Endothelial DHFR.
Circ Res. 2024 Feb 1. doi: 10.1161/CIRCRESAHA.123.323090.
Abstract

COSTE B, Delmas P
PIEZO Ion Channels in Cardiovascular Functions and Diseases.
Circ Res. 2024;134:572-591.
Abstract

CHU X, Kheirollahi V, Lingampally A, Chelladurai P, et al
GLI1+ Cells Contribute to Vascular Remodeling in Pulmonary Hypertension.
Circ Res. 2024 Apr 19. doi: 10.1161/CIRCRESAHA.123.323736.
Abstract

ZAFEIROPOULOS S, Ahmed U, Bekiaridou A, Jayaprakash N, et al
Ultrasound Neuromodulation of an Anti-Inflammatory Pathway at the Spleen Improves Experimental Pulmonary Hypertension.
Circ Res. 2024 May 7. doi: 10.1161/CIRCRESAHA.123.323679.
Abstract

ZHANG J, Li Y, Chen Y, Zhang J, et al
o(8)G Site-Specifically Modified tRF-1-AspGTC: A Novel Therapeutic Target and Biomarker for Pulmonary Hypertension.
Circ Res. 2024 May 15. doi: 10.1161/CIRCRESAHA.124.324421.
Abstract

ICHIMURA K, Boehm M, Andruska AM, Zhang F, et al
3D Imaging Reveals Complex Microvascular Remodeling in the Right Ventricle in Pulmonary Hypertension.
Circ Res. 2024 May 21. doi: 10.1161/CIRCRESAHA.123.323546.
Abstract

LI Y, Wei X, Xiao R, Chen Y, et al
SMYD2-Methylated PPARgamma Facilitates Hypoxia-Induced Pulmonary Hypertension by Activating Mitophagy.
Circ Res. 2024 May 21. doi: 10.1161/CIRCRESAHA.124.323698.
Abstract

RAFIKOVA O, James J, Kudryashova TV
EnFUSiasm for Healing: Ultrasound Neuromodulation in PAH.
Circ Res. 2024;135:57-59.
Abstract

KAZMIRCZAK F, Vogel NT, Prisco SZ, Patterson MT, et al
Ferroptosis Mediated Inflammation Promotes Pulmonary Hypertension.
Circ Res. 2024 Oct 18. doi: 10.1161/CIRCRESAHA.123.324138.
Abstract

PEI Y, Ren D, Yin Y, Shi J, et al
Endothelial FUNDC1 Deficiency Drives Pulmonary Hypertension.
Circ Res. 2024 Dec 10. doi: 10.1161/CIRCRESAHA.124.325156.
Abstract

BIAN JS, Chen J, Zhang J, Tan J, et al
ErbB3 Governs Endothelial Dysfunction in Hypoxia-Induced Pulmonary Hypertension.
Circulation. 2024 Jan 12. doi: 10.1161/CIRCULATIONAHA.123.067005.
Abstract

LUO Y, Qi X, Zhang Z, Zhang J, et al
Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension.
Circulation. 2024 Feb 5. doi: 10.1161/CIRCULATIONAHA.123.067579.
Abstract

AGGARWAL V, Giri J, Visovatti SH, Mahmud E, et al
Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
Circulation. 2024 Mar 7. doi: 10.1161/CIR.0000000000001197.
Abstract

SHEN H, Gao Y, Ge D, Tan M, et al
BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension.
Circulation. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.123.066430.
Abstract

RAO RJ, Chan SY
Mediating Metabolism: Inhibition of Malic Enzyme 1 (ME1) Restores Endothelial Bioenergetics and Adenosine Signaling in Pulmonary Hypertension.
Circulation. 2024;149:1372-1374.
Abstract

RUBIN LJ
Is There a Role for Calcium Channel Blockers in the Contemporary Treatment Paradigm for Pulmonary Arterial Hypertension?
Circulation. 2024;149:1565-1567.
Abstract

GERHARDT F, Fiessler E, Olsson KM, Kayser MZ, et al
Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.
Circulation. 2024 Apr 12. doi: 10.1161/CIRCULATIONAHA.122.063821.
Abstract

SALAHUDDIN A, Harris IS, Sabanayagam A
Double Whammy Complicating Management of Pulmonary Hypertension.
Circulation. 2024;149:1770-1774.
Abstract

JHENG JR, Bai Y, Noda K, Huot JR, et al
Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.
Circulation. 2024 May 28. doi: 10.1161/CIRCULATIONAHA.124.068624.
Abstract

ZHANG Q, Yaoita N, Tabuchi A, Liu S, et al
Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension.
Circulation. 2024 Jun 14. doi: 10.1161/CIRCULATIONAHA.124.068726.
Abstract

Correction to: Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
Circulation. 2024;149:e1412.
Abstract

HOEPER MM, Ewert R, Jansa P, Sirenko Y, et al
Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension.
Circulation. 2024 May 16. doi: 10.1161/CIRCULATIONAHA.123.068107.
Abstract

HOEPER MM, Oerke B, Wissmuller M, Leuchte H, et al
Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study.
Circulation. 2024 Jun 28. doi: 10.1161/CIRCULATIONAHA.124.069340.
Abstract

TANG H, Gupta A, Morrisroe SA, Bao C, et al
Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension.
Circulation. 2024 May 2. doi: 10.1161/CIRCULATIONAHA.123.065304.
Abstract

LIU B, Yi D, Xia X, Ramirez K, et al
General Capillary Endothelial Cells Undergo Reprogramming Into Arterial Endothelial Cells in Pulmonary Hypertension Through HIF-2alpha/Notch4 Pathway.
Circulation. 2024;150:414-417.
Abstract

BORDAN Z, Batori R, Haigh S, Li X, et al
PDZ-Binding Kinase, a Novel Regulator of Vascular Remodeling in Pulmonary Arterial Hypertension.
Circulation. 2024 Apr 29. doi: 10.1161/CIRCULATIONAHA.123.067095.
Abstract

HONG J, Medzikovic L, Sun W, Wong B, et al
Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.
Circulation. 2024 Aug 21. doi: 10.1161/CIRCULATIONAHA.124.069864.
Abstract

DELCROIX M, Pepke-Zaba J, D'Armini AM, Fadel E, et al
Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy.
Circulation. 2024;150:1354-1365.
Abstract

MCLAUGHLIN VV, Humbert M
Pulmonary Hypertension: From Therapeutic Nihilism to Multiple Therapeutic Interventions.
Circulation. 2024;150:1653-1655.
Abstract

NASROLLAHIZADEH A, Soleimani H, Nasrollahizadeh A, Hashemi SM, et al
Navigating the Sotatercept landscape: A meta-analysis of clinical outcomes.
Clin Cardiol. 2024;47:e24173.
Abstract

HU X, Yuan P, Chen J, Wang S, et al
Impact of different sequential triple oral combination therapies based selexipag on outcomes in pulmonary arterial hypertension.
Clin Cardiol. 2024;47:e24245.
Abstract

FEI Q, Pan J, Zhang F, Lin Y, et al
Comparison of Different Treatments of Persistent Pulmonary Hypertension of the Newborn: A Systematic Review and Network Meta-Analysis.
Crit Care Med. 2024 Feb 16. doi: 10.1097/CCM.0000000000006227.
Abstract

FLOREZ ID, Parra-Rodas L
Persistent Pulmonary Hypertension of the Newborn: Should Sildenafil and Inhaled Nitric Oxide at Medium Concentration Be the Standard of Treatment?
Crit Care Med. 2024;52:995-997.
Abstract

ZEDER K, Douschan P, Foris V, Sassmann T, et al
The prognostic relevance of exercise pulmonary hypertension in cardiac and pulmonary diseases.
Curr Opin Pulm Med. 2024 Jul 4. doi: 10.1097/MCP.0000000000001096.
Abstract

SHARKEY MJ, Checkley EW, Swift AJ
Applications of artificial intelligence in computed tomography imaging for phenotyping pulmonary hypertension.
Curr Opin Pulm Med. 2024 Jul 10. doi: 10.1097/MCP.0000000000001103.
Abstract

KOVACS G, Zeder K
Current hot topics in pulmonary hypertension.
Curr Opin Pulm Med. 2024;30:419-420.
Abstract

TITZ A, Hoyos R, Ulrich S
Pulmonary vascular diseases at high altitude - is it safe to live in the mountains?
Curr Opin Pulm Med. 2024;30:459-463.
Abstract

BLANCO I, Torres-Castro R, Barbera JA
Pulmonary vascular disease in chronic lung diseases: cause or comorbidity?
Curr Opin Pulm Med. 2024;30:437-443.
Abstract

EICHSTAEDT CA, Haas SO, Shaukat M, Grunig E, et al
Genetic background of pulmonary (vascular) diseases - how much is written in the codes?
Curr Opin Pulm Med. 2024;30:429-436.
Abstract

DATE N, Nakajima D, Ikeda M, Nishikawa S, et al
Effect of epoprostenol-induced thrombocytopaenia on lung transplantation for pulmonary arterial hypertension.
Eur J Cardiothorac Surg. 2024 Mar 27:ezae108. doi: 10.1093.
Abstract

KRUSZONA S, Aburahma K, Wand P, de Manna ND, et al
Extracorporeal membrane oxygenation as bridge to transplant in severe pulmonary hypertension.
Eur J Cardiothorac Surg. 2024 Nov 29:ezae420. doi: 10.1093.
Abstract

TAMURA Y, Tamura Y, Shigeta A, Hosokawa K, et al
Adult-onset idiopathic peripheral pulmonary artery stenosis.
Eur Respir J. 2023;62:2300763.
Abstract

HAFNER F, Kindt A, Strobl K, Forster K, et al
MRI pulmonary artery flow detects lung vascular pathology in preterms with lung disease.
Eur Respir J. 2023 Sep 7:2202445. doi: 10.1183/13993003.02445-2022.
Abstract

PLUNKETT MJ, Sayegh ALC, McWilliams TJ, Sithamparanathan S, et al
The skeletal muscle metaboreflex: a novel driver of ventilation, dyspnoea and pulmonary haemodynamics during exercise in pulmonary arterial hypertension.
Eur Respir J. 2024;63:2300952.
Abstract

DURRINGTON C, Hurdman JA, Elliot CA, Maclean R, et al
Systematic pulmonary embolism follow-up increases diagnostic rates of chronic thromboembolic pulmonary hypertension and identifies less severe disease: results from the ASPIRE Registry.
Eur Respir J. 2024 Feb 1:2300846. doi: 10.1183/13993003.00846-2023.
Abstract

GERGES C, Montani D, Humbert M, Lang IM, et al
Hemodynamic phenotypes of pulmonary hypertension associated with left heart disease: a moving target.
Eur Respir J. 2024 Feb 15:2302280. doi: 10.1183/13993003.02280-2023.
Abstract

MULLER J, Titz A, Schneider SR, Bauer M, et al
The effect of high altitude (2500 m) on incremental cycling exercise in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a randomised controlled cross-over trial.
Eur Respir J. 2024 Feb 29:2301001. doi: 10.1183/13993003.01001-2023.
Abstract

NAEIJE R
High altitude travelling with pulmonary arterial hypertension.
Eur Respir J. 2024;63:2400111.
Abstract

HOWARD LS, Price LC
Systematic pulmonary embolism follow-up: why we should all do it!
Eur Respir J. 2024;63:2400253.
Abstract

AGARWAL S, Fineman J, Cornfield DN, Alvira CM, et al
VIEWING PULMONARY HYPERTENSION THROUGH A PEDIATRIC LENS.
Eur Respir J. 2024 Apr 4:2301518. doi: 10.1183/13993003.01518-2023.
Abstract

GRYNBLAT J, Bogaard HJ, Eyries M, Meyrignac O, et al
Pulmonary vascular phenotype identified in patients with GDF2 (BMP9) or BMP10 variants: an international multicentre study.
Eur Respir J. 2024;63:2301634.
Abstract

WOOLF B, Perry JA, Hong CC, Wilkins MR, et al
Multi-biobank summary data Mendelian randomisation does not support a causal effect of IL-6 signalling on risk of pulmonary arterial hypertension.
Eur Respir J. 2024;63:2302031.
Abstract

SANGES S, Tian W, Dubucquoi S, Chang JL, et al
B-cells in pulmonary arterial hypertension: friend, foe or bystander?
Eur Respir J. 2024;63:2301949.
Abstract

GRYNBLAT J, Khouri C, Hlavaty A, Jais X, et al
Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors.
Eur Respir J. 2024 May 2:2302158. doi: 10.1183/13993003.02158-2023.
Abstract

MA JL, Wang AY, Lu D, Cheng CY, et al
The puzzles surrounding the impact of face masks on 6-minute walking distance in pulmonary hypertension.
Eur Respir J. 2024;63:2301879.
Abstract

WISSMULLER M, Wartner V, Hohmann C, Adler J, et al
Reply to: The puzzles surrounding the impact of face masks on 6-minute walking distance in pulmonary hypertension.
Eur Respir J. 2024;63:2400529.
Abstract

CAMPEDELLI L, Nouraie SM, Risbano MG
Non-arterial line cardiac output calculation misclassifies exercise pulmonary hypertension and increases risk of data loss particularly in black, Scleroderma, and Raynaud's patients during invasive exercise testing.
Eur Respir J. 2024 May 23:2302232. doi: 10.1183/13993003.02232-2023.
Abstract

NATHAN SD, Argula R, Trivieri MG, Aziz S, et al
Inhaled Treprostinil in Pulmonary Hypertension Associated with COPD: PERFECT study results.
Eur Respir J. 2024 May 29:2400172. doi: 10.1183/13993003.00172-2024.
Abstract

VALDEOLMILLOS E, Foray C, Albenque G, Batteux C, et al
Percutaneous atrial septal defect closure in patients with pulmonary arterial hypertension.
Eur Respir J. 2024;63:2301649.
Abstract

KOVACS G, Humbert M
Primum non nocere, secundum cavere, tertium sanare: lessons on the management of pulmonary hypertension associated with COPD.
Eur Respir J. 2024;63:2400765.
Abstract

THENAPPAN T
Impact of tricuspid regurgitation on right ventricular function and clinical outcomes in pulmonary arterial hypertension: food for thought.
Eur Respir J. 2024;63:2400797.
Abstract

YOSHIDA K, van Wezenbeek J, Wessels JN, de Man FS, et al
Tricuspid regurgitation in pulmonary arterial hypertension: a right ventricular volumetric and functional analysis.
Eur Respir J. 2024;63:2301696.
Abstract

LUIJTEN D, Valerio L, Boon GJAM, Barco S, et al
Optimisation of detecting chronic thromboembolic pulmonary hypertension in acute pulmonary embolism survivors: the InShape IV study.
Eur Respir J. 2024 Jun 27:2400544. doi: 10.1183/13993003.00544-2024.
Abstract

DUBROCK HM, Wagner TE, Carlson K, Carpenter CL, et al
An electrocardiogram-based AI algorithm for early detection of pulmonary hypertension.
Eur Respir J. 2024 Jun 27:2400192. doi: 10.1183/13993003.00192-2024.
Abstract

WEATHERALD J, Hemnes AR, Maron BA, Mielniczuk LM, et al
Phenotypes in Pulmonary Hypertension.
Eur Respir J. 2024 Jul 4:2301633. doi: 10.1183/13993003.01633-2023.
Abstract

BUDHRAM B, Zamanian RT, Weatherald J
Moving the needle on proteasome inhibitor-induced pulmonary arterial hypertension: a definite maybe.
Eur Respir J. 2024;63:2400946.
Abstract

PLUNKETT MJ, Sayegh ALC, McWilliams TJ, Sithamparanathan S, et al
The effects of peripheral chemoreflex suppression on ventilatory efficiency and exercise duration in pulmonary arterial hypertension.
Eur Respir J. 2024;64:2400307.
Abstract

OLSSON KM, Fuge J, Park DH, Kamp JC, et al
Right heart function during and after pregnancy in women with pulmonary arterial hypertension.
Eur Respir J. 2024;64:2400179.
Abstract

PATTERSON MT, Prins KW
An exercise in relaxation: right ventricular diastolic function predicts exercise capacity in pulmonary arterial hypertension.
Eur Respir J. 2024;64:2401142.
Abstract

CUBERO SALAZAR IM, Lancaster AC, Jani VP, Montovano MJ, et al
Poor cardiac output reserve in pulmonary arterial hypertension is associated with right ventricular stiffness and impaired interventricular dependence.
Eur Respir J. 2024;64:2400420.
Abstract

CASSADY SJ, Maron BA
Artificial intelligence meets pulmonary hypertension: early detection for a late-presenting disease.
Eur Respir J. 2024;64:2401138.
Abstract

VARGHESE NP, Austin ED, Galambos C, Mullen MP, et al
An Interdisciplinary Consensus Approach to Pulmonary Hypertension in Developmental Lung Disorders.
Eur Respir J. 2024 Aug 15:2400639. doi: 10.1183/13993003.00639-2024.
Abstract

ZEDER K, Avian A, Mak S, Giannakoulas G, et al
Pulmonary arterial wedge pressure in healthy subjects: a meta-analysis.
Eur Respir J. 2024;64:2400967.
Abstract

IVY D, Rosenzweig EB, Abman SH, Beghetti M, et al
Embracing the challenges of neonatal and paediatric pulmonary hypertension.
Eur Respir J. 2024 Aug 29:2401345. doi: 10.1183/13993003.01345-2024.
Abstract

AUSTIN ED, Aldred MA, Alotaibi M, Graf S, et al
Genetics and precision genomics approaches to pulmonary hypertension.
Eur Respir J. 2024 Aug 29:2401370. doi: 10.1183/13993003.01370-2024.
Abstract

FORD HJ, Brunetti C, Ferrari P, Meszaros G, et al
Exploring the patient perspective in pulmonary hypertension.
Eur Respir J. 2024 Aug 29:2401129. doi: 10.1183/13993003.01129-2024.
Abstract

MARON BA, Bortman G, De Marco T, Huston JH, et al
Pulmonary hypertension associated with left heart disease.
Eur Respir J. 2024 Aug 29:2401344. doi: 10.1183/13993003.01344-2024.
Abstract

PRESTON IR, Howard LS, Langleben D, Lichtblau M, et al
Management of pulmonary hypertension in special conditions.
Eur Respir J. 2024 Aug 29:2401180. doi: 10.1183/13993003.01180-2024.
Abstract

KOVACS G, Bartolome S, Denton CP, Gatzoulis MA, et al
Definition, classification and diagnosis of pulmonary hypertension.
Eur Respir J. 2024 Aug 29:2401324. doi: 10.1183/13993003.01324-2024.
Abstract

GUIGNABERT C, Aman J, Bonnet S, Dorfmuller P, et al
Pathology and pathobiology of pulmonary hypertension: current insights and future directions.
Eur Respir J. 2024 Aug 29:2401095. doi: 10.1183/13993003.01095-2024.
Abstract

SAVALE L, Benazzo A, Corris P, Keshavjee S, et al
Transplantation, bridging, and support technologies in pulmonary hypertension.
Eur Respir J. 2024 Aug 29:2401193. doi: 10.1183/13993003.01193-2024.
Abstract

HUMBERT M, Galie N, Rubin LJ, Simonneau G, et al
The Seventh World Symposium on Pulmonary Hypertension: our journey to Barcelona.
Eur Respir J. 2024 Aug 30:2401222. doi: 10.1183/13993003.01222-2024.
Abstract

SHLOBIN OA, Adir Y, Barbera JA, Cottin V, et al
Pulmonary hypertension associated with lung diseases.
Eur Respir J. 2024 Aug 29:2401200. doi: 10.1183/13993003.01200-2024.
Abstract

FARMAKIS IT, Konstantinides SV
COVID-19 changed the world - without changing CTEPH.
Eur Respir J. 2024;64:2401467.
Abstract

REDDY SA, Newman J, Leavy OC, Ghani H, et al
Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies.
Eur Respir J. 2024;64:2301742.
Abstract

SAHAY S, Benza RL
The evolution of the European risk stratification system for pulmonary arterial hypertension.
Eur Respir J. 2024;64:2400943.
Abstract

BOUCLY A, Beurnier A, Turquier S, Jevnikar M, et al
Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with pulmonary arterial hypertension.
Eur Respir J. 2024;64:2400197.
Abstract

KIM NH, Channick R, Delcroix M, Madani M, et al
Efficacy and safety of selexipag in patients with inoperable or persistent/recurrent CTEPH (SELECT randomised trial).
Eur Respir J. 2024;64:2400193.
Abstract

TOTH EN, Celant LR, Niglas M, Jansen S, et al
Deep phenotyping of unaffected carriers of pathogenic BMPR2 variants screened for pulmonary arterial hypertension.
Eur Respir J. 2024;64:2400442.
Abstract

PRICE LC, Lyon A, Boyd K
Reversible carfilzomib-induced pulmonary arterial hypertension: don't take your eyes off the ball!
Eur Respir J. 2024;64:2401087.
Abstract

DE BIE EMDD, Toshner M
What to do when pulmonary arterial hypertension screening suggests neither fish nor fowl? The DOLPHIN-GENESIS study.
Eur Respir J. 2024;64:2401369.
Abstract

ERJ Podcast October 2024: World Symposium on Pulmonary Hypertension.
Eur Respir J. 2024;64:24E6404.
Abstract

HEMNES AR, Celermajer DS, D'Alto M, Haddad F, et al
Pathophysiology of the right ventricle and its pulmonary vascular interaction.
Eur Respir J. 2024;64:2401321.
Abstract

RAJAGOPAL S, Bogaard HJ, Elbaz MSM, Freed BH, et al
Emerging multimodality imaging techniques for the pulmonary circulation.
Eur Respir J. 2024;64:2401128.
Abstract

CHIN KM, Gaine SP, Gerges C, Jing ZC, et al
Treatment algorithm for pulmonary arterial hypertension.
Eur Respir J. 2024;64:2401325.
Abstract

KIM NH, D'Armini AM, Delcroix M, Jais X, et al
Chronic thromboembolic pulmonary disease.
Eur Respir J. 2024;64:2401294.
Abstract

DARDI F, Boucly A, Benza R, Frantz R, et al
Risk stratification and treatment goals in pulmonary arterial hypertension.
Eur Respir J. 2024;64:2401323.
Abstract

WEATHERALD J, Fleming TR, Wilkins MR, Cascino TM, et al
Clinical trial design, end-points, and emerging therapies in pulmonary arterial hypertension.
Eur Respir J. 2024;64:2401205.
Abstract

DE JESUS PEREZ VA, Lai YC
TAZ and RUNX2 awareness in pulmonary hypertension due to left heart disease.
Eur Respir J. 2024;64:2400905.
Abstract

LIU SF, Kucherenko MM, Sang P, Li Q, et al
RUNX2 is stabilised by TAZ and drives pulmonary artery calcification and lung vascular remodelling in pulmonary hypertension due to left heart disease.
Eur Respir J. 2024;64:2300844.
Abstract

STOURM L, Grynblat J, Savale L, Lacoste-Palasset T, et al
Pulmonary hypertension in patients carrying FLNA loss-of-function variants.
Eur Respir J. 2024 Nov 7:2401132. doi: 10.1183/13993003.01132-2024.
Abstract

BALMAIN BN, Tomlinson AR, Goh JT, MacNamara JP, et al
Pulmonary gas exchange in relation to exercise pulmonary hypertension in patients with heart failure with preserved ejection fraction.
Eur Respir J. 2024 Nov 7:2400722. doi: 10.1183/13993003.00722-2024.
Abstract

HEUTS S, Kawczynski MJ, Leus A, Godinas L, et al
The volume-outcome relation for pulmonary endarterectomy in chronic thrombo-embolic pulmonary hypertension.
Eur Respir J. 2024 Nov 21:2401865. doi: 10.1183/13993003.01865-2024.
Abstract

"Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies." S.A. Reddy, J. Newman, O.C. Leavy, et al. Eur Respir J 2024; 64: 2301742.
Eur Respir J. 2024;64:2351742.
Abstract

HUMBERT M, Hassoun PM, Chin KM, Bortman G, et al
MK-5475, an inhaled soluble guanylate cyclase stimulator, for treatment of pulmonary arterial hypertension: the INSIGNIA-PAH study.
Eur Respir J. 2024;64:2401110.
Abstract

KOVACS G, Humbert M, Avian A, Lewis GD, et al
Prognostic relevance of Exercise Pulmonary Hypertension: Results of the multi-center PEX-NET Clinical Research Collaboration.
Eur Respir J. 2024 Nov 27:2400698. doi: 10.1183/13993003.00698-2024.
Abstract

"Targeting transforming growth factor-beta receptors in pulmonary hypertension." Christophe Guignabert and Marc Humbert. Eur Respir J 2021; 57: 2002341.
Eur Respir J. 2024;64:2052341.
Abstract

HIRATA Y, Tsuji T, Kotoku J, Sata M, et al
Echocardiographic artificial intelligence for pulmonary hypertension classification.
Heart. 2024 Jan 30:heartjnl-2023-323320. doi: 10.1136/heartjnl-2023-323320.
Abstract

CRISAN S, Baghina RM, Luca SA, Cozlac AR, et al
Comprehensive imaging in patients with suspected pulmonary arterial hypertension.
Heart. 2023 Jul 18:heartjnl-2022-322182. doi: 10.1136/heartjnl-2022-322182.
Abstract

SINGH N, Mehta S
Artificial intelligence to improve the diagnosis of pulmonary hypertension: promises and pitfalls.
Heart. 2024 Feb 15:heartjnl-2023-323693. doi: 10.1136/heartjnl-2023-323693.
Abstract

LUNA-LOPEZ R, Segura de la Cal T, Sarnago Cebada F, Martin de Miguel I, et al
Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease.
Heart. 2024;110:346-352.
Abstract

D'ALTO M, Bassareo PP
Raising the bar: triple therapy for pulmonary arterial hypertension associated with congenital heart disease.
Heart. 2024;110:309-310.
Abstract

UBBEN T, Frerker C, Fujita B, Rosenkranz S, et al
Association of pulmonary hypertension with the outcome in patients undergoing edge-to-edge mitral valve repair.
Heart. 2024 Feb 22:heartjnl-2023-323473. doi: 10.1136/heartjnl-2023-323473.
Abstract

KOSMIDIS D, Arvanitaki A, Farmakis IT, Liakos A, et al
Pulmonary vasodilators and exercise in Fontan circulation: a systematic review and meta-analysis.
Heart. 2024;110:552-559.
Abstract

GERGES C, Matsubara H, Lang I
Low diffusing capacity for carbon monoxide in chronic thromboembolic pulmonary hypertension: a biomarker for microvascular disease?
Heart. 2024 Jul 31:heartjnl-2024-324237. doi: 10.1136/heartjnl-2024-324237.
Abstract

MINATSUKI S, Hatano M, Hirose K, Saito A, et al
Differential effects of balloon pulmonary angioplasty on chronic thromboembolic pulmonary disease.
Heart. 2024 Jul 31:heartjnl-2024-323883. doi: 10.1136/heartjnl-2024-323883.
Abstract

FERRERO P, Krishnathasan K, Constantine A, Chessa M, et al
Pulmonary arterial hypertension in congenital heart disease.
Heart. 2024;110:1145-1152.
Abstract

RAVNESTAD H, Murbraech K, Gjonnaess E, Andersen R, et al
Right ventricular remodelling and long-term survival after pulmonary endarterectomy versus balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
Heart. 2024 Oct 28:heartjnl-2024-324243. doi: 10.1136/heartjnl-2024-324243.
Abstract

KEMPTON H, Kearney K
Right ventricle's road to recovery: remodelling after chronic thromboembolic pulmonary hypertension intervention.
Heart. 2024 Dec 3:heartjnl-2024-325167. doi: 10.1136/heartjnl-2024-325167.
Abstract

DANGI S, Thakur A, Kler N, Joshi R, et al
Extracorporeal Membrane Oxygenation with Bi-Caval Dual-Lumen Catheter in a Neonate with Persistent Pulmonary Hypertension and Interventricular Septal Hypertrophy.
Indian J Pediatr. 2024 Oct 23. doi: 10.1007/s12098-024-05299.
Abstract

WESSELS JN, Bogaard HJ
Double Down on Single-Tablet Combination Therapy in Pulmonary Arterial Hypertension: Possible Benefits for Selected Patients.
J Am Coll Cardiol. 2024;83:485-487.
Abstract

GRUNIG E, Jansa P, Fan F, Hauser JA, et al
Randomized Trial of Macitentan/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension.
J Am Coll Cardiol. 2024;83:473-484.
Abstract

LOWERY MM, Hill NS, Wang L, Rosenzweig EB, et al
Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension.
J Am Coll Cardiol. 2023;82:1989-2005.
Abstract

LOWERY MM, Hill NS, Wang L, Mehra R, et al
Reply: Probing Sleep-Related Hypoxia's Impact on RV Dysfunction and PAH Survival: Uncertainties Clarified?
J Am Coll Cardiol. 2024;83:e109.
Abstract

HUANG Z, Duan A, Luo Q, Liu Z, et al
Probing Sleep-Related Hypoxia's Impact on RV Dysfunction and PAH Survival: Uncertainties Clarified?
J Am Coll Cardiol. 2024;83:e107.
Abstract

BEKHUIS Y, Verwerft J, Claessen G
Exercise Echocardiography for mPAP/CO Slope Estimation: A New Standard for Routine Clinical Care?
J Am Coll Cardiol. 2024;83:e141-e142.
Abstract

FARBER HW, Schoenberg NC
Fucosylation: The Prognostic Impact of Sugar in Pulmonary Arterial Hypertension.
J Am Coll Cardiol. 2024;84:1104-1106.
Abstract

ZHANG ZJ, Liu C, Ma JL, Ma JS, et al
Prognostic Value of Plasma Immunoglobulin G N-Glycome Traits in Pulmonary Arterial Hypertension.
J Am Coll Cardiol. 2024;84:1092-1103.
Abstract

REDDY YNV, Frantz RP, Hassoun PM, Hemnes AR, et al
Clinical Implications of Pretest Probability of HFpEF on Outcomes in Precapillary Pulmonary Hypertension.
J Am Coll Cardiol. 2024 Oct 15:S0735-1097(24)08392.
Abstract

LANDSTEINER I, Ramesh A, Yang BQ, Lewis GD, et al
Hemodynamic Insights From Provocative Testing in Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction.
J Am Coll Cardiol. 2024 Oct 16:S0735-1097(24)09806.
Abstract

BRUCE MR, Frasco PE, Sell-Dottin KA, Cuevas CV, et al
Days Alive and Out of the Hospital After Heart Transplantation: A Retrospective Cohort Study.
J Cardiothorac Vasc Anesth. 2024;38:93-100.
Abstract

JHA AK, Rajkumar S, Parida S
Pulmonary Vascular Resistance-Pulmonary Artery Compliance Relationship and Time Constant in Pulmonary Hypertension Due to Valvular Heart Disease.
J Cardiothorac Vasc Anesth. 2024 Feb 1:S1053-0770(24)00091.
Abstract

YENIDOGANAY R, Rancati V, Yerly P, Lu H, et al
Atrial Flow Regulator: Should We Be Afraid of It?
J Cardiothorac Vasc Anesth. 2024;38:1284-1286.
Abstract

CORMICAN DS, Bhargava M, Drennen Z
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: An Emerging Therapy for a Complex Condition.
J Cardiothorac Vasc Anesth. 2024 May 25:S1053-0770(24)00364.
Abstract

SUAREZ-SIPMANN F, Sanchez Giralt JA, Magana Bru I, Perez Lucendo A, et al
Synergistic Effects of Lung Recruitment and Positive End-expiratory Pressure Titration Guided by Electrical Impedance Tomography and Inhaled Nitric Oxide in Severe Postoperative Pulmonary Hypertension.
J Cardiothorac Vasc Anesth. 2024 May 6:S1053-0770(24)00317.
Abstract

MORENO-DUARTE I, Parikh RB, Paquin J, Steppan J, et al
Selected 2023 Highlights in Congenital Cardiac Anesthesia.
J Cardiothorac Vasc Anesth. 2024 Mar 28:S1053-0770(24)00225.
Abstract

CARACCI B, Pehora C, Benson L, Steinberg BE, et al
Circulating High Mobility Group Box-1 Does Not Predict Pulmonary Arterial Hypertension in Children with Congenital Heart Disease: A Prospective Cohort Study.
J Cardiothorac Vasc Anesth. 2024;38:2356-2361.
Abstract

STEIN ML, O'Brien Charles AO, Staffa SJ, Zhang K, et al
Correlation of Transthoracic Echocardiographic Estimates of Right Ventricular Pressure with Right Ventricular Pressure Measurements on Cardiac Catheterization in Children with Pulmonary Hypertension.
J Cardiothorac Vasc Anesth. 2024 Sep 19:S1053-0770(24)00611.
Abstract

MODESTINI M, Massari D, Huisman S, Struys MMRF, et al
Impact of Persistent Pulmonary Hypertension of the Newborn in Neonates with Dextro-transposition of the Great Arteries.
J Cardiothorac Vasc Anesth. 2024 Sep 26:S1053-0770(24)00776.
Abstract

ATEFIPOUR N, Dianat M, Badavi M, Radan M, et al
The Role of Rosmarinic Acid in the Protection against Inflammatory Factors in Rats Model with Monocrotaline-Induced Pulmonary Hypertension: Investigating the Signaling Pathway of NFkappaB, OPG, Runx2, and P-selectin in Heart.
J Cardiovasc Pharmacol. 2023 Dec 26. doi: 10.1097/FJC.0000000000001534.
Abstract

LI J, He X, Liu F, Zheng X, et al
Tumor Necrosis Factor-alpha-Induced Protein-8-like 2 Transfected Adipose-Derived Stem Cells Regulated the Dysfunction of Monocrotaline Pyrrole-Induced Pulmonary Arterial Smooth Muscle Cells and Pulmonary Arterial Endothelial Cells.
J Cardiovasc Pharmacol. 2024;83:73-85.
Abstract

CONZATTI A, Colombo R, Siqueira R, Campos-Carraro C, et al
Sulforaphane improves redox homeostasis and right ventricular contractility in a model of pulmonary hypertension.
J Cardiovasc Pharmacol. 2024 Mar 14. doi: 10.1097/FJC.0000000000001557.
Abstract

KUMARI K, Vishwakarma VK, Kumar K, Mridha AR, et al
Effect of benidipine alone and in combination with bosentan and sildenafil in amelioration of pulmonary arterial hypertension in experimental model in rats.
J Cardiovasc Pharmacol. 2024 Jan 17. doi: 10.1097/FJC.0000000000001541.
Abstract

LUZ DE CASTRO A, Ortiz VD, Hickmann AR, Lacerda DS, et al
EFFECTS OF PTEROSTILBENE ON HEART AND LUNG OXIDATIVE STRESS PARAMETERS IN TWO EXPERIMENTAL MODELS OF CARDIOVASCULAR DISEASE: MYOCARDIAL INFARCTION AND PULMONARY ARTERIAL HYPERTENSION.
J Cardiovasc Pharmacol. 2024 May 4. doi: 10.1097/FJC.0000000000001572.
Abstract

DENG J, Yang G, Zhong N, Liang L, et al
Upregulation of Angiomotin-like 2 ameliorates experimental pulmonary arterial hypertension by inactivating YAP1 signaling.
J Cardiovasc Pharmacol. 2024 Jul 2. doi: 10.1097/FJC.0000000000001606.
Abstract

JANOWSKI AM, Ravellette KS, Insel M, Garcia JG, et al
Advanced Hemodynamic and Cluster Analysis for Identifying Novel RV function subphenotypes in Patients with Pulmonary Hypertension.
J Heart Lung Transplant. 2023 Dec 21:S1053-2498(23)02178.
Abstract

CRUZ-UTRILLA A, Lopez-Gude MJ, Velazquez M, Ynsaurriaga FA, et al
Comment on the article titled "Impact of sex on outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension" published by J. Chan et al.
J Heart Lung Transplant. 2023 Dec 21:S1053-2498(23)02177.
Abstract

PARIKH R, Farber HW
Response to "Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD" by Nathan et al.
J Heart Lung Transplant. 2023 Dec 27:S1053-2498(23)02199.
Abstract

GHIO S, Corsico A, Rapagnani A, Borrelli E, et al
Does pulmonary endarterectomy improve the clinical conditions of patients with chronic thromboembolic pulmonary disease without pulmonary hypertension?
J Heart Lung Transplant. 2024 Jan 4:S1053-2498(23)02203.
Abstract

MCLAUGHLIN V, Farber HW, Highland KB, Hemnes AR, et al
Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry).
J Heart Lung Transplant. 2024;43:272-283.
Abstract

CHIA AXF, Valchanov K, Ng C, Tsui S, et al
Perioperative extracorporeal membrane oxygenation support for pulmonary endarterectomy: A 17-year experience from the UK national cohort.
J Heart Lung Transplant. 2024;43:241-250.
Abstract

DESJARDIN JT, Kime N, Kolaitis NA, Kronmal RA, et al
Investigating the "sex paradox" in pulmonary arterial hypertension: results from the Pulmonary Hypertension Association Registry (PHAR).
J Heart Lung Transplant. 2024 Feb 13:S1053-2498(24)00044.
Abstract

ZEDER K, Marsh LM, Avian A, Brcic L, et al
Compartment-specific remodeling patterns in end-stage chronic obstructive pulmonary disease with and without severe pulmonary hypertension.
J Heart Lung Transplant. 2024 Feb 19:S1053-2498(24)01087.
Abstract

RAKO ZA, Yogeswaran A, Yildiz S, Weidemann P, et al
Liver stiffness is associated with right heart dysfunction, cardiohepatic syndrome, and prognosis in pulmonary hypertension.
J Heart Lung Transplant. 2024 Feb 17:S1053-2498(24)00056.
Abstract

BUNCLARK K, Toshner M
Anthropometrics are important to consider in purported sex differences in CTEPH outcomes.
J Heart Lung Transplant. 2024;43:688.
Abstract

BARBERA JA, Peinado VI, Blanco I
UNTANGLING SEVERE PULMONARY HYPERTENSION IN COPD.
J Heart Lung Transplant. 2024 Mar 22:S1053-2498(24)01538.
Abstract

WATABE K, Goda A, Tobita K, Yokoyama S, et al
Determinants of physical quality of life in patients with chronic thromboembolic pulmonary hypertension after treatment: Insights from invasive exercise stress test.
J Heart Lung Transplant. 2024 Apr 16:S1053-2498(24)01562.
Abstract

KANEZAWA M, Shimokawahara H, Ejiri K, Goten C, et al
Effects of medical therapy and age on cardiac output changes following balloon pulmonary angioplasty: Implications for combination therapy in chronic thromboembolic pulmonary hypertension.
J Heart Lung Transplant. 2024 May 15:S1053-2498(24)01661.
Abstract

GUREVICH S, Prins K
Balloon Pulmonary Angioplasty: New Quite the Fountain of Youth in Chronic Thromboembolic Pulmonary Hypertension.
J Heart Lung Transplant. 2024 Jul 5:S1053-2498(24)01729.
Abstract

GIALAMAS I, Arvanitaki A, Rosenkranz S, Wort SJ, et al
The impact of cardiovascular and lung comorbidities in patients with pulmonary arterial hypertension: A systematic review and meta-analysis.
J Heart Lung Transplant. 2024;43:1383-1394.
Abstract

CHIU S, Bunclark K, Appenzeller P, Ghani H, et al
Impact of Preoperative Body Mass Index on Long-term Survival, Quality of Life, and Functional Outcomes after Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension: Results from the UK National Cohort.
J Heart Lung Transplant. 2024 Sep 10:S1053-2498(24)01835.
Abstract

SIMPSON CE
The evolving epidemiology of systemic sclerosis-associated pulmonary hypertension.
J Heart Lung Transplant. 2024;43:1640-1641.
Abstract

SMITH H, Thompson AAR, Akil M, Alabed S, et al
The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registry.
J Heart Lung Transplant. 2024;43:1629-1639.
Abstract

GHIO S, Badagliacca R, D'Alto M, Scelsi L, et al
Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension.
J Heart Lung Transplant. 2024;43:1668-1676.
Abstract

BENZA RL, Simonneau G, Ghofrani HA, Corris PA, et al
Application of REVEAL Lite 2 and COMPERA 2.0 risk scores to patients with pulmonary arterial hypertension switching to riociguat in the REPLACE study.
J Heart Lung Transplant. 2024;43:1756-1760.
Abstract

BRITO DA ROCHA BR, Yogeswaran A, Lakatos BK, Fabian A, et al
Loss of Right Ventricular Outflow Function in Pulmonary Hypertension.
J Heart Lung Transplant. 2024 Oct 9:S1053-2498(24)01881.
Abstract

NAKAMURA J, Tsujino I, Masaki K, Hosokawa K, et al
Cancer as an Independent Mortality Risk in Chronic Thromboembolic Pulmonary Hypertension.
J Heart Lung Transplant. 2024 Oct 30:S1053-2498(24)01910.
Abstract

NATHAN SD, Kim HC, Chandel A
Response to: Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD.
J Heart Lung Transplant. 2024;43:2045.
Abstract

ZISMAN DA
Comment on: Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD.
J Heart Lung Transplant. 2024;43:2044.
Abstract

BENZA RL, Chin KM, Gaine S, Galie N, et al
Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON study.
J Heart Lung Transplant. 2024;43:1998-2007.
Abstract

GERGES C, Lang IM
Chronic Thromboembolic Pulmonary Hypertension and Cancer: a true relationship, but one likely beyond coagulation.
J Heart Lung Transplant. 2024 Nov 23:S1053-2498(24)01968.
Abstract

CASCINO TM, Sahay S, Moles VM, McLaughlin VV, et al
A new day has come: Sotatercept for the treatment of pulmonary arterial hypertension.
J Heart Lung Transplant. 2025;44:1-10.
Abstract

HICKS TD, Cameron J, Wang S, Ashrafi A, et al
Assessing the role of tracheostomy placement in bronchopulmonary dysplasia with pulmonary hypertension.
J Perinatol. 2024 Feb 5. doi: 10.1038/s41372-024-01881.
Abstract

MORONTA SC, Bischoff AR, Ryckman KK, Dagle JM, et al
Clinical and echocardiography predictors of response to first-line acetaminophen treatment in preterm infants with hemodynamically significant patent ductus arteriosus.
J Perinatol. 2024 Jan 31. doi: 10.1038/s41372-024-01883.
Abstract

CERVERA SB, Saeed S, Luu TM, Gorgos A, et al
Evaluation of the association between patent ductus arteriosus approach and neurodevelopment in extremely preterm infants.
J Perinatol. 2024 Jan 26. doi: 10.1038/s41372-024-01877.
Abstract

SANTELICES F, Masoli D, Kattan J, Toso A, et al
Vasopressin as adjunctive therapy in pulmonary hypertension associated with refractory systemic hypotension in term newborns.
J Perinatol. 2024 Jul 4. doi: 10.1038/s41372-024-02015.
Abstract

HAYASHI H, Ning Y, Kurlansky P, Vaynrub A, et al
Characteristics and prognostic significance of right heart remodeling and tricuspid regurgitation after pulmonary endarterectomy.
J Thorac Cardiovasc Surg. 2022 Apr 8. pii: S0022-5223(22)00391.
Abstract

ALNSASRA H, Perue RK, Khalil F, Regev O, et al
Reversibility of Precapillary Pulmonary Hypertension and Outcomes After Heart Transplantation Bridged with Left Ventricular Assist Devices: Insight from the UNOS.
J Thorac Cardiovasc Surg. 2024 Mar 5:S0022-5223(24)00188.
Abstract

NAWAYTOU H, Lakkaraju R, Stevens L, Reddy VM, et al
Management of pulmonary vascular disease associated with congenital left-to-right shunts: A single-center experience.
J Thorac Cardiovasc Surg. 2025;169:231-241.
Abstract

BOUCHET C, Guibert C, Freund-Michel V
[Nerve growth factor (NGF) in pulmonary hypertension (PH)].
Rev Mal Respir. 2024 Mar 8:S0761-8425(24)00137-2. doi: 10.1016/j.rmr.2024.
Abstract

PICCARI L, Wort SJ
Use of inhaled treprostinil in patients with interstitial lung disease and pulmonary hypertension: to boldly go where no other pulmonary vasodilator has gone before?
Thorax. 2024 Feb 2:thorax-2023-221167. doi: 10.1136/thorax-2023-221167.
Abstract

NATHAN SD, Johri S, Joly JM, King CS, et al
Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality.
Thorax. 2024;79:301-306.
Abstract

GONG S, Li H, Wang L
Pulmonary artery-pulmonary artery collaterals in chronic thromboembolic pulmonary hypertension.
Thorax. 2024 Apr 10:thorax-2023-221219. doi: 10.1136/thorax-2023-221219.
Abstract

CASSADY SJ, Maron BA
Mildly elevated pulmonary vascular resistance and worsened survival in PH-ILD: an opportunity for earlier diagnosis and intervention?
Thorax. 2024;79:387-388.
Abstract

SATO T, Furukawa T, Teramachi R, Fukihara J, et al
Mild elevation of pulmonary vascular resistance predicts mortality regardless of mean pulmonary artery pressure in mild interstitial lung disease.
Thorax. 2024;79:422-429.
Abstract

AGAOGLU ES, Semple T, Wells AU, Wort S, et al
Unilateral pleural effusion with pulmonary hypertension in sarcoidosis: do not forget the pulmonary veins!
Thorax. 2024 Apr 29:thorax-2023-220058. doi: 10.1136/thorax-2023-220058.
Abstract

MIARD C, de Montpreville VT, Bernaudin JF, Adam J, et al
Platelet aggregates in lung capillaries in severely decompensated pulmonary hypertension.
Thorax. 2024 Oct 7:thorax-2024-222034. doi: 10.1136/thorax-2024-222034.
Abstract

STACEL T, Kegler K, Medrala A, Sybila P, et al
Lung Transplantation in Patients With Pulmonary Hypertension With Extracorporeal Membrane Oxygenation (ECMO) Support: 5-Year Experience.
Transplant Proc. 2024 Apr 4:S0041-1345(24)00170.
Abstract

PAWLAK S, Sliwka J, Kwiatkowska J, Wierzyk A, et al
Pediatric Heart Transplantation in the Context of Severe Pulmonary Hypertension Secondary to Restrictive Cardiomyopathy-Case Report.
Transplant Proc. 2024 Apr 19:S0041-1345(24)00194.
Abstract

STACEL T, Sybila P, Medrala A, Ochman M, et al
Lung Transplantation in Patients With Systemic Scleroderma-Description of the First Consecutive Cases in Poland: Case Series Report and a Short Literature Review.
Transplant Proc. 2024 May 2:S0041-1345(24)00243.
Abstract

MATIAS MV, Cruz Z, Figueiredo C, Moita C, et al
Lung Transplantation in Pulmonary Arterial Hypertension: The Portuguese Experience.
Transplant Proc. 2024 Feb 28:S0041-1345(24)00013.
Abstract

SONNICK MA, Laothamatas K, Furfaro D, D'Ovidio F, et al
The Secondary Pulmonary Hypertension Diagnosis is Not Useful in Lung Allocation.
Transplant Proc. 2024 Sep 4:S0041-1345(24)00454.
Abstract

STEIERT D, Wittig C, Banerjee P, Preissner R, et al
An exploration into CTEPH medications: Combining natural language processing, embedding learning, in vitro models, and real-world evidence for drug repurposing.
PLoS Comput Biol. 2024;20:e1012417.
Abstract

SAKARIN S, Rungsipipat A, Roytrakul S, Jaresitthikunchai J, et al
Proteomic analysis of pulmonary arteries and lung tissues from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease.
PLoS One. 2024;19:e0296068.
Abstract

LIU H, Pan Z, Wu X, Gong C, et al
Jagged 2 inhibition attenuates hypoxia-induced mitochondrial damage and pulmonary hypertension through Sirtuin 1 signaling.
PLoS One. 2024;19:e0297525.
Abstract

ZHAN S, Wang L, Wang W, Li R, et al
Analysis of genes characterizing chronic thrombosis and associated pathways in chronic thromboembolic pulmonary hypertension.
PLoS One. 2024;19:e0299912.
Abstract

YONEDA K, Seki T, Kawazoe Y, Ohe K, et al
Immediate postnatal prediction of death or bronchopulmonary dysplasia among very preterm and very low birth weight infants based on gradient boosting decision trees algorithm: A nationwide database study in Japan.
PLoS One. 2024;19:e0300817.
Abstract

MATSUNAGA T, Kono A, Nishio M, Yoshii T, et al
Development and web deployment of prediction model for pulmonary arterial pressure in chronic thromboembolic pulmonary hypertension using machine learning.
PLoS One. 2024;19:e0300716.
Abstract

TURQUIER S, Huot L, Lamkhioued M, Subtil F, et al
Bioreactance assessment of cardiac output lacks reliability for the follow-up of patients with pulmonary hypertension.
PLoS One. 2024;19:e0298727.
Abstract

KRONBERGER C, Willixhofer R, Mousavi RA, Grzeda MT, et al
The one-minute sit-to-stand-test performance is associated with health-related quality of life in patients with pulmonary hypertension.
PLoS One. 2024;19:e0301483.
Abstract

SHEN T, Ma J, Zhang L, Yu X, et al
Correction: Positive Feedback-Loop of Telomerase Reverse Transcriptase and 15-Lipoxygenase-2 Promotes Pulmonary Hypertension.
PLoS One. 2024;19:e0308871.
Abstract

YAMAJI K, Sasaki KI, Nakano M, Yoshiga T, et al
Catheter-based examination for pulmonary microcirculatory function in patients with pulmonary hypertension.
PLoS One. 2024;19:e0312609.
Abstract

VASQUEZ MA, Vasquez SJ, Vargas N, Guilliod C, et al
In-hospital outcomes of cardiac tamponade in patients with pulmonary hypertension: A contemporary analysis.
PLoS One. 2024;19:e0312245.
Abstract

AULAK KS, Mavarakis L, Tian L, Paul D, et al
Characteristic disease defects in circulating endothelial cells isolated from patients with pulmonary arterial hypertension.
PLoS One. 2024;19:e0312535.
Abstract

ISHIBASHI T, Inagaki T, Okazawa M, Yamagishi A, et al
IL-6/gp130 signaling in CD4(+) T cells drives the pathogenesis of pulmonary hypertension.
Proc Natl Acad Sci U S A. 2024;121:e2315123121.
Abstract

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.

;